Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC6A,C-type lectin domain family 6 member A,36225,-0.140824295719787,0.0307923292859593,-0.201177261120267,-0.0804713303193067,4.88193985885522e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF15,Growth/differentiation factor 15,36446,-0.112982225060053,0.0288377330303262,-0.169504181799492,-0.0564602683206132,9.01590571948786e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,35248,-0.0967511239677202,0.025432054174735,-0.146597950150201,-0.0469042977852396,0.000143607631484079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG3,Proteasome assembly chaperone 3,36352,-0.127013769476204,0.0338413342033666,-0.193342784514803,-0.0606847544376055,0.000175963261039071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RA,Interleukin-2 receptor subunit alpha,36301,-0.100912352511023,0.0269450862427392,-0.153724721546792,-0.0480999834752546,0.000181739205509481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AREG,Amphiregulin,36331,-0.0993662930628483,0.0267865437095108,-0.151867918733489,-0.0468646673922072,0.000209196475954416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP3,Lysosome-associated membrane glycoprotein 3,36433,-0.121964068916986,0.0330964317501143,-0.186833075147211,-0.0570950626867624,0.000230271320675815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACYP1,Acylphosphatase-1,35289,-0.146528590900544,0.0417211939337805,-0.228302131010754,-0.0647550507903338,0.000447818337510993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL19,Interleukin-19,36183,-0.166671764210755,0.0475306180675186,-0.259831775623092,-0.073511752798419,0.000456688507271907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGLAP,Osteocalcin,35438,-0.198858727908937,0.0571301050793801,-0.310833733864522,-0.0868837219533519,0.000503329042298159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALLD,Palladin,35239,0.0891623018628565,0.0258431645798773,0.0385096992862971,0.139814904439416,0.000564144364405378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG4A,Cysteine protease ATG4A,36225,-0.130930605810566,0.0385533426247441,-0.206495157355065,-0.0553660542660675,0.000687345985194779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AARSD1,Alanyl-tRNA editing protein Aarsd1,36331,-0.122945617680678,0.036232784568542,-0.193961875435021,-0.051929359926336,0.000694532061773695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CARHSP1,Calcium-regulated heat-stable protein 1,36191,-0.110914628185429,0.0339362396002111,-0.177429657801843,-0.0443995985690149,0.00108708664058987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",35281,-0.13938474104793,0.0432983613381016,-0.224249529270609,-0.0545199528252509,0.001292373433638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53I3,Quinone oxidoreductase PIG3,35171,-0.107982167326364,0.0337265120308962,-0.17408613090692,-0.0418782037458072,0.00137334885920431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF3,Trefoil factor 3,36368,-0.0855321833255668,0.0267271086702114,-0.137917316319181,-0.0331470503319524,0.0013792876720057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPCAM,Epithelial cell adhesion molecule,36364,0.201620074695062,0.0632375080791064,0.0776745588600136,0.325565590530111,0.00143727671930812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK2A1,Casein kinase II subunit alpha,35417,-0.0890178924203088,0.0282141483210552,-0.144317623129577,-0.0337181617110406,0.00161218821775883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPC2,NPC intracellular cholesterol transporter 2,35321,-0.0663142233272743,0.0212142563018035,-0.107894165678809,-0.0247342809757395,0.00178074470018581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,36249,-0.0539890097598365,0.0177310822499973,-0.0887419309698312,-0.0192360885498417,0.00233632085278749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAN,Brevican core protein,36297,0.0668127653483463,0.0220959370612328,0.02350472870833,0.110120801988362,0.00250547698559168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDT,D-dopachrome decarboxylase,35438,-0.0806638152365928,0.0266975679012046,-0.132991048322954,-0.0283365821502319,0.00252634904353369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZB1,Marginal zone B- and B1-cell-specific protein,36394,-0.102055225488459,0.0340830620015091,-0.168858027011417,-0.0352524239655011,0.00276002099207626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNAS,Neuroendocrine secretory protein 55,35417,-0.158817406566366,0.0530685620579088,-0.262831788199868,-0.054803024932865,0.00277622051573363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRI1,Methylthioribose-1-phosphate isomerase,35275,-0.129916341142595,0.0435213246983562,-0.215218137551374,-0.0446145447338173,0.00284596226470121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHI3L1,Chitinase-3-like protein 1,36237,-0.157588250630895,0.0528690214007457,-0.261211532576357,-0.0539649686854337,0.00288545580324332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL24A1,Collagen alpha-1(XXIV) chain,35402,-0.106396550148169,0.03586939612476,-0.176700566552698,-0.0360925337436393,0.00302632500196765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX2,Peroxiredoxin-2,35319,-0.120454613879307,0.0407593514004109,-0.200342942624112,-0.0405662851345012,0.00313592492710232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST13,Hsc70-interacting protein,35312,-0.105678897695911,0.035893831959919,-0.176030808337352,-0.0353269870544699,0.003250007521932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA2,Carbonic anhydrase 2,36355,-0.133762388496274,0.0456390269241082,-0.223214881267526,-0.0443098957250225,0.00339074742673209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GLB2,Endophilin-B2,35416,-0.124404816503132,0.0424545068412896,-0.207615649912059,-0.0411939830942039,0.00339856556335659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9orf40,Uncharacterized protein C9orf40,35402,-0.153951145293608,0.0526386131454281,-0.257122827058647,-0.050779463528569,0.00346057464431585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIT,Citron Rho-interacting kinase,35275,-0.0886009664534815,0.0303082032267713,-0.148005044777953,-0.0291968881290098,0.00347583398838903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB2,DnaJ homolog subfamily B member 2,35312,-0.101520500300737,0.0347348485065102,-0.169600803373497,-0.0334401972279767,0.00348251018044193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP5,Tartrate-resistant acid phosphatase type 5,36400,-0.0579570619973762,0.0198465956650839,-0.0968563895009406,-0.0190577344938117,0.00350832651808751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK1,Adenylate kinase isoenzyme 1,36360,-0.119573348873731,0.0412744572485431,-0.200471285080876,-0.0386754126665867,0.00377854305833766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC9,DnaJ homolog subfamily C member 9,35402,-0.140802510620663,0.0487702842217137,-0.236392267695222,-0.045212753546104,0.00390208369094356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROS,Uroporphyrinogen-III synthase,35275,-0.129152682878716,0.0448537048829643,-0.217065944449326,-0.0412394213081056,0.00399797401968618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC2,WAP four-disulfide core domain protein 2,35988,-0.0788424696077663,0.0273950098910721,-0.132536688994268,-0.025148250221265,0.00401470387091335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOP56,Nucleolar protein 56,35214,-0.204768163142487,0.0716113202250015,-0.34512635078349,-0.0644099755014842,0.00425850988711144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL18A1,Collagen alpha-1(XVIII) chain,36401,-0.042651197547954,0.0149243139815892,-0.0719028529518688,-0.0133995421440391,0.0042776718336736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,36352,-0.114851839008558,0.0402969503755294,-0.193833861744596,-0.0358698162725209,0.00438252393296939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4R,Interleukin-4 receptor subunit alpha,36352,-0.0672059493713251,0.0235829400702902,-0.113428511909094,-0.0209833868335564,0.00438758449193915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM3,Intercellular adhesion molecule 3,36446,-0.048938879201541,0.0171929262895978,-0.0826370147291527,-0.0152407436739292,0.00443331760414239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPF,Centromere protein F,35321,-0.10321057216618,0.0363560373179829,-0.174468405309426,-0.0319527390229333,0.0045420609417407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR1,Hepatitis A virus cellular receptor 1,36411,-0.119278214727802,0.0421924589214497,-0.201975434213843,-0.0365809952417602,0.0047115153971549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDI2,Protein DDI1 homolog 2,35312,-0.144912547797518,0.0513148701166026,-0.245489693226059,-0.0443354023689768,0.00475836283142215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRA,Paired immunoglobulin-like type 2 receptor alpha,36382,-0.0764965351733313,0.027103263920967,-0.129618932458427,-0.023374137888236,0.00477950457274905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEND1,Cell cycle exit and neuronal differentiation protein 1,35212,-0.107038128075771,0.0380904485049609,-0.181695407145495,-0.032380849006048,0.00496854134372813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,36360,-0.117870872199514,0.0420784311291167,-0.200344597212583,-0.0353971471864455,0.00510465537427578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL17,C-X-C motif chemokine 17,36442,-0.0739745092624784,0.0264766067506668,-0.125868658493785,-0.0220803600311716,0.0052204074759439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAUR,Urokinase plasminogen activator surface receptor,36327,-0.0499090763053181,0.017863790407369,-0.0849221055037613,-0.0148960471068748,0.00522206504634249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APLP1,Amyloid-like protein 1,36360,0.0912978697819857,0.0327235655645589,0.0271596812754502,0.155436058288521,0.00528516947871396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,36350,0.202893023898957,0.072876138825339,0.0600557918012922,0.345730255996621,0.00538206986340673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL2,Kin of IRRE-like protein 2,36191,-0.069142971132375,0.0249057881081242,-0.117958315824298,-0.0203276264404517,0.00551478190825329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK4,Kallikrein-4,36427,-0.110045496942365,0.0397433464304217,-0.187942455945991,-0.0321485379387383,0.00563885369832433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA4,DnaJ homolog subfamily A member 4,35416,-0.125530652115415,0.0454354291270487,-0.21458409320443,-0.0364772110263992,0.00574698591930546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRD54,Ankyrin repeat domain-containing protein 54,36225,-0.102809425059894,0.0372441337391085,-0.175807927188546,-0.029810922931241,0.00578768303813476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA2_BOLA2B,BolA-like protein 2,35281,-0.094829021480648,0.0344399498902233,-0.162331323265486,-0.0273267196958104,0.00591439392035605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRB,Paired immunoglobulin-like type 2 receptor beta,36360,-0.101789454668202,0.0369871669334741,-0.174284301857811,-0.0292946074785925,0.00593777136754066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL1,Interleukin-1 receptor-like 1,36428,-0.0799215969789099,0.0290640261820685,-0.136887088295764,-0.0229561056620557,0.00597713975589927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,36297,-0.060598812065988,0.0220687366863223,-0.10385353597118,-0.0173440881607964,0.00604948143471585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,35312,-0.103475624560397,0.0377061946021911,-0.177379765980692,-0.0295714831401025,0.00608242417396921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF7,SLAM family member 7,36352,-0.104765825881729,0.0381950337458514,-0.179628092023598,-0.0299035597398606,0.00610474970385699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK2,BDNF/NT-3 growth factors receptor,36360,0.0446573739960311,0.0163030880610159,0.0127033213964399,0.0766114265956223,0.00617417295523762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,35239,-0.0848107044456863,0.0310139421617915,-0.145598031082798,-0.0240233778085751,0.00626382784063102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAN,Neurocan core protein,36428,0.0661691904304628,0.0242148692817319,0.0187080466382682,0.113630334222657,0.00629920575797976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL6,Fc receptor-like protein 6,36352,-0.121957529859218,0.0447501566102955,-0.209667836815397,-0.0342472229030384,0.00643995764242251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,36225,-0.106216819443584,0.0389774255121589,-0.182612573447416,-0.029821065439753,0.00644438850760046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPACT,Protein IMPACT,35416,-0.0965762871605669,0.035452416738938,-0.166063023968885,-0.0270895503522485,0.00646550589356122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE1,Ribonuclease pancreatic,35428,-0.0458883076881652,0.0168505215566845,-0.0789153299392668,-0.0128612854370636,0.00648216389743709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLVRB,Flavin reductase,36382,-0.119040098699968,0.0438241950246747,-0.204935520948331,-0.0331446764516056,0.00661720039551813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLB,Beta-klotho,36191,-0.130531991781082,0.0481373838983284,-0.224881264221806,-0.0361827193403586,0.00671117003132987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPE,Ribulose-phosphate 3-epimerase,35321,-0.120381934015633,0.0444660124263293,-0.207535318371239,-0.0332285496600278,0.00680252184995737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMG,Oligodendrocyte-myelin glycoprotein,36331,0.116026070122144,0.0429029050091686,0.0319363763041738,0.200115763940115,0.00685927803969813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD74,HLA class II histocompatibility antigen gamma chain,36428,-0.0611591277657963,0.0226207426767881,-0.105495783412301,-0.0168224721192916,0.00687377165113278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRAID,All-trans retinoic acid-induced differentiation factor,35402,-0.0502061649584728,0.0185924717958118,-0.0866474096782639,-0.0137649202386817,0.00694546140202888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGM2,Protein-glutamine gamma-glutamyltransferase 2,36348,-0.133519625405373,0.0495366129594971,-0.230611386805988,-0.036427864004759,0.00704743521212722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",35239,0.0777434319869075,0.028902535404089,0.021094462594893,0.134392401378922,0.00716808854198264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROD,Uroporphyrinogen decarboxylase,35312,-0.118104380336992,0.0440336176069241,-0.204410270846563,-0.031798489827421,0.00733490772514496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP1,Rho GTPase-activating protein 1,36225,-0.0777524023232853,0.0289933881239533,-0.134579443046234,-0.0209253616003369,0.00734139115901583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTYMK,Thymidylate kinase,35420,-0.1152754103239,0.0430360887110279,-0.199626144197515,-0.0309246764502855,0.00741303067418865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THSD1,Thrombospondin type-1 domain-containing protein 1,35193,0.0577834763808941,0.0215976448471886,0.0154520924804045,0.100114860281384,0.00748310373173321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF8,SLAM family member 8,36225,-0.0967962778388921,0.0361855923061664,-0.167720038758978,-0.025872516918806,0.00749033681975716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D17,TBC1 domain family member 17,36191,-0.0783349137701293,0.0293336834580606,-0.135828933347928,-0.0208408941923306,0.00759187967135254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR2,Asialoglycoprotein receptor 2,35428,-0.0454205855475263,0.0170477504867662,-0.0788341765015881,-0.0120069945934645,0.00773437466164301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,36227,-0.077009281830983,0.0289070473208298,-0.133667094579809,-0.0203514690821566,0.00773864365993663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT2,Angiopoietin-2,36427,-0.0628763782411093,0.0236080332931271,-0.109148123495638,-0.0166046329865802,0.00775390506026079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35391,-0.113349013915498,0.042715139790769,-0.197070687905405,-0.0296273399255904,0.00798407721155892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD1,Superoxide dismutase [Cu-Zn],36222,-0.0824186214741689,0.0310891274424859,-0.143353311261441,-0.0214839316868966,0.00804235215364799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35420,-0.0895803114956201,0.0338876036199124,-0.156000014590648,-0.0231606084005918,0.00822706295663665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD4,Sushi domain-containing protein 4,35391,-0.0692015327465279,0.0262735701132235,-0.120697730168446,-0.0177053353246099,0.00846241379529594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGBP1,Immunoglobulin-binding protein 1,35417,-0.101749974561513,0.0386758796739266,-0.177554698722409,-0.0259452504006168,0.00853845431609399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN8,Septin-8,35405,-0.0554435951765809,0.0211211720092022,-0.0968410923146171,-0.0140460980385446,0.0086854988025521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL23,C-C motif chemokine 23,36403,-0.0700128679995536,0.0266902849635022,-0.122325826528018,-0.0176999094710892,0.00873019491136701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5RA,Interleukin-5 receptor subunit alpha,36352,-0.0961567660709516,0.0366603888899966,-0.168011128295345,-0.0243024038465583,0.00873680283180579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,36352,-0.0623930660586799,0.0238566718894733,-0.109152142962047,-0.0156339891553122,0.00893283243969633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17C,Interleukin-17C,36227,-0.121977724376534,0.0468646455482804,-0.213832429651164,-0.0301230191019049,0.00926690257920503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLO1,Lactoylglutathione lyase,36249,-0.0974735083940865,0.0375420169269418,-0.171055861570892,-0.0238911552172805,0.00944059861282967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF8,Tumor necrosis factor ligand superfamily member 8,35438,-0.0586609179252456,0.0227909725371321,-0.103331224098025,-0.0139906117524667,0.0100797600646337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C3,Complement C3,35103,0.0746067823543336,0.0290949186328745,0.0175807418338994,0.131632822874768,0.0103642601190589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPME1,Protein phosphatase methylesterase 1,36331,-0.100854189460084,0.0393493028014726,-0.17797882295097,-0.0237295559691979,0.0103960585499481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL3,Follistatin-related protein 3,36359,-0.0539787397461318,0.0211158318892669,-0.0953657702490949,-0.0125917092431686,0.0105991404903147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPL,N-acetylneuraminate lyase,35420,-0.0740213157071755,0.028959889040752,-0.130782698227049,-0.0172599331873016,0.0106120177874434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK6,Kallikrein-6,36385,0.0509797329980851,0.0199473024214463,0.0118830202520503,0.0900764457441198,0.0106172003892357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LONP1,"Lon protease homolog, mitochondrial",35281,-0.137131199599379,0.0537836164068274,-0.242547087756761,-0.0317153114419978,0.0108063759787424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC1,Amiloride-sensitive amine oxidase [copper-containing],36227,0.0973043535508284,0.0381801396782242,0.0224712797815089,0.172137427320148,0.0108379524922572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF6,SLAM family member 6,36225,-0.062066694909151,0.024380793299536,-0.109853049776242,-0.0142803400420605,0.0109263944191197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG4,Proteasome assembly chaperone 4,35239,-0.0956175945848163,0.0377145451266689,-0.169538103033087,-0.0216970861365452,0.0112601759111121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",35281,-0.090928013158781,0.0358652166644752,-0.161223837821152,-0.0206321884964095,0.0112608839735304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD1,Sphingomyelin phosphodiesterase,36382,-0.0793617443359495,0.0313166608791574,-0.140742399659098,-0.0179810890128011,0.0112924523105284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPT,Dermatopontin,36446,-0.040466329088122,0.0159798947156334,-0.0717869227307634,-0.00914573544548054,0.0113517268707271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT19,"Keratin, type I cytoskeletal 19",36341,-0.111436674502639,0.0442992093245578,-0.198263124778772,-0.0246102242265055,0.0119065834772327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA11,Serpin A11,36446,-0.0646993777256893,0.0257876902177349,-0.11524325055245,-0.0141555048989289,0.0121315598609801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL4,Myosin light chain 4,35281,-0.0868156041949729,0.034619510984173,-0.154669845723952,-0.0189613626659937,0.0121775482119622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGL1,Fibrinogen-like protein 1,35428,-0.104727882040902,0.041834107822913,-0.186722733373811,-0.0227330307079922,0.0123256995872766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBI3_IL27,Interleukin-27,36413,-0.0488768001007626,0.0196240367042354,-0.0873399120410639,-0.0104136881604613,0.0127729151815239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILP,Rab-interacting lysosomal protein,36397,-0.0956424036763486,0.0384066265988408,-0.170919391810077,-0.0203654155426206,0.0127874089131696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300A,CMRF35-like molecule 8,35312,-0.0491249768542419,0.0197362375393195,-0.0878080024313082,-0.0104419512771756,0.0128339675459718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL9,C-X-C motif chemokine 9,36403,-0.107750438442052,0.0433778489970839,-0.192771022476337,-0.0227298544077679,0.0130142386466319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN1,Ficolin-1,35416,-0.0884560422843685,0.035613109781248,-0.158257737455614,-0.0186543471131225,0.0130247993617384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35321,-0.0578470632029608,0.0233101969645349,-0.103535049253449,-0.0121590771524724,0.0131052584130018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP2,Metalloproteinase inhibitor 2,35420,-0.0421983604667312,0.0170108633026601,-0.0755396525399451,-0.00885706839351739,0.0131397457707368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL11,C-X-C motif chemokine 11,36428,-0.130375167036035,0.0526318224360532,-0.233533539010699,-0.0272167950613704,0.0132675364584668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD80,T-lymphocyte activation antigen CD80,35420,-0.0535879993969223,0.021715195329391,-0.0961497822425287,-0.0110262165513159,0.0136226452385992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,36297,-0.0577469296304957,0.0234394217949632,-0.103688196348624,-0.0118056629123678,0.0137759078026616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIE,Peptidyl-prolyl cis-trans isomerase E,35321,0.0974007503961047,0.0395407442907824,0.0199008915861712,0.174900609206038,0.0137937219603843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGBL1,Integrin beta-like protein 1,35438,-0.060353275180557,0.0245387084462091,-0.108449143735127,-0.0122574066259872,0.0139394764073453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JUN,Transcription factor AP-1,36227,0.0744176916135264,0.0303126938675895,0.015004811633051,0.133830571594002,0.0141124630148816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,35206,0.0678660219406352,0.0278068564831945,0.0133645832335739,0.122367460647696,0.0146906693271733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MELTF,Melanotransferrin,35420,0.0469846918296625,0.0193723121492989,0.00901496001703662,0.0849544236422883,0.0153217638927865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6A,Ras-related protein Rab-6A,36352,0.0713451832818058,0.029454113416306,0.013615120985846,0.129075245577766,0.0154494657025515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_E,,36352,-0.0466127605623887,0.0192545607830894,-0.0843516996972439,-0.0088738214275335,0.0155081885107184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX15,Sorting nexin-15,35312,-0.0838623880888906,0.0346838368316105,-0.151842708278847,-0.0158820678989341,0.0156389738750278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP28,Ubiquitin carboxyl-terminal hydrolase 28,35416,-0.0556974134025722,0.0231522480302118,-0.101075819541787,-0.010319007263357,0.0161704121112709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS9,Galectin-9,36372,-0.0498328208279807,0.0207278195433802,-0.0904593471330058,-0.00920629452295554,0.0162352302830432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGA,Chromogranin-A,35438,-0.149161808859738,0.0621168110272245,-0.270910758473098,-0.0274128592463778,0.0163654806534133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GM2A,Ganglioside GM2 activator,35270,-0.0610559301851642,0.0254784826739685,-0.110993756226143,-0.0111181041441859,0.0165883082072452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERC2,ERC protein 2,35275,-0.117319270820189,0.049047302462172,-0.213451983646046,-0.0211865579943315,0.0167887787077328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAXX,Protein PAXX,35312,-0.0707753049261324,0.0296020268967069,-0.128795277643678,-0.0127553322085868,0.0168374572530015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPCDC,Phosphopantothenoylcysteine decarboxylase,36428,-0.0709304611081246,0.0296772928813117,-0.129097955155495,-0.0127629670607537,0.0168711343242513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YOD1,Ubiquitin thioesterase OTU1,35214,-0.096860622940693,0.0405881766764474,-0.17641344922653,-0.0173077966548561,0.0170438044964849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,36297,-0.0877106420207041,0.0367602659041266,-0.159760763192792,-0.015660520848616,0.0170579735464507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAPPA,Pappalysin-1,36227,-0.070682001005292,0.029655484390922,-0.128806750411499,-0.0125572515990849,0.0171781676417548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN3,Contactin-3,36382,0.0477061622567244,0.0200584173251426,0.00839166429944487,0.087020660214004,0.0174157580336101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD9,26S proteasome non-ATPase regulatory subunit 9,36331,-0.0871560625071555,0.0366601371980147,-0.159009931415264,-0.0153021935990467,0.0174610384815779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35420,-0.0410095018166981,0.0172881241921543,-0.0748942252333205,-0.00712477840007571,0.0177165798596534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG2,V-set and immunoglobulin domain-containing protein 2,35391,-0.0996345097871617,0.0420756916370565,-0.182102865395792,-0.017166154178531,0.0179158939392025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPA33,Cell surface A33 antigen,36331,0.21059423846975,0.0889400861462734,0.0362716696230545,0.384916807316446,0.0179196775876134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP1,Peptidoglycan recognition protein 1,36421,-0.0651716275147704,0.0275338685450111,-0.119138009862992,-0.0112052451665486,0.0179609653173242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBFOX3,RNA binding protein fox-1 homolog 3,35417,-0.0596352767136185,0.0252583323014896,-0.109141608024538,-0.0101289454026989,0.0182556958270263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES3,Carboxylesterase 3,36331,0.102749947987574,0.0435554252651432,0.0173813144678936,0.188118581507255,0.0183479864171176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS6,Growth arrest-specific protein 6,36408,-0.0377614814953832,0.0160237594290175,-0.0691680499762575,-0.00635491301450885,0.0184700266985045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,36428,-0.0694622247830656,0.0295062758494226,-0.127294525447934,-0.0116299241181973,0.0185916643482844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35417,-0.0469039915667212,0.0199382814908138,-0.0859830232887162,-0.00782495984472616,0.018680714964236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35438,-0.0586127122482077,0.0249401005004921,-0.107495309229172,-0.00973011526724311,0.0187973386782751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAST,Gastrin,35416,-0.213660507252251,0.090963768682229,-0.39194949386942,-0.0353715206350823,0.0188624610204395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL20,C-C motif chemokine 20,36442,-0.137128339121786,0.0584373641571353,-0.251665572869771,-0.0225911053738007,0.0189730409061945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A16,Protein S100-A16,36182,0.0919832085115897,0.0392432754661316,0.0150663885979719,0.168900028425208,0.0191099865950597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABGAP1L,Rab GTPase-activating protein 1-like,36227,-0.0917208029946941,0.039140301749757,-0.168435794424218,-0.0150058115651703,0.0191373491415278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAP1L4,Nucleosome assembly protein 1-like 4,35388,-0.0616757571676906,0.026449058789681,-0.113515912395465,-0.00983560193991582,0.0197394424483697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRIB,Protein scribble homolog,35281,-0.130486808135139,0.0561236833555099,-0.240489227511938,-0.0204843887583393,0.0201053963443105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP5,Vesicle-associated membrane protein 5,36249,-0.0822734890448549,0.035393183681721,-0.151644129061028,-0.0129028490286817,0.0201238763172789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5,T-cell surface glycoprotein CD5,36411,-0.0518665124117766,0.0223698917511253,-0.0957115002439823,-0.00802152457957096,0.0204453069648215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST2,Bone marrow stromal antigen 2,36428,-0.0765377508053021,0.0330957390098471,-0.141405399264602,-0.0116701023460017,0.0207716611392418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCA,Tubulin-specific chaperone A,35312,-0.123720788714044,0.0535413516359845,-0.228661837920574,-0.0187797395075145,0.0208796452216392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDCP1,CUB domain-containing protein 1,36297,-0.0780622919620575,0.0338724374577833,-0.144452269379313,-0.0116723145448022,0.0212178998556492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAEA,E3 ubiquitin-protein transferase MAEA,36225,-0.0576199947898275,0.0250543958024953,-0.106726610562718,-0.00851337901693677,0.0214889459092693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD79B,B-cell antigen receptor complex-associated protein beta chain,36442,-0.0691991801893454,0.0301066857058887,-0.128208284172887,-0.0101900762058035,0.0215636311165046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHISA5,Protein shisa-5,35438,-0.0396488298745099,0.017271007733141,-0.0735000050314664,-0.00579765471755352,0.0217267619251044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP25,Synaptosomal-associated protein 25,35212,-0.0677084271391706,0.0295246820792445,-0.12557680401449,-0.00984005026385144,0.0218660805868209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,35182,-0.0729735234460533,0.0318399845719329,-0.135379893207042,-0.0105671536850649,0.0219469300787937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99L2,CD99 antigen-like protein 2,36382,-0.0354533482914781,0.0154766678254814,-0.0657876172294217,-0.00511907935353453,0.0220060463000879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB118,Beta-defensin 118,35212,-0.0797274961210379,0.034889567503896,-0.148111048428674,-0.0113439438134017,0.0223393339747484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WIF1,Wnt inhibitory factor 1,36427,-0.0505374325543158,0.0221372835983705,-0.0939265084071219,-0.00714835670150962,0.0224645360155458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7,Complement component C7,35301,-0.0475769216320681,0.0208776141783631,-0.0884970454216598,-0.00665679784247651,0.0227104308740906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRN1,Leucine-rich repeat neuronal protein 1,36227,0.0576992552136265,0.0253505759833834,0.00801212628619512,0.107386384141058,0.0228727662076734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABRAXAS2,BRISC complex subunit Abraxas 2,35214,-0.0950508783313896,0.0419006174628836,-0.177176088558641,-0.0129256681041378,0.0233349845395014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP7,Insulin-like growth factor-binding protein 7,36446,-0.0447660096450194,0.0197788240937146,-0.0835325048687,-0.00599951442133875,0.0236447744913902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKLR,Pyruvate kinase PKLR,36383,-0.0987438939055216,0.0436444226596539,-0.184286962318443,-0.0132008254925999,0.0236985264075895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLYR1,Putative oxidoreductase GLYR1,35391,-0.0820951085107373,0.0363017818181263,-0.153246600874265,-0.0109436161472097,0.0237651618719157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NSFL1C,NSFL1 cofactor p47,36428,-0.0947259152109789,0.0419267285941883,-0.176902303255588,-0.0125495271663698,0.0238930917941914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAGR1,PAXIP1-associated glutamate-rich protein 1,35281,-0.0617002762998444,0.0273170804748904,-0.115241754030629,-0.00815879856905925,0.0239391485073886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35310,-0.089746764394839,0.0397620450389699,-0.16768037267122,-0.011813156118458,0.0240371933405662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF9,Multiple epidermal growth factor-like domains protein 9,36428,-0.027463448494905,0.012204532216093,-0.0513843316384473,-0.00354256535136269,0.0244619621959997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXN,Thioredoxin,35317,-0.0637983964457248,0.0283841671065925,-0.119431363974646,-0.00816542891680355,0.0246323394111196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNR,Tenascin-R,36297,0.0604529613501225,0.0269037226060238,0.00772166504231584,0.113184257657929,0.02466990103004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A14,Zinc transporter ZIP14,36191,-0.0496637352829214,0.0222040590742828,-0.0931836910685156,-0.0061437794973272,0.0253375807392711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",36397,-0.105269847297256,0.0470692548022626,-0.19752558670969,-0.0130141078848211,0.0253502788055818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX1,"Adrenodoxin, mitochondrial",35214,-0.0880655854113285,0.0394673697236975,-0.165421630069776,-0.0107095407528814,0.0256945141649608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS1BP3,HCLS1-binding protein 3,35281,-0.123097743876275,0.055253818822426,-0.23139522876823,-0.0148002589843199,0.02592629202777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPE,Carboxypeptidase E,36352,0.0541634145578035,0.024327774598592,0.00648097634456312,0.101845852771044,0.0260182466208284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP4,Dipeptidyl peptidase 4,36258,0.040329094919568,0.0181208049821391,0.00481231715457534,0.0758458726845607,0.0260745331520592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBXN1,UBX domain-containing protein 1,35312,-0.0962463386161234,0.0433362732732622,-0.181185434231717,-0.0113072430005296,0.0263929493618081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD72,B-cell differentiation antigen CD72,35312,-0.0614246374795042,0.0276574539021387,-0.115633247127696,-0.00721602783131229,0.0263937296633701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX2,"Ferredoxin-2, mitochondrial",35214,-0.0775052925539114,0.034922892596489,-0.14595416204303,-0.00905642306479304,0.0265016699343786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSP,Alpha-hemoglobin-stabilizing protein,36367,-0.121656883127877,0.0548258702764932,-0.229115588869804,-0.0141981773859505,0.026520037670642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE2,Angiotensin-converting enzyme 2,36249,-0.0755118860832533,0.0340529464281202,-0.142255661082369,-0.00876811108413773,0.0266217350759856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNF,Tumor necrosis factor,36243,-0.0539063505654809,0.0243115306124977,-0.101556950565976,-0.00625575056498535,0.0266332688141666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPS,Calcyphosin,35416,0.140415476844543,0.0636016759414399,0.0157561919993209,0.265074761689765,0.0272992882742287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME2,Proteasome activator complex subunit 2,36261,-0.0524236735945664,0.0237566961187496,-0.0989867979873155,-0.00586054920181722,0.0273677328785229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,36382,-0.053918518461901,0.0245163019282382,-0.101970470241248,-0.00586656668255404,0.0278888630839739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2AP,CD2-associated protein,36360,-0.0901698362880892,0.0410372230963121,-0.170602793556861,-0.00973687901931758,0.0280331008896546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS8,Prostasin,36349,-0.0584162129197757,0.0266540645725577,-0.110658179481989,-0.00617424635756268,0.0284373617501766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NENF,Neudesin,35391,-0.158612564987112,0.0723939290446933,-0.300504665914711,-0.0167204640595135,0.028491434224819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HJV,Hemojuvelin,35417,-0.0636616227351948,0.0290896804672198,-0.120677396450946,-0.00664584901944394,0.0286731048700041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLC2,Immunoglobulin lambda constant 2,35436,-0.035205855586753,0.0161238166374858,-0.066808536196225,-0.00360317497728088,0.029038392550914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP3,Tubulin polymerization-promoting protein family member 3,36191,-0.055645464333287,0.0254904441928435,-0.10560673495126,-0.00568419371531378,0.0290694381111493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TALDO1,Transaldolase,35416,-0.062099786172766,0.0284899203640887,-0.11794003008638,-0.00625954225915214,0.0293162738220709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WARS,"Tryptophan--tRNA ligase, cytoplasmic",36382,-0.0534001428616908,0.0245048127370807,-0.101429575826369,-0.00537070989701258,0.0293514321164726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL6A3,Collagen alpha-3(VI) chain,36446,-0.0507204659288431,0.0232897218051658,-0.0963683206669681,-0.00507261119071802,0.0294526956958836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON2,Serum paraoxonase/arylesterase 2,36249,-0.0499303655231798,0.0229275821243176,-0.0948684264868422,-0.00499230455951733,0.0294582432741716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRSF1,G-rich sequence factor 1,35172,-0.111875691496597,0.0514287743450762,-0.212676089212947,-0.011075293780248,0.0296427964223447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18BP,Interleukin-18-binding protein,36410,-0.044308980325822,0.0204367087814106,-0.0843649295373868,-0.00425303111425716,0.0301830897450875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL2,ADAMTS-like protein 2,35438,-0.046077708714624,0.0213044683011602,-0.087834466584898,-0.00432095084435007,0.0305929407485367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMMT,MICOS complex subunit MIC60,35391,-0.0621485910444664,0.0287874903385441,-0.118572072108013,-0.00572510998091995,0.0308981362781068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNG,Interferon gamma,36227,-0.159163519704617,0.0738181775614744,-0.303847147725107,-0.0144798916841272,0.0311052729033644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAT,Catalase,35344,-0.0756900438918581,0.0351492494903173,-0.14458257289288,-0.00679751489083624,0.0313267913184182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,35214,-0.0921567445494112,0.0428398018872724,-0.176122756248465,-0.00819073285035735,0.0315005252228376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL4,Early placenta insulin-like peptide,35391,-0.0673437665762895,0.0313463017727792,-0.128782518050937,-0.00590501510164236,0.031722221164419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT1,Deaminated glutathione amidase,35281,-0.0636797641297043,0.029668005508247,-0.121829054925868,-0.00553047333354015,0.0318795269189468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC5A,C-type lectin domain family 5 member A,36342,-0.0416596230157648,0.0194325014259411,-0.0797473258106094,-0.00357192022092027,0.0320816179718575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD48,CD48 antigen,36390,-0.0425447788967731,0.0198629508154902,-0.081476162495134,-0.0036133952984123,0.0322336848037634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK1,SLIT and NTRK-like protein 1,35239,0.0433820376762683,0.0202933945960698,0.00360698426797147,0.0831570910845652,0.0325777003735139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC1,Sialoadhesin,36403,-0.0597751238942444,0.0279721490087908,-0.114600535951474,-0.00494971183701435,0.03263550206452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR1,Asialoglycoprotein receptor 1,36297,-0.0415039246441077,0.0194704071012917,-0.0796659225626394,-0.00334192672557607,0.0330705661861758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35402,0.10564475221425,0.0495662703743748,0.00849486228047515,0.202794642148024,0.0330966926719021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLMH,Bleomycin hydrolase,36446,-0.0418583272315382,0.0196489319310184,-0.0803702338163343,-0.00334642064674214,0.0331795421755918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",36446,-0.0392348616311409,0.0184175802003807,-0.075333318823887,-0.00313640443839482,0.033180904521127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS8,Regulator of G-protein signaling 8,36227,0.0873661776449107,0.0411315959978852,0.00674824948905574,0.167984105800766,0.033699517863451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLB1,"Phospholipase B1, membrane-associated",35416,0.0780950325936921,0.0368413002683156,0.00588608406779352,0.150303981119591,0.0340650444260472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35420,-0.0847367732436671,0.0400443563809695,-0.163223711750367,-0.00624983473696682,0.0343782011647781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN15,Lipocalin-15,35417,-0.0812407185356624,0.0384118565622517,-0.156527957397676,-0.00595347967364901,0.0344703827962351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPA,Inosine triphosphate pyrophosphatase,35214,-0.090221982218375,0.0426758963371721,-0.173866739039232,-0.00657722539751764,0.0345459956664393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP2,Latent-transforming growth factor beta-binding protein 2,36446,-0.0438795520013762,0.0207614377388944,-0.0845719699696092,-0.00318713403314323,0.0345910109697119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPB,CCAAT/enhancer-binding protein beta,36249,-0.0530365120641301,0.0251000148355114,-0.102232541141732,-0.00384048298652773,0.0346351773808535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SART1,U4/U6.U5 tri-snRNP-associated protein 1,35214,-0.0523108087911585,0.0247873835360034,-0.100894080521725,-0.00372753706059174,0.0348667435614145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC5,Sialic acid-binding Ig-like lectin 5,36382,-0.157870820303593,0.0748483935709463,-0.304573671702647,-0.0111679689045379,0.0349611339729567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",35239,0.0571995181700121,0.0271255064278232,0.00403352557147867,0.110365510768545,0.035011634250583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP5,Rho GTPase-activating protein 5,35206,-0.105240108154373,0.049928572305068,-0.203100109872306,-0.0073801064364397,0.0350884304816455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,36433,-0.0534083241372089,0.02534765099596,-0.10308972008929,-0.0037269281851273,0.0351490751346377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRY2,Protein sprouty homolog 2,36227,-0.124484723150818,0.0592029168465402,-0.240522440170037,-0.00844700613159934,0.0355292973115544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,36225,0.173251423806431,0.0824077275231155,0.011732277861125,0.334770569751738,0.03555646186515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHC1,SHC-transforming protein 1,35206,-0.152303515067242,0.0725184694569763,-0.294439715202915,-0.0101673149315684,0.0357525342582055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM1,U6 snRNA-associated Sm-like protein LSm1,36225,-0.0753212069770957,0.0358669733776699,-0.145620474797329,-0.00502193915686268,0.0357629992059593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALCAM,CD166 antigen,36446,-0.0262963917852878,0.0125267546012796,-0.0508488308037959,-0.00174395276677967,0.035832145287045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA2,Ephrin type-A receptor 2,36110,-0.0444454176170302,0.0211872286116188,-0.085972385695803,-0.00291844953825746,0.0359638149270532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSG,Basigin,36433,-0.0276624013961921,0.0131995231359416,-0.0535334667426375,-0.0017913360497466,0.0361423737344691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC6,Putative tyrosine-protein phosphatase auxilin,35281,-0.109435536291072,0.0522312235733437,-0.211808734494826,-0.00706233808731864,0.0361932835259306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPP1,Osteopontin,36439,-0.0621115635410146,0.0296571369065558,-0.120239551877864,-0.00398357520416516,0.036266052816424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX,Glutaredoxin-1,36310,-0.0772740903318672,0.036910861399019,-0.149619378673944,-0.00492880198978984,0.0363369465469563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASA1,Ras GTPase-activating protein 1,36191,-0.0447519370678339,0.0213784244617997,-0.0866536490129613,-0.00285022512270653,0.0363562880769198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL46,"39S ribosomal protein L46, mitochondrial",36191,-0.0358726842696529,0.0171456686411112,-0.069478194806231,-0.00226717373307492,0.0364538818044069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAB2,Stabilin-2,35438,-0.0377037856009092,0.0180207960368922,-0.0730245458332179,-0.00238302536860042,0.0364575549224057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGCT,Gamma-glutamylcyclotransferase,35410,-0.0635897809293134,0.0303969186239708,-0.123167741432296,-0.00401182042633053,0.0364806728248635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",35272,-0.103745548793271,0.049673416270488,-0.201105444683427,-0.0063856529031143,0.036789513409761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB1,DnaJ homolog subfamily B member 1,36331,-0.115768543632481,0.0555029892605112,-0.224554402583083,-0.00698268468187924,0.0370315056559755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSTB,Cystatin-B,36261,-0.0570343818392388,0.0273718881149339,-0.110683282544509,-0.00338548113396844,0.0372247086747839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2CD2L,Phospholipid transfer protein C2CD2L,36184,-0.0541979864088273,0.0260753291899309,-0.105305631621092,-0.00309034119656267,0.0376982594240821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WDR46,WD repeat-containing protein 46,35391,-0.0479978568603208,0.0231095714888526,-0.0932926169784718,-0.00270309674216967,0.0378455482457737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM1,Intercellular adhesion molecule 1,36352,-0.0390410494891316,0.0188104691589983,-0.0759095690407682,-0.00217252993749496,0.0379762338907708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN3,Ataxin-3,35416,-0.0823988897460791,0.0398378672432989,-0.160481109542945,-0.00431666994921318,0.0386477854225206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2D1A,SH2 domain-containing protein 1A,36352,-0.0784131123175734,0.0379280405996545,-0.152752071892896,-0.00407415274225056,0.0387306448235691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFR,Epidermal growth factor receptor,36446,0.0214125018086445,0.0103704607675179,0.00108639870430941,0.0417386049129796,0.0389812803583411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPX,Sushi repeat-containing protein SRPX,35420,-0.0481712849179409,0.0233986403750275,-0.0940326200529948,-0.00230994978288708,0.0395624326248827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDA2R,Tumor necrosis factor receptor superfamily member 27,36427,-0.0526901672166412,0.0256044355222921,-0.102874860840334,-0.00250547359294865,0.0396399918044103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QPCT,Glutaminyl-peptide cyclotransferase,36380,-0.0356400278642152,0.01733528441039,-0.0696171853085797,-0.00166287041985075,0.0398258829528816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FARSA,Phenylalanine--tRNA ligase alpha subunit,35275,-0.089705108138414,0.0438032875711184,-0.175559551777806,-0.00385066449902186,0.040611863635288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP290,Centrosomal protein of 290 kDa,35321,0.0678876056845837,0.0332091756764668,0.00279762135870884,0.132977590010459,0.0409722626054188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCS,Copper chaperone for superoxide dismutase,36297,-0.0636750616849325,0.0311559647250207,-0.124740752545973,-0.00260937082389184,0.0410148745536166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,36379,-0.0788167599416478,0.0385946040759442,-0.154462183930498,-0.0031713359527971,0.041171060558833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT16,U8 snoRNA-decapping enzyme,35390,-0.110618237362441,0.0542807180293797,-0.217008444700025,-0.00422803002485712,0.0416031289955019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL22,C-C motif chemokine 22,36306,-0.0671704253502624,0.0330092044695949,-0.131868466110669,-0.00247238458985632,0.0418979617112065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PQBP1,Polyglutamine-binding protein 1,36225,-0.0753421189396066,0.0370572692180728,-0.147974366607029,-0.00270987127218389,0.0420772237312432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35420,-0.0418757123716496,0.0206090154478562,-0.0822693826494478,-0.00148204209385142,0.0422049062905444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRCP,Lysosomal Pro-X carboxypeptidase,36410,-0.0404390763093741,0.0199251971787484,-0.079492462779721,-0.00138568983902709,0.042439475089664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPLX2,Complexin-2,35206,-0.0416281387628675,0.0205150960857196,-0.081837727090878,-0.00141855043485699,0.0424873263132275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,36225,-0.0640456535951987,0.0315801678458297,-0.125942782573025,-0.00214852461737242,0.042594409479797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35417,-0.100966540972887,0.0498026720591618,-0.198579778208845,-0.00335330373693035,0.0426710292731899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB1,Interleukin-12 receptor subunit beta-1,36227,-0.0496850425962052,0.0245467123625116,-0.0977965988267279,-0.00157348636568246,0.0429974156134399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STIP1,Stress-induced-phosphoprotein 1,36370,-0.0840167535648671,0.0415129220605041,-0.165382080803455,-0.00265142632627907,0.0430205221884796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKAP4,Cytoskeleton-associated protein 4,36416,-0.0369421609931268,0.0182535437714647,-0.0727191067851975,-0.0011652152010561,0.0430238785823223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIA,Melanoma-derived growth regulatory protein,36397,-0.0479745160604309,0.0237987720406186,-0.0946201092600434,-0.0013289228608184,0.0438537724159876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSP1,Lymphocyte-specific protein 1,36352,-0.0521165130149251,0.0258572756367485,-0.102796773262952,-0.00143625276689802,0.0438848354329338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD27,CD27 antigen,36397,-0.056202308928623,0.0279006585507002,-0.110887599687996,-0.00151701816925057,0.0440075782839755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESR1,Estrogen receptor,35239,0.0714254464453466,0.0355264515113494,0.00179360148310188,0.141057291407591,0.0444240686124705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH2,Neurogenic locus notch homolog protein 2,35438,-0.0260997342784249,0.0129848080973144,-0.0515499581491611,-0.000649510407688687,0.0444719204173478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NACC1,Nucleus accumbens-associated protein 1,35391,-0.0719031375160032,0.0358140317183877,-0.142098639684043,-0.00170763534796325,0.0447205711476601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1,Macrophage colony-stimulating factor 1,36403,-0.0357884447542443,0.0178369667188992,-0.0707488995232868,-0.000827989985201859,0.044848748656532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR5,Cadherin-related family member 5,36360,0.0497843431244082,0.0248368967523939,0.00110402548971623,0.0984646607591001,0.045059324695584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC1,WAP four-disulfide core domain protein 1,35259,-0.0711064923988577,0.0355096046790574,-0.14070531756981,-0.00150766722790524,0.0452799316757858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",35206,-0.069024055137547,0.0344791823028701,-0.136603252451172,-0.00144485782392163,0.0453397720950297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO1,R-spondin-1,36297,-0.0433765151483663,0.0216741212807323,-0.0858577928586017,-0.000895237438130969,0.0453975651487612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G2A,"Phospholipase A2, membrane associated",36345,-0.0718129742119307,0.0359073027063213,-0.14219128751632,-0.00143466090754098,0.0455429238808243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,35214,0.0641884975931469,0.032134258293365,0.00120535133815157,0.127171643848142,0.0458147496023843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP10,Caspase-10,36191,-0.0909158614710619,0.0455169783646635,-0.180129139065802,-0.00170258387632144,0.0458198083543327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSPN,Persephin,36352,0.119216147346651,0.0597088981713947,0.00218670693071718,0.236245587762584,0.04590397946809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBAC1,Ubiquitin-associated domain-containing protein 1,36331,-0.0446007968629977,0.0223579184035261,-0.0884223169339089,-0.000779276792086517,0.0460967008304208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM19,Probable RNA-binding protein 19,35214,-0.0593713418595129,0.0297926008575322,-0.117764839540276,-0.00097784417874975,0.0463260439129586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNLR1,Interferon lambda receptor 1,36352,-0.046615695997385,0.023400695872913,-0.0924810599082944,-0.000750332086475493,0.0464019036121433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADM,Pro-adrenomedullin,36427,-0.0334932559403961,0.0168242960722705,-0.0664688762420463,-0.000517635638745809,0.0465440570629136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMP,Olfactory marker protein,35212,-0.062708993295334,0.0315137120708903,-0.124475868954279,-0.000942117636389107,0.0466476263419019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDUA,Alpha-L-iduronidase,36427,-0.0586018908565463,0.0294535233629282,-0.116330796647886,-0.000872985065207096,0.0466682651785876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCA,Alpha-synuclein,35312,-0.144616602239705,0.072780441443348,-0.287266267468667,-0.00196693701074252,0.0469640819917698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECSCR,Endothelial cell-specific chemotaxis regulator,35212,-0.0646632941195154,0.0325559138587943,-0.128472885282752,-0.00085370295627861,0.0470538943338331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIDA,"Axin interactor, dorsalization-associated protein",35275,-0.107214743250154,0.0540062007551453,-0.213066896730238,-0.00136258977006887,0.0471637110380665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDR1,Epithelial discoidin domain-containing receptor 1,36428,-0.0295333353053193,0.014887573435785,-0.0587129792394579,-0.00035369137118069,0.0473206203130659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YWHAQ,14-3-3 protein theta,35312,-0.0916249480660841,0.0461947611365033,-0.182166679893631,-0.00108321623853773,0.0473619427552381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAMBP,STAM-binding protein,36290,-0.0801331745455104,0.0404316043063453,-0.159379118985947,-0.000887230105073578,0.0475240315577712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35417,-0.0620227234299769,0.0312993959246396,-0.123369539442271,-0.000675907417683239,0.0475685327396819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD83,CD83 antigen,36352,-0.0436269811833833,0.0220550370483091,-0.0868548537980692,-0.000399108568697439,0.0479561595760377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFYA,Nuclear transcription factor Y subunit alpha,35214,-0.0520868847824857,0.0263350118088136,-0.10370350792776,-0.000470261637210978,0.0479903825037094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35420,-0.0935097359356527,0.0472998124607874,-0.186217368358796,-0.000802103512509519,0.0480904437329405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL13B,ADP-ribosylation factor-like protein 13B,35214,-0.0863871448107668,0.0437489051227484,-0.172134998851354,-0.000639290770180059,0.0483577419732753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDH1,"Malate dehydrogenase, cytoplasmic",35392,-0.0500749539293411,0.0253874523989599,-0.0998343606313024,-0.000315547227379732,0.0486050061060719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF21,Fibroblast growth factor 21,36413,-0.147428659939875,0.074769476970567,-0.293976834802187,-0.000880485077564164,0.0486733043833519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBPL,FK506-binding protein-like,35402,-0.0728109602072797,0.0369267482869984,-0.145187386849797,-0.000434533564762737,0.0486804895162897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6,Interleukin-6,36331,-0.0947919990332623,0.04824988575728,-0.189361775117531,-0.0002222229489936,0.0494986348835879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWF,von Willebrand factor,36446,-0.0907555085471974,0.0462113562240987,-0.181329766746431,-0.000181250347963846,0.0495772564162617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAG3,Lymphocyte activation gene 3 protein,36331,-0.0517602527719345,0.0263768896229915,-0.103458956432998,-6.15491108711119e-05,0.0497624716693123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3LG,Fms-related tyrosine kinase 3 ligand,36442,0.0433175258838005,0.0220853533721968,3.0233274294765e-05,0.0866048184933061,0.0498742275804446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK2,Serine protease inhibitor Kazal-type 2,35312,-0.0464527625608299,0.0237424698888675,-0.0929880035430103,8.24784213504445e-05,0.0504486349349216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA3,Protein disulfide-isomerase A3,35312,-0.0310697438966577,0.0159022860518121,-0.0622382245582093,9.87367648939697e-05,0.0507714405029255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELB,Transcription factor RelB,35239,0.0630893521353367,0.0323116493288597,-0.000241480549228318,0.126420184819902,0.0509218174199714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGFR,Opioid growth factor receptor,36331,-0.0410540092297837,0.0210409926877067,-0.0822943548976889,0.000186336438121451,0.0510789765549179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOC,Brother of CDO,36249,-0.0291740528358596,0.014961757883699,-0.0584990982879096,0.000150992616190469,0.0512266315372117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTAG1A_CTAG1B,Cancer/testis antigen 1,35307,-0.0605600278123909,0.0310579397148756,-0.121433589653547,0.000313534028765362,0.0512331127124947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP6,Lysophosphatidic acid phosphatase type 6,36413,-0.0841952505760155,0.0431841617908133,-0.16883620768601,0.000445706533978657,0.0512530629720748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL10,C-X-C motif chemokine 10,36403,-0.0861113699275031,0.0441689671760497,-0.17268254559256,0.000459805737554234,0.0512637447838724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36G,Interleukin-36 gamma,35212,-0.0800804940199562,0.041123213564666,-0.160681992606701,0.000521004566789135,0.0515415558402698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPESP1,Sperm equatorial segment protein 1,35420,-0.039077115396062,0.0200737093123652,-0.0784215856482979,0.000267354856173803,0.0516178648990152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAP,Prosaposin,35375,-0.0347203377576566,0.0178815454056488,-0.0697681667527283,0.000327491237415066,0.052220564507282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR4,Fibroblast growth factor receptor 4,35312,0.0650567283877743,0.0335384347834917,-0.000678603787869519,0.130792060563418,0.0524539903683198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIT2,Slit homolog 2 protein,36191,-0.0632004624878819,0.0325965131991436,-0.127089628358203,0.000688703382439607,0.0525570998067808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,36428,-0.0347644140685901,0.0179343068610439,-0.0699156555162362,0.00038682737905589,0.0526095295788409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA4,Ephrin-A4,36282,-0.0403368358470023,0.0208162979494513,-0.0811367798279268,0.000463108133922155,0.052693080121752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG4,V-set and immunoglobulin domain-containing protein 4,36371,-0.0527336442236559,0.0272228811614477,-0.106090491300093,0.000623202852781578,0.0527714101682968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC2,MAM domain-containing protein 2,35420,-0.0455564902549411,0.0235481058512049,-0.0917107777233026,0.000597797213420431,0.0530829541481993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEL1L,Protein sel-1 homolog 1,35281,-0.0369837539835505,0.0191805830425981,-0.0745776967470426,0.00061018877994172,0.0538783089069049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDRG1,Protein NDRG1,36191,-0.0783508750602598,0.0406627749794203,-0.158049914019924,0.00134816389940394,0.0540393656622364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMBS,Porphobilinogen deaminase,36427,-0.0535528996717638,0.0278143680510857,-0.108069061051892,0.000963261708364208,0.0542224736305491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2,Ataxin-2,35212,-0.132977986819934,0.0691145476242359,-0.268442500163437,0.00248652652356809,0.0543987933690861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREM2,Triggering receptor expressed on myeloid cells 2,36368,-0.0633951241025319,0.0329818821077736,-0.128039613033768,0.00124936482870437,0.0546302620207202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK4,Serine protease inhibitor Kazal-type 4,36352,-0.0827650937939001,0.0430603965459448,-0.167163471023952,0.00163328343615174,0.054636607001539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC38,Leucine-rich repeat-containing protein 38,35275,-0.0584399044063125,0.0304163039513569,-0.118055860150972,0.00117605133834711,0.0547361994776532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNC,Tenascin,36410,-0.0605122423971572,0.0315006456550128,-0.122253507880982,0.00122902308666783,0.054773055461317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18,Interleukin-18,36347,-0.0580196447816317,0.0302704691697056,-0.117349764354255,0.00131047479099129,0.0553148621289985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH3,Cadherin-3,36428,-0.0449717006203057,0.0234649235243754,-0.0909629507280814,0.00101954948747,0.055334475496169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP2B4,Plasma membrane calcium-transporting ATPase 4,35214,-0.0748322353254842,0.0391121701292656,-0.151492088778845,0.00182761812787634,0.0557605741361451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP43,Centrosomal protein 43,36183,-0.0836880603732561,0.0438348106389968,-0.16960428922569,0.00222816847917762,0.0562812066233386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX3,Syntaxin-3,35416,-0.0473857692588225,0.0248627889887183,-0.0961168356767104,0.00134529715906544,0.0567103675383135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGCR6,Protein DGCR6,35212,-0.0509997388056812,0.0267756434377818,-0.103479999943733,0.00148052233237109,0.0568658784428539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLTP,Phospholipid transfer protein,36432,-0.0427246759689388,0.0224631865727367,-0.0867525216515028,0.00130316971362521,0.0572125892817809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA1,BolA-like protein 1,35212,-0.0648993242384321,0.0341507241184354,-0.131834743510566,0.00203609503370134,0.0574311233867496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,36181,-0.0692126383608383,0.036441898893973,-0.140638760193025,0.00221348347134885,0.0575714551457234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF2,Trefoil factor 2,36390,-0.0708127613263098,0.0373042215922341,-0.143929035647089,0.00230351299446904,0.0577030506610238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSCAR,Osteoclast-associated immunoglobulin-like receptor,36381,-0.0415047483738241,0.0218750126076248,-0.0843797730847688,0.0013702763371205,0.0578206383137624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35402,-0.0372421910105248,0.0196730182268434,-0.0758013067351379,0.00131692471408824,0.0583964441809814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKB,Creatine kinase B-type,35438,-0.0708711439214995,0.0374400267208122,-0.144253596294291,0.00251130845129247,0.058414112176271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIF,Leukemia inhibitory factor,36191,-0.0624624745794481,0.0330045868531222,-0.127151464811568,0.00222651565267144,0.0584604132071751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP3,Stromelysin-1,36382,-0.0609042542456637,0.0321826199346264,-0.123982189317531,0.00217368082620397,0.0584701380957644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4D,C-type lectin domain family 4 member D,36352,-0.0753536129361678,0.0398209661134772,-0.153402706518583,0.00269548064624754,0.0584900029593926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR2,GMP reductase 2,35312,-0.080741729663468,0.042693111520999,-0.164420228244626,0.0029367689176901,0.0586432317427508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOBR,Apolipoprotein B receptor,35281,-0.0499000124550966,0.0263923300531513,-0.101628979359273,0.00182895444908008,0.0587116803788402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD1,Protein disulfide isomerase CRELD1,35312,-0.0450571122649645,0.0238720401293877,-0.0918463109185644,0.00173208638863539,0.0591480733870326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX1B,Syntaxin-1B,35275,0.0482805674033037,0.0256750112195949,-0.00204245458710222,0.0986035893937097,0.0600945683966951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,36446,-0.0331872907920118,0.0176526729562138,-0.0677865297861908,0.00141194820216717,0.0601460791755236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRHR,Growth hormone-releasing hormone receptor,36191,-0.0668637716443306,0.0355827587705122,-0.136605978834534,0.00287843554587323,0.0602715671628959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35448,-0.0307283867243428,0.0163566481135071,-0.0627874170268167,0.00133064357813109,0.0603390284632889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN3,CCN family member 3,36433,-0.0417983031690758,0.022256680260664,-0.0854213964799772,0.00182479014182558,0.060419747095997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBZ,Hemoglobin subunit zeta,35420,-0.12448567952663,0.0662842808598201,-0.254402870011877,0.00543151095861757,0.0604200225899357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSNA1,Sjoegren syndrome nuclear autoantigen 1,35402,-0.0618828245036738,0.0329593972833787,-0.126483243179096,0.00271759417174858,0.0604899803898229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC1,Syndecan-1,36360,-0.0493056718859806,0.0262808245450935,-0.100816087994364,0.00220474422240273,0.060681030818585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA1,Carbonic anhydrase 1,36213,-0.074318455564175,0.0396386477795703,-0.152010205212133,0.00337329408378283,0.060848129594382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BECN1,Beclin-1,35281,-0.0703188537068061,0.0375435266724387,-0.143904165984786,0.00326645857117373,0.0611169068850464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,36393,-0.0581675505024911,0.0310763213604168,-0.119077140368908,0.0027420393639258,0.0612797300089528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,36297,-0.0526035438813085,0.0281193209602709,-0.107717412963439,0.00251032520082242,0.0614241607641442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,36427,-0.0419161962383329,0.0224231917004678,-0.0858656519712498,0.00203325949458403,0.0616182159038414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5L,CD5 antigen-like,35420,-0.0569218644368373,0.0304846802085434,-0.116671837645582,0.0028281087719078,0.0619166389729208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2,Ribonucleoside-diphosphate reductase subunit M2,36225,-0.062240430116884,0.0333464457536463,-0.127599463794031,0.0031186035602627,0.0620160201344225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHK,Ketohexokinase,35281,-0.0735697738156464,0.0394625957720081,-0.150916461528782,0.00377691389748942,0.0623289080098452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACVRL1,Serine/threonine-protein kinase receptor R3,36282,-0.030893633772412,0.0165737630223575,-0.0633782092962326,0.00159094175140862,0.0623618346559193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549,UPF0606 protein KIAA1549,35321,0.0848174925005863,0.0455118667136492,-0.00438576625816609,0.174020751259339,0.0624208270967136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPD1,Glycerol-3-phosphate dehydrogenase,35391,0.0618770631637352,0.0332704827434599,-0.00333308301344629,0.127087209340917,0.0629585422795623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESM1,Endothelial cell-specific molecule 1,36368,-0.0414726568596243,0.022301492705712,-0.0851835825628199,0.00223826884357126,0.0629779587418609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OCLN,Occludin,35417,-0.0520448776227794,0.0280160107571894,-0.106956258706871,0.00286650346131184,0.0632611904462303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGED1,Melanoma-associated antigen D1,36225,-0.0553697992144749,0.0298101682620587,-0.11379772900811,0.00305813057916025,0.0632941755473791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPL,Lipoprotein lipase,36360,0.0546331009095749,0.0294279658924345,-0.00304571223959674,0.112311914058747,0.0634229377695006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD8A,T-cell surface glycoprotein CD8 alpha chain,36428,-0.0615971379237058,0.0331927160270619,-0.126654861336747,0.00346058548933544,0.0635308942955326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ULBP2,UL16-binding protein 2,36297,-0.0467156374101536,0.0251762631774473,-0.0960611132379502,0.00262983841764305,0.0635601287720186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN1A1,Butyrophilin subfamily 1 member A1,35379,-0.0469397985776744,0.0252968210902944,-0.0965215679146514,0.00264197075930258,0.0635636741489749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARK7,Parkinson disease protein 7,36382,-0.0615465980042471,0.0331822296879594,-0.126583768192647,0.00349057218415325,0.0636648585537514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMCH,Pro-MCH,35214,-0.0974138833969683,0.0525750784421934,-0.200461037143667,0.00563327034973075,0.0639523600555788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",36225,-0.0894986734839895,0.0483521061881971,-0.184268801612856,0.00527145464487676,0.0642146626281325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,36225,-0.0911805836013973,0.0492724783631406,-0.187754641193153,0.00539347399035822,0.0642779949923581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KITLG,Kit ligand,36360,0.0441820715225266,0.0238817584825712,-0.00262617510331292,0.0909903181483662,0.0643497505817711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHEK2,Serine/threonine-protein kinase Chk2,36249,0.039262120537864,0.0212247122315459,-0.00233831543596596,0.080862556511694,0.0643797709071799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,36427,-0.0396702990605159,0.0214508343426968,-0.0817139343722017,0.00237333625116994,0.0644467259500816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST3,Cystatin-C,36396,-0.034967623712356,0.0189160625054216,-0.0720431062229824,0.00210785879827039,0.0645612106731148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA3,Carbonic anhydrase 3,36433,-0.0720477145770424,0.0389758290047726,-0.148440339426397,0.00434491027231196,0.0645674805935576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS1,Nephrin,35239,0.0398678272209262,0.021577631958196,-0.00242433141713796,0.0821599858589903,0.0647023818462519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC1,MANSC domain-containing protein 1,36397,-0.0331752594506254,0.0179639455520107,-0.0683845927325663,0.00203407383131557,0.0648216040437212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE1,Adhesion G protein-coupled receptor E1,35402,-0.0656072810733503,0.0355368075504983,-0.135259423872327,0.00404486172562647,0.0649139027162051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGF,Hepatocyte growth factor,36442,-0.0415035016159207,0.0224925708781149,-0.0855889405370259,0.00258193730518454,0.0650478602329747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNDC1,Fibronectin type III domain-containing protein 1,35416,-0.0539624612208327,0.0292576867716807,-0.111307527293327,0.00338260485166149,0.0651744461760934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPY,Pancreatic prohormone,36371,-0.121758294587037,0.06604212807368,-0.25120086561145,0.00768427643737579,0.0652759705120091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFRC,Transferrin receptor protein 1,36403,-0.0444071628576704,0.0241299707853907,-0.0917019055970363,0.00288757988169539,0.0657605560199577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENR,Density-regulated protein,35239,-0.0642579572584319,0.0349172026840112,-0.132695674519094,0.00417976000222997,0.0657739135319088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QA,Complement C1q subcomponent subunit A,36408,-0.0260988801989503,0.0141901255426491,-0.0539115262625426,0.00171376586464205,0.0659226881422478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRG,Histidine-rich glycoprotein,35420,0.0357631458369149,0.0194662824321464,-0.00239076773009211,0.0739170594039219,0.0662303458692281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPSCR1,Tether containing UBX domain for GLUT4,35417,-0.0771729553642613,0.0420636334205748,-0.159617676868588,0.00527176614006536,0.0666020669468407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,36225,-0.0687454399963163,0.037514381004141,-0.142273626764433,0.00478274677180007,0.0669178936246973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35417,-0.0502074645917086,0.0274134571930829,-0.103937840690151,0.00352291150673396,0.067075261299342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM17,Splicing factor 45,35417,-0.0884596477571598,0.0483099263270286,-0.183147103358136,0.00622780784381625,0.0671354389300475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRK1,Protein BRICK1,36191,-0.0525583529922499,0.0287299211139224,-0.108868998375538,0.00375229239103807,0.067383098069595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBR,Tumor necrosis factor receptor superfamily member 3,36343,-0.0347695080734739,0.0190622914921127,-0.0721315993980148,0.00259258325106709,0.0681946836429903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300E,CMRF35-like molecule 2,36401,-0.0502778482179347,0.0275657385943554,-0.104306695862871,0.00375099942700197,0.0682047568799938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF2,Scavenger receptor class F member 2,36428,-0.0347801742450168,0.0190795692842945,-0.072176130042234,0.00261578155220033,0.0683595758243726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4B,Eukaryotic translation initiation factor 4B,36297,-0.0666640970811809,0.036576997477528,-0.138355012137136,0.00502681797477394,0.0684107358662641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF3,Wiskott-Aldrich syndrome protein family member 3,36191,-0.0973874974795762,0.0535319216139636,-0.202310063842945,0.00753506888379243,0.0689173019693066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAM,Cytotoxic and regulatory T-cell molecule,36297,-0.0610605811112303,0.0335810366008586,-0.126879412848913,0.00475825062645247,0.0690595625861237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA1,GDNF family receptor alpha-1,36413,-0.0337857955268436,0.0185907160110394,-0.0702235989084809,0.00265200785479369,0.069205325158622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP1,Fibroblast growth factor-binding protein 1,36397,0.0371830106390582,0.02047481324414,-0.00294762331945627,0.0773136445975726,0.0694063090262002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELE,E-selectin,36446,-0.0582826376099712,0.0321280929858556,-0.121253699862248,0.00468842464230586,0.0697081228834885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD6B,Deubiquitinase OTUD6B,35402,-0.0665014148370575,0.0366657047460977,-0.138366196139409,0.00536336646529401,0.0697687155299438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,36231,-0.0892776519116597,0.0492290249392583,-0.185766540792606,0.00721123696928647,0.0697947662294013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MERTK,Tyrosine-protein kinase Mer,36442,-0.029344561971322,0.016184513751811,-0.0610662089248714,0.00237708498222753,0.0698537430527712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1B,Interleukin-1 beta,36197,0.0669823627507233,0.0369558192435916,-0.00545104296671629,0.139415768468163,0.069952027100493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF168,E3 ubiquitin-protein ligase RNF168,35239,0.045918236377587,0.025339176609025,-0.00374654977610207,0.0955830225312761,0.0700135471453142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1,Programmed cell death protein 1,36412,-0.0511236082732105,0.028253060453267,-0.106499606761614,0.0042523902151929,0.0704166142925691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP4,Insulin-like growth factor-binding protein 4,36288,-0.0528952633358415,0.0292395876763682,-0.110204855181523,0.00441432850984014,0.0704888067428346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D1,DCN1-like protein 1,35212,-0.0856797687781339,0.0475700793390059,-0.178917124282585,0.00755758672631764,0.071732857521584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL1,Chordin-like protein 1,36390,-0.0366046348799798,0.0203343981174751,-0.076460055190231,0.00325078543027138,0.0718813980785661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK11,Serine/threonine-protein kinase STK11,36249,-0.082138566891547,0.0456497589532653,-0.171612094439947,0.00733496065685293,0.0720106441873751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,36397,-0.040465234545361,0.0225118139671621,-0.0845883899209986,0.00365792083027668,0.0722963918354097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAR,Immunoglobulin alpha Fc receptor,36352,-0.0566144014871072,0.0315192958008871,-0.118392221256846,0.00516341828263145,0.0725076801745577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRSK2,Serine/threonine-protein kinase BRSK2,35417,-0.0428356260844669,0.0238550016827465,-0.0895914293826501,0.00392017721371628,0.0725960773355211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTP4A3,Protein tyrosine phosphatase type IVA 3,35239,-0.0584649636095349,0.0326291884981877,-0.122418173065983,0.00548824584691301,0.0732150874950003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB1,Nuclear factor NF-kappa-B p105 subunit,35214,-0.0829410747202482,0.0463124299304008,-0.173713437383834,0.00783128794333737,0.0733590680239491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300C,CMRF35-like molecule 6,36428,-0.0403157242352799,0.0226326660347328,-0.0846757496633562,0.00404430119279642,0.0749042722620114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL1,Follistatin-related protein 1,35281,-0.0254628734581291,0.0143300310404563,-0.0535497342974234,0.00262398738116528,0.0756364454793679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TG,Thyroglobulin,35391,-0.129796245137903,0.0730811792784347,-0.273035356523635,0.0134428662478287,0.0757727936803776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF1,Trefoil factor 1,36347,-0.0931831431069017,0.0524736003471142,-0.196031399787245,0.00966511357344209,0.0758067466761386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADD1,Alpha-adducin,35312,-0.080058387956296,0.0452340303192965,-0.168717087382117,0.00860031146952503,0.0767984706344664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35402,-0.0254842008133109,0.0144196759373886,-0.0537467656505926,0.00277836402397087,0.0772235505380536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEBP1,Phosphatidylethanolamine-binding protein 1,36382,-0.0655536210912309,0.0371072982361349,-0.138283925634055,0.00717668345159346,0.0773382709857861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRN1,Neuritin,35417,-0.0424115864676631,0.02401133727544,-0.0894738075275255,0.00465063459219937,0.077392026535107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,36446,-0.0798627252021462,0.0452182877222285,-0.168490569137714,0.00876511873342176,0.0774110970927146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBP2,Poly(rC)-binding protein 2,35417,-0.0789241360405369,0.0446971261512718,-0.16653050329703,0.00868223121595593,0.0774861319257844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CERT,Ceramide transfer protein,36191,-0.0679484424662496,0.0384832553401961,-0.143375622933034,0.00747873800053479,0.0774960867591026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAP,Gamma-aminobutyric acid receptor-associated protein,35391,-0.0536920766685062,0.0304125840315738,-0.113300741370391,0.00591658803337851,0.0775364105509889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL8,Interleukin-8,36313,-0.0790107574463951,0.0448062145426163,-0.166830937949923,0.00880942305713286,0.077877902694216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPLAH,5-oxoprolinase,35281,-0.0759262631495446,0.0430612038373583,-0.160326222670767,0.00847369637167772,0.0779140000179472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR,GMP reductase 1,36442,-0.0575620199519658,0.0326689061033614,-0.121593075914554,0.00646903601062261,0.0781145109605597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,36446,-0.0306843113542663,0.0174185378676399,-0.0648246455748406,0.00345602286630796,0.0781808301556318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT1S1,Proline-rich AKT1 substrate 1,36191,-0.0738242794583337,0.0419406001274252,-0.156027855708087,0.0083792967914198,0.0784158300720661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1R,Huntingtin-interacting protein 1-related protein,35404,-0.0518807061483589,0.0295091151069728,-0.109718571758026,0.00595715946130776,0.078775539309849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LETM1,Mitochondrial proton/calcium exchanger protein,35417,-0.0579973540965814,0.0329996403724556,-0.122676649226594,0.00668194103343161,0.0788792769905522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD28,T-cell-specific surface glycoprotein CD28,36225,-0.042340719790224,0.024096262344024,-0.089569393984511,0.00488795440406307,0.078935959455786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARCL1,SPARC-like protein 1,36383,0.0303799645942168,0.017326973358364,-0.00358090318817659,0.0643408323766102,0.0795873766690351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPART,Spartin,35312,-0.0842435370532393,0.0480745421562516,-0.178469639679492,0.00998256557301372,0.079763330640069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLB1,Beta-galactosidase,36297,-0.0467156299123826,0.0267494416643053,-0.099144535574421,0.00571327574965581,0.0807820671504229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,36396,-0.0588417939090001,0.0336961585413441,-0.124886264650035,0.0072026768320344,0.0808107878935281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL1,Protein kinase C-binding protein NELL1,36397,0.0482931561252667,0.0276864790533757,-0.00597234281934961,0.102558655069883,0.0811517704141411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,36381,-0.0635605433119062,0.036492040752411,-0.135084943186632,0.00796385656281938,0.0815924324608054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR7L,Aflatoxin B1 aldehyde reductase member 4,35239,-0.0754275499076117,0.0433481502454149,-0.160389924388625,0.00953482457340142,0.081902745406992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDC,Aromatic-L-amino-acid decarboxylase,36350,0.0536259904042163,0.0308217845964817,-0.00678470740488786,0.11403668821332,0.0819243150448441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOSB,Protein fosB,36191,-0.0437152939250042,0.0251509578551447,-0.0930111713210877,0.00558058347107931,0.082234286574445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECI2,Enoyl-CoA delta isomerase 2,35214,-0.0683110519763368,0.0393089513063431,-0.145356596536769,0.00873449258409566,0.0822973927061744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTXR,Neuronal pentraxin receptor,36360,0.0375791006232624,0.0216287892531267,-0.00481332631286596,0.0799715275593907,0.0823494245540742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC1,Hamartin,35239,0.0804879453991474,0.0463734192227639,-0.0104039562774698,0.171379847075765,0.0826770007612926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMH,Granzyme H,36249,-0.0872753089717111,0.0505551889052001,-0.186363479225903,0.0118128612824811,0.0843305253697249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15,Interleukin-15,36352,-0.0371737465182676,0.0215363746340374,-0.0793850408009809,0.00503754776444574,0.0843741606441495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UGDH,UDP-glucose 6-dehydrogenase,35214,-0.106271487946818,0.0616438157827238,-0.227093366880956,0.0145503909873209,0.0847663594062191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,35281,-0.0827737635272208,0.0480508088749234,-0.176953348922071,0.0114058218676291,0.0850062546018023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35402,-0.03911819146877,0.0227119824168546,-0.083633677005805,0.00539729406826499,0.0850542797868575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,36227,-0.0476693794237021,0.0276780833252496,-0.101918422741191,0.00657966389378722,0.0850629699451943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CWC15,Spliceosome-associated protein CWC15 homolog,35360,-0.0682630995204397,0.039651771619242,-0.145980571894154,0.00945437285327466,0.0851985172470741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171A2,Protein FAM171A2,35417,-0.173395165718552,0.100879888008878,-0.371119746215953,0.024329414778848,0.0856954485672142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRG1,Scrapie-responsive protein 1,35420,-0.030337476382353,0.0176640446799995,-0.064959003955152,0.00428405119044603,0.0859429606875436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",35206,0.0554958257932668,0.0323479598699064,-0.00790617555174974,0.118897827138283,0.0862886944656051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEG1,Protein LEG1 homolog,35096,-0.0757818053620907,0.0442151380843123,-0.162443476007343,0.0108798652831614,0.0865934508078702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRG1,Leucine-rich alpha-2-glycoprotein,35448,-0.0298667637380112,0.0174283446545528,-0.0640263192609346,0.00429279178491221,0.0866354001514079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1B,Lithostathine-1-beta,36446,-0.062628363474088,0.0366608960660255,-0.134483719763498,0.00922699281532202,0.08762067899952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUCA1,Tissue alpha-L-fucosidase,36410,-0.0902744121390669,0.0531151536290931,-0.194380113252089,0.0138312889739556,0.089249654110747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THOP1,Thimet oligopeptidase,36315,-0.0344298522737879,0.0202683474026439,-0.07415581318297,0.00529610863539411,0.0894193084940332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRD1,Natural killer cells antigen CD94,36442,-0.0518667532436097,0.0305681193896585,-0.11178026724734,0.00804676076012092,0.0897850368664994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KEL,Kell blood group glycoprotein,36191,-0.0391255583982592,0.0230593391342745,-0.0843218631014371,0.00607074630491878,0.0897914911843629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP2B1,AP-2 complex subunit beta,35275,-0.0515792888974999,0.0304780132483542,-0.111316194864274,0.0081576170692744,0.0906315941225057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTproBNP,N-terminal prohormone of brain natriuretic peptide,36360,-0.122993964850292,0.0727065314192792,-0.265498766432079,0.0195108367314952,0.0907563086552411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSG1,Pregnancy-specific beta-1-glycoprotein 1,36297,-0.129570493221888,0.0766087177961791,-0.279723580102399,0.020582593658623,0.090817983905673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAP18,Chromatin complexes subunit BAP18,35416,-0.075486290730664,0.0446432668061801,-0.162987093670777,0.012014512209449,0.0909103056825044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENG,Endoglin,36446,-0.0188096098609399,0.0111562870410038,-0.0406759324613074,0.00305671273942746,0.0918369186677748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35312,-0.046122453999084,0.0273763424130813,-0.0997800851287234,0.00753517713055538,0.092086683216083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT8,"Keratin, type II cytoskeletal 8",35212,-0.0880902254185885,0.0523169326782944,-0.190631413468046,0.0144509626308686,0.0922759800983607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE5,Adhesion G protein-coupled receptor E5,36421,-0.0332787056547788,0.0197795770316945,-0.0720466766368999,0.00548926532734236,0.0925193615161795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35420,-0.0950494880278575,0.0565720300671886,-0.205930666959547,0.0158316909038322,0.0929783307284374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPO,Myeloperoxidase,36382,-0.0512102869458229,0.0304826752769589,-0.110956330488662,0.00853575659701652,0.0930046484111226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB4,Ephrin type-B receptor 4,36446,-0.0282470297449378,0.0168141619257669,-0.061202787119441,0.00470872762956536,0.0930092085624933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASC3,Protein CASC3,35275,-0.0444310174509852,0.0264575222529709,-0.0962877610668082,0.00742572616483769,0.0931383348282202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YJU2,Splicing factor YJU2,35391,-0.0339819658639347,0.0202416316315995,-0.0736555638618697,0.00569163213400028,0.0932384138550843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QDPR,Dihydropteridine reductase,36321,-0.0461412141570097,0.0274901024020801,-0.100021814865087,0.00773938655106726,0.093299918249045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPG1,Interphotoreceptor matrix proteoglycan 1,35212,-0.0305311417843437,0.018212547017738,-0.0662277339391102,0.00516545037042287,0.0937158086627776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYAP1,Synapse-associated protein 1,35312,-0.0605237381396229,0.0361131920825858,-0.131305594621491,0.0102581183422452,0.093799984486328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABCA2,ATP-binding cassette sub-family A member 2,35214,-0.0394096095698789,0.0235309165194972,-0.0855302059480935,0.00671098680833567,0.0940251639383521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHODH,Dihydroorotate dehydrogenase,35214,-0.0532194672637987,0.031778680564685,-0.115505681170581,0.00906674664298392,0.0940468343999618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FETUB,Fetuin-B,36399,-0.0339326083717102,0.0202636092213059,-0.0736492824454698,0.00578406570204926,0.0940641969846558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR2,Hepatitis A virus cellular receptor 2,36382,-0.0382796713018433,0.0228772987980985,-0.0831191769461163,0.00655983434242975,0.0943196167592716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXT,Oxytocin-neurophysin 1,36428,-0.146500386133344,0.0875647859276109,-0.318127366551461,0.0251265942847737,0.0943604197975888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFL7,Epidermal growth factor-like protein 7,36225,-0.0430712438176924,0.0257723723349557,-0.0935850935942055,0.00744260595882075,0.0947231956536305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNN,Tenascin-N,35438,0.0459641214378703,0.0275566946164503,-0.00804700001037227,0.0999752428861128,0.095369076156324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP1,Ran-specific GTPase-activating protein,35281,-0.0551643983884238,0.0331618365606574,-0.120161598047312,0.00983280127046481,0.096265778991034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",35212,-0.0333467549858319,0.0200487080552574,-0.0726422227741364,0.0059487128024727,0.09630707454797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP12,Macrophage metalloelastase,36369,-0.0578809668690142,0.034817418828809,-0.12612310777348,0.0103611740354514,0.0964734604681016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN2,Vascular non-inflammatory molecule 2,36331,-0.0489462389844367,0.0294634588133365,-0.106694618258576,0.00880214028970281,0.0967067057540861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRK5,G protein-coupled receptor kinase 5,36249,-0.0543414867263181,0.0327281820313561,-0.118488723507776,0.00980575005513973,0.0968808247769828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA11,Carbonic anhydrase-related protein 11,36225,-0.0319836577693539,0.0192689978803501,-0.06975089361484,0.00578357807613223,0.0969891056321446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL12,Stromal cell-derived factor 1,36227,-0.042057073631636,0.0253633720215725,-0.0917692827939181,0.00765513553064616,0.0973254377792996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A1,Collagen alpha-1(IX) chain,36352,-0.0509297255482561,0.0307777533005679,-0.111254122017369,0.00939467092085695,0.0980174905754811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSR,Insulin receptor,35239,-0.0184072605844334,0.0111255231421275,-0.0402132859430033,0.00339876477413649,0.0980763726338156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA,Adenosine deaminase,36442,-0.0374882659152206,0.0226632491464238,-0.0819082342422111,0.00693170241177001,0.0981416640479649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMB,Granzyme B,36352,-0.0710685954540702,0.042967231515864,-0.155284369225164,0.0131471783170232,0.0981676024331856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA2,Adenosine deaminase 2,36339,-0.0470924089691228,0.0285077861084062,-0.102967669741599,0.00878285180335329,0.0985960396472268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITM2A,Integral membrane protein 2A,36352,-0.0644665069411998,0.0390822935198426,-0.141067802240091,0.0121347883576918,0.0990877401172173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPB,Natriuretic peptides B,36249,-0.14496200134793,0.0880618379283349,-0.317563203687466,0.0276392009916067,0.0997797439995213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT2,Omega-amidase NIT2,35403,-0.0751715192290678,0.0457091773383549,-0.164761506812243,0.0144184683541079,0.100111048553424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEMIP2,Cell surface hyaluronidase,35239,0.0354318910229865,0.021546334342364,-0.00679892428804695,0.0776627063340199,0.100135075503642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TK1,"Thymidine kinase, cytosolic",35321,-0.0477097707384919,0.0290137425152353,-0.104576706068353,0.00915716459136929,0.10014794830431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK1,Serine protease inhibitor Kazal-type 1,36382,-0.0474855029049589,0.0289030875206485,-0.10413555444543,0.00916454863551221,0.10044292207794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOM,Apolipoprotein M,36399,0.029381925940533,0.017949291965477,-0.00579868631180193,0.0645625381928679,0.101686540380786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM2,Inactive carboxypeptidase-like protein X2,35420,-0.0278942457127156,0.0170598185382207,-0.0613314900476282,0.005542998622197,0.102081876839686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L,Seizure 6-like protein,36397,0.0289563994041439,0.0177290052184742,-0.00579245082406557,0.0637052496323533,0.102454185690005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN4,CCN family member 4,36427,-0.0417940874711635,0.02560751913079,-0.0919848249675118,0.00839665002518489,0.102701496602304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GAT1,"Beta-1,4-glucuronyltransferase 1",36382,0.025278150710234,0.0154947593800329,-0.00509157767463059,0.0556478790950985,0.102849749157372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPT1,Translationally-controlled tumor protein,36227,-0.0695965599406763,0.0426763312482132,-0.153242169187174,0.0140490493058215,0.102977309325121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTR1,Endosome-associated-trafficking regulator 1,35281,-0.0604158872384711,0.0371010120459181,-0.133133870848471,0.0123020963715285,0.103488425948305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRP15,RRP15-like protein,35212,-0.0931416389339393,0.057213794227629,-0.205280675620092,0.0189973977522135,0.103586194631495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2B,Ubiquitin-conjugating enzyme E2 B,35391,-0.0297088102240172,0.0182680762126897,-0.0655142396008891,0.00609661915285469,0.103943239896446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35402,-0.0655058443045091,0.0403813943228699,-0.144653377177334,0.0136416885683158,0.104815835413934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN1,Prorelaxin H1,35417,-0.0475472076725341,0.0293720536456521,-0.105116432818012,0.010022017472944,0.105542976500903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT1,Diamine acetyltransferase 1,35214,-0.0500641479844572,0.0309468997503141,-0.110720071495073,0.0105917755261585,0.10577026291029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD274,Programmed cell death 1 ligand 1,36297,-0.0359018941778697,0.0222042872827638,-0.0794222972520868,0.00761850889634746,0.105946393655109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,35239,-0.03383146318494,0.0209284101802559,-0.0748511471382416,0.00718822076836167,0.106031330492623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBA,Lysosomal acid glucosylceramidase,35275,-0.055909371199905,0.0346064399804206,-0.123737993561529,0.0119192511617194,0.106237659241533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB1,BPI fold-containing family B member 1,36348,-0.06330056256609,0.0391948351864511,-0.140122439531534,0.0135213143993542,0.106349799806941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP8,GTPase IMAP family member 8,35206,-0.0534924915502219,0.0331441820545328,-0.118455088377106,0.0114701052766624,0.106594424502738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSDE1,Cold shock domain-containing protein E1,35214,-0.120274052756394,0.0745434991427943,-0.26637931107627,0.025831205563483,0.106693820123262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA3,Alpha-1-antichymotrypsin,35424,-0.0159339774303225,0.00987809488390057,-0.0352950434027676,0.0034270885421226,0.106781732053118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDGF1,Teratocarcinoma-derived growth factor 1,36191,-0.15351038647439,0.0951704731138321,-0.340044513777501,0.033023740828721,0.106788660797829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG2,"Arginase-2, mitochondrial",35391,-0.0433181386869568,0.026863098970461,-0.0959698126690604,0.00933353529514672,0.106892837149033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLI2,Zinc finger protein GLI2,35239,0.0329868395229568,0.020471746754697,-0.00713778411624937,0.073111463162163,0.107158959965425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME1,Proteasome activator complex subunit 1,36280,-0.0392899684390156,0.0243875477765574,-0.0870895620810682,0.00850962520303695,0.107209703108908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11,Coagulation factor XI,35363,0.0311400348886172,0.0193375565500487,-0.00676157594947827,0.0690416457267127,0.10737488050336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FEN1,Flap endonuclease 1,36225,-0.0692383695050326,0.0430289503551736,-0.153575112201173,0.0150983731911076,0.107636905524932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC8,Sialic acid-binding Ig-like lectin 8,35281,-0.046189175869139,0.0287089753936119,-0.102458767640618,0.0100804159023404,0.107695359616038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHD3,EH domain-containing protein 3,35281,-0.117232308062501,0.0728998202518282,-0.260115955756084,0.0256513396310826,0.107858811893114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD109,CD109 antigen,36382,0.0338254445128108,0.0210367144730208,-0.00740651585430998,0.0750574048799316,0.107895676912076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC10,Sialic acid-binding Ig-like lectin 10,36352,-0.0356026556182705,0.0221462361101861,-0.0790092783942352,0.00780396715769414,0.107963290338093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD51,DNA repair protein RAD51 homolog 1,35321,-0.0553629257634247,0.0344799529785304,-0.122943633601344,0.0122177820744949,0.108401160694479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD160,CD160 antigen,36442,-0.0509098865747765,0.0317091915694103,-0.113059902050821,0.0112401289012677,0.108421972200202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBN,Nibrin,36227,-0.0574572546689865,0.0357995480325728,-0.127624368812829,0.0127098594748562,0.108544973065336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALMS1,Alstrom syndrome protein 1,35321,0.044802144501249,0.0279163059559481,-0.00991381517240932,0.0995181041749074,0.108573146113027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPIND1,Heparin cofactor 2,35438,-0.0284630511724966,0.0177513156953426,-0.063255629935368,0.00632952759037488,0.108889596435131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSN,Gelsolin,35403,0.0185125423692607,0.01155114123158,-0.00412769444463612,0.0411527791831575,0.109060789999453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH1,Acid ceramidase,35375,-0.046328427456492,0.0289270595738571,-0.103025464221252,0.0103686093082679,0.109303998132663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC28A,Coiled-coil domain-containing protein 28A,35275,0.0306441099042982,0.019142753167546,-0.006875686304092,0.0681639061126884,0.109468647212795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35438,-0.0647433314096485,0.040472685572,-0.144069795130769,0.0145831323114715,0.109720262162026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,36249,-0.0343292314731112,0.0214911471804364,-0.0764518799467666,0.00779341700054419,0.110228893690945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C1A,Cytosolic 5'-nucleotidase 1A,35416,-0.0319094728646229,0.0199813321561561,-0.0710728838906889,0.00725393816144301,0.110324461383838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRB1,Killer cell lectin-like receptor subfamily B member 1,36442,-0.0407205949608019,0.0255018691113811,-0.090704258419109,0.00926306849750514,0.110360794747896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC16A1,Monocarboxylate transporter 1,36191,-0.0565501492487154,0.0354810206911733,-0.126092949803415,0.0129926513059843,0.111022857187091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD1,26S proteasome non-ATPase regulatory subunit 1,35417,-0.0509771456903712,0.0319872475031577,-0.11367215079656,0.011717859415818,0.111060549423275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL8,C-C motif chemokine 8,36411,-0.060721876075172,0.0381055393359255,-0.135408733173586,0.0139649810232419,0.111087746931626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",35281,-0.090617025143157,0.0568936491563429,-0.202128577489589,0.0208945272032751,0.111269528745184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGRN,Neugrin,35416,-0.0231044968120872,0.0145074425347311,-0.0515390841801602,0.0053300905559857,0.111301619737499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIT,Bis(5'-adenosyl)-triphosphatase,36191,-0.0732867586889351,0.0460527056825568,-0.163550061826746,0.0169765444488762,0.111572168041464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EEF1D,Elongation factor 1-delta,35420,-0.0920446859982946,0.0578803433804246,-0.205490159023927,0.0214007870273377,0.111827406549193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY96,Lymphocyte antigen 96,36297,-0.0376684608227719,0.0237008861350876,-0.0841221976475437,0.00878527600199989,0.112031067302468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL13,C-X-C motif chemokine 13,36428,-0.0643042733081527,0.0405168477713,-0.143717294939901,0.0151087483235952,0.11253379137405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,36184,-0.0486496344756828,0.0306566281473722,-0.108736625644532,0.0114373566931666,0.112575861835118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",36227,-0.0726272530357835,0.0457843495945802,-0.162364578241161,0.0171100721695937,0.112718510222324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2L,Ataxin-2-like protein,35417,-0.0467578142873243,0.0295284442206566,-0.104633564959811,0.0111179363851627,0.113362041756607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3D,Protein FAM3D,35402,-0.0849795419796425,0.0537134837128169,-0.190257970056764,0.0202988860974786,0.113680067068264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP6,Dipeptidyl aminopeptidase-like protein 6,36331,0.0340897403070431,0.0215546356568901,-0.0081573455804614,0.0763368261945477,0.113796581016229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBQ1,Hemoglobin subunit theta-1,36427,-0.063199818135359,0.0399722388050761,-0.141545406193308,0.0151457699225901,0.113900549937597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN3A2,Butyrophilin subfamily 3 member A2,36352,-0.0385976236820126,0.0244325116605805,-0.0864853465367503,0.00929009917272517,0.114204907880336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BATF,Basic leucine zipper transcriptional factor ATF-like,35275,-0.0871277155785079,0.0552265548156188,-0.195371763017121,0.021116331860105,0.114699962769512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPMT,Thiopurine S-methyltransferase,36225,-0.0740591551908312,0.046945702005491,-0.166072731121593,0.0179544207399311,0.114714195278283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK6,SLIT and NTRK-like protein 6,36249,-0.0351945746813771,0.0223233391571361,-0.0789483194293639,0.0085591700666096,0.114936573201252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC10A,C-type lectin domain family 10 member A,36297,-0.0365350996448186,0.0232051629391642,-0.0820172190055804,0.00894701971594321,0.115430668088532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP25,Rho GTPase-activating protein 25,36225,-0.0595301159212824,0.037816688951225,-0.133650826265683,0.0145905944231186,0.115491809246987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGBL2,Cytosolic carboxypeptidase 2,35212,-0.0908098111096916,0.0577078871361696,-0.203917269896584,0.0222976476772007,0.115629794863495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB8,DnaJ homolog subfamily B member 8,36249,-0.0565169546729594,0.0359688477197348,-0.12701589620364,0.0139819868577208,0.116163606963443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEG1,Protein HEG homolog 1,35312,-0.0273907614201637,0.0174452532484143,-0.0615834577870557,0.00680193494672836,0.116443971343892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD3,Extracellular superoxide dismutase,35428,0.0568568970944412,0.0362200044737605,-0.0141343116741293,0.127848105863012,0.116520533112682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMNDC1,Survival of motor neuron-related-splicing factor 30,35402,-0.0627648345171701,0.0399849425494277,-0.141135321914048,0.0156056528797081,0.116533148377302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2BP,LRP2-binding protein,35275,0.0850069924912614,0.0541778588468905,-0.021181610848644,0.191195595831167,0.116691659603643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A14,Protein S100-A14,35417,0.0542242245545534,0.0346123926516861,-0.0136160650427514,0.122064514151858,0.117256020596791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SWAP70,Switch-associated protein 70,35402,-0.0347339901321858,0.0221724845670849,-0.0781920598836722,0.00872407961930055,0.117274209834238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35420,-0.0708273932798277,0.0452165605315369,-0.15945185192164,0.0177970653619847,0.117304929306805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSR1,Macrophage scavenger receptor types I and II,36428,-0.0453513037115404,0.0289680015421177,-0.102128586734091,0.0114259793110104,0.117494113101357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAP1,Proline-rich acidic protein 1,35438,-0.0396046755080827,0.0253745173900743,-0.0893387295926284,0.0101293785764629,0.118620428615799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35416,-0.0448549525768153,0.0287390508946253,-0.101183492330281,0.0114735871766503,0.118629673807607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,35212,-0.0577105412033082,0.0369761586262789,-0.130183812110815,0.0147627297041985,0.118635320555597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POF1B,Protein POF1B,35239,-0.0461955743264064,0.0296065313204873,-0.104224375714562,0.0118332270617487,0.118737333858796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35420,-0.0880792601927672,0.0564584024721763,-0.198737729038233,0.0225792086526985,0.118793327780577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,35281,-0.0516042844808522,0.0330974772129309,-0.116475339818197,0.0132667708564924,0.119010345739533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD5,Programmed cell death protein 5,36428,-0.0576845570651056,0.0370406191321181,-0.130284170564057,0.0149150564338459,0.119435326517068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LUZP2,Leucine zipper protein 2,35391,-0.0443524783902053,0.0285093965117915,-0.100230895553317,0.011525938772906,0.119827088434776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF1,Rho guanine nucleotide exchange factor 1,35416,-0.0866804794803108,0.0557415689391194,-0.195933954600985,0.0225729956403633,0.119986932713222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM25,Transmembrane protein 25,35417,-0.0444375285489164,0.0285834119368681,-0.100461015945178,0.0115859588473451,0.120077573037512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCG,Pro-glucagon,36225,0.124377445044037,0.0801597683066615,-0.0327357008370198,0.281490590925093,0.12079834601199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC13,Mucin-13,36191,-0.0505590670869763,0.0326193017114675,-0.114492898441452,0.0133747642675,0.121193001044185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM1,Isthmin-1,36352,-0.0386295622114198,0.024928295536054,-0.0874890214620856,0.0102298970392461,0.121275254619278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP4,Guanylate-binding protein 4,36191,-0.0470859894586644,0.0304114520288747,-0.106692435435259,0.01252045651793,0.121595798570666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP9,Matrix metalloproteinase-9,36370,-0.0588444392364217,0.0380099138463045,-0.133343870375179,0.0156549919023352,0.121634139812658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDI2,Isopentenyl-diphosphate delta-isomerase 2,36191,-0.0476450142980168,0.0308073482473325,-0.108027416862788,0.0127373882667549,0.122017725316356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL11,Eotaxin,36442,-0.0363355542077443,0.0234983040779075,-0.0823922302004429,0.00972112178495434,0.122074489949645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFIC,Nuclear factor 1 C-type,35417,-0.0439883737156503,0.0285663678850747,-0.0999784547703968,0.0120017073390961,0.123643905771327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HHEX,Hematopoietically-expressed homeobox protein HHEX,35416,-0.0721667997409694,0.046880901154492,-0.164053366003774,0.019719766521835,0.12376616198945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB2,Interleukin-12 receptor subunit beta-2,35239,0.0399133479543,0.0259328373269984,-0.0109150132066168,0.0907417091152168,0.123831113987966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC2,PDZ domain-containing protein GIPC2,35416,-0.0301199964058615,0.0195732125206763,-0.0684834929463871,0.00824350013466409,0.123894785810532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH17,Protocadherin-17,36360,0.0362280332756177,0.0235500369392588,-0.00993003912532964,0.082386105676565,0.124008935119821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP1,Metalloproteinase inhibitor 1,36297,-0.0288274084563186,0.0187993739513879,-0.0656741814010388,0.00801936448840165,0.125215991630152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4E,Eukaryotic translation initiation factor 4E,35239,-0.0860863026028581,0.0561919461505146,-0.196222517057867,0.0240499118521505,0.125573704503983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCF2,Neutrophil cytosol factor 2,36343,-0.0847886978081568,0.0555188091184656,-0.193605563680349,0.0240281680640357,0.126753857603124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35417,-0.0629598315690411,0.0412338688955912,-0.1437782146044,0.0178585514663177,0.126837683088705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,36225,0.0322535630448589,0.0211760753087851,-0.00925154456035992,0.0737586706500776,0.127775321865355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UHRF2,E3 ubiquitin-protein ligase UHRF2,35214,-0.0339858626189359,0.02239229929965,-0.0778747692462498,0.00990304400837801,0.129130502994619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCY2C,Heat-stable enterotoxin receptor,35321,-0.0790604288871098,0.0520976723821256,-0.181171866756076,0.0230510089818564,0.129181378895119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB17,Zinc finger and BTB domain-containing protein 17,36249,-0.04163158104183,0.0274499118346862,-0.095433408237815,0.012170246154155,0.129402894024717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF3,Fibroblast growth factor 3,35239,-0.0285233628125826,0.0188103931322934,-0.0653917333518776,0.00834500772671236,0.129480164493131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,36410,-0.041492050582736,0.02737339006408,-0.0951438951083328,0.0121597939428609,0.1296186687091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBLN2,Fibulin-2,35438,-0.0311073721878393,0.0205450161952156,-0.0713756039304619,0.00916085955478317,0.13004907915786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSBP1,Heat shock factor-binding protein 1,35281,-0.0885815712116086,0.0585607154350849,-0.203360573464375,0.0261974310411578,0.130421781411479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENAH,Protein enabled homolog,36227,-0.0467337010842094,0.0309308757491098,-0.107358217552465,0.0138908153840458,0.130856872647236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCPEP1,Retinoid-inducible serine carboxypeptidase,35258,-0.0469632134422469,0.0311407682400502,-0.107999119192745,0.0140726923082516,0.131582501817323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DFFA,DNA fragmentation factor subunit alpha,36442,-0.0643815381706923,0.0427740067633966,-0.14821859142695,0.0194555150855651,0.132327637779266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,36331,0.0189858623283093,0.0126223537091219,-0.00575395094156957,0.0437256755981881,0.132588037497165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFP,Alpha-fetoprotein,36271,0.0644729539408699,0.0428788723335168,-0.0195696358328231,0.148515543714563,0.13272732164732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FST,Follistatin,36390,-0.047738002618227,0.0317804102202443,-0.110027606649906,0.0145516014134519,0.133109894880109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD59,CD59 glycoprotein,36096,-0.0230442873740815,0.0153892217254739,-0.0532071619560103,0.00711858720784727,0.13432704924935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARFIP1,Arfaptin-1,35417,-0.0640430826924616,0.0427981086059132,-0.147927375560052,0.0198412101751283,0.13460020475835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LECT2,Leukocyte cell-derived chemotaxin-2,35420,-0.0630766866057273,0.0421540953441214,-0.145698713480205,0.0195453402687506,0.134616829479244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,36382,-0.0301361891420601,0.0201831002879754,-0.0696950657064918,0.00942268742237172,0.135444501922596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMPD3,AMP deaminase 3,35416,-0.0683388561851968,0.0457764469412292,-0.158060692190006,0.0213829798196123,0.135518651801827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE10,Inactive ribonuclease-like protein 10,35281,-0.0453868038966484,0.030429499237722,-0.105028622402584,0.0142550146092868,0.135871696063158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEPK,Rab9 effector protein with kelch motifs,36225,-0.0536386559135415,0.0359652641003592,-0.124130573550245,0.0168532617231625,0.135900925148703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLKB1,Plasma kallikrein,35324,0.023167395135875,0.0155931475890595,-0.00739517413868164,0.0537299644104317,0.137398786619395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPEP,Glutamyl aminopeptidase,35214,-0.0417225256256395,0.0281449442312119,-0.0968866163188149,0.0134415650675359,0.138281888575175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GET3,ATPase GET3,35420,-0.0519696253682883,0.0350686142382887,-0.120704109275334,0.0167648585387576,0.138406541740486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,36297,-0.0694431468480856,0.0468850348814414,-0.161337815215711,0.0224515215195395,0.138614500344502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP2B,DNA topoisomerase 2-beta,35239,-0.0742214400809791,0.0501165249178667,-0.172449828919998,0.0240069487580397,0.138664717681958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT1,Kunitz-type protease inhibitor 1,36360,-0.0247357086826155,0.0167121824941717,-0.0574915863711921,0.0080201690059611,0.138890404451672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP25,Ubiquitin carboxyl-terminal hydrolase 25,35391,-0.0663481192683278,0.0448339209975817,-0.154222604423588,0.0215263658869323,0.138960296537952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL5,Insulin-like peptide INSL5,35402,-0.0906391438307115,0.0612669933744989,-0.210722450844729,0.0294441631833063,0.139080893560292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNW1,Interferon omega-1,35214,-0.0343488771471664,0.0232304942939674,-0.0798806459633424,0.0111828916690096,0.139296483503988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL26,C-C motif chemokine 26,36352,0.0885762899581663,0.0599124857855708,-0.0288521821815525,0.206004762097885,0.139337285388578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSMB,Beta-microseminoprotein,36346,-0.0677594431522169,0.0458543734049107,-0.157634015025842,0.0221151287214081,0.139529584209083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP5,Microfibrillar-associated protein 5,36446,-0.0383454516269099,0.0259721899387459,-0.0892509439068519,0.0125600406530322,0.139878821251394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROK1,Prokineticin-1,36352,-0.0523282884905637,0.035481329226829,-0.121871693775149,0.017215116794021,0.14030708644731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHS1,"Enoyl-CoA hydratase, mitochondrial",35281,-0.0885220400096529,0.060040646485749,-0.206201707121721,0.0291576271024152,0.140434106338196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMC3,Structural maintenance of chromosomes protein 3,35206,-0.0505587567188042,0.0342933275684804,-0.117773678753026,0.0166561653154174,0.140452379478708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASP,Vasodilator-stimulated phosphoprotein,35428,-0.0674447399764052,0.0457473506047105,-0.157109547161638,0.0222200672088273,0.14045473646434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN1,Perilipin-1,36191,0.0324701610003314,0.0220384700080298,-0.0107252402154071,0.0756655622160698,0.140704343590467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSB,Cathepsin B,36375,-0.0505864610389155,0.0343453433741117,-0.117903334052174,0.0167304119743434,0.140828074062794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,36249,-0.0290837763544063,0.0197521196648733,-0.067797930897558,0.00963037818874538,0.140947180490824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,36327,-0.0260561947685663,0.0176999934931857,-0.0607481820152102,0.00863579247807763,0.141037469593823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZFYVE19,Abscission/NoCut checkpoint regulator,35402,-0.0830790929252809,0.056495188196962,-0.193809661791326,0.0276514759407646,0.141463085006439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH1A1,Retinal dehydrogenase 1,36382,-0.0516164733451268,0.0351291169917599,-0.120469542648976,0.0172365959587227,0.141785462923262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGF,Placenta growth factor,36442,-0.024450609461841,0.0166409818003954,-0.0570669337906159,0.00816571486693396,0.141794595150558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD6,MICOS complex subunit MIC25,35391,-0.0278346486986486,0.0189584239527463,-0.0649931596460313,0.009323862248734,0.142102224156417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIGR,Polymeric immunoglobulin receptor,36293,-0.0334228528876144,0.0227770888764481,-0.0780659470854526,0.0112202413102238,0.142314526596896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF149,E3 ubiquitin-protein ligase RNF149,35281,-0.0292172755999026,0.0199392700696206,-0.068298244936359,0.00986369373655366,0.142887136240774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE2,Adhesion G protein-coupled receptor E2,36403,-0.0265025653409243,0.0180880278385769,-0.061955099904535,0.00894996922268651,0.142910166301456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35416,-0.0386711730124794,0.026418482673991,-0.0904513990535018,0.013109053028543,0.143301208399472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35402,-0.0282894617619934,0.0193300949720139,-0.0661764479071406,0.00959752438315372,0.143383112618675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM3,Dynamin-3,35417,-0.0493481568837501,0.0337773436889609,-0.115551750514113,0.0168554367466132,0.144070334139063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSAB1,Tryptase alpha/beta-1,36430,-0.0494600855185436,0.0338558056179024,-0.115817464529632,0.0168972934925452,0.144085177827653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUSB,Beta-glucuronidase,36400,0.0563100862255784,0.0385555092732133,-0.0192587119499196,0.131878884401077,0.14419797872908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCLRE1C,Protein artemis,35206,0.0288132729125448,0.0197487466246242,-0.00989427047171858,0.0675208162968082,0.144619418625477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTIF3,"Translation initiation factor IF-3, mitochondrial",35402,-0.0802815799168702,0.0550751272770331,-0.188228829379855,0.0276656695461148,0.144981010076181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,35312,-0.046792699149233,0.0321553282311524,-0.109817142482292,0.0162317441838256,0.145662921556706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18R1,Interleukin-18 receptor 1,36442,-0.0308132650708316,0.0211764022519497,-0.0723190134846529,0.0106924833429898,0.145691654542937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEP1,Rab GTPase-binding effector protein 1,35312,-0.0713187869563388,0.0490378575780928,-0.167432987809401,0.0247954138967231,0.145897322753712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCL2,Phosducin-like protein 2,35206,-0.0503565503432814,0.0346674393001506,-0.118304731371577,0.0175916306850137,0.146398028150339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP4,Contactin-associated protein-like 4,35275,-0.0954510446036701,0.0657224328956321,-0.224267013079109,0.0333649238717687,0.146459840568451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5PO,"ATP synthase subunit O, mitochondrial",36191,0.0386381380899611,0.0266537214557282,-0.0136031559632662,0.0908794321431884,0.14720545654758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSIP1,PC4 and SFRS1-interacting protein,36352,-0.061193517937043,0.0422414402783805,-0.143986740882669,0.0215997050085828,0.147476140247567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LZTFL1,Leucine zipper transcription factor-like protein 1,35312,-0.0646061142651062,0.0446441358728168,-0.152108620575827,0.0228963920456147,0.147910209181879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPB1,Signal-regulatory protein beta-1,36361,-0.0442218334454633,0.0305894132705307,-0.104177083455703,0.0157334165647769,0.148316842624797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",36191,-0.0279942061798149,0.0193838492826672,-0.0659865507738426,0.00999813841421273,0.148726758837229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN2,Prorelaxin H2,35304,-0.0445197165755027,0.0308586346772145,-0.105002640542843,0.0159632073918378,0.14915658495235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",35214,-0.0536293996396799,0.0371905979534781,-0.126522971628497,0.0192641723491371,0.14935016517924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",35214,-0.0440277299236417,0.0305424619754173,-0.10389095539546,0.0158354955481763,0.149488365860744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORCS2,VPS10 domain-containing receptor SorCS2,36225,-0.033567731962994,0.0233011129559964,-0.0792379133567469,0.0121024494307589,0.149740445182374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB3,Receptor tyrosine-protein kinase erbB-3,36356,0.0175484041675683,0.0121843375274634,-0.00633289738625997,0.0414297057213966,0.149842433908445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB37,Ras-related protein Rab-37,36227,-0.0740178579535918,0.0514158843924663,-0.174792991362826,0.0267572754556422,0.150027579562966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAN,Versican core protein,36428,-0.0278928232048991,0.0194237891571133,-0.0659634499528412,0.010177803543043,0.151041743264761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHR1,Corticotropin-releasing factor receptor 1,36249,-0.0555642939146041,0.0386987011542023,-0.131413748176841,0.0202851603476325,0.151098455299431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35416,-0.0494676785674686,0.0344877515368717,-0.117063671579737,0.0181283144447999,0.151521240535222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR2,Folate receptor beta,36428,-0.0271091177960037,0.0189102099349947,-0.0641731292685932,0.00995489367658583,0.151738105445749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THTPA,Thiamine-triphosphatase,35382,-0.0787223437570088,0.0549537257472772,-0.186431646221672,0.0289869587076545,0.152045402259195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSB,Lupus La protein,36191,-0.0539781864774278,0.0376822256189228,-0.127835348690517,0.0198789757356609,0.152057606893086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYTL4,Synaptotagmin-like protein 4,35420,-0.0663155271048265,0.0463061071370473,-0.157075497093439,0.0244444428837861,0.152161999797168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKD2,Serine/threonine-protein kinase D2,35214,-0.0405967121731033,0.0283766715730565,-0.0962149884562941,0.0150215641100875,0.152586221733955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL32,Interleukin-32,36352,-0.0408877509216901,0.0285853529591511,-0.0969150427216262,0.0151395408782461,0.152653302367145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT2,NAD-dependent protein deacetylase sirtuin-2,36331,-0.0804527630715036,0.056275425246036,-0.190752596553734,0.0298470704107271,0.152868404677354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPLA2,Acyl-protein thioesterase 2,35212,-0.100288252145539,0.0701546254837156,-0.237791318093621,0.0372148138025441,0.152903414712001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35420,-0.0548191001595062,0.03834981034811,-0.129984728441802,0.0203465281227895,0.152925380552708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",35212,-0.0380210400174569,0.0266006945496559,-0.0901584013347824,0.0141163212998686,0.152962724751563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PREB,Prolactin regulatory element-binding protein,36227,-0.0272026910409903,0.0190764006267426,-0.0645924362694059,0.0101870541874252,0.153916602931928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A11,Protein S100-A11,36303,0.0446204886532643,0.031319329225237,-0.0167653966282002,0.106006373934729,0.154289310287247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGLN1,Egl nine homolog 1,36352,-0.0528275150141534,0.0370854501545664,-0.125514997317104,0.0198599672887968,0.154350907434924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11D,Transmembrane protease serine 11D,35405,-0.0363381519266284,0.0255312426202422,-0.0863793874623031,0.0137030836090464,0.154704719943835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSRP3,Cysteine and glycine-rich protein 3,35214,-0.0880592629208499,0.0618828237135144,-0.209349597399338,0.0332310715576384,0.154787950690961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,35212,-0.0448326213785643,0.031522177216616,-0.106616088723132,0.0169508459660031,0.15500362912487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBQLN3,Ubiquilin-3,35214,-0.0462957291843891,0.0325618458686848,-0.110116947087011,0.017525488718233,0.155142395224812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D2,DCN1-like protein 2,35206,0.0731657619652835,0.0514916736515724,-0.0277579183917984,0.174089442322365,0.155390677850786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSG1,Tryptase gamma,35239,0.0242471202031387,0.0170719967770905,-0.00921399347995874,0.0577082338862361,0.155575970276276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PZP,Pregnancy zone protein,35448,-0.0444250265596766,0.0313092986948734,-0.105791252001628,0.0169411988822752,0.155975559692758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG2,Bone marrow proteoglycan,35438,-0.0475107132551943,0.0334890766557194,-0.113149303500404,0.0181278769900158,0.156038496387588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE6,Ribonuclease K6,35382,-0.0297069294785857,0.0209695298247051,-0.0708072079350076,0.0113933489778362,0.156629413077819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHP1,Calcineurin B homologous protein 1,35212,-0.0647544302484299,0.0457405318944864,-0.154405872761623,0.0248970122647634,0.156917929993354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,36427,0.0239066126551342,0.0168892111503341,-0.0091962411995207,0.0570094665097891,0.156966143286137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35417,-0.0349566666436031,0.0247004069176095,-0.0833694642021178,0.0134561309149116,0.157052181077792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR1,TGF-beta receptor type-1,35239,-0.0190602305010401,0.013496642937122,-0.0455136506577992,0.00739318965571913,0.157936638344571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFD,Complement factor D,35448,-0.018668915798373,0.0132310726632577,-0.044601818218358,0.00726398662161206,0.158297201455307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMPER,BMP-binding endothelial regulator protein,35312,-0.0213060725417481,0.01510269684922,-0.0509073583662193,0.00829521328272305,0.158370299798003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,36249,-0.0527026501818985,0.0373719723360624,-0.125951715960581,0.0205464155967838,0.158519233319109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAM1,Vascular cell adhesion protein 1,36399,-0.0250028904904516,0.0177661848376955,-0.0598246127723349,0.00981883179143165,0.159372601452258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMRK2,Nicotinamide riboside kinase 2,35206,-0.0374045370349391,0.0266121425963147,-0.0895643365237159,0.0147552624538377,0.159911252276624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XRCC4,DNA repair protein XRCC4,36191,-0.0327002864316757,0.0232969860437663,-0.0783623790774576,0.0129618062141061,0.160474229103559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN2,Ficolin-2,36353,0.0358740715224369,0.0255697375719911,-0.0142426141186657,0.0859907571635394,0.160663358090894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REN,Renin,36360,-0.0757711029259596,0.054039719996472,-0.181688954119045,0.0301467482671256,0.160917588658056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB2,BPI fold-containing family B member 2,35407,-0.0599458396556403,0.0427552721746505,-0.143746173117955,0.0238544938066747,0.160944615442345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC1A4,Neutral amino acid transporter A,35275,-0.045189896489762,0.0323017954750084,-0.108501415620778,0.0181216226412545,0.161866912601223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES2,Retinoic acid receptor responder protein 2,36418,-0.041232326282567,0.0294796285941212,-0.0990123983270445,0.0165477457619106,0.161954342029938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC1,SPARC-related modular calcium-binding protein 1,36427,-0.0293569851451958,0.0209922294224837,-0.0705017548132638,0.0117877845228721,0.162015104825543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSM,Oncostatin-M,36320,-0.0630553941278452,0.0451017264927933,-0.15145477805372,0.0253439897980297,0.162135404270021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK7,Kallikrein-7,35154,0.0337950815533043,0.0241810557547915,-0.013599787726087,0.0811899508326956,0.162289733901505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35402,-0.127996364036598,0.0916239526138985,-0.307579311159839,0.0515865830866436,0.162471044426997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEAR1,Platelet endothelial aggregation receptor 1,36446,-0.0202097619051016,0.014470543228539,-0.048572026633038,0.00815250282283485,0.162572445928483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL21R,Interleukin-21 receptor,35239,-0.0476332006494801,0.0341489980836179,-0.114565236893371,0.019298835594411,0.163108169572796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNB2,Ephrin-B2,35275,-0.0488588462310301,0.035057523412819,-0.117571592120155,0.0198538996580953,0.163466247790995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35391,-0.0670335780840725,0.0481408752533933,-0.161389693580723,0.0273225374125785,0.163837286534889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,35206,-0.0487274063667621,0.0350158696226019,-0.117358510827062,0.0199036980935377,0.164100908348243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPY30,Protein dpy-30 homolog,36400,-0.053930977226625,0.0387680444278303,-0.129916344305172,0.0220543898519224,0.164232183092816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHBG,Sex hormone-binding globulin,35428,-0.0437170085169911,0.0314288579985228,-0.105317570194096,0.0178835531601135,0.164280212017495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLM2,Protein GOLM2,36428,-0.0198798103110179,0.0142947789565856,-0.0478975770659257,0.00813795644388981,0.164357895960944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL25,Interleukin-25,35181,-0.030177153049781,0.0217134312954062,-0.0727354783887772,0.0123811722892151,0.164643722820913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAC1,Cartilage acidic protein 1,36446,-0.026604372277678,0.0191573421423938,-0.0641527628767699,0.0109440183214139,0.164957571138846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,36350,-0.0289596746793618,0.020857882097371,-0.0698411235902089,0.0119217742314852,0.165049867050897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC15,Sialic acid-binding Ig-like lectin 15,36191,0.0676901310423544,0.0487696789847656,-0.0278984397677862,0.163278701852495,0.165194870578521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1,DNA topoisomerase 1,35402,-0.0973291424738248,0.0701346483613041,-0.234793053261981,0.0401347683143313,0.165263928079921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,36351,-0.0537231496569176,0.0387334493251262,-0.129640710334165,0.0221944110203298,0.165486093739217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53BP1,TP53-binding protein 1,35239,0.0756778251472682,0.0546502004018736,-0.0314365676404041,0.18279221793494,0.1661746561787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCT5,T-complex protein 1 subunit epsilon,36225,-0.0396852769944614,0.0286678311251595,-0.0958742259997741,0.0165036720108513,0.166306294188668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35420,-0.0269953230794271,0.0195149864484083,-0.0652446965183072,0.0112540503594531,0.16661869133475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD8,Frizzled-8,35212,-0.039315960308381,0.028427203633207,-0.0950332794294668,0.0164013588127047,0.166703904213096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3F,Semaphorin-3F,36360,-0.0238298559404512,0.0172306911614793,-0.0576020106169506,0.00994229873604823,0.166711335031279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPSE,Heparanase,35342,-0.0803192146659578,0.058102820056865,-0.194200741977413,0.0335623126454977,0.166910347993832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN2,Neuroligin-2,35212,-0.0424804269229757,0.0307520472311205,-0.102754439495972,0.0177935856500206,0.167211798580021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN1,Transcobalamin-1,35298,-0.0290897267859393,0.02109023775675,-0.0704265927891694,0.0122471392172908,0.167853365104656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFX1,Transcriptional repressor NF-X1,35214,-0.0583116101215107,0.0423193082878703,-0.141257454365736,0.0246342341227151,0.168286581956552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRC,Receptor-type tyrosine-protein phosphatase C,35438,-0.0201490720280366,0.0146249733203116,-0.0488140197358475,0.00851587567977417,0.168340104838281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPP1,Tripeptidyl-peptidase 1,36320,-0.0397607709707053,0.0289035568112315,-0.096411742320719,0.0168902003793084,0.168977616802383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35321,-0.0434765678937826,0.0316060562643535,-0.105424438171915,0.0184713023843502,0.169002879205207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2,T-cell surface antigen CD2,35214,-0.0340009507577894,0.0247283175553249,-0.0824684531662262,0.0144665516506474,0.169188706162642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGES2,Prostaglandin E synthase 2,35198,-0.0473563562637827,0.0345140653310551,-0.115003924312651,0.0202912117850854,0.170087112461021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOH,Beta-2-glycoprotein 1,36382,-0.0311075450371133,0.0227143195211428,-0.0756276112985532,0.0134125212243265,0.170881906079821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUOX,"Sulfite oxidase, mitochondrial",35417,-0.0544131638013037,0.0397468978901514,-0.132317083666,0.023490756063393,0.171051353343643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC1,Stanniocalcin-1,36428,-0.0384492853818429,0.0280963064490208,-0.0935180460219236,0.0166194752582378,0.171203797231518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,35193,-0.0455430193659642,0.033341989500849,-0.110893318787628,0.0198072800556998,0.172010297951571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RETN,Resistin,36348,-0.0381246347567132,0.0279192932228338,-0.0928464494734675,0.0165971799600411,0.172129437271317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",35214,0.0342916627032439,0.0251921165909565,-0.0150848858150308,0.0836682112215185,0.173499515647849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK2B,Divergent protein kinase domain 2B,35312,0.0243321968731445,0.0178977560005141,-0.0107474048878631,0.0594117986341522,0.174034810255276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,35281,-0.0359723361725546,0.0264724994367797,-0.0878584350686427,0.0159137627235335,0.174242314712339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG4,Chondroitin sulfate proteoglycan 4,35438,-0.0287239347819141,0.021143040142107,-0.0701642934604438,0.0127164238966156,0.174337441686752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2A,Sodium channel protein type 2 subunit alpha,35212,0.0428322359921914,0.0315423876606368,-0.0189908438226569,0.10465531580704,0.174537998451741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLGA3,Golgin subfamily A member 3,35417,-0.0656599731262235,0.0483780318496116,-0.160480915551462,0.0291609692990153,0.174758301400427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDNRB,Endothelin receptor type B,35239,0.0375351337256031,0.027667113661435,-0.0166924090508095,0.0917626765020157,0.174936857183466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP1,Caspase-1,36191,0.0612407926256647,0.0452152771229648,-0.0273811505353462,0.149862735786676,0.175643920140426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCN,Decorin,36249,-0.0207854878943936,0.0153470759960434,-0.0508657568466387,0.0092947810578516,0.1756644689521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1A,5-hydroxytryptamine receptor 1A,35212,-0.0644925343304563,0.0476367486005864,-0.157860561587606,0.0288754929266929,0.17583827781713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF23,Fibroblast growth factor 23,36415,-0.0463777045122796,0.0342869365492379,-0.113580100148786,0.0208246911242266,0.176214672841201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,36410,-0.038017852558898,0.028110872515421,-0.0931151626891232,0.0170794575713271,0.176281709243464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XG,Glycoprotein Xg,36417,-0.0288396770918762,0.0213561030426031,-0.0706976390553783,0.0130182848716259,0.176924081565584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP29,Endoplasmic reticulum resident protein 29,35312,-0.100826715124589,0.0746824457895369,-0.247204308872082,0.0455508786229029,0.177042677110246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNGB3,Cyclic nucleotide-gated cation channel beta-3,35212,-0.0446434775702473,0.0330825124645037,-0.109485202000675,0.02019824686018,0.177240504943561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRP,Gastrin-releasing peptide,35281,-0.0481219203289552,0.0356643189806051,-0.118023985530941,0.0217801448730307,0.177290317488489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH1,Somatotropin,36350,-0.147064813777572,0.10904479096356,-0.360792604066149,0.0666629765110053,0.177487504308347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA4,Protein disulfide-isomerase A4,35438,-0.0510418059467108,0.0379224386130997,-0.125369785628386,0.0232861737349646,0.178366659466439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL14,C-C motif chemokine 14,36366,-0.0348059862585284,0.0258685567604186,-0.0855083575089488,0.015896384991892,0.178508313930816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35391,-0.083177410043581,0.0618772685056264,-0.204456856314609,0.0381020362274468,0.178922552987512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYZL1,Quinone oxidoreductase-like protein 1,35281,-0.0764510956979997,0.056884567321886,-0.187944847648896,0.0350426562528969,0.179008498025006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR101,Probable G-protein coupled receptor 101,35212,-0.0485570012156667,0.0361462626790185,-0.119403676066543,0.0222896736352095,0.179210045127559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,36225,-0.0560797145586347,0.0418085529791597,-0.138024478397788,0.0258650492805184,0.179851626422609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARF6,ADP-ribosylation factor 6,35402,-0.0893102136222662,0.066589370817852,-0.219825380425256,0.0412049531807238,0.179901912956851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IST1,IST1 homolog,35356,-0.0822740563573036,0.0613715155430908,-0.202562226821762,0.0380141141071542,0.180102939455186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD1,COMM domain-containing protein 1,35281,-0.0509532958390269,0.0380189054390166,-0.125470350499499,0.0235637588214457,0.180227286623184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM58,E3 ubiquitin-protein ligase TRIM58,35391,-0.0736794507783069,0.0550013676201063,-0.181482131313715,0.0341232297571015,0.180426801966632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKA,Diacylglycerol kinase alpha,35239,-0.0460308764174776,0.0343641482682415,-0.113384607023231,0.0213228541882756,0.180457366156424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35404,-0.0672797033699463,0.050236638048377,-0.165743513944765,0.0311841072048726,0.180536462495172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDHD2,Phospholipase DDHD2,35417,-0.0543284122512792,0.0406046917797178,-0.133913608139526,0.0252567836369678,0.180950667438792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,36428,0.0498382447226366,0.0372619643866349,-0.0231952054751679,0.122871694920441,0.181098315741068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI3,Elafin,36280,-0.0477746841374299,0.0357192002607558,-0.117784316648511,0.0222349483736514,0.181100092140466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDHB15,Protocadherin beta-15,35391,-0.0335026536770172,0.0251059576519272,-0.0827103306747946,0.0157050233207602,0.182105341897427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2,Prothrombin,35448,0.0126123539723959,0.00945657563658356,-0.00592253427530789,0.0311472422200997,0.1823466369351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB14,EF-hand calcium-binding domain-containing protein 14,35402,-0.0245336328579866,0.0184291740810086,-0.0606548140567634,0.0115875483407902,0.183159309235229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTLA4,Cytotoxic T-lymphocyte protein 4,35438,-0.0250016444170985,0.0187953128025011,-0.0618404575100007,0.0118371686758036,0.183498875542118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC15,Thioredoxin domain-containing protein 15,36397,-0.0236783651022606,0.0178077872292827,-0.0585816280716548,0.0112248978671335,0.183671264230718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMI,N-myc-interactor,35367,-0.0592865457935642,0.0445979584331698,-0.146698544322577,0.0281254527354485,0.183779804166872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PITHD1,PITH domain-containing protein 1,35193,-0.0665065657088286,0.0500415048700921,-0.164587915254209,0.0315747838365518,0.183889245989244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD5,Mothers against decapentaplegic homolog 5,36331,0.0166296060969434,0.0125173049692193,-0.00790431164272635,0.0411635238366132,0.184045795654159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF9,Protein turtle homolog A,35420,0.0694611762494857,0.0522959357043705,-0.0330388577310804,0.171961210230052,0.184149903407294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QSOX1,Sulfhydryl oxidase 1,35322,-0.0380489968663964,0.0286815711729067,-0.0942648763652936,0.0181668826325008,0.184690186042411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RG,Cytokine receptor common subunit gamma,35391,-0.0309955611625316,0.0233760121804683,-0.0768125450362494,0.0148214227111861,0.184903177550467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",35239,0.0534175681880508,0.0403262345920789,-0.0256218516124239,0.132456987988525,0.185342097726205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",35212,0.046505022579576,0.035116609921382,-0.0223235328663328,0.115333578025485,0.185452814229665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBN1,Drebrin,35239,0.0421531936513241,0.0318376090701214,-0.0202485201261138,0.104554907428762,0.185551027699204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF2,TNF receptor-associated factor 2,36352,-0.0590576230010231,0.0446699327872996,-0.14661069126413,0.0284954452620841,0.18618078994892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP1,Dipeptidase 1,36290,-0.0428874492325979,0.0324433216732833,-0.106476359712233,0.0207014612470375,0.186237676175791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT1,Vascular endothelial growth factor receptor 1,36322,-0.0182125955960404,0.0137810529091084,-0.045223459297893,0.00879826810581211,0.186354530611117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO3,Forkhead box protein O3,36225,-0.0783803942907929,0.0593283279255069,-0.194663917024786,0.0379031284432007,0.186501236247354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART5,Ecto-ADP-ribosyltransferase 5,35212,-0.0546836005659098,0.0413948024295897,-0.135817413327906,0.026450212196086,0.186542999970433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTH3,Cytohesin-3,35206,-0.0616817263978396,0.0467094886137678,-0.153232324080824,0.0298688712851451,0.186705212251932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST7,Cystatin-F,36385,-0.0793481263430668,0.060109451986682,-0.197162652236964,0.0384663995508298,0.186856764433494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22,Interleukin-22,35391,-0.0576315873273718,0.0436576812983508,-0.143200642672139,0.0279374680173958,0.186857408027883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC16,Mucin-16,36331,-0.162181390061911,0.123066560400867,-0.403391848447611,0.0790290683237883,0.187601269612411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRLB,Fc receptor-like B,36225,-0.0524765079171978,0.0398395718045557,-0.130562068654127,0.0256090528197314,0.187815999238189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,36402,-0.0269059265965278,0.0204457764449808,-0.0669796484286901,0.0131677952356345,0.188227633194027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRN,Agrin,36403,-0.0297324891627893,0.0225958646120911,-0.0740203838024879,0.0145554054769092,0.188270384291855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSH1,Chorionic somatomammotropin hormone 1,35428,-0.0234581218617482,0.0178376295107341,-0.0584198757027871,0.0115036319792906,0.188527393170843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPI,Glucose-6-phosphate isomerase,35428,-0.0392447003786369,0.029848162558752,-0.0977470989937909,0.0192576982365171,0.188621705361721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2B,Alpha-amylase 2B,35854,-0.0412245946815139,0.0314187529903322,-0.102805350542565,0.0203561611795372,0.189531092018927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB2,Integrin beta-2,36317,-0.0236172690227372,0.0180187039770138,-0.0589339288176842,0.0116993907722098,0.189998512478524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG3,Secretogranin-3,36381,0.0286240623553097,0.0218439346843273,-0.0141900496259719,0.0714381743365912,0.190105983726086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK24,Serine/threonine-protein kinase 24,36191,-0.051070291802214,0.0389746188449977,-0.12746054473841,0.0253199611339815,0.190121339206485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1A,Lithostathine-1-alpha,36334,-0.0429773327439715,0.0328013446941303,-0.107267968344467,0.0213133028565238,0.190159910755427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGN,Cingulin,35275,-0.0350948927466404,0.0268009370402907,-0.0876247293456102,0.0174349438523293,0.190426311044941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE,Angiotensin-converting enzyme,35428,0.0221813451879632,0.0169417264357283,-0.0110244386260643,0.0553871290019906,0.190490142292574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,35214,-0.057825260753049,0.0441933845490524,-0.144444294469192,0.0287937729630937,0.190767402035293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA1,Glucosamine-6-phosphate isomerase 1,35281,-0.0288622973678934,0.0220658859042543,-0.0721114337402318,0.014386839004445,0.190920879155134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200,OX-2 membrane glycoprotein,36352,0.0220822743107524,0.0168969160914257,-0.011035681228442,0.0552002298499468,0.191294797027343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RP2,Protein XRP2,36331,-0.0354886355940002,0.0271762440671906,-0.0887540739656938,0.0177768027776933,0.191638936786986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB6,DnaJ homolog subfamily B member 6,35257,-0.0685943619787514,0.0526433643704753,-0.171775356144883,0.0345866321873801,0.192623866984833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSNAX,Translin-associated protein X,35214,-0.0329079991565466,0.0252577200521143,-0.0824131304586906,0.0165971321455974,0.192662581176906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF1,Signaling lymphocytic activation molecule,36227,-0.0511710005825865,0.0392924662116952,-0.128184234357509,0.0258422331923362,0.192852828845087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,36382,-0.0241364293721854,0.0185345467509478,-0.060464141004043,0.0121912822596722,0.19287605778431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD3,Sphingomyelin phosphodiesterase 3,35239,0.0457548069484923,0.0351490611421782,-0.0231373528901769,0.114646966787161,0.193056167157954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPBP,Platelet basic protein,35406,-0.0690140612300617,0.0530274538741588,-0.172947870823413,0.0349197483632896,0.193143176258176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2A,Pancreatic alpha-amylase,36067,-0.0399917537470563,0.0307474276134185,-0.100256711869357,0.020273204375244,0.193420643609247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAAM1,Disheveled-associated activator of morphogenesis 1,35312,-0.0678710431020797,0.0521905395563031,-0.170164500632434,0.0344224144282743,0.193496711963235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,36249,-0.041717485823843,0.032087187261981,-0.104608372857326,0.0211734012096397,0.193599198815979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,36385,-0.0408122013392794,0.0314536739277354,-0.102461402237641,0.020836999559082,0.194489245766974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,35281,-0.0386996433589483,0.0298361164572123,-0.0971784316150844,0.0197791448971878,0.194654974291393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL4,Angiopoietin-related protein 4,36390,-0.0365345202914431,0.0282047747527912,-0.091815878806914,0.0187468382240277,0.195247607383454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35420,-0.063748011477077,0.0492561694547197,-0.160290103608328,0.0327940806541737,0.19563960295999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BP1,SH3 domain-binding protein 1,35402,-0.0403982739912042,0.0312168360175437,-0.10158327258559,0.0207867246031815,0.19567275345226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP4,Bone morphogenetic protein 4,36282,0.0379742962265826,0.0293448183366423,-0.0195415477132362,0.0954901401664014,0.19568284980626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSC,Dipeptidyl peptidase 1,36357,0.0362218710419865,0.0279983651754597,-0.0186549247019144,0.0910986667858874,0.195806015214507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC25,Leucine-rich repeat-containing protein 25,36331,-0.0326899536688069,0.0252735223599524,-0.0822260574943137,0.0168461501566999,0.195898473907616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",36249,0.0732366164225338,0.0566432808058262,-0.0377842139568855,0.184257446801953,0.196072604947647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMFG,Glia maturation factor gamma,35420,-0.0583015941864477,0.0451023986709112,-0.146702295581434,0.0300991072085382,0.196180271374739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA5,Annexin A5,36163,-0.0249107367026998,0.0192833501320284,-0.0627061029614755,0.012884629556076,0.196460182649442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLURP1,Secreted Ly-6/uPAR-related protein 1,35396,-0.0310296815945499,0.024037356445286,-0.0781429002273104,0.0160835370382106,0.196788518036057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F12,Coagulation factor XII,35448,-0.0343300558889445,0.0266044768352053,-0.0864748304859468,0.0178147187080579,0.196964226429426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDDC2,5'-deoxynucleotidase HDDC2,35402,-0.036148586698255,0.0280138956383737,-0.0910558221494675,0.0187586487529575,0.196966612482942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF1C,Kinesin-like protein KIF1C,35214,-0.0304241622579943,0.0235841877788381,-0.076649170304517,0.0158008457885283,0.197091964870324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP4,Metalloproteinase inhibitor 4,36382,-0.0338574808529745,0.026266935910942,-0.0853406752384209,0.0176257135324718,0.197447501862193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFA1_DEFA1B,Neutrophil defensin 1,36227,-0.0471535364746457,0.0365980649571873,-0.118885743790733,0.0245786708414414,0.197643537284701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL6B,Myosin light chain 6B,35275,-0.0734923215752269,0.057047817715781,-0.185306044298158,0.038321401147704,0.197705097407228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGFL2,Hepatoma-derived growth factor-related protein 2,35416,-0.0521203210693106,0.0404897872404097,-0.131480304060514,0.0272396619218924,0.198056402642752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS2,Trypsin-2,36410,-0.0454603796176111,0.0353237321442494,-0.11469489462034,0.0237741353851177,0.198148038358912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICA1,Islet cell autoantigen 1,36227,-0.0647491875925141,0.0503291597050811,-0.163394340614473,0.0338959654294449,0.198305950678451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B1,Aldo-keto reductase family 1 member B1,36225,-0.0608167950578174,0.0473138938118355,-0.153552026929015,0.0319184368133801,0.198698451009459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,36297,-0.0356317456374744,0.0277226189168587,-0.0899680787145175,0.0187045874395687,0.198731095179026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD7B,OTU domain-containing protein 7B,35417,-0.0496662511717974,0.0386624881761925,-0.125444727997135,0.0261122256535398,0.198976127059853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,35206,0.0218739023205888,0.0170285172317259,-0.0115019914535939,0.0552497960947716,0.199000705465885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGA,Alpha-N-acetylgalactosaminidase,35226,0.0460979963295862,0.0358874241403555,-0.0242413549855105,0.116437347644683,0.199010545271111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO2,Gamma-enolase,36428,-0.0523438263976873,0.0408347593971637,-0.132379954816128,0.0276923020207536,0.199938155138663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF1,Scavenger receptor class F member 1,36446,-0.0340615428919146,0.0266007155549902,-0.0861989453796954,0.0180758595958662,0.200419194540564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP3,Dual specificity protein phosphatase 3,36191,0.0720256969436346,0.0562730403518421,-0.0382694621459758,0.182320856033245,0.200611287115621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTA2,"Actin, aortic smooth muscle",36249,-0.0357036472246252,0.0279058235061138,-0.0903990612966083,0.0189917668473579,0.20078649606139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIP2A,FHF complex subunit HOOK interacting protein 2A,35214,-0.0391177639671755,0.0305997172372499,-0.0990932097521853,0.0208576818178343,0.201168241099443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTUS1,Microtubule-associated tumor suppressor 1,35321,-0.0451723125349705,0.0353950176894361,-0.114546547206265,0.0242019221363242,0.201921311705552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB1,Beta-crystallin B1,35420,-0.0513731853825552,0.0402754058823892,-0.130312980912038,0.0275666101469276,0.202163181527772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TWF2,Twinfilin-2,35438,-0.0668031320596714,0.0523969873759179,-0.16950122731647,0.0358949631971277,0.202377127821855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC4,Apical endosomal glycoprotein,35391,-0.0439962808269277,0.0345720970766305,-0.111757591097124,0.0237650294432681,0.203209507489455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS4B,Vacuolar protein sorting-associated protein 4B,35391,-0.0755452188362219,0.0593785211796588,-0.191927120348353,0.0408366826759094,0.203326688656504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN2,Neutrophil gelatinase-associated lipocalin,36169,-0.0329932096829441,0.0259473094984821,-0.083849936299969,0.0178635169340809,0.203576705235732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN6,Dynactin subunit 6,36191,-0.057926874317045,0.0455738133586113,-0.147251548499923,0.0313977998658332,0.203750938619244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD3,Mothers against decapentaplegic homolog 3,35391,-0.0404068193825225,0.0318284279276136,-0.102790538120645,0.0219768993556001,0.204303406522456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VGF,Neurosecretory protein VGF,35417,0.0247645235894256,0.0195129159520746,-0.0134807916766407,0.0630098388554919,0.204440401600748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX1,Heme oxygenase 1,36281,-0.0397002504961994,0.0312940008679434,-0.101036492197369,0.0216359912049698,0.204617666634358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF4,Neurotrophin-4,36225,-0.0321184535446819,0.0253589041515955,-0.0818219056818091,0.0175849985924453,0.205356313557958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",36331,-0.0287749060200641,0.0227229907883515,-0.073311967965233,0.0157621559251048,0.205434697370084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGCC,Regulator of cell cycle RGCC,35417,-0.0599833098477696,0.0473760028660148,-0.152840275465159,0.0328736557696195,0.205520500569784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2,Brorin,36275,-0.033130045400787,0.0261732871075981,-0.0844296881316793,0.0181695973301053,0.205627727325983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT18,"Keratin, type I cytoskeletal 18",36331,-0.0654403348584416,0.0517351288241636,-0.166841187353802,0.0359605176369191,0.205944524142615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,36271,-0.0419721966541987,0.0331820103301067,-0.107008936901208,0.0230645435928105,0.205945890509956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",35281,-0.0598223280717288,0.047297919565831,-0.152526250420758,0.0328815942772999,0.20599206309095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35417,-0.0235846222414576,0.018680737352016,-0.060198867451409,0.0130296229684938,0.206812551390585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA14,Carbonic anhydrase 14,36427,0.0287636593800308,0.0227842565560279,-0.0158934834697838,0.0734208022298455,0.206832742939447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLC,Galectin-10,36347,0.053921959473921,0.0427252637420271,-0.0298195574604521,0.137663476408294,0.206967393020957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP1,Guanylate-binding protein 1,35408,-0.0520579735741514,0.041275765821437,-0.132958474584168,0.028842527435865,0.207275612691922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKIV2L,Helicase SKI2W,35214,-0.0322278618315414,0.0255659371484875,-0.082337098642577,0.0178813749794942,0.207509729752928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBI,Transforming growth factor-beta-induced protein ig-h3,36347,-0.0220124312021442,0.017473398041598,-0.0562602913636764,0.0122354289593879,0.20779409515865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1,Allograft inflammatory factor 1,36225,-0.0417270669562019,0.0331631816569751,-0.106726903003873,0.0232727690914694,0.208348659032523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RB,Interleukin-17 receptor B,36277,-0.0428824398241198,0.0341255324689856,-0.109768483463332,0.024003603815092,0.20893681520442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XCL1,Lymphotactin,36427,-0.0453048131561795,0.0360651306379191,-0.115992469206501,0.025382842894142,0.209086088511865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12B,Interleukin-12 subunit beta,36442,-0.0457677096053692,0.0364371859504114,-0.117184594068175,0.0256491748574372,0.209130545484364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG1,Adhesion G-protein coupled receptor G1,36331,-0.0654053538924443,0.0521222722390161,-0.167565007480916,0.0367542996960271,0.209576253290742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA2,Pulmonary surfactant-associated protein A2,36225,-0.0415090287880016,0.0330796434847937,-0.106345130018197,0.0233270724421941,0.209585483160542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5F1D,"ATP synthase subunit delta, mitochondrial",35214,-0.0396847098811057,0.0316549552589095,-0.101728422188568,0.022359002426357,0.210012472978504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP47,Ubiquitin carboxyl-terminal hydrolase 47,35214,0.0675450197001863,0.0539157434017838,-0.03812983736731,0.173219876767683,0.210331373031402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGHMBP2,DNA-binding protein SMUBP-2,35214,-0.0443551160677521,0.0354239371421621,-0.11378603286639,0.0250758007308855,0.210573798658243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM106A,Transmembrane protein 106A,35391,-0.0556277849720736,0.0444394896684153,-0.142729184722168,0.0314736147780204,0.21070285795554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA5A,von Willebrand factor A domain-containing protein 5A,35206,-0.0604085001018709,0.0485166811359657,-0.155501195128364,0.0346841949246219,0.213140640791868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",35281,-0.0377461273668082,0.0303388100866198,-0.097210195136583,0.0217179404029667,0.213491093914013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAP1,Antigen peptide transporter 1,35321,-0.0447642862304744,0.0359913339229806,-0.115307300719516,0.0257787282585676,0.213638509302353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",35312,-0.0689887506778178,0.0554732568174731,-0.177716334040065,0.0397388326844293,0.213679807047447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRXN3,Neurexin-3,35275,0.0278738032703477,0.0224143084529678,-0.0160582412974691,0.0718058478381645,0.213705116350958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CX3CL1,Fractalkine,36297,-0.0269626148528952,0.0217180495894305,-0.0695299920481789,0.0156047623423885,0.214467936005446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7A,B-cell CLL/lymphoma 7 protein family member A,35206,-0.0479583978095622,0.0386308338266681,-0.123674832109832,0.0277580364907074,0.214486565785668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKKL1,Dickkopf-like protein 1,36331,0.0699701026646096,0.0563796190541976,-0.0405339506816177,0.180474156010837,0.214626912827249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAK4,Serine/threonine-protein kinase PAK 4,36191,-0.0486656969976057,0.0392155904257889,-0.125528254232152,0.0281968602369405,0.214655367495956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA1,Pulmonary surfactant-associated protein A1,36225,-0.0452000189213082,0.0364525925037115,-0.116647100228583,0.0262470623859662,0.21502890839214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5,Interleukin-5,36227,-0.110922954529665,0.0894958015191313,-0.286334725507163,0.064488816447832,0.215231073074302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB4A_DEFB4B,Beta-defensin 4A,36277,-0.118968050939563,0.0960270710600164,-0.307181110217195,0.0692450083380691,0.215423152450378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTX3,Pentraxin-related protein PTX3,36352,-0.0387689657421648,0.0313046395829133,-0.100126059324675,0.0225881278403453,0.215593002402397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",36381,0.0273663351583296,0.0220984564989517,-0.0159466395796159,0.070679309896275,0.215614825414076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS3,"Nitric oxide synthase, endothelial",36191,-0.043413548557987,0.0350580068939596,-0.112127242070148,0.0253001449541738,0.215633504861716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCOF1,Treacle protein,35420,-0.0257395061405614,0.0208790759383133,-0.0666624949796555,0.0151834826985328,0.217700846510558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC79,Protein unc-79 homolog,35206,-0.0432428090240687,0.0351222828631866,-0.112082483435914,0.025596865387777,0.218293524277114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIP,Gastric inhibitory polypeptide,35281,-0.0458604631541463,0.0372764923211555,-0.118922388103611,0.0272014617953184,0.218640414483123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35402,-0.0784213021360848,0.0637742883786286,-0.203418907358197,0.0465763030860273,0.218867464363092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB2B,Ras-related protein Rab-2B,35391,-0.0461098084391013,0.0375112362583301,-0.119631831505428,0.0274122146272257,0.219033539246623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX5,Sorting nexin-5,35281,-0.0227531393066742,0.0185113836487376,-0.0590354512581998,0.0135291726448515,0.219065673953475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX9,Sorting nexin-9,36360,-0.0524175845524555,0.0427168182548533,-0.136142548331968,0.0313073792270571,0.219827282744963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,36428,-0.055308576187566,0.0451368612011562,-0.143776824141832,0.0331596717667002,0.220482241571613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD55,Complement decay-accelerating factor,36133,-0.0210005556981267,0.0171665053977508,-0.0546469062777184,0.0126457948814649,0.221241021581809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35417,-0.0593250941825971,0.0486154303126601,-0.154611337595411,0.0359611492302167,0.222399868059068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36A,Interleukin-36 alpha,35239,-0.0418538941846661,0.0343061852594988,-0.109094017293284,0.0253862289239516,0.22250862085057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTPN,Myotrophin,36249,0.0260502029024011,0.0213594769866148,-0.0158143719913639,0.0679147777961662,0.222654036051328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RICTOR,Rapamycin-insensitive companion of mTOR,35239,0.0380588623149859,0.0312238676976176,-0.0231399183723447,0.0992576430023165,0.222928618403044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2orf69,UPF0565 protein C2orf69,35275,-0.0476931784397776,0.0392079426598892,-0.12454074605316,0.0291543891736052,0.223873610540167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35391,-0.0628707971593539,0.0516873290632486,-0.164177962123321,0.0384363678046133,0.223891212886335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,35281,-0.031278443335834,0.0257371096484663,-0.0817231782468278,0.0191662915751599,0.224296842223942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A4,Protein S100-A4,36397,-0.0439131519429273,0.0361359305740949,-0.114739575868153,0.0269132719822988,0.224321535315675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD2,Mothers against decapentaplegic homolog 2,35391,-0.0528228817203575,0.0435881913422998,-0.138255736751265,0.03260997331055,0.225611335581096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSO,Cathepsin O,36442,-0.0242224041069212,0.0199948639245709,-0.0634123373990802,0.0149675291852377,0.225769641805964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTL1,Cytokine-like protein 1,35438,-0.0192320182484581,0.0158755878777088,-0.0503481704887674,0.0118841339918511,0.225779994670539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN3,Centrin-3,35402,-0.0582577293931886,0.0480913234410568,-0.15251672333766,0.0360012645512827,0.225789044047135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBP,Protein AMBP,36411,-0.0155511878389688,0.0128487497080017,-0.040734737266652,0.00963236158871443,0.226193104401485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED10,Transmembrane emp24 domain-containing protein 10,35214,-0.0351865688466356,0.029121543061735,-0.0922647932476361,0.0218916555543649,0.226992442234321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT6C,"Keratin, type II cytoskeletal 6C",35214,-0.028417517551936,0.0235340491858719,-0.074544253956245,0.017709218852373,0.227284578868233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,35312,-0.0644046277937588,0.0533677863498607,-0.169005489039486,0.0401962334519681,0.227553069015215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO3,R-spondin-3,36427,-0.0218747213459567,0.0181267007604355,-0.0574030548364103,0.0136536121444968,0.227560991503503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGT1,Protein SGT1 homolog,36225,-0.0615056336673746,0.0509915769801021,-0.161449124548375,0.0384378572136254,0.227784042243735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHPK,Sedoheptulokinase,35321,-0.030012533363667,0.0248882353408198,-0.0787934746316738,0.0187684079043398,0.227905553628516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXN,"Frataxin, mitochondrial",36427,-0.0556303786213493,0.0461373026797775,-0.146059491873713,0.0347987346310146,0.227950616675393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA2,Integrin alpha-2,35312,0.0262693631990351,0.0217869669552534,-0.0164330920332617,0.0689718184313318,0.227965347467635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM26,Tripartite motif-containing protein 26,35206,0.0436273046534021,0.0362198061935358,-0.0273635154859281,0.114618124792732,0.228437952530913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK1,Cyclin-dependent kinase 1,35206,0.0281265937889656,0.0233547157946736,-0.0176486491685947,0.0739018367465259,0.22851262705793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPS16,"28S ribosomal protein S16, mitochondrial",35239,-0.0212466669490099,0.0176612553412821,-0.0558627274179228,0.0133693935199031,0.229019560907141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12A_IL12B,Interleukin-12,36331,-0.0627611958510942,0.0521947580027414,-0.165062921536467,0.039540529834279,0.229232018612311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA10,N-alpha-acetyltransferase 10,35214,-0.0383927883545626,0.0319345356178843,-0.100984478165616,0.0241989014564907,0.229320119757256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP7,Matrilysin,36235,-0.037969030997541,0.031605488442486,-0.0999157883448137,0.0239777263497316,0.229658600918484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3BP,Galectin-3-binding protein,35448,-0.0238824551779642,0.0198810735649997,-0.0628493593653636,0.0150844490094352,0.229693574839339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKZ,Diacylglycerol kinase zeta,36227,-0.0272845320423909,0.0227168971034482,-0.0718096503651493,0.0172405862803675,0.229765376526779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRPEL1,"GrpE protein homolog 1, mitochondrial",36331,-0.0462922706891589,0.0385659884961533,-0.121881608141619,0.0292970667633015,0.230047442004957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGEA3,Melanoma-associated antigen 3,35321,-0.0639718759377516,0.0534245379982103,-0.168683970414244,0.0407402185387406,0.231187278264125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO6,Unconventional myosin-VI,35417,-0.0274460123959774,0.0229263076973358,-0.0723815754827557,0.0174895506908008,0.231297381274563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD1C,T-cell surface glycoprotein CD1c,36397,-0.0191532868192752,0.0160168423359802,-0.0505462977977964,0.012239724159246,0.231805529980451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35391,-0.040729479231059,0.0340651897639376,-0.107497251168377,0.0260382927062587,0.231885393959056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPYL1,Testis-specific Y-encoded-like protein 1,35239,-0.0299310495621995,0.0250939242541687,-0.0791151411003702,0.0192530419759712,0.233009874987298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10,V-set and immunoglobulin domain-containing protein 10,35391,-0.0259805910425173,0.0217906893024337,-0.0686903420752873,0.0167291599902527,0.233197342465012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS10,Regulator of G-protein signaling 10,35417,-0.0449259447668936,0.037686565197703,-0.118791612554392,0.0289397230206043,0.233269674223084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC134,Coiled-coil domain-containing protein 134,35391,-0.0365451616661538,0.0306666233969092,-0.0966517435240958,0.0235614201917882,0.233427775432774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG16L1,Autophagy-related protein 16-1,35402,-0.0629521840606273,0.0528733276582366,-0.166583906270771,0.0406795381495164,0.233847260687351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCB,Calcitonin gene-related peptide 2,35416,-0.030264236682904,0.0254771036300359,-0.0801993597977744,0.0196708864319663,0.234918380281747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM3,Paralemmin-3,35214,-0.0557849611992558,0.0469731715092438,-0.147852377357374,0.0362824549588621,0.23504105887388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPDC1,Neural proliferation differentiation and control protein 1,36360,-0.0256824280481002,0.0216351472688715,-0.0680873166950883,0.0167224605988878,0.235239472989189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20,Interleukin-20,36227,-0.0389077485247641,0.0327847910519399,-0.103165938986566,0.0253504419370381,0.235361544853962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA1,Carboxypeptidase A1,36446,-0.0463703202124733,0.039073844245692,-0.12295505493403,0.030214414509083,0.23537082023771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESAM,Endothelial cell-selective adhesion molecule,36446,-0.0241049533497281,0.0203319047593764,-0.0639554866781059,0.0157455799786496,0.235829892432501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6AP2,Renin receptor,36225,-0.0288598108562483,0.0243531899316321,-0.0765920631222472,0.0188724414097507,0.236036706198071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRDT,Bromodomain testis-specific protein,35214,-0.027237872213993,0.0229880895595382,-0.0722945277506878,0.0178187833227017,0.236116061711267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMC1,COX assembly mitochondrial protein homolog,35420,-0.0673055667001634,0.0568199099636245,-0.178672590228867,0.0440614568285407,0.236243818498778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYOU1,Hypoxia up-regulated protein 1,36446,-0.0171970701151306,0.014519288611823,-0.0456548757943036,0.0112607355640424,0.23628200392354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAFB2,Scaffold attachment factor B2,35417,-0.0209089875625825,0.0176693683545547,-0.0555409495375096,0.0137229744123446,0.236717001062356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MILR1,Allergin-1,36227,-0.0388521202099242,0.0328334162525029,-0.10320561606483,0.0255013756449815,0.236726181455433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTOA,Otoancorin,35212,0.0391481466339966,0.0330929797505468,-0.0257140936770751,0.104010386945068,0.236866039560131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35417,-0.0874092878571778,0.0739339045792923,-0.232319740832591,0.0575011651182351,0.237146704627871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4D,Semaphorin-4D,36428,-0.0225042420298163,0.0190399191210752,-0.0598224835071236,0.0148139994474911,0.237264190858991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSD,Cathepsin D,35934,-0.0307493172839903,0.0260172231866841,-0.0817430747298912,0.0202444401619107,0.237293771157377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZI2,5-azacytidine-induced protein 2,35417,-0.0412815100202017,0.0349559033231654,-0.109795080533606,0.0272320604932025,0.237663901105763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STEAP4,Metalloreductase STEAP4,35212,-0.0555752413395856,0.0470742747805319,-0.147840819909428,0.0366903372302569,0.237813789128585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18RAP,Interleukin-18 receptor accessory protein,36250,-0.132738302113354,0.112524426517704,-0.353286178088053,0.0878095738613457,0.238183241203277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35391,-0.0283834475757307,0.0240723607024063,-0.0755652745524472,0.0187983794009857,0.2384081396733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPO,Lactoperoxidase,36103,-0.0459033132729073,0.0389360058867235,-0.122217884810885,0.0304112582650707,0.238461659307715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN4,Prefoldin subunit 4,35206,-0.0404131272827521,0.0342824033992153,-0.107606637945214,0.0267803833797099,0.238512508163946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,36225,-0.0612907847644093,0.0520572044630629,-0.163322905512013,0.040741335983194,0.239086224820956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH1,Neurogenic locus notch homolog protein 1,36446,-0.0120595306526758,0.0102456572024706,-0.0321410187695181,0.00802195746416649,0.239218860483754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTF2,Transcription termination factor 2,35275,-0.0368365885286284,0.0312973454221718,-0.098179385556085,0.0245062084988283,0.23924650878064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINH1,Serpin H1,35321,-0.0960435212101219,0.0816638288658603,-0.256104625787208,0.0640175833669642,0.239607010809115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPPK1,Epiplakin,35281,-0.0543028906723096,0.0461755683831434,-0.144807004703271,0.0362012233586515,0.239637213403913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MBL2,Mannose-binding protein C,35368,0.0795982072193108,0.0677756856369716,-0.0532421366291536,0.212438551067775,0.240265716648119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",35206,0.0427594119926733,0.0364804175193338,-0.0287422063452209,0.114261030330567,0.241195491173549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP6,Charged multivesicular body protein 6,35420,-0.0411154910604986,0.0351187681063026,-0.109948276548852,0.0277172944278545,0.241741875531964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPR,Nucleoprotein TPR,35214,-0.0390078977099245,0.0333193790180186,-0.104313880585241,0.0262980851653921,0.2417548558552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIF,Macrophage migration inhibitory factor,36370,-0.0505178735088262,0.0431642982768728,-0.135119898131497,0.0340841511138445,0.241894009304094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC12,WAP four-disulfide core domain protein 12,36419,-0.0482292930470083,0.0412163170049524,-0.129013274376715,0.0325546882826985,0.241979014389836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNIP4,Kv channel-interacting protein 4,36191,-0.0364906262273342,0.031190325986006,-0.0976236651599059,0.0246424127052374,0.242067334877984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35402,-0.0748062151225768,0.0640084517203033,-0.200262780494371,0.0506503502492176,0.242572308816724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L1,Mortality factor 4-like protein 1,35321,-0.029089974611657,0.0249163392991577,-0.0779259996380061,0.0197460504146922,0.243051535198804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELT,Tumor necrosis factor receptor superfamily member 19L,36382,-0.0221559662344785,0.018984130346097,-0.0593648617128287,0.0150529292438717,0.243217472411464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHIT1,Chitotriosidase-1,36391,-0.115603642558666,0.0991191680705297,-0.309877211976904,0.0786699268595726,0.243527917980729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,36368,-0.0294168302491001,0.025299422932897,-0.0790036991975782,0.0201700386993779,0.244970808232517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT2,Thialysine N-epsilon-acetyltransferase,35321,-0.0507875722582143,0.0437154357166406,-0.13646982626283,0.0348946817464013,0.24537145772654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY9,T-lymphocyte surface antigen Ly-9,36268,-0.0226914037305798,0.019536171157856,-0.0609822991999776,0.015599491738818,0.245474880644019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,36325,-0.136598292730928,0.117768535357109,-0.367424622030861,0.0942280365690062,0.2461333047687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST6,Cystatin-M,36174,-0.0366544381256034,0.0316175847892141,-0.0986249043124632,0.0253160280612563,0.246371360909105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,35214,0.0271525440589903,0.0234452619170103,-0.0188001692983499,0.0731052574163305,0.24685897031162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKG1,cGMP-dependent protein kinase 1,35312,-0.0910772970310544,0.0786463830871939,-0.245224207881954,0.0630696138198457,0.246884411291838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL13,C-C motif chemokine 13,36429,-0.0510398761381691,0.0440849762193163,-0.137446429528029,0.0353666772516908,0.246999708576562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,36138,-0.0492090543714902,0.0425757235854143,-0.132657472598902,0.0342393638559219,0.247802420776485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTPBP2,GTP-binding protein 2,35275,-0.0583626798212019,0.0505019703029238,-0.157346541614933,0.0406211819725287,0.24786912053768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L15,Bcl-2-like protein 15,35239,-0.0434411495529391,0.0376080884508696,-0.117153002916644,0.0302707038107653,0.248094627596134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL1A1,Collagen alpha-1(I) chain,36446,-0.0184927801036644,0.016011989103499,-0.0498762787465224,0.0128907185391936,0.248155777359393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBKS,Ribokinase,36172,-0.0380597203631927,0.0329674958578448,-0.102676012244568,0.026556571518183,0.248350354061421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA1,Alpha-1-antitrypsin,35323,-0.00634339177154962,0.00549516132689291,-0.0171139079722597,0.00442712442916049,0.248397812768438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHACTR2,Phosphatase and actin regulator 2,35417,-0.0822006297691369,0.0712165964938905,-0.221785158897162,0.0573838993588885,0.248448497219844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD34,Hematopoietic progenitor cell antigen CD34,36413,0.0174959816850488,0.0151624342457443,-0.0122223894366101,0.0472143528067077,0.248578049031257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB4,Receptor tyrosine-protein kinase erbB-4,36397,0.0176802287170714,0.0153226648668347,-0.0123521944219246,0.0477126518560674,0.248595355427691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLGAP5,Disks large-associated protein 5,35417,-0.037037107716723,0.0321502805649715,-0.100051657624067,0.0259774421906211,0.249365525386155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UMOD,Uromodulin,36422,0.0396853303399363,0.0345051219959321,-0.0279447087720905,0.107315369451963,0.250128926956192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA4,Kallistatin,35324,0.0175928933491305,0.0153160757735191,-0.0124266151669669,0.0476124018652279,0.25074291674279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFAP,Glial fibrillary acidic protein,36213,-0.036195359682428,0.0315122000748596,-0.0979592718291527,0.0255685524642967,0.250754250958944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM2,Paralemmin-2,35416,-0.0271719231525287,0.023733599822992,-0.073689778805593,0.0193459325005356,0.252306408665797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3D,T-cell surface glycoprotein CD3 delta chain,35212,-0.0238757179276555,0.0208655307071973,-0.0647721581137622,0.0170207222584512,0.25255883751342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L1,Bcl-2-like protein 1,35416,-0.0703693086632087,0.0615143579910486,-0.190937450325664,0.0501988329992466,0.252688658519626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SATB1,DNA-binding protein SATB1,35417,-0.022810499069327,0.0199509151391054,-0.0619142927419736,0.0162932946033195,0.252945183899003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GALT1,"Beta-1,4-galactosyltransferase 1",36403,-0.0204375766056684,0.0178758200215156,-0.0554741838478389,0.0145990306365022,0.252948500752966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBP,Lipopolysaccharide-binding protein,36410,-0.0425039342891941,0.0372235591923777,-0.115462110306254,0.0304542417278663,0.253551881850697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFA,Protransforming growth factor alpha,36352,-0.0344578622739476,0.0301850830209115,-0.0936206249949341,0.0247049004470388,0.253678191823668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP1,"Fatty acid-binding protein, liver",36368,-0.0688047554990095,0.0602808718504749,-0.18695526432594,0.0493457533279213,0.253740440575143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",36191,-0.0363480901522931,0.0318541927846177,-0.0987823080101439,0.0260861277055576,0.253876889115018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON1,Spondin-1,36381,-0.0244560224875245,0.0214509278082718,-0.0664998409917373,0.0175877960166883,0.254286135939595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPD52L2,Tumor protein D54,35312,-0.0767530016663243,0.0673267346774143,-0.208713401634056,0.0552073983014076,0.254327685741869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSS,Cathepsin S,34779,-0.0177144388159347,0.0155407683386019,-0.0481743447595944,0.012745467127725,0.254389797146739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RWDD1,RWD domain-containing protein 1,36428,-0.0454360466863722,0.0398625829058577,-0.123566709181853,0.0326946158091088,0.254400318927698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARBP2,RISC-loading complex subunit TARBP2,36191,-0.0566494285108329,0.0497590575960608,-0.154177181399112,0.0408783243774462,0.254961292654495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",36271,0.0310694213584291,0.027290728272182,-0.0224204060550477,0.0845592487719059,0.254966701216647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL1,Delta-like protein 1,36397,-0.0224617031188807,0.0197399010467138,-0.0611519091704397,0.0162285029326783,0.255207075730994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200R1,Cell surface glycoprotein CD200 receptor 1,36330,-0.026187471400471,0.0230633982153244,-0.0713917319025069,0.0190167891015649,0.256222486880175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPPED1,Serine/threonine-protein phosphatase CPPED1,36428,-0.0481670950482549,0.0424210865672891,-0.131312424720142,0.0349782346236318,0.256223723944106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD5,Sushi domain-containing protein 5,35273,-0.0249815710159273,0.022002618511882,-0.0681067032992159,0.0181435612673613,0.256256367901792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",36290,-0.0692177893846032,0.0609844431129955,-0.188747297886074,0.0503117191168679,0.256410587569034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB1,Calbindin,36331,0.033522627456307,0.0295493764107495,-0.0243941503087621,0.091439405221376,0.256639149841137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL7,Angiopoietin-related protein 7,36427,-0.0260512610745051,0.0229676501798337,-0.0710678554269791,0.0189653332779689,0.256723563558906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRH,Corticoliberin,36210,0.0628750772890957,0.0554536509047891,-0.045814078484291,0.171564233062482,0.25690411792414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP3,Metalloproteinase inhibitor 3,36403,0.0955045171464041,0.0842405572280792,-0.0696069750206312,0.260616009313439,0.256953140943162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TANK,TRAF family member-associated NF-kappa-B activator,36227,-0.0496467012221339,0.0438388055117223,-0.13557076002511,0.0362773575808417,0.257470042492282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCA,Calcitonin,36290,-0.0473042925037229,0.0417966692010872,-0.129225764137854,0.0346171791304079,0.257768621385965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD1,Bromodomain-containing protein 1,35321,-0.0219716950200228,0.0194256024349258,-0.0600458757924774,0.0161024857524319,0.258070357387598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNC4,Potassium voltage-gated channel subfamily C member 4,35212,-0.0404133833393138,0.0357504034744585,-0.110484174149252,0.0296574074706248,0.258339484151951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTD,Deoxycytidylate deaminase,35312,-0.0672014110025039,0.0594574631290774,-0.183738038735496,0.0493352167304877,0.258417943887842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLN,Mesothelin,36319,-0.0426256499281677,0.0377775565967891,-0.116669660857874,0.031418361001539,0.259217457690322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD276,CD276 antigen,36368,-0.0259775581764072,0.023038615517949,-0.0711332445915872,0.0191781282387729,0.25954098760938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIA1,Nucleolysin TIA-1 isoform p40,36157,-0.0872844402319263,0.0775598751575581,-0.23930179554074,0.0647329150768877,0.260466241795139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTS,6-pyruvoyl tetrahydrobiopterin synthase,36155,-0.0404255755041366,0.036019958692327,-0.111024694541098,0.0301735435328244,0.261769180520435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,36403,0.0292535405511854,0.0260793409729213,-0.0218619677557405,0.0803690488581112,0.262021770798023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF2,Fibroblast growth factor 2,36352,-0.0490488431534721,0.0437439315444098,-0.134786948980515,0.0366892626735711,0.262209738583784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF19,Fibroblast growth factor 19,36403,0.0555523769486731,0.0495492108870148,-0.0415640763898758,0.152668830287222,0.262258965851686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UXS1,UDP-glucuronic acid decarboxylase 1,36225,-0.0379579117335651,0.0338779056805451,-0.104358606867434,0.0284427834003034,0.262567706075945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTDH,Protein LYRIC,35239,-0.0655815270221372,0.0585555813237512,-0.18035046641669,0.0491874123724151,0.26276352738053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVPL,Envoplakin,35321,-0.024043695731872,0.0214696508882421,-0.0661242114728264,0.0180368200090825,0.262803576650619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYDGF,Myeloid-derived growth factor,35420,-0.0693983243323011,0.061968878291648,-0.190857325783931,0.0520606771193289,0.262803858448632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6ST,Interleukin-6 receptor subunit beta,36360,0.0123995503310893,0.0110925780771166,-0.00934190270005916,0.0341410033622379,0.263679629422249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTP1,Glutathione S-transferase P,36147,-0.0489259780832071,0.0437791999485211,-0.134733209982308,0.0368812538158942,0.263792642794691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,36360,-0.0232269275576031,0.0208261904468233,-0.0640462608333768,0.0175924057181707,0.264770035536872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYDC1,Pyrin domain-containing protein 1,35281,-0.0288841543428954,0.0259345661456859,-0.0797159039884398,0.021947595302649,0.26543818384853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP1,Inactive pancreatic lipase-related protein 1,35416,-0.056509965716422,0.0508280896566971,-0.156133021443548,0.0431130900107043,0.266273068053653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,36419,-0.0206882530566954,0.018608957363198,-0.0571618094885635,0.0157853033751726,0.26628854737372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7R,Interleukin-7 receptor subunit alpha,36382,0.0367322385003178,0.0330481591793598,-0.0280421534912275,0.101506630491863,0.2664006542054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAMBI,BMP and activin membrane-bound inhibitor homolog,36225,-0.0210768234966049,0.0189666721250403,-0.0582515008616839,0.0160978538684741,0.266496277791218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,35312,-0.0267033448742805,0.024044988069973,-0.0738315214914277,0.0204248317428666,0.266802455283279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSZ,Cathepsin Z,36390,-0.0230631246835349,0.0207768181444623,-0.0637856882466811,0.0176594388796113,0.267018353656636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRAS,Ras-related protein R-Ras,35275,-0.0899985216750643,0.0811132690402426,-0.24898052899394,0.0689834856438111,0.267240614936811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMN,Protein amnionless,36227,0.0332833492148882,0.0300288697602338,-0.0255732355151701,0.0921399339449465,0.267736351205679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP1G2,AP-1 complex subunit gamma-like 2,35391,-0.0553365259690366,0.049932199383693,-0.153203636761075,0.0425305848230018,0.267804083658355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRC1,Macrophage mannose receptor 1,35428,-0.0204003664341091,0.0184220618634969,-0.056507607686563,0.0157068748183449,0.268169027061976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMD,Dystrophin,35281,-0.0353968148464845,0.0319922864073469,-0.0981016962048845,0.0273080665119155,0.268589723101334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB2,Calretinin,36191,-0.0212307695610382,0.0191914138660737,-0.0588459407385428,0.0163844016164663,0.268650317841694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1F,V-type proton ATPase subunit F,36184,-0.0475340142955572,0.043000147223818,-0.13181430285424,0.0367462742631261,0.269007715099474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE4,Ribonuclease 4,35196,-0.019461300292367,0.017633178296147,-0.0540223297528151,0.0150997291680811,0.269778335687788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA3A,Chymotrypsin-like elastase family member 3A,36434,-0.0415026268687975,0.0376302562432231,-0.115257929105515,0.0322526753679197,0.270104745201395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK2,SLIT and NTRK-like protein 2,36427,-0.0279630438732655,0.025361118562048,-0.0776708362548797,0.0217447485083487,0.270239744213852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EZR,Ezrin,36428,-0.0168158273718933,0.0152518661077413,-0.0467094849430662,0.0130778301992797,0.270262662243379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN1,Neuroligin-1,35275,0.0482073814014813,0.0437353849273444,-0.0375139730561138,0.133928735859076,0.270396091957944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRADD,Death domain-containing protein CRADD,36290,-0.0527328998261949,0.0478983940375417,-0.146613752139776,0.0411479524873868,0.270963368949434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM1,V-set and transmembrane domain-containing protein 1,36191,-0.0353666926284935,0.0321378824740114,-0.0983569422775559,0.0276235570205689,0.271166374567543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT5,ADP-sugar pyrophosphatase,36382,-0.0355831472704468,0.0323482256753144,-0.0989856695940631,0.0278193750531694,0.27136762589502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APRT,Adenine phosphoribosyltransferase,36280,-0.0331430498811713,0.030187182746633,-0.092309928064572,0.0260238283022294,0.272277623157705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6,Seizure protein 6 homolog,35275,0.0217635521228944,0.0198429002988772,-0.0171285324629049,0.0606556367086936,0.272775366335948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP1,Syntaxin-binding protein 1,35417,-0.052984292528982,0.0483298811755726,-0.147710859633104,0.0417422745751403,0.272987725640883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAGLN3,Transgelin-3,35206,0.0434134249596515,0.0396357856451918,-0.0342727149049243,0.121099564824227,0.273425248226593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPC,C-type natriuretic peptide,36352,-0.0352542990922687,0.0321949826890581,-0.0983564651628226,0.0278478669782852,0.273542688479819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP2,Insulin-like growth factor-binding protein 2,36439,-0.0423842306524026,0.0387318965199864,-0.118298747831576,0.0335302865267707,0.273860752394351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RB,Interleukin-10 receptor subunit beta,36403,-0.0204165536570428,0.018658426435365,-0.0569870694703582,0.0161539621562725,0.273891999260864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,36297,0.0253703968817135,0.0231925089926901,-0.0200869207439592,0.0708277145073861,0.274033828773349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G15,Phospholipase A2 group XV,36397,-0.0186777638722876,0.0170750502140004,-0.0521448622917283,0.0147893345471532,0.2740516927585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MVK,Mevalonate kinase,36227,-0.0560901927960427,0.0512796394058801,-0.156598286031568,0.0444179004394823,0.274075689425233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3B,Protein FAM3B,36331,0.0243565097045332,0.0222789715770628,-0.01931027458651,0.0680232939955763,0.274320474421051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3B1,AP-3 complex subunit beta-1,35402,-0.05234675277445,0.0478999784816675,-0.146230710598518,0.0415372050496183,0.27450884215359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,36352,-0.0605776396327824,0.0554459342736492,-0.169251670809135,0.04809639154357,0.274626736312385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD1,Leiomodin-1,35417,-0.0249463637100493,0.0228650341470587,-0.0697618306382843,0.0198691032181857,0.27530335630645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIF1A,Hypoxia-inducible factor 1-alpha,35239,0.0415963249562382,0.0381366230860368,-0.0331514562923939,0.11634410620487,0.275440187537598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,35214,-0.0394027951248722,0.0361622130665367,-0.110280732735284,0.0314751424855398,0.275927540474714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLA2,Src-like-adapter 2,35417,-0.0705593653855966,0.0648018616426136,-0.197571014205119,0.0564522834339261,0.276263167357263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLOD4,Glyoxalase domain-containing protein 4,36365,-0.0243380502895859,0.0223756123174958,-0.0681942504318776,0.0195181498527057,0.276762214139722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUMB,Protein numb homolog,35239,-0.0561120543877957,0.0515893656873518,-0.157227211135005,0.0450031023594139,0.276785472636468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFD,Vascular endothelial growth factor D,36429,-0.0258475655536322,0.023787313289074,-0.0724706996002172,0.0207755684929528,0.27724478935375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASET2,Ribonuclease T2,36413,-0.0187028799078407,0.0172175558961007,-0.0524492894641981,0.0150435296485167,0.277396712758489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEFTY2,Left-right determination factor 2,36413,0.0343507522766036,0.0316347206773529,-0.0276533002510081,0.0963548048042154,0.277578949394768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1F,Protein phosphatase 1F,35420,-0.0356189737607533,0.0328207292926893,-0.0999476031744242,0.0287096556529177,0.27784922272163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI5,Ecotropic viral integration site 5 protein homolog,35239,-0.0608340714801168,0.0560578387259979,-0.170707435383073,0.0490392924228392,0.277875530926247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDM3A,Lysine-specific demethylase 3A,35239,0.060260795701708,0.0555329605361839,-0.0485838069492123,0.169105398352628,0.277904848971426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",36191,-0.0377472646127134,0.034879047898314,-0.106110198493409,0.030615669267982,0.27918620194235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLHL41,Kelch-like protein 41,35417,-0.0313371664357258,0.0289604144357808,-0.0880995787298562,0.0254252458584045,0.279263800692217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN4,Alpha-actinin-4,36227,-0.0227674534360885,0.0210766495827913,-0.0640776866183593,0.0185427797461824,0.280080525777947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCP2,Non-specific lipid-transfer protein,36225,-0.0510710474805685,0.0472858431088867,-0.143751299973986,0.0416092050128494,0.280157219624955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3,Granulocyte colony-stimulating factor,36227,0.034325423467712,0.031809184595015,-0.0280205783385175,0.0966714252739415,0.280578302759837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS1,"Nitric oxide synthase, brain",36191,-0.0369979857444862,0.0343721514506434,-0.104367402587747,0.0303714310987749,0.281788090027349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,36442,-0.0279176372720538,0.0259370268834167,-0.0787542099635504,0.0229189354194429,0.281801092479842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTF1,Cardiotrophin-1,36249,-0.0573567863417559,0.0534568403038384,-0.162132193337279,0.0474186206537673,0.283327986641939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM3,Junctional adhesion molecule C,35312,-0.0332609221286503,0.0310025976532933,-0.0940260135291051,0.0275041692718046,0.283383846256503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX1,Neuronal pentraxin-1,36382,0.0271453541694894,0.0253292617501852,-0.0224999988608735,0.0767907071998524,0.283891059170982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B2M,Beta-2-microglobulin,35448,-0.0228625033413839,0.0213438643449655,-0.0646964774575163,0.0189714707747485,0.284142838438996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRC,Chymotrypsin-C,36369,0.0453557245215129,0.0423854575080007,-0.0377197721941685,0.128431221237194,0.284620420327175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2,Apoptosis regulator Bcl-2,35402,-0.0380865011999691,0.0356520682034096,-0.107964554878652,0.0317915524787137,0.285434376749324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHM,Rab proteins geranylgeranyltransferase component A 1,35275,-0.0409446570255096,0.0384316409687378,-0.116270673324236,0.0343813592732165,0.286742119841393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP30,Rho GTPase-activating protein 30,35321,-0.0259529760922112,0.024386605945509,-0.0737507237454089,0.0218447715609865,0.28726611623828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH17,Cadherin-17,36360,0.0476219020213879,0.0447559828319623,-0.0400998243292582,0.135343628372034,0.287349002170491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK,Neuroblast differentiation-associated protein AHNAK,35281,-0.0216292674727804,0.0203330925776739,-0.0614821289250213,0.0182235939794605,0.287485495765149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR2,Toll-like receptor 2,35321,0.0161022576720705,0.015154313725105,-0.0136001972291353,0.0458047125732763,0.288026703213149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,35303,0.03267815380049,0.0307553093416243,-0.0276022525090936,0.0929585601100737,0.288041350891636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX7,Syntaxin-7,35239,0.0333041902185109,0.0313616120400768,-0.0281645693800398,0.0947729498170615,0.28830476928415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM172A,Cotranscriptional regulator FAM172A,35281,-0.040235201687676,0.037892867917849,-0.11450522280666,0.034034819431308,0.288361970255512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA80,N-alpha-acetyltransferase 80,35275,-0.0805830020329317,0.075910445456744,-0.22936747512815,0.0682014710622865,0.288480572526271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LF,CMRF35-like molecule 1,36427,-0.0414970478830003,0.0391212363813067,-0.118174671190362,0.0351805754243608,0.288848285740381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPP,Lipoma-preferred partner,35214,-0.0436502898408957,0.0411810239158994,-0.124365096716059,0.0370645170342671,0.289204750544933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGOLN2,Trans-Golgi network integral membrane protein 2,35428,-0.0181680336895497,0.0171408969011892,-0.0517641916158805,0.0154281242367811,0.289220619808409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),H2AP,Huntingtin-interacting protein M,35206,-0.0340483065666529,0.0321275871763357,-0.0970183774322708,0.0289217642989651,0.289285399495259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGA1,ADP-ribosylation factor-binding protein GGA1,36191,-0.0437698820213168,0.0413645712408378,-0.124844441653359,0.0373046776107253,0.290024021107597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH9,Protocadherin-9,35402,-0.0232637042543447,0.0219952217868737,-0.0663743389566172,0.0198469304479278,0.290246696772058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3A,Regenerating islet-derived protein 3-alpha,36446,-0.0434205329039648,0.0411708653884819,-0.124115429065389,0.0372743632574597,0.291624120966958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB1,Carboxypeptidase B,36446,-0.0401663497859107,0.0380933478076854,-0.114829311488974,0.0344966119171527,0.291726253785366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1D,V-type proton ATPase subunit D,36331,-0.0177130180500531,0.0168134817319861,-0.0506674422447458,0.0152414061446396,0.292147148714079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG3,Proteoglycan 3,35438,-0.0328752570791114,0.0312281089819027,-0.0940823506836406,0.0283318365254178,0.292498300140312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA,Lymphotoxin-alpha,36352,0.0275568611670333,0.0262056882503051,-0.0238062878035647,0.0789200101376313,0.293036832116232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB10,Ras-related protein Rab-10,35420,-0.0355233016254545,0.0337929039306663,-0.101757393329561,0.0307107900786515,0.293204810334749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFHD1,EF-hand domain-containing protein D1,35417,-0.0236756700552634,0.0225418873545985,-0.0678577692702763,0.0205064291597496,0.29362250362596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGFR,Tumor necrosis factor receptor superfamily member 16,35420,-0.0199883253413415,0.0190338995540117,-0.0572947684672044,0.0173181177845213,0.293692914520811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,36381,-0.0207809407237189,0.0198196118608228,-0.0596273799709316,0.0180654985234938,0.294441754753203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,35212,-0.0402148642370494,0.0383678932779296,-0.115415935061791,0.0349862065876925,0.294616914910491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCLN,Nicalin,36227,0.0336861408356559,0.0321554201747553,-0.0293384827068645,0.0967107643781762,0.29485717932606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,35181,-0.0216491662527549,0.0206949863247507,-0.0622113394492662,0.0189130069437564,0.295553950710536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,35312,-0.0383256520742659,0.0366374467031791,-0.110135047612497,0.0334837434639652,0.295566032074914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,36249,0.0543615213113,0.0519756579784116,-0.0475107683263867,0.156233810948987,0.295641432181674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACRT,Extracellular glycoprotein lacritin,35378,0.0345637656950185,0.0330584594244399,-0.0302308147768837,0.0993583461669207,0.295816787810856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRS,Receptor-type tyrosine-protein phosphatase S,36446,-0.0164719000856464,0.0157561628338136,-0.0473539792399211,0.0144101790686283,0.295861033810629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNRPB2,U2 small nuclear ribonucleoprotein B'',35416,-0.0315261689200704,0.0301582528427081,-0.0906363444917782,0.0275840066516374,0.295898179884134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA7,Thyroxine-binding globulin,35448,0.0126330398308563,0.012085533789935,-0.0110546063974163,0.0363206860591288,0.29592353835326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4C,C-type lectin domain family 4 member C,36352,-0.0324989018809521,0.0310975780607195,-0.0934501548799623,0.0284523511180581,0.296029534563295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMA,Granzyme A,36442,-0.0238468830876458,0.0228198094714226,-0.0685737096516341,0.0208799434763425,0.296054129556644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP10,Bone morphogenetic protein 10,35312,-0.0189036239503729,0.0181190826152947,-0.0544170258763505,0.0166097779756047,0.296850975124117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGB,Secretogranin-1,36412,-0.0276115590979757,0.026485201110214,-0.0795225532739952,0.0242994350780437,0.297201947754537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAMR1,Inactive serine protease PAMR1,36382,0.0178089819781945,0.0170869887875649,-0.0156815160454327,0.0512994800018218,0.297328997416502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,35281,-0.0177062637822234,0.0169908942605185,-0.0510084165328396,0.0155958889683928,0.29740526278668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3S2,AP-3 complex subunit sigma-2,35416,-0.0309757079372655,0.0297309848466887,-0.0892484382367753,0.0272970223622443,0.297514200885219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZU1,Azurocidin,36138,-0.0525730841549831,0.0504615919920819,-0.151477804459464,0.0463316361494975,0.297520489835782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF3,Neurotrophin-3,36352,-0.0238835987812454,0.0229250513869549,-0.068816699499677,0.0210495019371863,0.297533930632132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAX,Integrin alpha-X,35321,-0.0360148060148085,0.0345841598220605,-0.103799759266047,0.0317701472364302,0.297746297303188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD302,CD302 antigen,36331,-0.0211895009259077,0.0203685280944237,-0.0611118159909781,0.0187328141391628,0.298233021676525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",36397,-0.0235981299433609,0.0227273983606845,-0.0681438307303025,0.0209475708435806,0.299159686975509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART3,Ecto-ADP-ribosyltransferase 3,36410,0.0239573052516625,0.0231082490115136,-0.0213348628109041,0.069249473314229,0.299890590806083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,35312,-0.0279291205173232,0.0269476206315176,-0.0807464569550978,0.0248882159204513,0.300046036935294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB11FIP3,Rab11 family-interacting protein 3,35420,-0.0696806871033394,0.0673108141881051,-0.201609882912025,0.0622485087053466,0.300612032751486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,36368,-0.0193624832764428,0.0187069415576316,-0.0560280887294007,0.0173031221765151,0.300683858726204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA6,Carbonic anhydrase 6,36361,0.0414623344027812,0.0400735557048295,-0.0370818347786847,0.120006503584247,0.30086462254234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPGDS,Hematopoietic prostaglandin D synthase,36225,-0.0249034975517319,0.0240766977439537,-0.0720938251298811,0.0222868300264173,0.301012700848656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK11,Kallikrein-11,36325,-0.020721843825649,0.0200382515571917,-0.0599968168777447,0.0185531292264468,0.301117768431957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDA,Cytidine deaminase,35408,0.0318481482965278,0.0308054317289692,-0.0285304978922518,0.0922267944853075,0.301247243290614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZCCHC8,Zinc finger CCHC domain-containing protein 8,35214,0.0419674655303148,0.0406247754461616,-0.0376570943441619,0.121592025404792,0.3016215234507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC27,Cell division cycle protein 27 homolog,36225,-0.0403369050243683,0.0390537834362606,-0.116882320559439,0.0362085105107024,0.301707171041587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCR,Breakpoint cluster region protein,36352,-0.0600163343425039,0.0581135116624123,-0.173918817200832,0.0538861485158242,0.301758979288829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP2,Pancreatic lipase-related protein 2,36368,0.195714858069597,0.189561118499531,-0.175824934189484,0.567254650328678,0.301890034146147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA10,Annexin A10,36191,-0.0563773134410219,0.0546989629797371,-0.163587280881307,0.0508326539992628,0.302724934056003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGXT,Serine--pyruvate aminotransferase,36360,0.0501985381159598,0.0487329157074332,-0.0453179766706092,0.145715052902529,0.303009757707576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPEP,Aspartyl aminopeptidase,35416,0.0358085431706088,0.0348376204308261,-0.0324731928738104,0.104090279215028,0.304050962688659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMD,Osteomodulin,36403,-0.027944833159484,0.0271881571221507,-0.0812336211188995,0.0253439547999314,0.30406377366722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,36331,-0.0216266727685084,0.0210609268601235,-0.0629060894143505,0.0196527438773336,0.304520087366876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP9,Fatty acid-binding protein 9,36352,0.0375635335547688,0.0366029932873948,-0.0341783332885251,0.109305400398063,0.304812148567759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35402,-0.0763063973800832,0.0744176473754978,-0.222164986236059,0.0695521914758924,0.305223682350367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS,RNA-binding protein with multiple splicing,35239,-0.0432907896762262,0.0422258722457071,-0.126053499277812,0.0394719199253598,0.305300629253364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP7,Caspase-7,35416,-0.053391262402092,0.0521368871627037,-0.155579561240991,0.0487970364368072,0.305847094633276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2,Complement C2,36399,0.0152108817582886,0.0148638707713157,-0.0139223049534901,0.0443440684700673,0.306178668569654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGA4,Pepsin A-4,35428,-0.0521587776197202,0.0509963390453304,-0.152111602148568,0.0477940469091274,0.306444683081785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRBP,Acrosin-binding protein,35391,-0.024923528797716,0.0243794354198084,-0.0727072222205405,0.0228601646251084,0.306670455978175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPT,Microtubule-associated protein tau,36191,-0.0340001590316035,0.0332982610666867,-0.0992647507223095,0.0312644326591024,0.30725225767001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD248,Endosialin,35438,-0.0262818793160838,0.0257651600098735,-0.0767815929354357,0.0242178343032682,0.307741915054435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,35206,-0.0370461079322848,0.0363210444396592,-0.108235355034017,0.0341431391694472,0.307787226805484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS5,Transmembrane protease serine 5,36262,0.0252795687811983,0.0248279539972247,-0.0233832210533621,0.0739423586157587,0.308622630257522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C5,Complement C5,35448,0.00936346543875366,0.00919701519141649,-0.00866268433642266,0.02738961521393,0.30867063065826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2A,DNA-directed RNA polymerase II subunit RPB1,35239,0.01843032094157,0.0181091471218859,-0.0170636074173264,0.0539242493004664,0.308844426904696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP2,Methionine aminopeptidase 2,36413,-0.0365647454483737,0.035932862935096,-0.106993156801162,0.0338636659044145,0.308909279044589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC22D1,TSC22 domain family protein 1,35417,-0.0417967318207439,0.0411302741359358,-0.122412069127178,0.0388186054856902,0.30957195852541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRNN,Cornulin,36172,0.0447264184336309,0.0440311694999489,-0.041574673786269,0.131027510653531,0.309764652061798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH6,Cadherin-6,36360,-0.0248714921320704,0.0245132223419499,-0.0729174079222923,0.0231744236581515,0.310323465423843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIRC2,Baculoviral IAP repeat-containing protein 2,36225,-0.040743165623351,0.0402033117760019,-0.119541656704315,0.0380553254576127,0.310890598507336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX4,Syntaxin-4,36331,0.0384894602916786,0.0380303403395979,-0.0360500067739333,0.11302892735729,0.31153771597321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF1,Pigment epithelium-derived factor,35353,-0.017343563152166,0.017168786522578,-0.0509943847364189,0.016307258432087,0.312448788203223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL28,"39S ribosomal protein L28, mitochondrial",35417,0.0245098462297451,0.0243283319217533,-0.0231736843368914,0.0721933767963817,0.313752448671123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35417,-0.0631610920795324,0.0627668815663386,-0.186184179949556,0.0598619957904912,0.314319759281007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL17,C-C motif chemokine 17,36363,-0.0592976382149322,0.0589738310645078,-0.174886347101367,0.0562910706715031,0.314694565170214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFM,Afamin,35448,0.0124295968812485,0.0123634523228616,-0.0118027696715602,0.0366619634340572,0.314767238871203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCA2A,Guanylin,36340,0.0228575603691844,0.0227431867695431,-0.02171908569912,0.0674342064374888,0.314916955536894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP13,Collagenase 3,36191,-0.0208925900298583,0.0208260920055953,-0.0617117303608251,0.0199265503011085,0.315802433594596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSD1,Tryptase delta,35417,-0.0239791752654275,0.0239123276650966,-0.0708473374890168,0.0228889869581618,0.315998516874744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",35312,-0.0652354355443554,0.0651270172162978,-0.192884389288299,0.0624135181995883,0.316545165622391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST1,Cystatin-SN,34616,0.0670655185902816,0.0669921036091051,-0.0642390044835643,0.198370041664128,0.316825133445945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK12,Kallikrein-12,36225,0.0888695029810881,0.0890312120356226,-0.0856316726087321,0.263370678570908,0.31822464907944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3B,Sodium channel subunit beta-3,35212,-0.030051383729563,0.0301057490912831,-0.0890586519484778,0.0289558844893518,0.3182253383105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN2,Dynactin subunit 2,36331,0.0598224135188744,0.0599502600254756,-0.0576800961310577,0.177324923168807,0.318377464366397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS1,Protein MTSS 1,35402,-0.0702954876580268,0.0704687576328844,-0.20841425261848,0.0678232773024267,0.318540775296383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FURIN,Furin,36397,0.0206954645109868,0.0207633334706079,-0.0200006690914047,0.0613915981133783,0.3189284310167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF1,Formylglycine-generating enzyme,35239,-0.0431023834099743,0.0432614721949198,-0.127894868912017,0.0416901020920686,0.319133294805715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI2B,Protein EVI2B,35206,-0.0244136720662966,0.0245316315566404,-0.0724956699173117,0.0236683257847185,0.3196831703246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35321,-0.0403362933867278,0.0405459230713843,-0.119806302606641,0.0391337158331855,0.319858326089865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35321,-0.0422907711444776,0.0425314138677265,-0.125652342325222,0.0410708000362664,0.320095661409052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNT,Aryl hydrocarbon receptor nuclear translocator,36227,-0.0227039724338687,0.0228631494906721,-0.0675157454355861,0.0221078005678487,0.320725681013583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNG,Uracil-DNA glycosylase,35391,-0.0210599883888036,0.0212387173216623,-0.0626878743392616,0.0205678975616544,0.321438842160463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD244,Natural killer cell receptor 2B4,36442,-0.0176344513747847,0.0177954288190663,-0.0525134918601547,0.0172445891105854,0.321741122303008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP2,Contactin-associated protein-like 2,36352,0.0266818423880517,0.0269263362073442,-0.026093776578343,0.0794574613544463,0.32175818903478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN3,Matrilin-3,36282,-0.0214102127592441,0.0216072628581175,-0.0637604479611544,0.0209400224426661,0.321777819596675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSLP,Thymic stromal lymphopoietin,36249,-0.0385750175089168,0.0389414906241181,-0.114900339132188,0.0377503041143547,0.321920217525023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,36225,-0.0428068938977517,0.043228986564599,-0.127535707564366,0.0419219197688623,0.322092910971117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC1,Glypican-1,36427,0.0184563440877233,0.0186901439724045,-0.0181763380981896,0.0550890262736361,0.323435152149647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT5B,Signal transducer and activator of transcription 5B,36331,-0.0858108110280055,0.0869906251004814,-0.256312436224949,0.0846908141689381,0.32395193146544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA6,Corticosteroid-binding globulin,35448,0.010078459136303,0.0102253732920427,-0.00996327251610081,0.0301201907887067,0.324351666012734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAG,S-arrestin,35212,0.0324960916031038,0.0329759546631093,-0.0321367795365905,0.0971289627427981,0.324443633684983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGR,Tyrosine-protein kinase Fgr,36191,-0.0384427004924932,0.0390550883673223,-0.114990673692445,0.0381052727074586,0.324992284758125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR2,Complement receptor type 2,36410,0.0301489476681789,0.030709993465767,-0.0300426395247244,0.0903405348610823,0.326265381346541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP10,Inactive dipeptidyl peptidase 10,36352,-0.0226208299988855,0.0230565710054288,-0.0678117091695258,0.0225700491717549,0.326575986024602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCTS1,Malignant T-cell-amplified sequence 1,35402,0.0167071957328331,0.0170327520662437,-0.0166769983170046,0.0500913897826709,0.326686963247334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLRAP1,Low density lipoprotein receptor adapter protein 1,35417,-0.0597794545375905,0.0609717737799671,-0.179284131146326,0.0597252220711449,0.326904751418746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4C,Semaphorin-4C,36331,-0.01751173293419,0.0178649966118608,-0.0525271262934372,0.0175036604250571,0.327007832913481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRTN,Neurturin,36227,-0.0319073063510671,0.0325513567861838,-0.0957079656519874,0.0318933529498532,0.327014049476229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COLEC12,Collectin-12,36368,-0.0170443765569277,0.017394226211611,-0.0511370599316853,0.0170483068178298,0.327174931532292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE2,Glia-derived nexin,35420,-0.039547239003256,0.0403694236442961,-0.118671309346076,0.0395768313395644,0.327305135644973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA1,Paraneoplastic antigen Ma1,35281,-0.034468728107561,0.0352186046256842,-0.103497193173902,0.03455973695878,0.327763201345036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPHN1,Oligophrenin-1,35416,-0.0652633058431141,0.0667286612928616,-0.196051481977123,0.0655248702908947,0.328092521821606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP5,Retinol-binding protein 5,36331,-0.0345109159369716,0.0353479801233548,-0.103792956978747,0.0347711251048038,0.32893933897259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPO,Erythropoietin,36352,0.0458486759596018,0.0470075867136733,-0.0462861939991978,0.137983545918401,0.329421468995524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TERF1,Telomeric repeat-binding factor 1,35239,0.0182442455588517,0.0187081895253675,-0.0184238059108685,0.054912297028572,0.329499577018899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALY,Neuron-specific vesicular protein calcyon,35214,-0.0242063436874655,0.0248223132404231,-0.0728580776386947,0.0244453902637637,0.329507761705321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL34,Interleukin-34,36182,-0.0222627303308851,0.0228326301209531,-0.0670146853679532,0.022489224706183,0.32957411182969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX16,Syntaxin-16,36225,-0.0361621572021979,0.0371377758083665,-0.108952197786596,0.0366278833822006,0.330224239176001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35321,-0.0265754004482604,0.0273124508601729,-0.0801078041341992,0.0269570032376785,0.330584693837653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1MT,"DNA topoisomerase I, mitochondrial",35206,-0.0304141556668621,0.0312740603272906,-0.0917113139083516,0.0308830025746274,0.330838891214758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCNE1,G1/S-specific cyclin-E1,35239,0.054602447778346,0.05615850321268,-0.0554682185185068,0.164673114075199,0.330944343758656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK14,Kallikrein-14,36427,-0.0290065700058698,0.0298395873160643,-0.0874921611453558,0.0294790211336162,0.331041523979885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC3,Membrane primary amine oxidase,36410,-0.018392132902011,0.0189240600470882,-0.0554832905943038,0.0186990247902819,0.331137110346802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A2,Secretoglobin family 3A member 2,36390,-0.052977509449768,0.0545526745153638,-0.159900751499881,0.0539457326003451,0.331518279885005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC25A,M-phase inducer phosphatase 1,35206,0.0249881040449227,0.0257417193027434,-0.0254656657884543,0.0754418738782998,0.331724801928544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD6,T-cell differentiation antigen CD6,36433,-0.0329215642368129,0.0339178606614783,-0.0994005711333103,0.0335574426596845,0.331766882948891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP11,Low-density lipoprotein receptor-related protein 11,36360,-0.0228368930011503,0.0236468193793881,-0.069184658984751,0.0235108729824504,0.334202366254765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35402,-0.0294304176511738,0.0304917781959181,-0.0891943029151733,0.0303334676128258,0.334486294540765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM1,Dynamin-1,35402,-0.068748233416365,0.0712754202908836,-0.208448057186497,0.0709515903537668,0.334811150680468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD2,"Superoxide dismutase [Mn], mitochondrial",36382,-0.023869792614625,0.0248024882269756,-0.0724826695394971,0.0247430843102471,0.335883558251196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHB,Lutropin subunit beta,36225,-0.0531314448011369,0.0552340364220133,-0.161390156188283,0.0551272665860091,0.336116318349485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL5,Fc receptor-like protein 5,36382,-0.0358677185013328,0.0372906941161497,-0.108957478968986,0.0372220419663206,0.336161833777447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2B,V-set and transmembrane domain-containing protein 2B,35321,0.0246600133267089,0.0256778692447744,-0.0256686103930489,0.0749886370464666,0.336911668152043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,35214,-0.0199700244446976,0.0208186803534853,-0.0607746379375288,0.0208345890481335,0.337478469313691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLG4,Disks large homolog 4,35416,-0.0424403392279605,0.0442442498323608,-0.129159068899388,0.0442783904434667,0.337480988140874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM5,Intercellular adhesion molecule 5,36360,-0.0280636818386766,0.0292660597958663,-0.0854251590385746,0.0292977953612213,0.337633606980375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",36331,-0.0421615671560168,0.0439732021610355,-0.128349043391646,0.0440259090796128,0.337691289741419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C19orf12,Protein C19orf12,36191,-0.039253607199742,0.0409792679966489,-0.119572972473174,0.0410657580736899,0.338151618396725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG1,Arginase-1,36316,-0.0323923429673495,0.0338177013291138,-0.0986750375724125,0.0338903516377135,0.338170054544316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A1,Collagen alpha-1(IV) chain,36360,-0.0245527376162845,0.0256335397599652,-0.0747944755458162,0.0256890003132472,0.338177571085299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARS1,"Methionine--tRNA ligase, cytoplasmic",35301,-0.0511888493119557,0.0534788432696651,-0.156007382120499,0.0536296834965879,0.338514581529902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCTD5,BTB/POZ domain-containing protein KCTD5,35309,-0.0274754580436149,0.028707850927282,-0.0837428458610877,0.0287919297738578,0.338569141924555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,35097,-0.0640488314482827,0.0671636563776506,-0.195689597948478,0.0675919350519126,0.340313375660203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB1A1,Uteroglobin,36372,0.0330218376529242,0.0346283170938049,-0.0348496638509334,0.100893339156782,0.340314253156609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIAE,Sialate O-acetylesterase,36389,-0.028233266202614,0.0296359837253971,-0.0863197943043923,0.0298532618991643,0.340790094025893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD7,FERM domain-containing protein 7,35275,-0.0201128912086517,0.0211123304459729,-0.0614930588827586,0.0212672764654552,0.340799786870312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLF4,Krueppel-like factor 4,35212,-0.0248904856301295,0.026172728453353,-0.0761890333987013,0.0264080621384423,0.341638283333463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS4,Galectin-4,36368,-0.0338599443945885,0.0356309268603767,-0.103696561040927,0.03597667225175,0.341993639126701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT1,Dynein light chain Tctex-type 1,35275,-0.0485075079857583,0.0510735793224175,-0.148611723457697,0.05159670748618,0.342273299100026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTD1,D-aminoacyl-tRNA deacylase 1,35312,-0.0516301660382301,0.054368074840592,-0.15819159272579,0.0549312606493303,0.342332086514467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17D,Interleukin-17D,36227,0.0208085166551412,0.0219180616653381,-0.0221508842089215,0.0637679175192039,0.342461222907277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROC,Vitamin K-dependent protein C,36399,0.0153494474736971,0.0161903551681989,-0.0163836486559726,0.0470825436033669,0.343130097789079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLSCR3,Phospholipid scramblase 3,35403,-0.0339749817990765,0.0359233999520623,-0.104384845705119,0.0364348821069655,0.344306862096975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRCAM,Neuronal cell adhesion molecule,36360,0.0171331307616199,0.0181181991311583,-0.0183785395354503,0.0526448010586901,0.344368710329365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35402,-0.0819544579764683,0.0867485220381212,-0.251981561171186,0.0880726452182491,0.344830402854351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SARG,Specifically androgen-regulated gene protein,35395,-0.0642638775945234,0.0680445118892937,-0.197631120897539,0.0691033657084923,0.344982254724034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BACH1,Transcription regulator protein BACH1,36352,-0.0438217484908022,0.0464102470675997,-0.134785832743298,0.0471423357616933,0.345086188807093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,35212,-0.0470241033507433,0.049803604224355,-0.144639167630479,0.0505909609289926,0.3451100761607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTNB,Dystrobrevin beta,35377,-0.0255741361661782,0.0270987287123317,-0.0786876444423484,0.0275393721099919,0.345339743290203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACYBP,Calcyclin-binding protein,35301,-0.0606449098929397,0.0643368949611101,-0.186745224016716,0.0654554042308361,0.345915249265444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOT13,Acyl-coenzyme A thioesterase 13,35402,-0.06675200521156,0.0708163640219877,-0.205552078694656,0.0720480682715359,0.345918603120519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA9,Serpin A9,36294,0.0441617590725767,0.0468515901049449,-0.0476673575331152,0.135990875678269,0.345923614915805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A13,Protein S100-A13,35239,0.0220532564965756,0.0234214289531442,-0.023852744251587,0.0679592572447381,0.346442989683189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,36297,-0.0564752456753155,0.0600579570215099,-0.174188841437475,0.0612383500868439,0.347072207715728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPRC5C,G-protein coupled receptor family C group 5 member C,35391,-0.0343741098563822,0.0365575845535474,-0.106026975581335,0.0372787558685707,0.347114191960024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK3,NT-3 growth factor receptor,36428,0.0127035297966422,0.0135135440779238,-0.0137830165960884,0.0391900761893729,0.347218645332763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCP1,Plastin-2,35438,-0.0280140491464347,0.0298873078787598,-0.0865931725888039,0.0305650742959346,0.348628893356374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35391,-0.0201042840462762,0.0214657509705626,-0.0621771559485789,0.0219685878560265,0.349013753350712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RB,Cytokine receptor common subunit beta,35239,0.0255115836286767,0.0272537340466681,-0.0279057351027928,0.0789289023601462,0.349271125812816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC4,MANSC domain-containing protein 4,35214,-0.0416476712859353,0.0445449794294968,-0.128955830967749,0.0456604883958785,0.349847602958452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX2,Neuronal pentraxin-2,35438,-0.0192459860605571,0.020607996886481,-0.0596376599580599,0.0211456878369456,0.350387141575964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SF3B4,Splicing factor 3B subunit 4,36331,-0.0440620420508445,0.047232194129727,-0.13663714254511,0.0485130584434205,0.350912691565543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD5,26S proteasome non-ATPase regulatory subunit 5,35275,-0.0336989683408012,0.0361502697557678,-0.104553497062106,0.0371555603805037,0.351274659528988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPTC,Opticin,36331,-0.0274614003285275,0.0294755506259671,-0.0852334795554229,0.0303106788983679,0.351540115954886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAEP,Glycodelin,36297,-0.053393850110861,0.0573101343038386,-0.165721713346385,0.0589340131246626,0.351541309960335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTO1,Protein LTO1 homolog,36227,-0.0257767606489467,0.0276749517941445,-0.0800196661654699,0.0284661448675766,0.351672859234149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNDA,Myeloid cell nuclear differentiation antigen,36347,-0.0612670949320223,0.0661045249317023,-0.190831963798159,0.0682977739341141,0.354050489955204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYM,Ketimine reductase mu-crystallin,35212,-0.0438327037950374,0.0473165069331613,-0.136573057384034,0.0489076497939587,0.354289655250082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBL1,Neuroblastoma suppressor of tumorigenicity 1,36397,-0.0162124959081343,0.0175086222023086,-0.0505293954246591,0.0181044036083905,0.354491494896464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTN,Pleiotrophin,36249,-0.0293265884766952,0.0316788402932011,-0.0914171154513695,0.032763938497979,0.354609188613855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBN2,Fibrillin-2,35275,-0.0349117117936763,0.0377410970997998,-0.108884262109284,0.0390608385219313,0.354986116524987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGR,Progesterone receptor,35239,0.0575721378934887,0.0622387939035229,-0.0644158981574163,0.179560173944394,0.354992355296956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD177,CD177 antigen,36371,0.0765077316199058,0.082730705672847,-0.0856444514988744,0.238659914738686,0.355111261645429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MME,Neprilysin,36331,-0.0483599746199327,0.0523329540326403,-0.150932564523908,0.0542126152840423,0.35547452909395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF4,Cyclic AMP-dependent transcription factor ATF-4,35206,0.0203922433375571,0.022070264754591,-0.0228654755814412,0.0636499622565555,0.355539470103134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35321,0.0512205511307175,0.0554810103875949,-0.0575222292289684,0.159963331490403,0.355934813125526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRM,Receptor-type tyrosine-protein phosphatase mu,36341,0.0146907917916633,0.0159190112667628,-0.0165104702911918,0.0458920538745183,0.356118751274405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH9,Myosin-9,35438,-0.0661533831258434,0.0716852014070522,-0.206656377883666,0.0743496116319788,0.356130525712431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL16,C-X-C motif chemokine 16,36438,-0.0138971228157328,0.0150722389836814,-0.0434387112237483,0.0156444655922827,0.356541339701986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEK7,Serine/threonine-protein kinase Nek7,35321,-0.0452735230414406,0.0491025156083876,-0.14151445363388,0.050967407550999,0.356554218111589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL21,C-C motif chemokine 21,36403,-0.0252084397978714,0.0273813356501055,-0.0788758576720782,0.0284589780763354,0.35726755890227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAM,Basal cell adhesion molecule,36382,0.0146355312196502,0.0159016169883843,-0.016531638077583,0.0458027005168834,0.357405070882023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,35275,-0.0286535224070878,0.0311392304556941,-0.0896864141002483,0.0323793692860727,0.357518135120703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLR,Low-density lipoprotein receptor,36361,-0.0296004030362258,0.0321762920003002,-0.0926659353568142,0.0334651292843626,0.357632721220272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNL1,Thioredoxin-like protein 1,35196,-0.0574126992349582,0.0625538540696773,-0.180018253211526,0.0651928547416093,0.358753999291646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFE2,Transcription factor NF-E2 45 kDa subunit,35281,-0.0426913489367674,0.046526910819801,-0.133884094143577,0.0485013962700425,0.358884307746992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTC,Probetacellulin,36225,-0.0439284557501331,0.0479718247252721,-0.137953232211666,0.0500963207114001,0.359848497131111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERMAP,Erythroid membrane-associated protein,35239,-0.0258047320379955,0.0281815789158688,-0.0810406267130983,0.0294311626371073,0.359882008507822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JPT2,Jupiter microtubule associated homolog 2,35402,-0.0496412119361155,0.0542187017061639,-0.155909867280197,0.0566274434079657,0.359926145022375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM25,RNA-binding protein 25,35206,-0.0273088208146945,0.029827774553771,-0.0857712589400856,0.0311536173106967,0.359939654605046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NHLRC3,NHL repeat-containing protein 3,35167,-0.0185484974414863,0.0202653360373183,-0.0582685560746302,0.0211715611916576,0.360080550950274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPN1,Epsin-1,35321,-0.0244867816454538,0.0267959122768759,-0.0770067697081306,0.0280332064172231,0.360844626614097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN5,Contactin-5,36387,0.0223583547570367,0.0245041980069775,-0.0256698733366392,0.0703865828507127,0.361573210412503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN1,Cerebellin-1,35212,-0.0541925680219548,0.0594762818604242,-0.170766080468386,0.0623809444244765,0.362246162434564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,35214,-0.0266024576569367,0.0292227743565995,-0.0838790953958718,0.0306741800819984,0.362683334355095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON3,Serum paraoxonase/lactonase 3,36403,0.0169846369012706,0.0186581475356978,-0.0195853322686972,0.0535546060712383,0.362691215541517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APPL2,DCC-interacting protein 13-beta,35312,-0.0634419820405159,0.0697166790221297,-0.20008667292389,0.0732027088428584,0.362859840226504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3RA,Interleukin-3 receptor subunit alpha,36227,-0.0187795051706422,0.0206635804799108,-0.0592801229112673,0.0217211125699829,0.363475523746571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHL1,Neural cell adhesion molecule L1-like protein,36398,-0.0175548080269287,0.0193572754284131,-0.0554950678666183,0.0203854518127609,0.36449834820338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN2,Transcobalamin-2,36439,-0.0175623780026832,0.0193749544096603,-0.0555372886456175,0.020412532640251,0.364729212896203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA5,Protein disulfide-isomerase A5,35206,0.035512290870295,0.0391844533100028,-0.0412892376173105,0.1123138193579,0.364821226920545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRING1,SREBP regulating gene protein,35206,-0.0349036052458948,0.0385242424073814,-0.110411120364362,0.0406039098725728,0.364963345664965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35417,-0.0250024911514977,0.0276167117516122,-0.0791312461846576,0.0291262638816622,0.365320775454582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA1,Ephrin-A1,36372,-0.0170262244272614,0.0188091395397438,-0.0538921379251593,0.0198396890706365,0.365384435861669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1RL,Complement C1r subcomponent-like protein,35435,-0.0111109157008718,0.0122874989423768,-0.0351944136279303,0.0129725822261867,0.365900137694396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK1,Docking protein 1,35416,-0.0762740932570155,0.0844206155007905,-0.241738499638565,0.0891903131245339,0.366295144112037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL4,ADAMTS-like protein 4,35281,0.0131318810461217,0.0145526757094824,-0.0153913633444638,0.0416551254367073,0.366896674932286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN2,Centrin-2,36191,-0.0381187958219256,0.0422780471501396,-0.120983768236199,0.0447461765923479,0.367289005501307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOPH1,Enolase-phosphatase E1,35391,-0.0301351249532653,0.0334264286478588,-0.0956509251030686,0.0353806751965381,0.367338498881918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLUL1,Clusterin-like protein 1,36350,-0.0261402994545287,0.0290241579982776,-0.0830276491311528,0.0307470502220954,0.367810401608237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR4,Complement factor H-related protein 4,35436,-0.0413804193842901,0.045973450159473,-0.131488381696857,0.0487275429282769,0.368105036168705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAP,Cartilage-associated protein,35275,-0.0274821476808048,0.0305704640325571,-0.0874002571846167,0.0324359618230071,0.36870044297685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3BL1,Uroplakin-3b-like protein 1,35307,-0.0302245090881492,0.0338341963447586,-0.0965395339238761,0.0360905157475777,0.371725034196156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GL3,Endophilin-A3,35288,-0.0477128986079994,0.0534251085613659,-0.152426111388277,0.0570003141722778,0.371849571265795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYGD,Gamma-crystallin D,35416,-0.054259032605399,0.0608513586607283,-0.173527695580426,0.0650096303696284,0.372606947172698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD23B,UV excision repair protein RAD23 homolog B,36225,-0.0263748259523708,0.0295868070947056,-0.0843649678579938,0.0316153159532522,0.372724348450176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WNT9A,Protein Wnt-9a,36227,-0.016626604384528,0.0186686872777326,-0.0532172314488838,0.0199640226798278,0.37316645970081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM24,Transcription intermediary factor 1-alpha,35307,-0.037081674700382,0.0417219602860811,-0.118856716861101,0.044693367460337,0.37415590032035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,36381,-0.0203238523455966,0.0228830308469591,-0.0651745928056364,0.0245268881144433,0.374483012022816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HK2,Hexokinase-2,36249,-0.0155516275783585,0.0175129609371518,-0.049877031015176,0.0187737758584589,0.374567391747483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA10,Ephrin type-A receptor 10,36191,-0.0370769963624172,0.0417806510956224,-0.118967072509837,0.0448130797850027,0.374883180247827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANGAP1,Ran GTPase-activating protein 1,36225,0.0266158005834349,0.030023364662036,-0.0322299941541556,0.0854615953210253,0.375376898859783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A4,Collagen alpha-4(IV) chain,35307,0.0298769411624332,0.0337724774540586,-0.0363171146475216,0.0960709969723881,0.37637832330917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA2,Apolipoprotein A-II,35428,-0.0273516073349246,0.0309268002055072,-0.0879681357377187,0.0332649210678695,0.376515385936377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMM2,Phosphomannomutase 2,35214,-0.0333022870782117,0.0376842960406608,-0.107163507317907,0.0405589331614836,0.376883803371634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL28A1,Collagen alpha-1(XXVIII) chain,35275,-0.0417491337836632,0.0472764402480529,-0.134410956669847,0.0509126891025205,0.377225044612904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC37A2,Leucine-rich repeat-containing protein 37A2,35402,-0.0241464343697505,0.0273674229315014,-0.0777865833154933,0.0294937145759922,0.377645654052852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5A,Cytochrome b5,35206,-0.0406330356363128,0.0460993834063913,-0.13098782711284,0.0497217558402141,0.37812439833486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,36297,-0.0429363030630251,0.0487189639482604,-0.138425472401615,0.0525528662755653,0.37818217466252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSBPL2,Oxysterol-binding protein-related protein 2,35416,-0.0215432747277228,0.0244883571631678,-0.0695404547675317,0.0264539053120861,0.379036642013881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM5,PDZ and LIM domain protein 5,35417,-0.0643296531167143,0.0731602597538686,-0.207723762234297,0.0790644560008682,0.379273797214189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILPL2,RILP-like protein 2,35420,-0.0534797552932296,0.0608374127624318,-0.172721084307596,0.0657615737211368,0.379402498104264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA4,Carboxypeptidase A4,35185,0.0242685566295203,0.0276247920759469,-0.0298760358393357,0.0784131490983763,0.379704197562717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,36331,-0.0256957793064037,0.0292901687018897,-0.0831045099621075,0.0317129513493002,0.380362245767749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSPN,Claspin,36184,0.0189956383959086,0.0216810578160102,-0.0234992349234713,0.0614905117152885,0.380984126740188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",35275,-0.0261193828665398,0.0298360888771846,-0.0845981170658217,0.032359351332742,0.381375003731722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35402,0.0404609669808315,0.0462690798036972,-0.0502264294344149,0.131148363396078,0.381895652202227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA5,Plasma serine protease inhibitor,35356,-0.0178929414573572,0.0204796893090211,-0.0580331325030384,0.0222472495883241,0.382320036032179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,36331,-0.0156188284863078,0.0178824400900378,-0.0506684110627818,0.0194307540901662,0.382465174119379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGK,N-acetyl-D-glucosamine kinase,35272,-0.030831177243018,0.0353051598524223,-0.100029290553766,0.0383669360677297,0.382546718855649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMMR,Hyaluronan mediated motility receptor,35192,-0.0273965643993654,0.031381460432128,-0.0889042268463362,0.0341110980476054,0.382688482762286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX2,Transcription factor SOX-2,35404,-0.0133284062991379,0.0152768651256137,-0.0432710619453408,0.0166142493470649,0.382992905483733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA7,Carbonic anhydrase 7,35321,-0.0188853986017525,0.0216957730944136,-0.0614091138668032,0.0236383166632982,0.384080755643469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP3,Caspase-3,36446,-0.0477787835343364,0.0549062743803178,-0.155395081319759,0.0598375142510864,0.384226450209277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",36352,-0.0235906842866416,0.0271140542018548,-0.076734230522277,0.0295528619489938,0.384300211213434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BID,BH3-interacting domain death agonist,36352,0.0375567521041673,0.0432153304920425,-0.0471452956602361,0.122258799868571,0.384842983947033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPA2,Replication protein A 32 kDa subunit,35239,-0.0171542937225219,0.0197448900171078,-0.0558542781560532,0.0215456907110094,0.384992873217903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP170,Centrosomal protein of 170 kDa,35281,-0.0413098211954089,0.0475507224726956,-0.134509237241892,0.0518895948510744,0.385016630462867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP44,Endoplasmic reticulum resident protein 44,36314,-0.0141676347628982,0.0163339376077645,-0.0461821524741167,0.0178468829483202,0.38576628791803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH2,Neutral ceramidase,36297,0.0295674960371089,0.0341538908797785,-0.037374130087257,0.0965091221614748,0.386676347003077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHMT1,"Serine hydroxymethyltransferase, cytosolic",36390,-0.0470318753655063,0.054449090557574,-0.153752092858351,0.0596883421273387,0.387739161390734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTN,Neuroplastin,36225,0.0443974976416192,0.0514144992847298,-0.0563749209564513,0.14516991623969,0.387880557229279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPA,CCAAT/enhancer-binding protein alpha,35239,0.0198504430285392,0.0230220869832034,-0.0252728474585394,0.0649737335156179,0.388592563025941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC59,Leucine-rich repeat-containing protein 59,35420,-0.0265278235850209,0.0307882081625004,-0.0868727115835217,0.0338170644134798,0.38892827669673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35420,0.040250169085498,0.0467401816911581,-0.0513605870291719,0.131860925200168,0.389190226652674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRP14,Signal recognition particle 14 kDa protein,36331,-0.0332582369191539,0.0386714312126856,-0.109054242096018,0.04253776825771,0.389806439891512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R2,Interleukin-1 receptor type 2,36358,0.0109684302846486,0.0127622048804615,-0.014045491281056,0.0359823518503532,0.390123069495431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIT,Mast/stem cell growth factor receptor Kit,36399,0.0164949891098747,0.0192102295139787,-0.0211570607375235,0.0541470389572729,0.390558601560701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3C,Protein FAM3C,36350,-0.0166932034702204,0.0194734388462963,-0.0548611436089611,0.0214747366685203,0.391346847591225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35417,0.0145595618957735,0.0169865654207207,-0.018734106328839,0.047853230120386,0.39141037323474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAYN,Layilin,36290,-0.0200401521428279,0.023390971127837,-0.0658864555533885,0.0258061512677326,0.391613469266666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBH,Dopamine beta-hydroxylase,35416,-0.0576046769426582,0.0672654938729182,-0.189445044933578,0.0742356910482615,0.391821808942276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNXB,Tenascin-X,36382,0.0140473427356596,0.0164052090990861,-0.0181068670985491,0.0462015525698684,0.391875162929989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,36446,-0.0129865716184904,0.0151849562000523,-0.0427490857705929,0.016775942533612,0.39245421557312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYN,Tyrosine-protein kinase Lyn,36331,-0.0459162148505755,0.0538253184814507,-0.151413839074219,0.0595814093730679,0.393654776072918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35417,-0.0426410696153181,0.0500465393415439,-0.140732286724744,0.0554501474941079,0.394231152884331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELN,Elastin,35420,-0.0192369706726791,0.0225863232943712,-0.0635061643296467,0.0250322229842885,0.394408484312125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR3,Folate receptor gamma,36378,0.100492412329145,0.118108806028924,-0.131000847487546,0.331985672145836,0.394883229052438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F9,Coagulation factor IX,36399,0.00960932839734124,0.0113081651167553,-0.0125546752314992,0.0317733320261817,0.395481751512932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKCQ,Protein kinase C theta type,36227,0.0235975859193892,0.0277854916723117,-0.0308619777583417,0.0780571495971201,0.395755944548054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST5,Cystatin-D,36224,0.0307670055956187,0.0362434750072138,-0.0402702054185203,0.101804216609758,0.395967077269602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL16,C-C motif chemokine 16,36446,-0.027577120239851,0.0325237619826721,-0.0913236937258882,0.0361694532461862,0.396517838597137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN1,Dynactin subunit 1,36427,-0.0345126716286855,0.0407141601814506,-0.114312425584329,0.0452870823269577,0.396642993068152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLON5,IgLON family member 5,35206,-0.0480156659791146,0.0566721031927569,-0.159092988236918,0.0630616562786888,0.396887287777531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1,Huntingtin-interacting protein 1,35214,-0.0179838467313559,0.0212305765922063,-0.0595957768520802,0.0236280833893683,0.396988145286582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF6,Fibroblast growth factor 6,35239,-0.0219851473168304,0.0259736512436717,-0.0728935037544269,0.0289232091207662,0.397340624133885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIAP1,TP53-regulated inhibitor of apoptosis 1,36427,-0.0332214712354534,0.03930831319415,-0.110265765095987,0.0438228226250807,0.398054334900562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLI1,Friend leukemia integration 1 transcription factor,36225,-0.0593818437874192,0.0703358015615879,-0.197240014848132,0.0784763272732932,0.398551745539078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORBS1,Sorbin and SH3 domain-containing protein 1,35417,-0.021807487974034,0.0258523329157808,-0.0724780604889644,0.0288630845408964,0.398958688052013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBI,Acyl-CoA-binding protein,36352,-0.041243167976514,0.0489168018554374,-0.137120099613171,0.0546337636601433,0.399184545193188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF10,Rho guanine nucleotide exchange factor 10,35417,-0.0490103732885799,0.0582672340607716,-0.163214152047692,0.0651934054705325,0.400306903334977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,35212,-0.0173691972394555,0.0206538397975757,-0.0578507232427039,0.0231123287637929,0.400399846689002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO2,Amphoterin-induced protein 2,36331,-0.0126463522998832,0.0150391383798847,-0.0421230635244571,0.0168303589246907,0.400434333855912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF11,Multiple epidermal growth factor-like domains protein 11,35214,0.0176919770585616,0.021039595007663,-0.023545629156458,0.0589295832735811,0.400443171808543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGACT,Gamma-glutamylaminecyclotransferase,35420,-0.0369981866663865,0.0440153188845646,-0.123268211680133,0.0492718383473602,0.400618221222176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP2,Retinol-binding protein 2,36331,-0.0413033848692103,0.0491397075088505,-0.137617211586557,0.0550104418481366,0.400639599603085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR5,Proline-rich protein 5,35239,-0.0245190052051925,0.0291936867413371,-0.0817386312182132,0.0327006208078281,0.401012506294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINK1,Misshapen-like kinase 1,35416,-0.0484436952108133,0.0577067591292629,-0.161548943104169,0.0646615526825421,0.401232017236292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSF,Cathepsin F,36397,-0.0211560432084342,0.025217969961951,-0.0705832643338581,0.0282711779169897,0.401537952415044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL3,Fc receptor-like protein 3,36227,-0.0297366801472478,0.0354646485870156,-0.0992473913777984,0.0397740310833027,0.401785214074804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXYD5,FXYD domain-containing ion transport regulator 5,36227,0.0349192241973919,0.0416493166491224,-0.0467134364348881,0.116551884829672,0.401828690167692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB2,Receptor tyrosine-protein kinase erbB-2,36397,0.0128277192074219,0.0153124023443998,-0.0171845893876017,0.0428400278024456,0.402207940486582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",35214,0.0357533100526249,0.0427726790196094,-0.0480811408258096,0.119587760931059,0.403249235320079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMS,Spermine synthase,35212,-0.0332722495866136,0.0398714367998126,-0.111420265714246,0.0448757665410192,0.404038972081698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC3,PDZ domain-containing protein GIPC3,35402,-0.051135333968623,0.0612996426760548,-0.171282633613691,0.0690119656764445,0.404207997908602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSAP,Gamma-secretase-activating protein,36225,-0.0438212312234857,0.0525391009690469,-0.146797869122818,0.0591554066758463,0.404270483045625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1R,Complement C1r subcomponent,35448,-0.0105058661983275,0.0125981924511915,-0.0351983234026629,0.0141865910060078,0.404358740798871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC14A,C-type lectin domain family 14 member A,36382,-0.0173707390810977,0.0208500160562055,-0.0582367705512604,0.023495292389065,0.404800038305077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,36331,0.021042673836816,0.0252749604980983,-0.0284962487394566,0.0705815964130886,0.40512630323872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM2,Intercellular adhesion molecule 2,36446,-0.0169657733694156,0.0203931073884954,-0.0569362638508666,0.0230047171120355,0.405472098364614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1A,C-type lectin domain family 1 member A,36249,-0.0183613236198845,0.0220746084584386,-0.0616275561984243,0.0249049089586552,0.405558581211256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN2,Nectin-2,36350,-0.0163151256952716,0.0196308979615766,-0.0547916856999618,0.0221614343094186,0.405948137334338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSR,"Glutathione reductase, mitochondrial",35392,-0.0113537360432736,0.0136836482313188,-0.0381736865766585,0.0154662144901113,0.406723303824041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS2,Protein MTSS 2,35391,-0.0515365135853936,0.0621598382908674,-0.173369796635494,0.0702967694647065,0.40708165318789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF12,Tumor necrosis factor ligand superfamily member 12,36442,0.0148192641878095,0.0178937079148227,-0.020252403325243,0.049890931700862,0.407594154897959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPD,Pulmonary surfactant-associated protein D,36360,-0.0360326831532538,0.0435114382903019,-0.121315102202246,0.049249735895738,0.407630241151578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL2,Fc receptor-like protein 2,36399,-0.026997238823506,0.0326260931262506,-0.0909443813509573,0.0369499037039453,0.40799594397285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAM,Peptidyl-glycine alpha-amidating monooxygenase,36422,-0.0146643582473437,0.0177259718023316,-0.0494072629799136,0.0200785464852263,0.408105166677092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL3,Myosin light chain 3,35281,-0.0377815504385434,0.045687804829841,-0.127329647905032,0.051766547027945,0.40829756597502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPRE3,Microtubule-associated protein RP/EB family member 3,35206,-0.0757347160401462,0.0916078726657138,-0.255286146464945,0.103816714384653,0.408424535298882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECAP2,Adaptin ear-binding coat-associated protein 2,35214,-0.0349952482995885,0.0423474916351216,-0.117996331904427,0.0480058353052498,0.408619599346407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN2,Calsyntenin-2,36442,-0.0208487829560922,0.0252452394592069,-0.0703294522961377,0.0286318863839533,0.408916325074485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO9B,Unconventional myosin-IXb,36227,0.0348827515500697,0.0422387641721173,-0.0479052262272802,0.11767072932742,0.408918970527366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APCS,Serum amyloid P-component,35392,0.0180720002375626,0.0218862592058163,-0.0248250678058374,0.0609690682809626,0.408992696067931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP1,Prolow-density lipoprotein receptor-related protein 1,36331,0.0138694679114399,0.0168137546561362,-0.0190854912145871,0.0468244270374669,0.40946263141334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS4,Thrombospondin-4,36384,-0.0242950378311527,0.0294648952661174,-0.0820462325527429,0.0334561568904375,0.40965912651975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS2,RNA-binding protein with multiple splicing 2,35281,-0.0531373980562225,0.064444148670047,-0.179447929449515,0.0731731333370697,0.40965964487627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,36352,-0.0794121221650429,0.0965507955711833,-0.268651681484562,0.109827437154476,0.41082512951738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED4,Transmembrane emp24 domain-containing protein 4,35214,-0.0278205477442764,0.0338296916560539,-0.094126743390142,0.0384856479015893,0.410898511742531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F3,Tissue factor,36375,0.0142090249993882,0.0172840752496382,-0.0196677624899026,0.048085812488679,0.411054301910823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THAP12,52 kDa repressor of the inhibitor of the protein kinase,35193,0.0445523546935918,0.0542457531172069,-0.0617693214161337,0.150874030803317,0.411504710095235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],36331,-0.0287965841984571,0.0351008176594612,-0.0975941868110011,0.0400010184140869,0.412017569969845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI2,Tissue factor pathway inhibitor 2,36378,-0.0196746937298423,0.0240324490010528,-0.0667782937719058,0.0274289063122212,0.413000715538309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCHE,Cholinesterase,35314,0.0141487269560187,0.0173314849387028,-0.0198209835238388,0.0481184374358762,0.41432617587039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECE1,Endothelin-converting enzyme 1,36191,-0.0183686633058011,0.022511901723373,-0.0624919906836123,0.02575466407201,0.414554550333917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSTN,Osteocrin,35275,-0.0215465021647086,0.0264135740706346,-0.0733171073431523,0.0302241030137352,0.414683117977892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAT,Tissue-type plasminogen activator,36428,-0.0261107180494954,0.0320474296224578,-0.0889236801095126,0.0367022440105218,0.41524091185926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD3,Ly6/PLAUR domain-containing protein 3,36333,0.0178007866861175,0.0218550088814378,-0.0250350307215005,0.0606366040937355,0.415388833390779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB33A,Ras-related protein Rab-33A,35214,-0.0331989992566428,0.0408799616038226,-0.113323724000135,0.0469257254868494,0.416760996492348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH3,Neurogenic locus notch homolog protein 3,36446,-0.0174785754735779,0.021543929839016,-0.0597046779580493,0.0247475270108936,0.417220430332258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH1,Neurexophilin-1,36191,0.0191804299374181,0.0236549163744655,-0.0271832061565343,0.0655440660313704,0.417483255903011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPH,Hephaestin,35420,-0.01352042776918,0.0166849950942783,-0.0462230181539655,0.0191821626156055,0.417778902344911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNPO1,Transportin-1,35321,-0.0173279795755017,0.0213865250988434,-0.0592455687692347,0.0245896096182313,0.417840128001648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,35275,0.0220083625158309,0.0271774990355648,-0.0312595355938761,0.0752762606255379,0.418086315462495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP6,Gastrotropin,36231,-0.0303300179017769,0.0374651151591466,-0.103761643613704,0.0431016078101505,0.418224171781845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTB,Lymphotoxin-beta,35391,-0.0188239524456868,0.0232812252812616,-0.0644551539969596,0.0268072491055861,0.418807106182742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEC31A,Protein transport protein Sec31A,35281,-0.038847366875964,0.0480943747742169,-0.133112341433429,0.0554176076815011,0.41927642485373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTTG1,Securin,35321,0.0213173145892491,0.0263994364944664,-0.030425580939905,0.0730602101184033,0.419414846600824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBX2,Chromobox protein homolog 2,35214,-0.0209315672947231,0.0259329040933785,-0.0717600593177449,0.0298969247282987,0.419615871230966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP1,Retinol-binding protein 1,35275,-0.0357292991927118,0.0442935872744293,-0.122544730250593,0.0510861318651697,0.419901304371313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOC,Myocilin,36382,0.023042275078964,0.0285842870110557,-0.0329829274627052,0.0790674776206333,0.42020215113841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC5,Thioredoxin domain-containing protein 5,36428,-0.0342611667140827,0.0425046260766673,-0.117570233824351,0.0490479003961851,0.420236271776666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1L,Allograft inflammatory factor 1-like,35281,-0.0282772864572484,0.0351265818284926,-0.0971253868410939,0.0405708139265971,0.420844746393654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH1,Protocadherin-1,36419,-0.0113463780405266,0.0141112759381538,-0.0390044788793081,0.0163117227982549,0.42138609761353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35391,-0.0223336227607818,0.0277843006459584,-0.0767908520268602,0.0321236065052966,0.421530808725755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1B,C-type lectin domain family 1 member B,36428,-0.048596581688838,0.0604948276716984,-0.167166443925367,0.0699732805476909,0.42181737204773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD1,Polycystin-1,35420,-0.013562256264542,0.0168861973077032,-0.0466592029876402,0.0195346904585562,0.421915042053134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADIPOQ,Adiponectin,35448,-0.0353601119240446,0.0440641967532944,-0.121725937560502,0.0510057137124125,0.422312730648491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD163,Scavenger receptor cysteine-rich type 1 protein M130,36410,-0.0219363244025703,0.0273709149103514,-0.075583317626859,0.0317106688217184,0.422899584220453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX33,Testis-expressed protein 33,35321,-0.0204910381366259,0.0255726010431741,-0.0706133361812472,0.0296312599079954,0.422995560654387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BA,Platelet glycoprotein Ib alpha chain,36357,-0.01706911419716,0.0213043351292182,-0.0588256110504276,0.0246873826561076,0.423040248648044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON2,Spondin-2,36330,-0.0181964072171132,0.022711823591305,-0.0627115814560709,0.0263187670218445,0.423050341014132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACC3,Transforming acidic coiled-coil-containing protein 3,36331,0.0596508057644412,0.0744663321108652,-0.0863032051728546,0.205604816701737,0.423132861357233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHBP1,EH domain-binding protein 1,35420,-0.0373804480478713,0.0466758670450463,-0.128865147456162,0.0541042513604194,0.423248056825705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORN4,MORN repeat-containing protein 4,35206,0.0390952405722953,0.0488212758023084,-0.0565944600002292,0.13478494114482,0.423289010731856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR15L,Protein GPR15L,35402,-0.03060091014083,0.0382433703777708,-0.105557916081261,0.0443560957996008,0.423647282062022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP3,"Fatty acid-binding protein, heart",35420,-0.0263535627935698,0.0329472627344653,-0.0909301977531217,0.0382230721659822,0.423816008743296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN2B2,Epididymis-specific alpha-mannosidase,35420,-0.030447966082894,0.038089043644833,-0.105102491626767,0.0442065594609788,0.424095328002919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCLY,Selenocysteine lyase,36397,-0.0239144900849012,0.0299216751206568,-0.0825609733213885,0.0347319931515861,0.424179738127233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD6,Programmed cell death protein 6,36360,-0.0348890631537922,0.043681799197661,-0.120505389581208,0.0507272632736234,0.424485411019144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASSF2,Ras association domain-containing protein 2,36225,-0.0300087291631669,0.0375744795361776,-0.103654709054075,0.0436372507277411,0.424522352237777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DARS1,"Aspartate--tRNA ligase, cytoplasmic",36290,-0.0367722170137509,0.0462309651489692,-0.12738490870573,0.0538404746782286,0.426406114413546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH7,Protocadherin-7,35402,-0.0188434886384577,0.0237145625763707,-0.0653240312881443,0.027637054011229,0.426879115127834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLPBP,Pyridoxal phosphate homeostasis protein,36360,-0.0340922314428257,0.0429619321659745,-0.118297618488136,0.0501131556024842,0.427486569024913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6B,Ras-related protein Rab-6B,36191,0.0241872109528678,0.0305367070854206,-0.0356647349345566,0.0840391568402921,0.42834668708579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35379,-0.0542081193635328,0.0684463315455164,-0.188362929192745,0.0799466904656794,0.428402764628842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R1,Interleukin-1 receptor type 1,36372,-0.011709413371077,0.0147892789298688,-0.0406964000736198,0.0172775733314658,0.42853255428803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP3,Fibroblast growth factor-binding protein 3,35416,-0.0187048954936119,0.023636063640757,-0.0650315802294956,0.0276217892422719,0.428757689198393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOTL2,Angiomotin-like protein 2,35364,-0.0240136617494118,0.030371555857536,-0.0835419112301825,0.0355145877313588,0.429171133137101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3L,Microfibrillar-associated protein 3-like,35275,-0.0335001429611475,0.0423965240246411,-0.116597330049444,0.049597044127149,0.429463690782269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC2,"Myosin-binding protein C, fast-type",35281,-0.0417637766452029,0.0528687610922384,-0.14538654838599,0.0618589950955843,0.429586649220371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WAS,Wiskott-Aldrich syndrome protein,36227,-0.0334047325392788,0.0422914137492005,-0.116295903487712,0.0494864384091541,0.429630135436181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,36227,-0.0269964943758689,0.0341999631893569,-0.0940284222270085,0.0400354334752706,0.429921208679971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB2,Transforming growth factor beta-2 proprotein,35391,-0.0256243482444139,0.0324864387157761,-0.089297768127335,0.0380490716385071,0.430276260716975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPK2,SRSF protein kinase 2,36352,-0.0423836890105395,0.0538281461167176,-0.147886855399306,0.063119477378227,0.431080266770469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDP1,Tyrosyl-DNA phosphodiesterase 1,35391,-0.0355837246063551,0.0452314068933075,-0.124237282117238,0.0530698329045277,0.431485298475291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB8,Serpin B8,36442,-0.0304827239719476,0.0387630902226417,-0.106458380808325,0.04549293286443,0.431667507401187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTRA2,"Serine protease HTRA2, mitochondrial",36397,-0.0304171205668743,0.0386855095260892,-0.106240719238009,0.0454064781042606,0.431737233447278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,35214,0.0257980496025699,0.0328422278513092,-0.0385727169859961,0.0901688161911358,0.432182825250005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,35275,-0.0277058109753908,0.0352769211705142,-0.0968485764695987,0.041436954518817,0.432261025357315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PACS2,Phosphofurin acidic cluster sorting protein 2,35214,-0.0304118597337883,0.0387993496469997,-0.106458585041908,0.0456348655743312,0.433174252737804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPOCK1,Testican-1,36297,0.0128937355625425,0.0164618333244956,-0.0193714577534689,0.045158928878554,0.433506268094688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G1,V-type proton ATPase subunit G 1,35281,-0.0357610889596675,0.0457009007146353,-0.125334854360353,0.0538126764410176,0.433949500259905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,35239,-0.0171028378150108,0.0218803852043824,-0.0599883928156002,0.0257827171855786,0.434449973466402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP1,Lysosome-associated membrane glycoprotein 1,35248,-0.013601149606485,0.0174204095997605,-0.0477451524220156,0.0205428532090455,0.434974508325636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP29,Dual specificity phosphatase 29,35275,-0.0336522034005751,0.0431048048957306,-0.118137620996207,0.0508332141950569,0.43500549806978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRM1,Muscarinic acetylcholine receptor M1,35275,0.0181803641408499,0.0233001556949873,-0.0274879410213251,0.0638486693030249,0.435263557701218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPA,Apolipoprotein(a),35313,-0.0889320722216387,0.11407142805461,-0.312512071208674,0.134647926765397,0.435646252345528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP3,Zona pellucida sperm-binding protein 3,35281,-0.131339865265741,0.168576915815718,-0.461750620264548,0.199070889733066,0.435945541880879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB27B,Ras-related protein Rab-27B,35420,-0.0401294266322066,0.0515306225148227,-0.141129446761259,0.0608705934968459,0.436157114276062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRB,Receptor-type tyrosine-protein phosphatase beta,35420,0.0143284332681026,0.0184103128655049,-0.021755779948287,0.0504126464844922,0.436431779136846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STOML2,"Stomatin-like protein 2, mitochondrial",35206,-0.045701577553134,0.0587299658522101,-0.160812310623466,0.0694091555171978,0.436502634554815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEPE,Matrix extracellular phosphoglycoprotein,36368,0.0126812347596391,0.0162968246110944,-0.0192605414781059,0.0446230109973841,0.43651129026571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,36249,-0.016657093322659,0.0214083097398843,-0.0586173804128322,0.0253031937675142,0.436555773509027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTN,Titin,35214,-0.0326929833123621,0.0421365806201307,-0.115280681327818,0.0498947147030941,0.437849577005726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL2,Protein kinase C-binding protein NELL2,36403,0.0146628523977184,0.0188985784525116,-0.0223783613692044,0.0517040661646413,0.437850814083661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCC1,Regulator of chromosome condensation,35391,-0.0264911745322636,0.0341533709044014,-0.0934317815048905,0.0404494324403631,0.437983324697607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGLL,Monoglyceride lipase,36390,0.0428726690358126,0.0552869188136836,-0.0654896918390073,0.151235029910633,0.438094710892198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCIN,Adseverin,35212,-0.0355367775264476,0.0458583397763983,-0.125419123488188,0.054345568435293,0.438414378635227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4G,C-type lectin domain family 4 member G,36352,-0.0164410266943728,0.0212487410359686,-0.0580885591248713,0.0252065057361256,0.439109394535746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIRBP,Cold-inducible RNA-binding protein,35402,-0.0461704500947419,0.059749439614455,-0.163279351739074,0.07093845154959,0.439708975077407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF3,Immunoglobulin superfamily member 3,36331,0.0173145425043355,0.0224099766964529,-0.0266090118207123,0.0612380968293832,0.439769024698552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL2,Podocalyxin-like protein 2,36397,-0.0139358496428559,0.0180371082037849,-0.0492885817222743,0.0214168824365625,0.439772028066986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC6,Sialic acid-binding Ig-like lectin 6,36427,-0.0167961819254684,0.0217708019323981,-0.0594669537129687,0.0258745898620319,0.440435601473585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY75,Lymphocyte antigen 75,36352,-0.0191957914387556,0.0249074207592584,-0.0680143361269021,0.0296227532493908,0.440918723551806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",36382,-0.0223884878975024,0.029055490435785,-0.0793372491516411,0.0345602733566362,0.441003527089416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASN,Vasorin,36262,0.0137544780158733,0.0178547696512983,-0.0212408705006713,0.0487498265324179,0.441116184581154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP112,Centrosomal protein of 112 kDa,35214,-0.0213483609651759,0.0277866020826477,-0.0758101010471654,0.0331133791168136,0.442340937072023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED8,Protein TMED8,35402,-0.049277438129584,0.0642175314571739,-0.175143799785645,0.0765889235264769,0.442901562637655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARD3,Partitioning defective 3 homolog,35321,0.0353088364667015,0.0460358654060182,-0.0549214597290942,0.125539132662497,0.443119750468801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCARE,Photoreceptor cilium actin regulator,35212,-0.0424745536977067,0.0554228908758123,-0.151103419814299,0.0661543124188854,0.443485026708222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,36279,0.0166578826148819,0.0217437625731897,-0.0259598920285698,0.0592756572583337,0.443642705402656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL7,C-C motif chemokine 7,36352,-0.0294816513625924,0.0385397843740944,-0.105019628735817,0.0460563260106327,0.444316597734624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME1,Nucleoside diphosphate kinase A,35239,0.0102661658431616,0.0134212335628799,-0.016039451940083,0.0365717836264062,0.444349227061059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,36390,0.0366397541068224,0.0479277705972927,-0.0572986762638713,0.130578184477516,0.444607162721444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP3,Cysteine-rich secretory protein 3,35368,-0.0133774966200909,0.0175056939784932,-0.0476886568179376,0.0209336635777558,0.44478934353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM21,E3 ubiquitin-protein ligase TRIM21,36352,-0.0380536124744173,0.0498636604630581,-0.135786386982011,0.0596791620331766,0.445397180519489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LATS1,Serine/threonine-protein kinase LATS1,35239,-0.0406294876734046,0.0532405054634112,-0.144980878381691,0.0637219030348814,0.445414969315936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,36396,-0.0325677093993132,0.0427764092020779,-0.116409471435386,0.0512740526367595,0.446474503542631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35321,0.0293786758654829,0.0386135431902118,-0.0463038687873322,0.105061220518298,0.446782728232093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL15A1,Collagen alpha-1(XV) chain,35438,-0.0131204735083778,0.0172769001297456,-0.0469831977626792,0.0207422507459237,0.447628290930207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35416,-0.02981426591532,0.0392837939265702,-0.106810502011398,0.0471819701807576,0.447913797479607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35391,-0.0228304008878887,0.0300827429362683,-0.0817925770429747,0.0361317752671972,0.447929166495014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYMP,Thymidine phosphorylase,36313,-0.0317740232622879,0.0418858808534524,-0.113870349735055,0.0503223032104789,0.448125642495114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1,Integrin beta-1,36377,0.0103504342169356,0.0136773421341211,-0.0164571563659418,0.037158024799813,0.449219848804274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,35239,0.0211803655862515,0.0280085309077731,-0.0337163549929838,0.0760770861654868,0.449552029079011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB7,Integrin beta-7,36427,-0.0223587046163146,0.0296125387282744,-0.0803992805237323,0.0356818712911032,0.450248484544686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL1,Kin of IRRE-like protein 1,35212,-0.027113755824556,0.0359488680669947,-0.0975735372358655,0.0433460255867536,0.450739951251708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM7,PDZ and LIM domain protein 7,36403,0.0601107916856932,0.0797217487096835,-0.0961438357852865,0.216365419156673,0.450869380791216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT5,Glutathione hydrolase 5 proenzyme,36297,-0.0114409308814926,0.0151764947240359,-0.0411868605406029,0.0183049987776177,0.45095912795138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB2,Lamin-B2,35416,-0.0141263761421729,0.0187404518890783,-0.0508576618447664,0.0226049095604205,0.451003503518923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1LG2,Programmed cell death 1 ligand 2,36331,0.0148921735976823,0.019772454950218,-0.023861838104745,0.0536461853001096,0.451367937224161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL3,Insulin-like 3,35416,0.0367134964119616,0.0487875951114624,-0.0589101900065046,0.132337182830428,0.45176865742199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F13B,Coagulation factor XIII B chain,35420,0.0119047668968305,0.0158352790547771,-0.0191323800505327,0.0429419138441937,0.452207200401358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTLA,B- and T-lymphocyte attenuator,35206,-0.043083402736531,0.0573394603799079,-0.15546874508115,0.0693019396080885,0.45245677443267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR1B,Cornifin-B,35321,-0.0384976506712313,0.0513664936540069,-0.139175978233085,0.0621806768906223,0.453602692958218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAPRT,Nicotinate phosphoribosyltransferase,35416,-0.0158355053155991,0.0211609263483891,-0.0573109209584417,0.0256399103272435,0.454285163774845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,36438,-0.0135691498754457,0.0181439838740166,-0.0491313582685183,0.0219930585176269,0.454569212786583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA3,GDNF family receptor alpha-3,36277,-0.0139114557761337,0.0186094870437694,-0.0503860503819217,0.0225631388296542,0.45475859809392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDSN,Corneodesmosin,36420,0.0211253791093303,0.0283465437491416,-0.0344338466389873,0.0766846048576478,0.456142337531539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD2,Glutamate decarboxylase 2,35239,-0.0217956026807309,0.029277431615188,-0.0791793686464993,0.0355881632850375,0.456632831031803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOST,Sclerostin,36350,0.0185019252635933,0.0249034728155084,-0.0303088814548031,0.0673127319819897,0.457539011707141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35420,-0.0189018276592348,0.0254483997383915,-0.0687806911464821,0.0309770358280126,0.457660390364688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35417,-0.0427073136189297,0.0575247362759787,-0.155455796719848,0.0700411694819885,0.457863044304544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAME,Melanoma antigen preferentially expressed in tumors,35206,-0.0119479745010661,0.0161021185150956,-0.0435081267906534,0.0196121777885213,0.45810870020391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL1,Angiopoietin-related protein 1,36256,-0.0137101695001765,0.0184853898808443,-0.0499415336666314,0.0225211946662785,0.458308345338008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELP,P-selectin,36410,-0.026388636817506,0.0355803817871668,-0.0961261851203529,0.0433489114853408,0.45831595011917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH4,Myosin-4,35214,0.0215266098752542,0.0290566763382624,-0.0354244757477401,0.0784776954982485,0.45881389093631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JCHAIN,Immunoglobulin J chain,36227,-0.029915409831281,0.0404410260425304,-0.109179820874641,0.0493490012120786,0.459488986705592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKBIE,NF-kappa-B inhibitor epsilon,36225,-0.0232033074188118,0.0313776795190099,-0.0847035592760713,0.0382969444384476,0.459637540492367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,35239,0.0205605250033912,0.0278224018276565,-0.0339713825788157,0.075092432585598,0.459940708158656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4,Interleukin-4,36227,0.044063893213303,0.0596359590514616,-0.0728225865275618,0.160950372954168,0.460003753411489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35402,-0.0410256620646499,0.0555293853716993,-0.149863257393181,0.0678119332638808,0.460050343886466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT8,"Alpha-(1,6)-fucosyltransferase",36297,-0.0278325890809033,0.0377064074337554,-0.101737147651064,0.0460719694892573,0.460454062900978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C3A,Cytosolic 5'-nucleotidase 3A,36344,-0.0408351464470999,0.0553282729542895,-0.149278561437507,0.0676082685433074,0.460507029593807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROS1,Vitamin K-dependent protein S,35448,0.0121352329594515,0.0164429368284075,-0.0200929232242273,0.0443633891431302,0.460529368808267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDM1,Nuclear protein MDM1,35275,0.014639801825399,0.0198394638929614,-0.0242455474048053,0.0535251510556032,0.460595685257684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT2,Linker for activation of T-cells family member 2,36331,-0.0582100166514093,0.078909890567029,-0.212873402162786,0.0964533688599676,0.46073496306082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GYS1,"Glycogen [starch] synthase, muscle",36249,-0.0426968054209188,0.0578928577954394,-0.15616680669998,0.0707731958581425,0.460834231171421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC28A1,Sodium/nucleoside cotransporter 1,35206,-0.0279700961195036,0.0379668260441436,-0.102385075166025,0.0464448829270178,0.461334587984163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM40,E3 ubiquitin ligase TRIM40,35275,-0.0339204253604591,0.0460844027741494,-0.124245854797792,0.0564050040768737,0.46172865106812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENSA,Alpha-endosulfine,35391,-0.0242126654933713,0.0329344453990805,-0.0887641784755691,0.0403388474888265,0.46225917909285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1A,Protein phosphatase 1A,36225,-0.014724866813538,0.0200352554735523,-0.0539939675417005,0.0245442339146245,0.462395801174003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG2,Adhesion G-protein coupled receptor G2,36360,0.0126583480919581,0.0172532296033348,-0.021157981930578,0.0464746781144943,0.463167842251118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAVL4,ELAV-like protein 4,35212,-0.0387781484266134,0.0528651905339899,-0.142393921873234,0.0648376250200069,0.463264442816925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARC,SPARC,36397,0.0326452263337763,0.0445194488518516,-0.0546128934158528,0.119903346083405,0.463411467528882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PF4,Platelet factor 4,35406,-0.0450567176540432,0.061489758855281,-0.165576645010394,0.0754632097023076,0.46373760852111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",36341,-0.0325993151394102,0.0444955172490325,-0.119810528947514,0.0546118986686936,0.463800417190671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA0319,Dyslexia-associated protein KIAA0319,35416,-0.014317255779405,0.0195555236844739,-0.0526460822009739,0.0240115706421639,0.464114608712792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH,Parathyroid hormone,35275,-0.0376066636608411,0.051376300442957,-0.138304212529037,0.0630908852073547,0.464206141090694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAND5,DAN domain family member 5,35239,0.0277276858040421,0.0379193410385835,-0.0465942226315816,0.102049594239666,0.464668212119561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASL,Neural Wiskott-Aldrich syndrome protein,35239,0.0276557149904056,0.0378615707243511,-0.0465529636293227,0.101864393610134,0.465147819194457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GORASP2,Golgi reassembly-stacking protein 2,35402,-0.0219608434003575,0.030083512517601,-0.0809245279348554,0.0370028411341404,0.465420182063489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPL14,60S ribosomal protein L14,35281,-0.018370930648443,0.0251876228966453,-0.0677386715258678,0.0309968102289817,0.4658074541944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3R,Granulocyte colony-stimulating factor receptor,35239,-0.0139557561294963,0.0191543149796026,-0.0514982134895174,0.0235867012305249,0.46627708655901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG2,Secretogranin-2,36382,-0.0155649034806184,0.0213859522151201,-0.0574813698222538,0.026351562861017,0.466753791649989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,36162,-0.0397486344417399,0.0546340815326017,-0.146831434245639,0.0673341653621594,0.466917930507767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYNU,Kynureninase,36442,-0.0208307274423807,0.0286370487231846,-0.0769593429398226,0.0352978880550611,0.467001493778541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSHB,Thyrotropin subunit beta,36360,-0.0373112324820545,0.0513357552453204,-0.137929312762882,0.0633068477987735,0.467367383628041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,36297,0.0139871839927738,0.0192525276149291,-0.0237477701324872,0.0517221381180347,0.467549159648024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEBP1,Heme-binding protein 1,36249,-0.0259548910462252,0.035746206855456,-0.096017456482919,0.0441076743904685,0.467808925306547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB2A2,Mammaglobin-A,35214,0.0137604528477793,0.0189707497720011,-0.0234222167053429,0.0509431224009014,0.468264902740944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CANT1,Soluble calcium-activated nucleotidase 1,36329,-0.00947612377617459,0.0130747437691811,-0.0351026215637696,0.0161503740114204,0.468619643599204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG3,Desmoglein-3,36403,-0.0158841950169199,0.0219197277659004,-0.0588468614380846,0.0270784714042448,0.468688494586719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATOX1,Copper transport protein ATOX1,36397,-0.0321351678892595,0.0443595847975538,-0.119079954092465,0.0548096183139459,0.468828721745509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3,Interleukin-3,35206,-0.0277138140753319,0.0382944904826038,-0.102771015421235,0.0473433872705715,0.469276626138348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSRC1,Proline/serine-rich coiled-coil protein 1,36225,-0.0270982280661361,0.037519669980017,-0.100636781226969,0.0464403250946972,0.470170600338727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR1,Natural cytotoxicity triggering receptor 1,36342,0.0174821847310539,0.0242484163845298,-0.0300447113826246,0.0650090808447324,0.470956524806774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR2,Interferon gamma receptor 2,36297,-0.0242056531690276,0.0336217767239547,-0.0901043355479789,0.0416930292099236,0.471585787322779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,36390,0.0408781091423165,0.0567973816872225,-0.0704447589646396,0.152200977249273,0.471721893749357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBP1,Z-DNA-binding protein 1,35239,-0.0185835333371727,0.0258594308943439,-0.0692680178900868,0.0321009512157414,0.472392635484834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIP,Pancreatic triacylglycerol lipase,35428,-0.028671090292775,0.0400044801965404,-0.107079871477994,0.0497376908924442,0.473587936142857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,35301,-0.0212653698724041,0.0296723217112816,-0.079423120426516,0.0368923806817078,0.473602919946735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPA1,Inositol monophosphatase 1,36297,-0.0278385488081435,0.0389295700512252,-0.104140506108545,0.0484634084922579,0.47457054633528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,35224,-0.0122746667315221,0.0171686295734417,-0.0459251806954678,0.0213758472324237,0.474669236666941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",36352,-0.0311396951113413,0.0435590125785344,-0.116515359765269,0.0542359695425861,0.474703273007576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC12A,C-type lectin domain family 12 member A,35239,0.00942582996370441,0.0132111686222703,-0.0164680605359454,0.0353197204633542,0.475579822038438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRV1,Acrosomal protein SP-10,35239,-0.0359433011597706,0.0503798476263213,-0.13468780250736,0.0628012001878191,0.475597354000004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GID8,Glucose-induced degradation protein 8 homolog,35417,-0.0157900229927675,0.0221601507335008,-0.059223918430429,0.027643872444894,0.476156350216138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSL,Cathepsin L1,36360,-0.0112807786433987,0.0158455270933349,-0.042338011746335,0.0197764544595376,0.476536280873613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVR,Poliovirus receptor,36428,0.0167234949532174,0.0235116998759806,-0.0293594368037047,0.0628064267101394,0.47693122408498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALB,Ras-related protein Ral-B,35239,-0.0132710654884222,0.0186577718281212,-0.0498402982715397,0.0232981672946954,0.476932690363494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSB,Arylsulfatase B,36331,-0.0254263566275295,0.0357660263075499,-0.0955277681903272,0.0446750549352683,0.477164437876552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT2,RAC-beta serine/threonine-protein kinase,35417,-0.0558647486466568,0.0789396730481009,-0.210586507820935,0.0988570105276209,0.47916483082097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD36,Platelet glycoprotein 4,35239,0.0197364509088146,0.0278968967603402,-0.0349414667414523,0.0744143685590814,0.479296526266799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO1,Amphoterin-induced protein 1,35275,-0.0227089102136741,0.0321424902308081,-0.0857081910660579,0.0402903706387097,0.479899662727709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MKI67,Proliferation marker protein Ki-67,35239,0.0185919922878518,0.0263283072762349,-0.0330114899735686,0.0701954745492722,0.48011597877166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN4,Nectin-4,36397,-0.015223411497823,0.0215621110877138,-0.057485149229742,0.0270383262340961,0.480194789655344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLEKHO1,Pleckstrin homology domain-containing family O member 1,35416,-0.0304059602376888,0.043068060252829,-0.114819358333234,0.054007437857856,0.480215874205888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS2,Thrombospondin-2,36382,-0.0172752260359775,0.0244718685284363,-0.0652400883517125,0.0306896362797576,0.480259633392807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",35214,-0.0189647428617023,0.0268786027188624,-0.0716468041906726,0.033717318467268,0.48048272130635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFB,Platelet-derived growth factor subunit B,36403,0.0382315320742434,0.0542335139674143,-0.0680661553018886,0.144529219450375,0.480868528678081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRR,Receptor-type tyrosine-protein phosphatase R,35416,0.016169332148066,0.022966304053939,-0.0288446237976544,0.0611832880937863,0.481430538737094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL3,C-C motif chemokine 3,36352,-0.0261129310056675,0.037119883996739,-0.098867903639276,0.0466420416279409,0.481782316122188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT7,N-acetylgalactosaminyltransferase 7,36331,0.00933206586877933,0.0132709296359761,-0.0166789562177338,0.0353430879552925,0.48195649123677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUS,RNA-binding protein FUS,36213,-0.0178593744557463,0.0254204655815117,-0.0676834869955092,0.0319647380840167,0.482353978832063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35402,-0.0476487501582398,0.067826141073829,-0.180587986662945,0.0852904863464649,0.482385597635179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",35281,-0.0305975876256214,0.0435870230465818,-0.116028152796922,0.0548329775456789,0.482713193965761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",35281,-0.0111707995244172,0.0159352276938079,-0.0424038458042806,0.0200622467554463,0.483321786857523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP4,Peptidoglycan recognition protein 4,35214,-0.0276740437283057,0.0395658183954701,-0.105223047783427,0.0498749603268157,0.484302104757536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2R,Cation-independent mannose-6-phosphate receptor,36382,-0.0103257524688376,0.0147739882022178,-0.0392827693451845,0.0186312644075093,0.484628167278812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,36297,0.0309397177668664,0.0442848657400052,-0.0558586190835437,0.117738054617277,0.484792302167981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP2,Dipeptidase 2,36331,0.0130490533653553,0.0186793423896699,-0.0235624577183977,0.0496605644491083,0.48483602428065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,36400,-0.0263526886331371,0.0377277070151146,-0.100298994382762,0.0475936171164876,0.48488899942145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35417,-0.0210610128972849,0.0301528296777711,-0.0801605590657162,0.0380385332711465,0.484905972358828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DXO,Decapping and exoribonuclease protein,35416,-0.0199691445425893,0.0285899603272104,-0.0760054667839216,0.036067177698743,0.484911276689591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTT2B,Glutathione S-transferase theta-2B,35416,0.104094950842819,0.149076801580366,-0.188095580254699,0.396285481940337,0.485038257944489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCYT2,Ethanolamine-phosphate cytidylyltransferase,35402,-0.0333902902194271,0.0478841841459284,-0.127243291145447,0.0604627107065926,0.485632705288265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTG,Protogenin,36427,0.0112938258020654,0.0162304842408238,-0.0205179233099493,0.0431055749140802,0.486551174780312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLFM4,Olfactomedin-4,35089,-0.054715377560054,0.0786988215305459,-0.208965067759924,0.099534312639816,0.486925872271163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRX,Cone-rod homeobox protein,36249,-0.0478688697541215,0.0689481999439662,-0.183007341644295,0.0872696021360523,0.487533915678314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK6,Serine protease inhibitor Kazal-type 6,36427,0.0231494624764966,0.0334364604725909,-0.0423860000497816,0.0886849250027748,0.488744870262356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",36331,-0.0159614713893404,0.0230544383018785,-0.0611481704610223,0.0292252276823415,0.488747406600204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR37,Prosaposin receptor GPR37,36249,-0.0303461620690312,0.0438972262358265,-0.116384725491251,0.0556924013531888,0.489399640982036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53INP1,Tumor protein p53-inducible nuclear protein 1,36249,0.0145019848859611,0.0209812583028126,-0.0266212813875516,0.0556252511594738,0.489470417725972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPJ,Centromere protein J,35321,0.0313421722222455,0.0454156953996568,-0.0576725907610818,0.120356935205573,0.490146353958536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",36331,-0.0196973883419796,0.0285658533287347,-0.0756864608662996,0.0362916841823405,0.490503950064906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN4,Cerebellin-4,36427,-0.0142308388935373,0.0206616268717937,-0.0547276275622529,0.0262659497751783,0.490998328531816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCC,Tubulin-specific chaperone C,36297,-0.035462714195793,0.0515380759239884,-0.13647734300681,0.0655519146152242,0.491420049018224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAO1,Hydroxyacid oxidase 1,36427,0.0550147512367454,0.0800227137043473,-0.101829767623775,0.211859270097266,0.491796549203856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF22,Kinesin-like protein KIF22,35214,0.0532732445514125,0.0775462815549338,-0.0987174672962577,0.205263956399083,0.492117730563017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS15,Enteropeptidase,36331,0.0398592499004535,0.0580542550692051,-0.0739270900351886,0.153645589836096,0.492365838088713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,36249,0.0245380491725502,0.0357598996648762,-0.0455513541706072,0.0946274525157076,0.492616494008251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA4,Carbonic anhydrase 4,36446,-0.0105328018382295,0.0153502999086794,-0.0406193896592412,0.0195537859827822,0.492632509468951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFI,Complement factor I,35448,-0.00855140857367022,0.0124795290200037,-0.0330112854528775,0.015908468305537,0.49322111305388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL15,C-C motif chemokine 15,36446,-0.0189717491166212,0.0276903352444299,-0.0732448061957038,0.0353013079624613,0.493277642536468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDO1,"Indoleamine 2,3-dioxygenase 1",35281,-0.0273063008519485,0.039905072839108,-0.1055202436166,0.0509076419127032,0.493823512886544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,36290,-0.0486620807220328,0.0711189325370679,-0.188055188494686,0.0907310270506202,0.493848970119824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPN,Asporin,35420,-0.0118211915551286,0.0173036015678828,-0.0457362506281788,0.0220938675179217,0.49452886132535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35416,-0.0170833553822781,0.0250130836468985,-0.0661089993301992,0.0319422885656429,0.494646942407917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNAT1,CDK-activating kinase assembly factor MAT1,35321,0.0189355766178809,0.0277915502121016,-0.0355358617978382,0.0734070150336,0.495680267334473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPB41L5,Band 4.1-like protein 5,35275,-0.0263900617337051,0.0388140866919647,-0.102465671649956,0.0496855481825457,0.496587721637363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,35312,0.0093219095149794,0.0137114173972516,-0.0175524685836338,0.0361962876135926,0.496615819168277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZT1,Mitotic-spindle organizing protein 1,36225,0.0227702624921383,0.03349526387018,-0.0428804546934144,0.0884209796776911,0.496650044228945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP4,Zona pellucida sperm-binding protein 4,35206,0.0143769750198173,0.0211851765256664,-0.0271459709704889,0.0558999210101235,0.49739609690687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDAP1,28 kDa heat- and acid-stable phosphoprotein,35420,-0.0412842272252106,0.0608884599041793,-0.160625608637402,0.0780571541869808,0.497777611315113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHR,Growth hormone receptor,35312,-0.0120981426134758,0.0178745258526671,-0.0471322132847033,0.0229359280577517,0.498534892083507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,35214,0.0109201648505546,0.0161579510154855,-0.020749419139797,0.0425897488409063,0.499169169294611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFC1,Cryptic protein,36225,-0.0201413308197714,0.0298583342493039,-0.078663665948407,0.0383810043088643,0.499975555704631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG5,Chondroitin sulfate proteoglycan 5,35212,-0.0219990791896397,0.0326408341957366,-0.0859751142132834,0.0419769558340041,0.500353620051908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP6,Bone morphogenetic protein 6,36241,-0.01737026348209,0.025796381587231,-0.0679311713930628,0.0331906444288827,0.500740076755104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100G,Protein S100-G,35417,-0.0200507900046062,0.0298087006964372,-0.078475843369623,0.0383742633604107,0.501195653542543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX1,ATP-dependent RNA helicase DDX1,35402,-0.020713638166689,0.03080938901057,-0.0811000406274062,0.0396727642940281,0.501407711942765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,35212,-0.0261232096390895,0.0389213372665389,-0.102409030681506,0.0501626114033267,0.50213184898902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMCN2,Hemicentin-2,35298,-0.0244265546996556,0.0364084236526632,-0.0957870650588755,0.0469339556595642,0.502307114151178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM13A,Protein FAM13A,35402,-0.0279456723230996,0.0416615538469376,-0.109602317863097,0.0537109732168982,0.502386634786441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN2,Contactin-2,36427,0.0192286451021362,0.0286804042587691,-0.0369849472450511,0.0754422374493236,0.502595307037169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA1,Laminin subunit alpha-1,35214,-0.0218905979541731,0.0326532903543766,-0.0858910470487511,0.0421098511404049,0.50263182773285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF20,Fibroblast growth factor 20,35239,-0.0194520280520155,0.0290172528969901,-0.0763258437301162,0.0374217876260852,0.502653443409475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARCO,Macrophage receptor MARCO,36360,-0.0113970934369818,0.0170088691092577,-0.0447344768911268,0.0219402900171633,0.502836239228232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35417,-0.0349102430256583,0.0521802222713424,-0.137183478677489,0.0673629926261728,0.503499827691877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTD,Biotinidase,35448,0.00865423673889785,0.012936860811026,-0.0167020104507132,0.0340104839285089,0.503545965836186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR3,Transforming growth factor beta receptor type 3,36446,-0.0135110287287397,0.0202049773309565,-0.0531127842974145,0.0260907268399351,0.503709402641671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRGN,Neurogranin,35428,-0.0381543332681878,0.0571205792613876,-0.150110668620508,0.073802002084132,0.504183058744296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP5,Fatty acid-binding protein 5,36404,-0.0290053180872776,0.0434465268542478,-0.114160510721603,0.0561498745470481,0.504404200386359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROCR,Endothelial protein C receptor,35214,0.0139078443218992,0.0208606006283655,-0.0269789329096972,0.0547946215534957,0.504986821479222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP2,Fibroblast growth factor-binding protein 2,35438,-0.0211259304163038,0.0317677843713165,-0.0833907877840841,0.0411389269514765,0.506067930225393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAP,Prolyl endopeptidase FAP,36446,-0.0114422734684204,0.0172248369786608,-0.0452029539465956,0.0223184070097547,0.506526341196608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,36297,-0.0120385709454116,0.0181800267995798,-0.047671423472588,0.0235942815817648,0.507873095448333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL1,Interferon lambda-1,36191,-0.0189420419461064,0.0286224239352544,-0.075041992859205,0.0371579089669922,0.508127429719532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REST,RE1-silencing transcription factor,35206,-0.0150536565513857,0.0227497555011686,-0.0596431773336762,0.0295358642309049,0.508184826029419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA2,Paraneoplastic antigen Ma2,35212,-0.0185121384623359,0.0279861101720022,-0.0733649143994602,0.0363406374747884,0.508332465421211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35438,0.011053332375155,0.0167226636081836,-0.0217230882968849,0.0438297530471949,0.508650055934817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RB,Interleukin-2 receptor subunit beta,36227,0.0168221913810505,0.0254858486872954,-0.0331300720460485,0.0667744548081495,0.509236889026565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOCK9,Dedicator of cytokinesis protein 9,35212,-0.0505655217880251,0.0767236165776284,-0.200943810280177,0.0998127667041266,0.509881995789979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC1,Plexin domain-containing protein 1,36225,0.0135958847901016,0.0206677698858193,-0.0269129441861042,0.0541047137663074,0.510668732776226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,36249,0.00907362644481528,0.0138014584590293,-0.0179772321348822,0.0361244850245128,0.51091969180205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC4A1,Band 3 anion transport protein,35438,-0.0197436191513393,0.0300439397269384,-0.0786297410161385,0.03914250271346,0.511103468083582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD84,SLAM family member 5,36352,-0.0131414337358348,0.0200066822808389,-0.0523545310062792,0.0260716635346095,0.511297058089958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM4,Intercellular adhesion molecule 4,36352,-0.0222075717008616,0.0338187709253114,-0.0884923627144719,0.0440772193127487,0.511418053209626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGF,Hepatoma-derived growth factor,36413,-0.0386715165935514,0.0589660939269722,-0.154245060690417,0.0769020275033142,0.511956777622677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOE,Apolipoprotein E,35448,0.0301877614092288,0.0460388535788544,-0.060048391605326,0.120423914423783,0.512040098886735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPBGL,Trophoblast glycoprotein-like,35275,-0.0175592408116948,0.0267955381674169,-0.0700784956198319,0.0349600139964423,0.512296414697098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BB,Platelet glycoprotein Ib beta chain,35214,0.0279176019549325,0.0426888064783153,-0.0557524587425656,0.111587662652431,0.513150028968736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R9B,Neurabin-2,36442,0.0392169691789983,0.059983174389541,-0.078350052624502,0.156783990982499,0.513261732670613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAAA,N-acylethanolamine-hydrolyzing acid amidase,36258,-0.024694032520611,0.0377942492888007,-0.0987707611266604,0.0493826960854385,0.513532152814411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,36392,0.00904214025860324,0.0138433690697815,-0.0180908631181685,0.036175143635375,0.51366443608309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB1,Transforming growth factor beta-1 proprotein,36433,-0.0160384699424183,0.0245673766303126,-0.064190528137831,0.0321135882529945,0.513882689701851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL2A1,Collagen alpha-1(II) chain,35281,-0.0325433070860445,0.0498924843288454,-0.130332576370581,0.0652459621984925,0.51425246225911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP2,Tubulin polymerization-promoting protein family member 2,35321,0.0326490647199576,0.0501145092869527,-0.0655753734824696,0.130873502922385,0.514755140439774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF1R,Insulin-like growth factor 1 receptor,36331,-0.00897364953439346,0.0137823446835342,-0.0359870451141205,0.0180397460453336,0.515004541880468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAX1BP1,Tax1-binding protein 1,35416,-0.025660175783256,0.0394486716568724,-0.102979572230726,0.0516592206642138,0.515412718710069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRK1,NKG2-D type II integral membrane protein,35416,-0.0194117770819819,0.0298854542444883,-0.077987267401179,0.0391637132372152,0.516013828932113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLN,Promotilin,36352,-0.0367657908674318,0.0566142677716357,-0.147729755699838,0.0741981739649741,0.516095160924569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP45,Rho GTPase-activating protein 45,35312,-0.0337297833159567,0.0519407377966365,-0.135533629397364,0.0680740627654508,0.516110858441902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPQ,Carboxypeptidase Q,35428,-0.014401023783797,0.0222050937126778,-0.0579230074606456,0.0291209598930516,0.516655783879496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",35281,-0.013372931321202,0.0206337249895122,-0.053815032300646,0.0270691696582419,0.516938007320702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR1,Complement receptor type 1,35405,-0.0146395256111526,0.0225888793931596,-0.0589137292217454,0.0296346779994402,0.516953596571003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB2,Beta-crystallin B2,35416,-0.0337192918273982,0.0520423464940903,-0.135722290955815,0.0682837073010188,0.517060418935782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR4,Proline-rich protein 4,35259,-0.0285673541268886,0.0441042911190512,-0.115011764720229,0.0578770564664517,0.517188783932738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCAM,Cell surface glycoprotein MUC18,36410,0.0138551927796124,0.0213995401459993,-0.0280879059065462,0.0557982914657709,0.517359511736854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",36352,-0.0338897116528494,0.052349379059381,-0.136494494609236,0.0687150713035374,0.517409632266993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POSTN,Periostin,35438,-0.0154728694672609,0.0239040910345788,-0.0623248878950353,0.0313791489605135,0.517468328456397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN7,Tetraspanin-7,35212,-0.0381675408643072,0.0590271848896058,-0.153860823247935,0.0775257415193202,0.517909341156104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G1B,Phospholipase A2,36438,0.0184590891710715,0.0285508483956417,-0.0375005736843862,0.0744187520265292,0.517954182665261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22RA1,Interleukin-22 receptor subunit alpha-1,36227,-0.0180683136322654,0.0280067155811799,-0.072961476171378,0.0368248489068473,0.518856093877303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSH,Pro-cathepsin H,36221,-0.0313723190914525,0.0486601238153239,-0.126746161769487,0.0640015235865824,0.519127513908691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP1,Src kinase-associated phosphoprotein 1,36290,-0.0302882445873461,0.047073989101255,-0.122553263225806,0.0619767740511138,0.519973799887156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD1,Mothers against decapentaplegic homolog 1,36225,-0.0335713979188404,0.0522211753518137,-0.135924901608395,0.0687821057707145,0.520329781799458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB2,Lysosome membrane protein 2,36154,-0.0139207799769974,0.0216727173465104,-0.0563993059761577,0.0285577460221629,0.520687779930856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL18,C-C motif chemokine 18,36270,-0.0280506027376002,0.0438546765209728,-0.114005768718707,0.0579045632435064,0.522436312786486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53,Cellular tumor antigen p53,36225,-0.0173973748991506,0.0272555763352564,-0.0708183045162531,0.0360235547179519,0.523295845527873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGF,Pro-epidermal growth factor,36356,0.041526986522076,0.0651814715846633,-0.0862286977838639,0.169282670828016,0.524081361478365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1R,Macrophage colony-stimulating factor 1 receptor,35428,-0.0161215891379039,0.0253205732140211,-0.0657499126373853,0.0335067343615775,0.524344161470297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX5,"Peroxiredoxin-5, mitochondrial",36442,-0.0266262570590259,0.0419017352722928,-0.10875365819272,0.055501144074668,0.525158149512901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLK1,Protein delta homolog 1,36446,0.0222899068259436,0.0351011493299772,-0.0465083458608118,0.0910881595126989,0.525435870049056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMTOR5,Ragulator complex protein LAMTOR5,35391,0.0161664346647002,0.0254666150293227,-0.0337481307927723,0.0660810001221726,0.525576473271875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_A,,35417,-0.0130593335824362,0.0205776847453171,-0.0533915956832577,0.0272729285183853,0.525689362175307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD86,T-lymphocyte activation antigen CD86,35402,-0.0120845239264906,0.0190602164955573,-0.049442548257783,0.0252735004048017,0.526092312279234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBD,Thrombomodulin,36360,-0.0119090031351782,0.0187896315998048,-0.0487366810707957,0.0249186748004393,0.526226905812005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17A,Interleukin-17A,36216,-0.0176314179677,0.0278241350396762,-0.0721667226454652,0.0369038867100653,0.526314539662552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT3,RAC-gamma serine/threonine-protein kinase,36197,-0.0230113288181683,0.0363198891919619,-0.0941983116344136,0.0481756539980769,0.52637971989598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECR,Peroxisomal trans-2-enoyl-CoA reductase,35281,-0.0114365702256927,0.0180594698064367,-0.0468331310463087,0.0239599905949232,0.526579332232997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",36323,-0.0426417878241264,0.0674110837871991,-0.174767512047037,0.0894839363987837,0.527039048063177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERCC1,DNA excision repair protein ERCC-1,35206,0.0135141082902538,0.0213909741685981,-0.0284122010801985,0.0554404176607061,0.527563261689777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2,Microtubule-associated protein 2,35416,-0.0180324488937085,0.0285692267263857,-0.0740281332774244,0.0379632354900074,0.527943176761541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC50,Coiled-coil domain-containing protein 50,35417,-0.0303731069009171,0.0481444905043859,-0.124736308289513,0.0639900944876792,0.528146086971991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTNNA1,Catenin alpha-1,35212,-0.0135790209566464,0.021547217427005,-0.0558115671135761,0.0286535252002834,0.528588743441959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN2,Matrilin-2,36381,-0.011900755694014,0.0188971673002937,-0.0489392036025898,0.0251376922145617,0.528869020975244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP350,Centrosome-associated protein 350,35206,-0.0154598561788623,0.0245608296094544,-0.0635990822133929,0.0326793698556682,0.529077292172147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF16,Fibroblast growth factor 16,35239,-0.0184751567001336,0.0293766913371479,-0.0760534717209436,0.0391031583206763,0.529434823323043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBS,Cystathionine beta-synthase,35281,0.0203182314918934,0.0323397403242998,-0.0430676595437343,0.0837041225275211,0.529847759502755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOL1,Apolipoprotein L1,35428,-0.0228634782851697,0.0363941761448951,-0.094196063529164,0.0484691069588246,0.529884122377371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35321,-0.0279287856326014,0.0445149458819059,-0.115178079561137,0.0593205082959342,0.530418848829461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFC,Platelet-derived growth factor C,36225,-0.0113847742275053,0.0181464546028793,-0.0469518252491488,0.0241822767941381,0.53042868626053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO3,Beta-enolase,35281,0.022792253461289,0.0363481851640259,-0.0484501894602018,0.0940346963827798,0.530647743282158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13,Tumor necrosis factor ligand superfamily member 13,36403,-0.0109724411225749,0.0175029953727911,-0.0452783120532453,0.0233334298080956,0.530751630586194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZD2,PDZ domain-containing protein 2,35214,-0.0236447169846735,0.0377291212990018,-0.097593794730717,0.05030436076137,0.530881810907154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",35275,-0.0303580498327381,0.048506285538001,-0.12543036948722,0.0647142698217439,0.531431533234573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRN,Progranulin,36346,-0.00963667738373751,0.0154280406212078,-0.0398756370013048,0.0206022822338298,0.532239791725444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTHRC1,Collagen triple helix repeat-containing protein 1,35438,-0.0117103094638297,0.0187501027789603,-0.0484605109105918,0.0250398919829325,0.532291617659549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB16,Zinc finger and BTB domain-containing protein 16,36225,-0.0284482268097416,0.0455678600346174,-0.117761232477592,0.0608647788581086,0.532447788111749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A1,Secretoglobin family 3A member 1,35312,-0.0102183295394113,0.0164056900809814,-0.0423734820981347,0.0219368230193122,0.533404491398257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLK,STE20-like serine/threonine-protein kinase,35321,-0.0315421765971311,0.0506633649957606,-0.130842371988822,0.0677580187945596,0.533581406870759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGT,Angiotensinogen,35428,-0.00866127268993052,0.0139250206206055,-0.0359543131063174,0.0186317677264563,0.533968870869011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35417,-0.029292678915355,0.0471012918769788,-0.121611210994233,0.0630258531635234,0.534025026228715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA6C,Semaphorin-6C,35239,0.0105660862572237,0.0169918159547587,-0.0227378730141034,0.0438700455285508,0.534074579328882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPK1,Thiamin pyrophosphokinase 1,35420,-0.01076980823686,0.0173218752874605,-0.0447206838002825,0.0231810673265626,0.534131604863838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN4,Contactin-4,36382,0.009499124027562,0.0152844207259176,-0.0204583405952364,0.0394565886503604,0.534296576943299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCDC2C,Doublecortin domain-containing protein 2C,35206,-0.0239692423383388,0.0385744133584279,-0.0995750925208575,0.0516366078441799,0.534375346622051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35402,-0.0192327206647783,0.0310025493504918,-0.0799977173917422,0.0415322760621856,0.535044015171847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDNF,Glial cell line-derived neurotrophic factor,36191,-0.0150913321532198,0.0243355764450792,-0.062789061985575,0.0326063976791354,0.535189391529126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THY1,Thy-1 membrane glycoprotein,36428,-0.0115743092236765,0.0187151129069907,-0.0482559305213782,0.0251073120740252,0.536300062218568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLNL,Mesothelin-like protein,35275,0.0145106034943812,0.023491284005212,-0.0315323131558343,0.0605535201445966,0.53679519387575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIT1,ARF GTPase-activating protein GIT1,35239,-0.0374324773499059,0.0606037376356732,-0.156215803115825,0.0813508484160136,0.536823047317528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN4B,Sodium channel subunit beta-4,35281,0.0168609167886561,0.0273314395458382,-0.0367087047211868,0.0704305382984989,0.537320097719077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAP3,Cytosol aminopeptidase,36227,-0.0190850945852225,0.0309466169144611,-0.0797404637375663,0.0415702745671214,0.537445848302148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNER,Delta and Notch-like epidermal growth factor-related receptor,36352,0.0099232780266047,0.016093851485279,-0.0216206708845421,0.0414672269377515,0.537526025139511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXLNA,Alpha-taxilin,36297,-0.03447430367325,0.0560424707161603,-0.144317546276924,0.0753689389304242,0.538477989112055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGDS,Prostaglandin-H2 D-isomerase,36324,-0.012522807537113,0.0203767952204482,-0.0524613261691916,0.0274157110949655,0.538863512579405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC5D,Netrin receptor UNC5D,35239,0.0102845311058076,0.0167406256315625,-0.0225270951320548,0.04309615734367,0.539010040415992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD93,Complement component C1q receptor,36107,-0.0126758102428592,0.0206391671837255,-0.0531285779229612,0.0277769574372429,0.5391279139973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOC2B,Double C2-like domain-containing protein beta,35275,0.0132706085068156,0.0216704503429756,-0.0292034741654165,0.0557446911790476,0.54030749440612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF9,Fibroblast growth factor 9,35193,-0.0157588922916981,0.0257915663615045,-0.066310362360247,0.0347925777768509,0.541216434963897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX9,Transcription factor SOX-9,35275,-0.0105162686963079,0.0172215593349903,-0.0442705249928888,0.023237987600273,0.541457077294759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEK,Angiopoietin-1 receptor,36397,0.00861397857255187,0.0141114646791813,-0.0190444921986435,0.0362724493437473,0.541600145280534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35391,-0.0355169497204311,0.058203913197678,-0.14959661958788,0.0785627201470178,0.541741214886529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSHB,Follitropin subunit beta,35281,-0.0206396802392868,0.0338330382396459,-0.0869524351889927,0.0456730747104191,0.541854684829933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3G,Semaphorin-3G,35312,-0.0169621985997334,0.0278812148123764,-0.0716093796319912,0.0376849824325243,0.542962216689857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,35206,0.0323326160319043,0.0531650462786381,-0.0718708746742265,0.136536106738035,0.54310730973376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35438,0.00973748490979219,0.0160271155842051,-0.0216756616352498,0.0411506314548341,0.543499338598681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMT,Catechol O-methyltransferase,36183,-0.0321010120269723,0.0528999119704169,-0.13578483948899,0.0715828154350449,0.543986478790398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NARS1,"Asparagine--tRNA ligase, cytoplasmic",35417,-0.0179247076951921,0.0295426469336113,-0.0758282956850703,0.0399788802946861,0.54404555904064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YES1,Tyrosine-protein kinase Yes,36331,-0.0439184897994366,0.0723982374880375,-0.18581903527599,0.0979820556771168,0.544119935020039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPHA2,Glycoprotein hormone alpha-2,35402,-0.0178160914881061,0.0293747710475589,-0.0753906427413214,0.0397584597651093,0.544198341950514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPKAPK2,MAP kinase-activated protein kinase 2,35321,0.0283188399454033,0.0467587278740411,-0.0633282666877172,0.119965946578524,0.544777915348771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX6B1,Cytochrome c oxidase subunit 6B1,35420,-0.0124051106131138,0.0204879566699748,-0.0525615056862644,0.0277512844600368,0.544880149505428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG4,BAG family molecular chaperone regulator 4,35239,-0.0188829159279347,0.0312181786433257,-0.080070546068853,0.0423047142129836,0.545288587808334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GASK1A,Golgi-associated kinase 1A,35214,-0.0161337638245436,0.0267294516323579,-0.068523489023965,0.0362559613748778,0.546135667946471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKN3,Serine/threonine-protein kinase N3,35321,-0.027477870224708,0.0455819586081674,-0.116818509096716,0.0618627686473001,0.546648504556437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGP1,SURP and G-patch domain-containing protein 1,35402,-0.0152238898249439,0.0252826122305837,-0.064777809796888,0.0343300301470002,0.547097210645876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASQ2,Calsequestrin-2,35214,0.01874392282718,0.03115552053697,-0.0423208974252812,0.0798087430796412,0.547446806578367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM1,Neural cell adhesion molecule 1,36410,0.0115726182515334,0.0192403151169244,-0.0261383993776383,0.0492836358807052,0.547540832252907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN1,Pantetheinase,35428,-0.0275791003488922,0.0458885687176565,-0.117520695035499,0.0623624943377146,0.547860813022204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI,Tissue factor pathway inhibitor,36366,0.011593289988395,0.019321181577767,-0.0262762259040282,0.0494628058808183,0.548505150804644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARA5,Scavenger receptor class A member 5,36428,-0.0114477398853118,0.0190935021728567,-0.0488710041441109,0.0259755243734873,0.548816902486846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHPS,Deoxyhypusine synthase,35391,-0.0154256408283529,0.0257462946046059,-0.0658883782533805,0.0350370965966747,0.5491012789715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX25,ATP-dependent RNA helicase DDX25,35275,0.0144455949923722,0.0241210719167727,-0.0328317059645023,0.0617228959492467,0.549276117415122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM3,Myomesin-3,35312,0.035106999720309,0.0587420428423172,-0.0800274042506327,0.150241403691251,0.550097683956481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31RA,Interleukin-31 receptor subunit alpha,35216,-0.0145921387821287,0.0244173140586703,-0.0624500743371224,0.033265796772865,0.550119716574556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB2,Nuclear factor NF-kappa-B p100 subunit,35321,0.0205685551691835,0.0344386191306984,-0.0469311383269854,0.0880682486653524,0.550360809100131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLG,Plasminogen,35289,-0.00817201178996874,0.0136857023540349,-0.0349959884038771,0.0186519648239396,0.550449192523595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPRKB,EKC/KEOPS complex subunit TPRKB,35206,-0.0237132239881982,0.0397238142311299,-0.101571899881213,0.0541454519048163,0.550561678097556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX2,Sorting nexin-2,35391,-0.0309816519165125,0.0519152678697007,-0.132735576941126,0.070772273108101,0.550680467250095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK1C,Divergent protein kinase domain 1C,35275,0.0160608283039342,0.0269148703576294,-0.0366923175970195,0.0688139742048878,0.550711915554887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,36381,-0.00993252356174229,0.01674258455973,-0.042747989298813,0.0228829421753285,0.553033111701959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A2,Collagen alpha-2(IX) chain,35321,-0.0169346144449364,0.0285695816887087,-0.0729309945548055,0.0390617656649326,0.553370469464989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35428,0.0142172568830753,0.0239922189357442,-0.0328074922309834,0.0612420059971339,0.553485217034394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELPLG,P-selectin glycoprotein ligand 1,36352,-0.0103259972358887,0.0174311601714672,-0.0444910711719644,0.0238390767001869,0.553610006267296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171B,Protein FAM171B,35391,-0.0095003060080733,0.0160383006151189,-0.0409353752137064,0.0219347631975598,0.55363707434248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP8,Neutrophil collagenase,36419,-0.0280187273915005,0.0473061730732299,-0.120738826615031,0.0647013718320302,0.553678425093624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA1,von Willebrand factor A domain-containing protein 1,36413,0.0156301844171589,0.0263945652364549,-0.0361031634462927,0.0673635322806105,0.553752391838357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK1,Interleukin-1 receptor-associated kinase 1,36227,-0.0257044511436498,0.0434302397998169,-0.110827721151291,0.0594188188639914,0.553965995764987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFA2,BPI fold-containing family A member 2,35067,0.0411091584704351,0.069731103745124,-0.095563804870008,0.177782121810878,0.555522884742607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL24,Interleukin-24,36227,0.0191127733423014,0.0324387973534729,-0.0444672694705055,0.0826928161551083,0.555749475155099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLLT1,Protein ENL,35206,0.0252873255701724,0.042968969623327,-0.0589318548915484,0.109506506031893,0.556217483798676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,35230,0.0140129328221482,0.023820359848287,-0.0326749724804942,0.0607008381247907,0.556369433556452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF4,E3 ubiquitin-protein ligase RNF4,35321,-0.0246341676608718,0.0419538807709066,-0.106863773971849,0.0575954386501052,0.557109453559599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS7_LGALS7B,Galectin-7,36331,-0.0157287957370362,0.0268023769884963,-0.068261454634489,0.0368038631604166,0.557327505256094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH2,Growth hormone variant,36225,0.0625589284195977,0.10660746663288,-0.146391706180846,0.271509563020042,0.557346374276321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RFC4,Replication factor C subunit 4,35391,-0.00793836335523929,0.0135382030442723,-0.0344732413220131,0.0185965146115345,0.557649882823467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A5,Zinc transporter ZIP5,36352,-0.0194607939467945,0.0332480165564933,-0.0846269063975215,0.0457053185039324,0.558349708363879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA9,Carbonic anhydrase 9,36427,-0.0182128609262746,0.0311716620209705,-0.0793093184873769,0.0428835966348276,0.559052708794388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35417,-0.0265494528449948,0.045441371521122,-0.115614541026394,0.0625156353364043,0.559068396860244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB6,Ephrin type-B receptor 6,36290,-0.0124608818171935,0.0213460922581191,-0.0542992226431069,0.0293774590087199,0.559403909693049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZN,Kazrin,35402,-0.0378450008380165,0.0649161300802562,-0.165080615795319,0.0893906141192857,0.559925913930012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP2,"Fatty acid-binding protein, intestinal",36360,0.0294884635986284,0.0506666476994116,-0.0698181658922184,0.128795093089475,0.560578679829652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK10,Kallikrein-10,36376,-0.0147141509741889,0.0253037278517609,-0.0643094575636403,0.0348811556152625,0.56092088295427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIT1,Signaling threshold-regulating transmembrane adapter 1,36227,-0.020472625718004,0.03547287173887,-0.0899994543261892,0.0490542028901812,0.563866927852354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTK7,Inactive tyrosine-protein kinase 7,36191,-0.0137207247823563,0.023774103797645,-0.0603179682257404,0.0328765186610279,0.563870882084269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD1,Ly6/PLAUR domain-containing protein 1,36191,-0.023349392164685,0.0404833310908927,-0.102696721102835,0.0559979367734647,0.564116374580518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBN,Ameloblastin,36227,-0.0108719441140685,0.0188558895912518,-0.0478294877129221,0.0260855994847851,0.564241117226714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,36297,-0.034874947384223,0.0605369031231466,-0.15352727750559,0.0837773827371444,0.564569891166929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFAP2A,Transcription factor AP-2-alpha,35212,-0.0220481391834939,0.0382743066678578,-0.0970657802524952,0.0529695018855075,0.564598957152676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BABAM1,BRISC and BRCA1-A complex member 1,35239,-0.0103436979159452,0.0179598615032288,-0.0455450264622737,0.0248576306303833,0.56468111869242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COCH,Cochlin,35420,-0.0170449618134292,0.0296107633006769,-0.0750820578827559,0.0409921342558974,0.564883405720503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MESD,LRP chaperone MESD,36382,-0.0442483026374203,0.0768813282507165,-0.194935706008825,0.106439100733984,0.564943960652038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1A,Meprin A subunit alpha,35402,0.0262843955976651,0.0457311070477982,-0.0633485742160193,0.11591736541135,0.565474679028986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFH,Complement factor H,35058,-0.00843898189189556,0.0146830369212052,-0.0372177342574578,0.0203397704736667,0.565486745941891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRH,Receptor-type tyrosine-protein phosphatase H,35402,-0.0176099563953986,0.0306403630452355,-0.0776650679640601,0.0424451551732629,0.565494287484936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIPF,Gastric triacylglycerol lipase,35281,-0.0227613218019675,0.039637533285221,-0.100450887041001,0.0549282434370656,0.565828933372993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIM,Vimentin,36249,-0.0433189260869664,0.0754830797229132,-0.191265762343876,0.104627910169944,0.566061059851362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEP,Leptin,36360,0.0244284545017499,0.0425863993935544,-0.0590408883096168,0.107897797313117,0.56624227556078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB6,Heat shock protein beta-6,36427,-0.0142140219199086,0.0249065405041891,-0.0630308413081192,0.034602797468302,0.568224578641874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYZL2,Lysozyme-like protein 2,35206,-0.0127117801165025,0.0222861735376225,-0.0563926802502426,0.0309691200172376,0.568435451509914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF41,E3 ubiquitin-protein ligase NRDP1,36225,-0.0242599546805916,0.0426065400461665,-0.107768773171078,0.0592488638098948,0.5691062381166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK2,"Adenylate kinase 2, mitochondrial",35416,-0.0378330560012373,0.06644963791605,-0.168074346316695,0.0924082343142206,0.569139656987311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,36397,-0.0346768573349947,0.0609883332502379,-0.154213990505461,0.0848602758354717,0.569657692993102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK2,Protein AHNAK2,35281,-0.0105496478388125,0.0185557216002681,-0.046918862175338,0.025819566497713,0.569690135668588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAC1,Zinc phosphodiesterase ELAC protein 1,35417,-0.0300537657986627,0.0529723800505318,-0.133879630697705,0.0737720991003796,0.570498340282434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMIP,C-Maf-inducing protein,35391,-0.0296464552665197,0.0522787601657242,-0.132112825191339,0.0728199146582997,0.570677563891811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXJ3,Forkhead box protein J3,35239,0.0160107605984774,0.0282544980139227,-0.0393680555088111,0.0713895767057658,0.570964634682068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP4,Caspase-4,35321,0.0612646687284396,0.108422394016625,-0.151243223544145,0.273772561001025,0.572056711385838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP1A,Charged multivesicular body protein 1a,36297,-0.028495609630417,0.0504508531089823,-0.127379281724022,0.0703880624631882,0.572214594594053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA13,Carbonic anhydrase 13,36273,0.0374452281568518,0.0663133532064832,-0.0925289441278553,0.167419400441559,0.572315447494776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRAXIN,Draxin,36297,0.015705898853723,0.0278157101396394,-0.0388128930199702,0.0702246907274162,0.572335595223784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX58,Antiviral innate immune response receptor RIG-I,36225,-0.0203596858284894,0.0360605771121311,-0.0910384169682665,0.0503190453112876,0.57236606503547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC11A,C-type lectin domain family 11 member A,36375,-0.0176352811780042,0.0312901662969695,-0.0789640071200645,0.043693444764056,0.573040864826272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCC1,GRIP and coiled-coil domain-containing protein 1,35416,-0.0376885605441109,0.0668753210817557,-0.168764189864352,0.0933870687761302,0.573070824735399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR158,Probable G-protein coupled receptor 158,35417,-0.0128210219865265,0.0227541826503227,-0.0574192199811591,0.031777176008106,0.57314348131007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARAF,Serine/threonine-protein kinase A-Raf,35321,-0.0239056903509602,0.042477713942798,-0.107162009678844,0.0593506289769238,0.573603969245835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABHD14B,Protein ABHD14B,36283,-0.0205375545171814,0.0365087992947065,-0.0920948011348062,0.0510196921004435,0.573767913496328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGA,Protein O-GlcNAcase,35402,-0.0246865131978655,0.0440446784862639,-0.111014083030943,0.0616410566352118,0.575166857176703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFAT5,Nuclear factor of activated T-cells 5,35239,-0.0298686624709288,0.0533071640590208,-0.13435070402661,0.074613379084752,0.575287167522248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK4,Dickkopf-related protein 4,36286,0.016560841113717,0.0296671380435212,-0.0415867494515846,0.0747084316790185,0.576710606096318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASH1,Tubulinyl-Tyr carboxypeptidase 1,36352,-0.0293904903229907,0.0526758816664582,-0.132635218389249,0.0738542377432674,0.57689620813327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL4,Delta-like protein 4,35281,-0.0308989784437854,0.055406227161382,-0.139495183680094,0.0776972267925234,0.577083009885033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL25,C-C motif chemokine 25,36442,-0.0169306687055882,0.0303745775757982,-0.0764648407541526,0.0426035033429762,0.577274095670344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOCS2,Molybdopterin synthase catalytic subunit,35312,-0.023377890512076,0.0419536904180383,-0.105607123731431,0.0588513427072789,0.577390100281609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD2,Polycystin-2,35214,-0.0204124591173562,0.036669376835431,-0.0922844377148009,0.0514595194800884,0.577778881485095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10,Interleukin-10,36227,-0.0288391854175579,0.0518188682947346,-0.130404167275238,0.072725796440122,0.577860619474543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSH3,Protein phosphatase Slingshot homolog 3,35206,0.0102719581635722,0.0184962602375629,-0.025980711902051,0.0465246282291955,0.578673728350829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,35018,-0.0174319225870521,0.031435811387078,-0.0790461129057251,0.0441822677316208,0.579241345106062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIFR,Leukemia inhibitory factor receptor,36352,-0.00858656194777827,0.0155202954554138,-0.0390063410403893,0.0218332171448328,0.580111343233405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEB,Nebulin,35214,0.0136749371643346,0.0247193751004631,-0.0347750380325731,0.0621249123612422,0.580142055774311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRD2,Protein ZNRD2,35402,-0.0247247279886762,0.0447555950248691,-0.11244569423742,0.0629962382600672,0.580667630279122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35391,-0.037556805952793,0.0680188495103414,-0.170873750993062,0.0957601390874761,0.580863503376737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB2,Plexin-B2,36409,-0.00840575477672043,0.0152402508889558,-0.0382766465190738,0.021465136965633,0.581274033709109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2,Low-density lipoprotein receptor-related protein 2,35275,-0.0138368358079832,0.0250872699857692,-0.0630078849800909,0.0353342133641244,0.581278276871463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD3,Bromodomain-containing protein 3,35214,-0.0167537829496983,0.0304058100595099,-0.0763491706663377,0.0428416047669412,0.581650028020233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIAPIN1,Anamorsin,36397,-0.0217643347336823,0.0395027058957205,-0.0991896382892945,0.0556609688219298,0.581679503920321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,35214,-0.00977951307845415,0.0177607330315048,-0.0445905498202035,0.0250315236632952,0.581910833961712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL2,Angiopoietin-related protein 2,36380,-0.0142028201207944,0.0259383826150213,-0.0650420500462361,0.0366364098046473,0.584011084616545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",36352,-0.0332469287926985,0.0607235282216416,-0.152265044107116,0.085771186521719,0.5840433252653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,36225,-0.0152354132012169,0.0278700449252447,-0.0698607012546965,0.0393898748522627,0.584630317166509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRZB,Secreted frizzled-related protein 3,36271,-0.00887897884792766,0.0162511613305969,-0.0407312550558975,0.0229732973600422,0.584835962942341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),A1BG,Alpha-1B-glycoprotein,35448,-0.00587723970314646,0.0107577835523472,-0.026962495465747,0.015208016059454,0.584862451627896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAPIN,SNARE-associated protein Snapin,35417,-0.0197156952335855,0.0361162028972085,-0.0905034529121142,0.0510720624449432,0.585156909634823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BANK1,B-cell scaffold protein with ankyrin repeats,36352,-0.0366667684946383,0.0672030791527465,-0.168384803634021,0.0950512666447447,0.585350063537465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLNK,B-cell linker protein,35239,-0.0135374471974321,0.0248520767419119,-0.0622475176115795,0.0351726232167152,0.585965538018297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,36227,0.0128953522743282,0.0237025477516421,-0.0335616413188903,0.0593523458675468,0.586424859152492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA7A,Semaphorin-7A,36428,-0.00988008007555918,0.0182106462404464,-0.045572946706834,0.0258127865557157,0.587460396317085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL2,C-C motif chemokine 2,36282,-0.0187521927990209,0.0345815968468113,-0.0865321226187709,0.0490277370207292,0.587656930380422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEO1,Neogenin,35417,0.00747798210313603,0.0138037195776302,-0.0195773082690191,0.0345332724752911,0.58801926804487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN6,Prefoldin subunit 6,35275,0.0223052594922588,0.0412392651961309,-0.0585237002921577,0.103134219276675,0.58861402392012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK15,Kallikrein-15,35382,-0.0181233263893496,0.0335414465937139,-0.0838645617130288,0.0476179089343296,0.58899145631282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL24,"39S ribosomal protein L24, mitochondrial",35214,-0.0134508383073472,0.024927027444082,-0.0623078120977479,0.0354061354830534,0.589486944132639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG3,BAG family molecular chaperone regulator 3,36282,-0.0136502451384655,0.0253185839404475,-0.0632746696617425,0.0359741793848116,0.58980763214098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDO2,"Tryptophan 2,3-dioxygenase",35275,-0.0133300925490791,0.0247352147256369,-0.0618111134113273,0.0351509283131692,0.589967625039709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTR,Transthyretin,35385,0.00857442824155434,0.0159120022560099,-0.0226130961802251,0.0397619526633338,0.58999907453126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF43,E3 ubiquitin-protein ligase RNF43,35321,-0.0205231617006101,0.0381568381543365,-0.0953105644831095,0.0542642410818894,0.590690984006288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35321,-0.0128224182858682,0.023936525204212,-0.0597380076861238,0.0340931711143873,0.592196270973051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK4,Interleukin-1 receptor-associated kinase 4,36352,-0.0351725508626343,0.0656827917750862,-0.163910822741803,0.0935657210165347,0.59232694192258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA4,Laminin subunit alpha-4,36403,-0.0112810898799752,0.0210904303289828,-0.0526183333247815,0.0300561535648311,0.592741450265438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC8,Histone deacetylase 8,35239,0.0204522785017675,0.0383541701340831,-0.0547218949610354,0.0956264519645705,0.593881630702551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP5,Platelet glycoprotein V,35312,0.0121588853572759,0.0228188148134012,-0.0325659916769905,0.0568837623915423,0.594160416103334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIPR1,Vasoactive intestinal polypeptide receptor 1,35281,0.00767180091728908,0.0144209987945982,-0.0205933567201233,0.0359369585547015,0.594753596586268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLH1,Glutamate carboxypeptidase 2,35239,0.0340907976667717,0.0642076780893454,-0.0917562513883453,0.159937846721889,0.595475837237337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSMR,Oncostatin-M-specific receptor subunit beta,36418,-0.00683815547857719,0.012899553446634,-0.0321212802339798,0.0184449692768254,0.596053399015221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,35281,-0.011874509353498,0.022403444163993,-0.0557852599149243,0.0320362412079284,0.596110096911263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTPP1,dCTP pyrophosphatase 1,36360,0.0107805454037848,0.0203478535327949,-0.0291012475204933,0.0506623383280629,0.59625841098112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOA,Elongin-A,36331,-0.0188787000167441,0.0357505036882944,-0.0889496872458011,0.0511922872123129,0.597468498896126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO4,Roundabout homolog 4,35281,-0.00587748908859959,0.0111396908713901,-0.0277112831965242,0.015956305019325,0.597784496222039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMB1,Laminin subunit beta-1,35281,-0.010003309018447,0.0189708074917799,-0.0471860917023356,0.0271794736654416,0.598004410041264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLA,Alpha-galactosidase A,35301,-0.012397014014217,0.0235219222797131,-0.0584999816824546,0.0337059536540206,0.598184361556706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AAMDC,Mth938 domain-containing protein,35281,-0.0172045436322912,0.0326559829130963,-0.0812102701419599,0.0468011828773776,0.59832250586618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR1,Folate receptor alpha,36364,0.0100034146813589,0.0190392500031623,-0.0273135153248391,0.0473203446875569,0.599314365079069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF5,E3 ubiquitin-protein ligase RNF5,35281,-0.0236321607416721,0.0450279227111339,-0.111886889255494,0.0646225677721503,0.599718078254093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR2,Cadherin-related family member 2,36331,-0.0235835251834575,0.0449817266248417,-0.111747709368147,0.0645806590012323,0.600092271501687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP73,Tumor protein p73,35275,-0.0113575733795187,0.0216649691317476,-0.053820912877744,0.0311057661187067,0.60013297815861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EP300,Histone acetyltransferase p300,35239,0.0102731640878789,0.0196353349292235,-0.0282120923733992,0.0487584205491569,0.600855787279617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFB,Complement factor B,35329,-0.0106205439274424,0.0203096618914777,-0.0504274812347387,0.0291863933798539,0.601041425099921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THRAP3,Thyroid hormone receptor-associated protein 3,35214,0.0354879037995785,0.0678798452916033,-0.0975565929719639,0.168532400571121,0.601129391431172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLNS1A,Methylosome subunit pICln,35275,0.0111566263266859,0.0213429416591288,-0.0306755393252066,0.0529887919785783,0.601180209512371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD7,T-cell antigen CD7,35226,-0.0149155844502952,0.0285470893356869,-0.0708678795482416,0.0410367106476513,0.601348011493081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZHX2,Zinc fingers and homeoboxes protein 2,35416,-0.0116063907541221,0.022232551306057,-0.0551821913139937,0.0319694098057495,0.601657629889497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CILP,Cartilage intermediate layer protein 1,35438,-0.0174776361451108,0.0335505157891701,-0.0832366470918843,0.0482813748016626,0.602430562800401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5IF1,"ATPase inhibitor, mitochondrial",36403,-0.0365598407530307,0.070377945595414,-0.174500614120042,0.101380932613981,0.603442940169919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEFL,Neurofilament light polypeptide,36172,-0.0150879642213,0.0290599905974915,-0.0720455457923833,0.0418696173497834,0.603637334920573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIL1,Nucleotide exchange factor SIL1,35281,-0.010183660856409,0.0197125393892357,-0.048820238059311,0.028452916346493,0.605448409687823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD2,Protein disulfide isomerase CRELD2,36390,-0.0169368382029651,0.0328070883246884,-0.0812387313193542,0.0473650549134241,0.605691868534922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX2,Heme oxygenase 2,36191,0.0148340512502501,0.0287437726979418,-0.0415037432377158,0.071171845738216,0.605815693026393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID4B,AT-rich interactive domain-containing protein 4B,36191,-0.0144320159209705,0.0280586280950528,-0.0694269269872741,0.040562895145333,0.607022045921318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO1,Forkhead box protein O1,36352,-0.0278326082077267,0.0541203811014669,-0.133908555166602,0.0782433387511485,0.607077561906342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTKN2,Rhotekin-2,35214,0.0170656104179951,0.0333229993107947,-0.0482474682311625,0.0823786890671526,0.60858085820043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED1,Transmembrane emp24 domain-containing protein 1,35321,0.0178038057635765,0.0347657615973975,-0.0503370869673226,0.0859446984944756,0.608594263735829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFA,Platelet-derived growth factor subunit A,36446,-0.0230772176502572,0.045078951877565,-0.111431963330285,0.0652775280297702,0.608716368659875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORT1,Sortilin,36350,-0.0120313274099464,0.0235134327104128,-0.0581176555223555,0.0340550007024627,0.608891543441647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENDOU,Poly(U)-specific endoribonuclease,34960,-0.0181281058706407,0.0354709757386691,-0.0876512183184321,0.0513950065771506,0.609322511513677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD22,B-cell receptor CD22,36442,0.013970498373126,0.0273966450771191,-0.0397269259780274,0.0676679227242794,0.610112778840538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC2L,C-type lectin domain family 2 member L,35275,-0.0162553802959047,0.0319104408195394,-0.078799844302202,0.0462890837103926,0.610485930234136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB104A_DEFB104B,Beta-defensin 104,35212,0.0172135594475245,0.0338157859732897,-0.0490653810601233,0.0834924999551723,0.610743434626749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL16,Pro-interleukin-16,36442,-0.0138297331887151,0.0271862011336363,-0.0671146874106423,0.0394552210332121,0.610975100629959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1B,Meprin A subunit beta,36360,0.0384069384621013,0.0755631041977071,-0.109696745765405,0.186510622689607,0.611275202089478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPG,Macrophage-capping protein,36301,0.018865306361142,0.0371319472037843,-0.0539133101582752,0.0916439228805591,0.6114261034744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID3A,AT-rich interactive domain-containing protein 3A,35212,-0.0127664554120573,0.0251392891956949,-0.0620394622356193,0.0365065514115047,0.611592012147504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA1,DnaJ homolog subfamily A member 1,35206,-0.0150274244378202,0.029601749029049,-0.0730468525347563,0.0429920036591159,0.61171515392014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF75D,Zinc finger protein 75D,35321,0.0199209519667788,0.0392670829378634,-0.0570425305914335,0.0968844345249912,0.611949005399705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIT,Vitrin,35420,-0.0122517827041538,0.0242596630156124,-0.0598007222147541,0.0352971568064466,0.613557809209035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAC3,Ras-related C3 botulinum toxin substrate 3,35275,-0.0222050642777719,0.0441197029034026,-0.108679681968441,0.0642695534128972,0.614777685115908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1B,Protein phosphatase 1B,35239,0.0192731101465327,0.038295915569743,-0.0557868843701635,0.094333104663229,0.614794174188383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5E,5'-nucleotidase,36397,-0.0181258749167002,0.0360853569994694,-0.0888531746356602,0.0526014248022599,0.615467964244854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGFAC,Hepatocyte growth factor activator,35370,-0.00874872803831746,0.0174343029342968,-0.0429199617895393,0.0254225057129043,0.615818239668984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH2,"Aldehyde dehydrogenase, mitochondrial",35391,-0.016164073266675,0.0322267800670468,-0.0793285621980867,0.0470004156647368,0.615985940686584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP2,Integrin beta-1-binding protein 2,36249,-0.0354981487623259,0.0708279477370457,-0.174320926326936,0.103324628802284,0.616254144894474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN2A1,Butyrophilin subfamily 2 member A1,36403,-0.00872216745907397,0.0174499501405655,-0.0429240697345824,0.0254797348164345,0.617203628731322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMR1,Synaptic functional regulator FMR1,36225,-0.0113297807919625,0.0227593914646174,-0.0559381880626127,0.0332786264786876,0.618635761647918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TET2,Methylcytosine dioxygenase TET2,35310,-0.0323856225539839,0.0650632038116116,-0.159909502024743,0.0951382569167747,0.618673684255717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGM2,Phosphoglucomutase-2,35275,-0.0181551130302847,0.0365054178280801,-0.0897057319733217,0.0533955059127523,0.618976782053734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA12,Carbonic anhydrase 12,36331,-0.0102261895201137,0.0205755910070538,-0.050554347893939,0.0301019688537117,0.619200220622392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35416,-0.00797939007137833,0.016056025170532,-0.0394491994056211,0.0234904192628645,0.61922656949924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRC,Proto-oncogene tyrosine-protein kinase Src,36384,0.0379747816575527,0.0764788678273546,-0.111923799284062,0.187873362599168,0.61952897936116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD1,Sushi domain-containing protein 1,36249,-0.0153897159713208,0.0309989773907459,-0.0761477116571827,0.0453682797145412,0.619586196469056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,36352,-0.0382570047315386,0.0770613122235042,-0.189297176689607,0.11278316722653,0.619592966652874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMB,RGM domain family member B,36428,-0.0087789665667755,0.0176848202149492,-0.043441214188076,0.025883281054525,0.619618460785971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT2,Signal transducer and activator of transcription 2,35239,-0.0236712996213432,0.0478240474439958,-0.117406432611575,0.0700638333688886,0.620641783135649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTBDN,Retbindin,36331,0.00944508608613247,0.01909237465839,-0.0279759682443118,0.0468661404165768,0.620823862538482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,36410,-0.0132049472603693,0.0266975032543317,-0.0655320536388594,0.0391221591181209,0.620887982836906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,36225,-0.020224362135088,0.0410342517490529,-0.100651495563232,0.0602027712930556,0.622123100947388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACHE,Acetylcholinesterase,35312,0.0103020290479956,0.0209135891222934,-0.0306886056316995,0.0512926637276907,0.622313092607095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBEGF,Proheparin-binding EGF-like growth factor,36397,0.0228488770646466,0.0463928072483757,-0.0680810251421698,0.113778779271463,0.622374542591281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP1,Insulin-like growth factor-binding protein 1,36433,-0.0372081939019232,0.0758270149279407,-0.185829143160687,0.111412755356841,0.623654661290424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTF,Ciliary neurotrophic factor,35212,-0.0107359896677676,0.0218817085237962,-0.053624138374408,0.0321521590388729,0.623700653498268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT2,Kunitz-type protease inhibitor 2,36403,-0.0124884910098368,0.0254572160289736,-0.062384634426625,0.0374076524069513,0.623747081166183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC27A4,Long-chain fatty acid transport protein 4,36191,0.0204139636444357,0.0417309865789829,-0.0613787700503708,0.102206697339242,0.624729607384348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A12,Protein S100-A12,36264,-0.0237849580887919,0.0486541862159848,-0.119147163072122,0.0715772468945383,0.624957833591719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FIS1,Mitochondrial fission 1 protein,36378,0.0236566564024932,0.048561743523442,-0.071524360903453,0.118837673708439,0.626169772568798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB1,Scavenger receptor class B member 1,36191,0.0171618556694061,0.0352665675324386,-0.0519606166941735,0.0862843280329857,0.626534074994258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11B,Transmembrane protease serine 11B,35212,0.0235959622606206,0.0485038927034745,-0.0714716674381895,0.118663591959431,0.626647687311237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANK2,Ankyrin-2,35214,-0.0210779148387077,0.0434927223692261,-0.106323650682391,0.0641678210049755,0.627955860988995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LARP1,La-related protein 1,35391,-0.0190193666566799,0.039317369185275,-0.096081410259819,0.0580426769464591,0.628587810089777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPM3,Tropomyosin alpha-3 chain,35214,0.0133817972643366,0.0276997086431942,-0.040909631676324,0.0676732262049972,0.629040558990121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ODAM,Odontogenic ameloblast-associated protein,36182,0.0179278462846285,0.0371166213570758,-0.0548207315752402,0.0906764241444971,0.629100955350912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDNF,Cerebral dopamine neurotrophic factor,36331,0.0102142606324958,0.021183613010124,-0.0313056208673472,0.0517341421323388,0.629694676519401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXK,Tyrosine-protein kinase TXK,35321,-0.0235654351309395,0.0489831033412094,-0.11957231767971,0.0724414474178309,0.630467480853335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFAP1,Actin filament-associated protein 1,35312,0.0251615637515752,0.0524283920757933,-0.0775980847169796,0.12792121222013,0.63129967528152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI1,Neuroserpin,35301,-0.00924402154071823,0.0193006328191459,-0.0470732618662442,0.0285852187848077,0.631991957182386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACTB2,Endoribonuclease LACTB2,36360,-0.0199961760845692,0.0418285692095236,-0.101980171735235,0.0619878195660971,0.632628714352827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35321,0.0207746937597103,0.0434617846769138,-0.0644104042070408,0.105959791726461,0.6326679019857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS2,Podocin,35239,-0.0321525064399964,0.0673382755707471,-0.164135526558661,0.0998305136786679,0.633039455122442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN2,Prefoldin subunit 2,36191,-0.0163724069393044,0.0343319374510756,-0.0836630043434126,0.0509181904648038,0.633458472337242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SBSN,Suprabasin,35427,-0.010448612131009,0.0219140167505681,-0.0534000849621224,0.0325028607001044,0.633520970106647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM5,Tripartite motif-containing protein 5,36352,0.026171574623246,0.054907266691349,-0.0814466680917981,0.13378981733829,0.63362558589729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA2,DnaJ homolog subfamily A member 2,36425,-0.0246502287975465,0.0517563852243076,-0.126092743837189,0.0767922862420964,0.633893463290793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,36297,-0.0161512903878376,0.0339783637736371,-0.0827488833841664,0.0504463026084911,0.634558955698095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCLM,Glutamate--cysteine ligase regulatory subunit,35214,-0.0138213431010846,0.0291333821494391,-0.0709227721139853,0.0432800859118161,0.635220481558031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FH,"Fumarate hydratase, mitochondrial",35212,-0.0252801465866265,0.0533048653321133,-0.129757682637568,0.0791973894643155,0.63533464583989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF8,Immunoglobulin superfamily member 8,36360,-0.0091523659766385,0.0193256872316762,-0.0470307129507238,0.0287259809974468,0.635809917529527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",35214,-0.026175687410306,0.0555246489436866,-0.135003999339932,0.0826526245193197,0.637354610300767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL5A1,Collagen alpha-1(V) chain,35312,-0.0121335914900442,0.0257743292695888,-0.0626512768584384,0.0383840938783499,0.637827024254496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYAL1,Hyaluronidase-1,36347,-0.00690019540460415,0.0147082073450104,-0.0357282818008245,0.0219278909916162,0.638984498750712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMS1,PMS1 protein homolog 1,35275,0.0148011561945223,0.031581949815019,-0.0470994654429149,0.0767017778319596,0.639330396527041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPT1,Palmitoyl-protein thioesterase 1,35275,-0.0214752733867874,0.0458713873531595,-0.11138319259898,0.0684326458254052,0.639685009905191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,36225,-0.0374354677208535,0.0799814087400282,-0.194199028851309,0.119328093409602,0.63976182780576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC2,Stanniocalcin-2,36371,-0.0073209343520747,0.0156436809314805,-0.0379825489777765,0.0233406802736271,0.639812894562025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAGE2A,G antigen 2A,35206,0.0198180965614336,0.0424305852308877,-0.0633458504911064,0.102982043613973,0.640465996364209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1S,Complement C1s subcomponent,35448,-0.00624133540049821,0.0133645938280165,-0.0324359393034105,0.0199532685024141,0.640512395097486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35417,-0.0165532964840369,0.0354894220273546,-0.0861125636576519,0.0530059706895782,0.640924767194263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS22,Brain-specific serine protease 4,35239,-0.0107792667672554,0.023114563115986,-0.056083810474588,0.0345252769400771,0.640988292737177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASEH2A,Ribonuclease H2 subunit A,35417,-0.0145315811463847,0.0311661338332843,-0.0756172034596219,0.0465540411668525,0.641044358466409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40,Tumor necrosis factor receptor superfamily member 5,36372,-0.0146240634266992,0.0314158022009204,-0.0761990357405033,0.0469509088871049,0.641587388514913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX53,Probable ATP-dependent RNA helicase DDX53,35275,-0.0103714701387176,0.022318298938213,-0.0541153360576151,0.0333723957801798,0.642157920003286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRB3,Adhesion G protein-coupled receptor B3,36282,0.0101831786481361,0.0219149598286401,-0.0327701426159984,0.0531364999122706,0.64218356269179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA2,Heat shock-related 70 kDa protein 2,35391,-0.0104150735821417,0.0224282417809193,-0.0543744274727435,0.0335442803084601,0.642396727008392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC51B,Organic solute transporter subunit beta,35214,0.0226354076644258,0.0487810244894119,-0.0729754003348216,0.118246215663673,0.642649656005424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGA,Glycoprotein hormones alpha chain,36382,0.0186423487028373,0.0402974927002156,-0.0603407369895852,0.0976254343952599,0.643652150276954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSP90B1,Endoplasmin,36156,0.0190662436730009,0.0412775442327415,-0.0618377430231724,0.0999702303691742,0.644164930228201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN1A,Cyclin-dependent kinase inhibitor 1,36331,0.0310805218998582,0.0673935591363988,-0.101010854007483,0.1631718978072,0.644683945725914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUOX2,Dual oxidase 2,36249,-0.0216230927018764,0.0469251422044062,-0.113596371422512,0.0703501860187597,0.644956501539371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBNL,Drebrin-like protein,36403,0.026969560618454,0.0585872470393446,-0.0878614435786615,0.141800564815569,0.645292113562044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,36331,0.01107060797477,0.0240704683690721,-0.0361075100286113,0.0582487259781512,0.645584130445837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBPL1,Insulin-like growth factor-binding protein-like 1,36360,-0.0101072393761666,0.0220220057993562,-0.0532703707429048,0.0330558919905715,0.646276172005527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11R,Junctional adhesion molecule A,36382,-0.0162099484786878,0.0353364713363532,-0.0854694322979399,0.0530495353405644,0.646440942081724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLMP,CXADR-like membrane protein,36427,-0.0062871013518788,0.0137328489230234,-0.0332034852410046,0.020629282537247,0.647099260940914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYAT1,Kynurenine--oxoglutarate transaminase 1,36352,-0.016807013233158,0.0367640030509324,-0.0888644592129855,0.0552504327466695,0.647570280068835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MB,Myoglobin,36446,-0.0153495373852708,0.0336092306894376,-0.0812236295365686,0.0505245547660269,0.647896054398962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELENOP,Selenoprotein P,35448,0.00665536260026984,0.014607541190604,-0.021975418133314,0.0352861433338537,0.648685246652805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI16,Peptidase inhibitor 16,35428,-0.00714877628505423,0.015735113053078,-0.0379895978690871,0.0236920452989787,0.649614353246657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA2013,Uncharacterized protein KIAA2013,35391,-0.0151371430313803,0.0334118925112548,-0.0806244523534396,0.0503501662906791,0.650531074924129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRA2,Ankyrin repeat family A protein 2,35206,-0.0161318642012305,0.0357997287101892,-0.0862993324732013,0.0540356040707404,0.652283918757985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IZUMO1,Izumo sperm-egg fusion protein 1,35206,-0.013031258922471,0.0289239923496227,-0.0697222839277316,0.0436597660827895,0.652341268056637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR1,Cadherin-related family member 1,36191,-0.0126547071785686,0.028105300513104,-0.0677410961842524,0.0424316818271152,0.652536553625776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA1,Glutathione S-transferase A1,36347,0.0239744771403778,0.0533096064269316,-0.0805123514564081,0.128461305737164,0.65292488059663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP4,Microfibril-associated glycoprotein 4,35312,0.00924172673774557,0.0205515702640815,-0.0310393509798542,0.0495228044553453,0.652953734878258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,35214,0.0187265548992898,0.0417964318801692,-0.0631944515858418,0.100647561384421,0.654139043704301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35391,0.0175411727098191,0.039207973091329,-0.0593064545491856,0.0943887999688239,0.654610648179741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECM1,Extracellular matrix protein 1,35284,0.0103298310180552,0.023101049526588,-0.0349482260540573,0.0556078880901678,0.654776513913764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNIP1,TNFAIP3-interacting protein 1,35416,-0.024856522636148,0.0556087150957116,-0.133849604223743,0.0841365589514468,0.654898058132365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC2,Mucin-2,35438,0.0263675916917528,0.05903184910696,-0.0893348325578888,0.142070015941395,0.655130846834773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMC3,26S proteasome regulatory subunit 6A,35206,0.0085474531072384,0.0191493481924697,-0.0289852693500022,0.046080175564479,0.655355181641286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPAG1,Sperm-associated antigen 1,35417,-0.0155067434557539,0.0347675719768114,-0.0836511845303042,0.0526376976187964,0.655604320513146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOMO1,Nodal modulator 1,36382,-0.0065742723453581,0.0147677589551306,-0.035519079897414,0.0223705352066978,0.656204972535797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP9,Caspase-9,35239,0.0170956745693497,0.0384794196863722,-0.0583239880159399,0.0925153371546392,0.656855349346523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHH,Sonic hedgehog protein,35239,0.0117431315860475,0.0264468685140119,-0.0400927307014158,0.0635789938735108,0.657038740916467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGF,Beta-nerve growth factor,36297,0.00339111088203305,0.00765427779231759,-0.0116112735909094,0.0183934953549755,0.657754107593086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRLF1,Cytokine receptor-like factor 1,36403,-0.00710459780437962,0.0160471780920842,-0.0385570668648646,0.0243478712561054,0.657972942195488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP8,Vesicle-associated membrane protein 8,35239,-0.0243516351812215,0.055162806493209,-0.132470735907911,0.0837674655454682,0.65890285367355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G2,V-type proton ATPase subunit G 2,35214,-0.0266724703210223,0.0605102074880136,-0.145272476997529,0.0919275363554845,0.659378756381645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB14,DnaJ homolog subfamily B member 14,35402,-0.0179777495952141,0.0407898070190312,-0.0979257713525153,0.0619702721620871,0.65941569334505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXIN1,Axin-1,36352,-0.0266229896544061,0.0604778218890143,-0.145159520556874,0.0919135412480619,0.659797738619259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TST,Thiosulfate sulfurtransferase,36181,-0.0208432220565827,0.0474233131338041,-0.113792915798839,0.0721064716856735,0.66030254944189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNST,Consortin,36360,-0.0303239857249198,0.0691480047778785,-0.165854075089562,0.105206103639722,0.661009990128382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH23,Cadherin-23,35416,-0.00735416163236057,0.0167717589466019,-0.0402268091677003,0.0255184859029792,0.661050098514513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKAP12,A-kinase anchor protein 12,35312,0.00560557543463175,0.0128145828172762,-0.0195110068872296,0.0307221577564931,0.661809739610711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPK2,Death-associated protein kinase 2,35239,-0.015656317295754,0.0358738698421454,-0.0859691021863591,0.054656467594851,0.662542702961199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF12,Rho guanine nucleotide exchange factor 12,36352,-0.0284589508646698,0.0653035768370218,-0.156453961465232,0.0995360597358929,0.66299885098351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR2,Anterior gradient protein 2 homolog,36131,-0.0284485331169179,0.0652903937686178,-0.156417704903409,0.0995206386695729,0.663051197272087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR4,Toll-like receptor 4,35239,0.00790053360242936,0.0181346506050668,-0.0276433815835016,0.0434444487883603,0.663099318058327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,36382,0.00996487879483221,0.0228750528952703,-0.0348702248798975,0.0547999824695619,0.663124007419289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH2,Cadherin-2,36360,-0.00987237606725469,0.0227215651505684,-0.0544066437623688,0.0346618916278594,0.66394307808652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL28,C-C motif chemokine 28,36327,-0.015864404689516,0.0365343593296178,-0.0874717489755669,0.055742939596535,0.664132778511558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MN1,Transcriptional activator MN1,35275,-0.0164839707647144,0.0379867381555611,-0.090937977549614,0.0579700360201853,0.664347299045587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD82,CD82 antigen,35321,-0.0113583752230786,0.0261984426342723,-0.0627073227862524,0.0399905723400951,0.664629392847988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHLHE40,Class E basic helix-loop-helix protein 40,35212,-0.0188554214851749,0.0434909583377722,-0.104097699827208,0.0663868568568586,0.664632184226426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7B,B-cell CLL/lymphoma 7 protein family member B,35391,-0.0122247550160697,0.0281994967103442,-0.0674957685683443,0.0430462585362049,0.664659618858395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML1,Trem-like transcript 1 protein,35428,-0.0143036311189398,0.0330125113299671,-0.0790081533256753,0.0504008910877958,0.664827012287414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG4,Regenerating islet-derived protein 4,36381,-0.0141847862647307,0.0327714039234799,-0.0784167379547514,0.0500471654252899,0.665143738404836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK5,Serine protease inhibitor Kazal-type 5,36382,0.00940024491991565,0.0217452899244825,-0.03322052333207,0.0520210131719013,0.66554450625754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBLD,Phenazine biosynthesis-like domain-containing protein,36191,0.0138581312213836,0.0320978946267212,-0.0490537422469899,0.076770004689757,0.665939478149002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF5,Fibroblast growth factor 5,36227,0.00892285988730203,0.0207232350054122,-0.0316946807233059,0.04954040049791,0.666792266707333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAMT,Guanidinoacetate N-methyltransferase,35214,0.00984556521650716,0.0228747931616318,-0.0349890293802912,0.0546801598133055,0.666912019625958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP8,Caspase-8,36397,-0.0170188217681663,0.0395973770030632,-0.0946296806941702,0.0605920371578376,0.667356393808457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENND2B,DENN domain-containing protein 2B,35214,0.0132715037059114,0.0309188023733853,-0.0473293489459237,0.0738723563577466,0.66776589056429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THPO,Thrombopoietin,36249,-0.0105153376864356,0.0245327505971023,-0.058599528856756,0.0375688534838848,0.668209606977753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,35275,0.0273771415475616,0.0638826074047967,-0.0978327689658399,0.152587052060963,0.668263068092973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAM,Integrin alpha-M,36382,0.00851437796997546,0.0198684027752895,-0.0304276914695919,0.0474564474095428,0.668271861077435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASS1,Argininosuccinate synthase,35214,-0.0210276158959585,0.0490764950527403,-0.117217546199329,0.0751623144074124,0.668327117106348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP29,Synaptosomal-associated protein 29,36397,-0.0248416025118834,0.0581148277405447,-0.138746664883351,0.0890634598595843,0.669059118340278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD2,Leiomodin-2,35212,0.0171516346348573,0.0401250830863513,-0.0614935282143912,0.0957967974841058,0.669063842906923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRO3,Tyrosine-protein kinase receptor TYRO3,36360,-0.00776304288766754,0.0181717315698858,-0.0433796367646437,0.0278535509893087,0.669243323853447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUOM,Fucose mutarotase,35312,-0.0171979740236549,0.0403629553666399,-0.0963093665422691,0.0619134184949593,0.670062267854042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RA,Interleukin-10 receptor subunit alpha,36227,-0.0159228304923075,0.0374588433779351,-0.0893421635130604,0.0574965025284454,0.670794760350379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,36397,0.0121434966289256,0.0285851087376106,-0.0438833164967911,0.0681703097546424,0.67098133223988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRL,Appetite-regulating hormone,36360,0.0233357867438885,0.0549378028575474,-0.0843423068569044,0.131013880344681,0.671019009981811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORD,Sorbitol dehydrogenase,36386,0.0180334541765002,0.0425365679913265,-0.0653382190864998,0.1014051274395,0.671613651508992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF5,Rho guanine nucleotide exchange factor 5,35212,-0.0197157894249067,0.0465607904530402,-0.110974938712865,0.071543359863052,0.671988014527463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL11,Interleukin-11,36227,-0.017297538113271,0.0408694703673568,-0.0974017000332903,0.0628066238067482,0.672134115770885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPS10,40S ribosomal protein S10,35214,0.0110009408639355,0.0259923621558122,-0.0399440889614564,0.0619459706893273,0.672137150677246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICALL2,MICAL-like protein 2,35275,-0.0182523012707072,0.0433035708106062,-0.103127300059495,0.066622697518081,0.673407502650075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,36297,0.0167889179451114,0.0398567034128334,-0.0613302207440422,0.094908056634265,0.673598442398335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YTHDF3,YTH domain-containing family protein 3,36227,-0.0229101168373435,0.0544010846554616,-0.129536242762048,0.0837160090873613,0.673670500990496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA2,Interleukin-13 receptor subunit alpha-2,35212,0.00751393576971408,0.0178646835894009,-0.0275008440655117,0.0425287156049399,0.674060173861389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK9,Proprotein convertase subtilisin/kexin type 9,36446,0.0104990762729034,0.0249941941902778,-0.0384895443400411,0.0594876968858478,0.674453627204098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREG1,Protein CREG1,36288,-0.0104149088404157,0.0248096161579854,-0.0590417565100672,0.0382119388292357,0.674649225538194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIM1,Cysteine-rich motor neuron 1 protein,36403,-0.00557097670111757,0.013286891600261,-0.0316132842376292,0.020471330835394,0.675021320950289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD209,CD209 antigen,36370,-0.0103687127486807,0.0247690296543413,-0.0589160108711897,0.0381785853738283,0.675509303642419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XPNPEP2,Xaa-Pro aminopeptidase 2,36397,0.0261851947470098,0.0628066520113447,-0.0969158431952258,0.149286232689245,0.676751148879887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RHOC,Rho-related GTP-binding protein RhoC,36252,-0.0310550441892707,0.0745321566566888,-0.177138071236381,0.115027982857839,0.676935116737471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC7A,C-type lectin domain family 7 member A,36442,-0.0159860693388129,0.0383959124813257,-0.0912420578022113,0.0592699191245855,0.677167549615108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK13,Mitogen-activated protein kinase 13,35206,0.0115015681483901,0.027643431359765,-0.0426795573167493,0.0656826936135295,0.677374541840518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD8,Ly6/PLAUR domain-containing protein 8,36225,-0.0132514857292942,0.0318682549452378,-0.0757132654219603,0.0492102939633719,0.677553771210956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPHOSPH8,M-phase phosphoprotein 8,36249,-0.0200961975857815,0.048347381941987,-0.114857066192076,0.074664671020513,0.677669567699334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B4,Protein ATP1B4,35206,-0.0107253037590827,0.0258302000213305,-0.0613524958008905,0.039901888282725,0.677993179733507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS27,Serine protease 27,36342,0.0106423965877783,0.0256539607920778,-0.0396393665646941,0.0609241597402507,0.678268417610141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANPEP,Aminopeptidase N,36397,0.00741259462597506,0.0178902346494398,-0.027652265286927,0.0424774545388771,0.678639311402173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFB,Vascular endothelial growth factor B,35239,-0.00773748449845182,0.018687409605134,-0.0443648073245144,0.0288898383276108,0.678853646808881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIP2,Cysteine-rich protein 2,36297,0.0098003317319418,0.0236739581495115,-0.0366006262411008,0.0562012897049844,0.678907856725641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC42BPB,Serine/threonine-protein kinase MRCK beta,35402,-0.0265282990269119,0.0640903944536594,-0.152145472156084,0.0990888741022604,0.67894696161982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCB,Tubulin-folding cofactor B,36297,-0.0263242472128999,0.0636104332073521,-0.15100069629931,0.0983522018735103,0.679007172609619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",36227,-0.0301581141912316,0.0729127783472314,-0.173067159751805,0.112750931369342,0.679165730375945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG6,Large proline-rich protein BAG6,36249,-0.00938442416485268,0.0228118462461005,-0.0540956428072096,0.0353267944775043,0.680803621451076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,36331,0.024472011725574,0.0596388543394539,-0.0924201427797556,0.141364166230904,0.681571278305895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGH,Gamma-glutamyl hydrolase,36255,0.00894669403540731,0.0218158570483944,-0.0338123857794456,0.0517057738502603,0.681744662710752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PER3,Period circadian protein homolog 3,35239,-0.0315964982152042,0.0771894368206873,-0.182887794383751,0.119694797953343,0.68230681444533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAD,Chondroadherin,35312,0.0133186272457899,0.0325543315771996,-0.0504878626455213,0.0771251171371011,0.682465940821081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH4,Cadherin-4,35212,-0.0123396644791736,0.0302526603639793,-0.071634878792573,0.0469555498342258,0.683371205509016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCNA,Proliferating cell nuclear antigen,35206,-0.0167859436083947,0.0413367202942347,-0.0978059153850947,0.0642340281683054,0.684699548550252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTBS,Di-N-acetylchitobiase,35327,0.00666803637684299,0.0164822782716846,-0.0256372290356588,0.0389733017893448,0.68581659591739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL5,ADAMTS-like protein 5,35420,0.0101123270420271,0.0249993303849429,-0.0388863605124609,0.0591110145965151,0.68585609392933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAB2,Disabled homolog 2,36427,-0.0284156598685783,0.070273333757701,-0.166151394033672,0.109320074296516,0.685960649848998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT14,"Keratin, type I cytoskeletal 14",35977,-0.00715705063381022,0.0177479635019473,-0.041943059097627,0.0276289578300066,0.686769390166207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35391,-0.0117645278019741,0.0292002432252597,-0.0689970045234832,0.0454679489195349,0.687041992922895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEO1,RNA polymerase-associated protein LEO1,35417,-0.00876759235583445,0.0217641568804917,-0.0514253398415982,0.0338901551299294,0.687075735084804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNDP1,Beta-Ala-His dipeptidase,36410,-0.011981893473004,0.0297663436517023,-0.0703239270303405,0.0463601400843324,0.687304772245804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAMPT,Nicotinamide phosphoribosyltransferase,36225,-0.0142788772822196,0.0355287319109117,-0.0839151918276066,0.0553574372631673,0.687772325844718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLGN,Calmegin,35275,0.0114389256708222,0.0284936555442477,-0.0444086391959033,0.0672864905375476,0.688099135744621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP2,Src kinase-associated phosphoprotein 2,36403,0.0267485247730189,0.0666819465366782,-0.10394809043887,0.157445139984908,0.688331936320414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALY,RNA-binding protein Raly,35391,0.0126364688566548,0.0315099840231365,-0.0491230998286927,0.0743960375420023,0.688411396659541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMA1,Proteasome subunit alpha type-1,36225,0.0114612380707763,0.0287055489258199,-0.0448016378238307,0.0677241139653833,0.689707075171642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTLC1,Serine palmitoyltransferase 1,35416,-0.0098482723838301,0.024705374290073,-0.0582708059923732,0.038574261224713,0.690180455863934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3,"TNF receptor-associated factor 3, Isoform 2",35239,0.00909116836228556,0.0228506071727657,-0.0356960216963352,0.0538783584209063,0.690753055414303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH3,Neurexophilin-3,35239,0.0075251943037833,0.0189543534522793,-0.0296253384626842,0.0446757270702507,0.691369183212851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,35232,-0.00861267470942422,0.0217085020941337,-0.0511613388139263,0.0339359893950778,0.691571740583399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GJA8,Gap junction alpha-8 protein,35206,0.0156714257874075,0.0396558651702848,-0.0620540699463506,0.0933969215211656,0.69271995976559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERI1,3'-5' exoribonuclease 1,35321,0.00877687917840677,0.0222245593401798,-0.0347832571283456,0.0523370154851591,0.692917130658865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",36184,-0.0120033745591734,0.0304705936578228,-0.0717257381285061,0.0477189890101592,0.693642469036721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN1,Tetraspanin-1,36249,0.0168390547347387,0.0428211879520668,-0.0670904736513123,0.10076858312079,0.69415323520495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX6,Peroxiredoxin-6,36427,-0.015139615911483,0.0385627943459988,-0.0907226928296407,0.0604434610066746,0.694629135487397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRB,Platelet-derived growth factor receptor beta,36446,-0.008498140292443,0.0218536100900807,-0.0513312160690011,0.0343349354841151,0.697386205342595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER2,Low affinity immunoglobulin epsilon Fc receptor,36382,0.0127876117287427,0.0329909018687015,-0.0518745559339122,0.0774497793913976,0.698315959136169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP2,Neuropilin-2,36382,-0.00723515336139162,0.0186694165802938,-0.0438272098587675,0.0293569031359843,0.698367649066388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,35275,-0.0113819179327156,0.0293778695674403,-0.0689625422848985,0.0461987064194674,0.698450199062134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARTN,Artemin,36227,-0.0110204531747255,0.0284796264391375,-0.0668405209954349,0.044799614645984,0.698798128565392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRB1,Chymotrypsinogen B,36382,0.0142092164173733,0.0368109800575419,-0.0579403044954088,0.0863587373301554,0.699504509372138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MST1,Hepatocyte growth factor-like protein,35326,-0.0158130830014805,0.0410232075822527,-0.0962185698626958,0.0645924038597348,0.699904998097456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,36352,-0.0247952904199107,0.0643466783105632,-0.150914779908615,0.101324199068793,0.699997654240211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMVK,Phosphomevalonate kinase,36178,0.0265885788592788,0.0691955940374533,-0.10903478545413,0.162211943172687,0.700803020770571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDR,Vascular endothelial growth factor receptor 2,36397,0.00606903972654706,0.0158713735602726,-0.0250388524515872,0.0371769319046814,0.70218408053222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN9,Septin-9,36331,-0.00703668486242721,0.0184024504841064,-0.0431054878112758,0.0290321180864213,0.70219268824843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPCAT2,Lysophosphatidylcholine acyltransferase 2,36331,0.0106122376936712,0.0277661004934202,-0.0438093192734324,0.0650337946607747,0.702323491339875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35402,0.00974710099091048,0.02550403719001,-0.0402408119015091,0.05973501388333,0.702341866586691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5R2,NADH-cytochrome b5 reductase 2,35334,-0.0136243936248434,0.035650361547719,-0.0834991022583726,0.0562503150086858,0.702350684505437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTNL10,Butyrophilin-like protein 10,35206,0.00940998254237054,0.0246309428926799,-0.038866665527282,0.0576866306120231,0.702445887247016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35448,0.00453204642768113,0.011863491082446,-0.018720396093913,0.0277844889492753,0.702462287792292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIN2,Bridging integrator 2,36382,0.0218284792305208,0.0572347089996342,-0.0903515504087623,0.134008508869804,0.702928606366402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY6D,Lymphocyte antigen 6D,36338,-0.00975269577072037,0.0255777752354796,-0.0598851352322604,0.0403797436908196,0.702995181294994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C8B,Complement component C8 beta chain,35448,-0.00722731831951221,0.0189604541842735,-0.0443898085206883,0.0299351718816639,0.703083717031715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C4BPB,C4b-binding protein beta chain,36397,0.0096923833424553,0.0255925038088845,-0.0404689241229583,0.0598536908078689,0.70490724336954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOG,Myelin-oligodendrocyte glycoprotein,36427,0.00807688902568664,0.0213331299108345,-0.033736045599549,0.0498898236509223,0.704990253534817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,36414,0.00713197953493296,0.018858632847461,-0.0298309408460906,0.0440948999159565,0.7053071426581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC44A4,Choline transporter-like protein 4,35275,-0.0167656000429834,0.044341222716739,-0.103674396567792,0.070143196481825,0.705366427839302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIB,Peptidyl-prolyl cis-trans isomerase B,36366,-0.0223955154817438,0.0592544294749307,-0.138534197252608,0.0937431662891204,0.705475113424028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRV1,Adhesion G-protein coupled receptor V1,35212,0.0170360156504156,0.0451146691881466,-0.0713887359583517,0.105460767259183,0.705729280466365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6R,Interleukin-6 receptor subunit alpha,36347,-0.00819102885763186,0.0218544296819511,-0.051025711034256,0.0346436533189923,0.707820713090093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPM,Carboxypeptidase M,36387,0.00817368065220847,0.0218283676859873,-0.0346099200123267,0.0509572813167437,0.708078939179864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGMN,Legumain,36403,-0.00836748989139908,0.0225105195732614,-0.0524881082549915,0.0357531284721933,0.710116241406548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM2,Isthmin-2,35438,-0.00962581160680413,0.0260351736841714,-0.0606547520277801,0.0414031288141718,0.711601171157618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP2,E3 SUMO-protein ligase RanBP2,35212,-0.00762846566869429,0.020658554497523,-0.0481192324838393,0.0328623011464507,0.711943760050964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3,Microfibril-associated glycoprotein 3,36249,0.0114705721400345,0.031072483855845,-0.0494314962174218,0.0723726404974907,0.712023049205153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFT20,Intraflagellar transport protein 20 homolog,35275,-0.0100670222162629,0.0273003986377113,-0.063575803546177,0.0434417591136512,0.712326907576795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPCAL1,Hippocalcin-like protein 1,36442,-0.017220950352551,0.0467554199468303,-0.108861573448338,0.0744196727432365,0.712645492171735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3E,T-cell surface glycoprotein CD3 epsilon chain,35321,-0.00868572081392373,0.0236360140698795,-0.0550123083908875,0.03764086676304,0.713275013665912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEMP1,Mast cell-expressed membrane protein 1,35239,0.02079988343956,0.0566634249521828,-0.0902604294667183,0.131860196345838,0.71357386067479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI2,Serpin I2,35402,-0.0130758344615666,0.0357117470580052,-0.0830708586952568,0.0569191897721237,0.714266080197688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35416,-0.0222647013843246,0.0608763184758343,-0.14158228559696,0.0970528828283106,0.714574021184014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT1,Glutathione hydrolase 1 proenzyme,36372,-0.011732858956465,0.032256005305446,-0.0749546293551391,0.0514889114422091,0.716061503781754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS2,Growth arrest-specific protein 2,35321,-0.0118951171585088,0.0327118275900327,-0.0760102992349729,0.0522200649179554,0.716144235313526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOF,Apolipoprotein F,35428,0.00535681397120567,0.0147772902012621,-0.0236066748232681,0.0343203027656794,0.716988372462196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,35214,-0.010531187317486,0.0290536117066389,-0.0674762662624982,0.0464138916275262,0.717010355898109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRAP,BRCA1-associated protein,35344,-0.0242749792820637,0.0681734957568222,-0.157895030965435,0.109345072401308,0.721795494689858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPGR,X-linked retinitis pigmentosa GTPase regulator,35275,0.00925422633308186,0.0260144925612187,-0.0417341790869068,0.0602426317530705,0.722052498376893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSNL1,Visinin-like protein 1,35416,0.00852552717886906,0.023971651543037,-0.0384589098454835,0.0555099642032216,0.722114459759211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI4,Protein-arginine deiminase type-4,36182,-0.0173825312106908,0.0489602268744924,-0.113344575884696,0.0785795134633143,0.722575048405825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNA4,Plexin-A4,36352,-0.0184745546373283,0.052083554733023,-0.120558321914053,0.0836092126393969,0.722817352235725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3G,T-cell surface glycoprotein CD3 gamma chain,35239,-0.020019317422752,0.0565450397415333,-0.130847595316157,0.0908089604706533,0.723319775990419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REPS1,RalBP1-associated Eps domain-containing protein 1,35239,0.00874921448345434,0.0248419304283045,-0.0399409691560225,0.0574393981229312,0.724703977901574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNU13,NHP2-like protein 1,35214,-0.0144077119934776,0.0411777576733754,-0.0951161170332935,0.0663006930463382,0.726433011579267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,36225,-0.00972029855364548,0.0277998501817409,-0.0642080049098575,0.0447674078025666,0.726609668887377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX6,Syntaxin-6,36225,0.0146119487619139,0.0417904306103844,-0.0672972952344395,0.0965211927582673,0.726613206414924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RA,Interleukin-17 receptor A,36382,0.00980779520416741,0.0280575758062404,-0.0451850533760638,0.0648006437843986,0.726679469135534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RA,Interleukin-20 receptor subunit alpha,36227,-0.00983439125843838,0.0281346731788955,-0.0649783506890736,0.0453095681721968,0.726689140635204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKZF2,Zinc finger protein Helios,36225,-0.019384237879677,0.0555776893605084,-0.128316509026273,0.0895480332669195,0.72726693046038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FYB1,FYN-binding protein 1,36367,-0.0203585402519892,0.0584854828820061,-0.134990086700721,0.0942730061967427,0.727778590624233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,36227,-0.00940724321657357,0.027047787566145,-0.0624209068462177,0.0436064204130705,0.728000167765039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL2,Interferon lambda-2,35212,-0.0135566052233241,0.0390076181948494,-0.090011536885229,0.0628983264385808,0.728199799011905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCAT,Phosphatidylcholine-sterol acyltransferase,35428,0.00471371458186871,0.013572005857042,-0.0218874168979336,0.031314846061671,0.728368988393952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB2,Carboxypeptidase B2,35438,0.00492072439825019,0.014200184886631,-0.0229116379795465,0.0327530867760469,0.728959593943479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB5,Integrin beta-5,36397,-0.00841639192972863,0.0242973406932777,-0.0560391796885529,0.0392063958290956,0.729058641055345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRAS,GTPase Hras,35310,-0.0225279631759575,0.0651451095927486,-0.150212377977745,0.10515645162583,0.729495871090792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNF1A,Hepatocyte nuclear factor 1-alpha,35275,0.0148743464538071,0.0431084866015489,-0.0696182872852286,0.0993669801928429,0.730072845729742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,36352,0.0087964839868303,0.02552125060476,-0.0412251671984993,0.0588181351721599,0.730350404247955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,35214,0.0111485159465869,0.0324170899436599,-0.0523889803429865,0.0746860122361602,0.73092703681558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC12A2,Solute carrier family 12 member 2,35214,0.00537474642103109,0.0156869465530965,-0.025371668823038,0.0361211616651002,0.731892249127302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYAR,Cell growth-regulating nucleolar protein,36225,-0.0120829580388041,0.0354368983379075,-0.0815392787811028,0.0573733627034946,0.733135529928614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN1,Nectin-1,35239,-0.00719340770981379,0.0211563227318093,-0.04865980026416,0.0342729848445324,0.733859158363385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAV3,Guanine nucleotide exchange factor VAV3,35212,-0.0210721339476244,0.0620876334218419,-0.142763895454435,0.100619627559186,0.734325221323473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA2,GDNF family receptor alpha-2,36331,0.00457409772737623,0.0134791846178603,-0.0218451041236299,0.0309932995783824,0.734359617382635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3A,Sodium channel protein type 3 subunit alpha,35275,0.00759491270755443,0.0225060115057033,-0.0365168698436241,0.0517066952587329,0.735780667422756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REXO2,"Oligoribonuclease, mitochondrial",35214,0.0106351459346104,0.0316090420307818,-0.051318576445722,0.0725888683149427,0.736536509333815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC4,Syndecan-4,36360,0.0100272781512657,0.0298233148222032,-0.0484264189002527,0.068480975202784,0.736712711829891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS28,Vacuolar protein sorting-associated protein 28 homolog,35321,-0.0137114691934839,0.041048579840779,-0.0941666856814108,0.066743747294443,0.738368130875844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF31,E3 ubiquitin-protein ligase RNF31,35239,0.00699822752450944,0.0209805692166776,-0.0341236881401787,0.0481201431891976,0.738725015284972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35321,-0.0111441716673469,0.033451819543399,-0.0767097379724091,0.0544213946377152,0.739039271914792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,35206,0.0139668986006949,0.0419521491340744,-0.0682593137020909,0.0961931109034807,0.739202877792197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA2,Carboxypeptidase A2,36405,0.0140589341553247,0.0422720206293207,-0.0687942262781438,0.0969120945887933,0.73945912525159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OFD1,Oral-facial-digital syndrome 1 protein,35321,0.0132997117469676,0.0401720891989448,-0.0654375830829642,0.0920370065768994,0.74060409561341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD58,Lymphocyte function-associated antigen 3,36361,0.0036835999512637,0.0111445144608009,-0.0181596483919061,0.0255268482944335,0.741008946976367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7orf50,Uncharacterized protein C7orf50,35416,-0.0049655337409414,0.0150397675891437,-0.034443478215663,0.0245124107337802,0.741289979937854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIGYF2,GRB10-interacting GYF protein 2,35417,-0.0156516969219091,0.0474183276446774,-0.108591619105477,0.0772882252616586,0.741352930648893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL19,C-C motif chemokine 19,36428,0.0274603684860701,0.0832209964213384,-0.135652784499753,0.190573521471893,0.741432763174949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT1,Angiopoietin-1,36337,0.0175674754517741,0.0533431232649638,-0.086985046147555,0.122119997051103,0.74191614403528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP3R1,Calcineurin subunit B type 1,36297,-0.00857822854181183,0.0261263740740004,-0.0597859217268526,0.042629464643229,0.742667323659299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TADA3,Transcriptional adapter 3,35391,-0.00812596074145702,0.0248453551914974,-0.0568228569167918,0.0405709354338778,0.743632368070689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1GALT1C1,C1GALT1-specific chaperone 1,35214,-0.00682823203556695,0.0209359192930662,-0.0478626338499767,0.0342061697788428,0.744322857742059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLINT1,Clathrin interactor 1,35206,-0.00994177445690164,0.0305143898814251,-0.0697499786244949,0.0498664297106916,0.744582399828852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP6,Insulin-like growth factor-binding protein 6,36345,-0.00659160665397795,0.0203111081259656,-0.0464013785808706,0.0332181652729147,0.745544713393109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2,Granulocyte-macrophage colony-stimulating factor,35214,0.00751457757017623,0.0231941936523376,-0.0379460419884055,0.052975197128758,0.745960425790779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC80,Coiled-coil domain-containing protein 80,36360,-0.00780089926413233,0.0241247026038758,-0.0550853163677289,0.0394835178394642,0.746434081230513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F10,Coagulation factor X,35428,0.00554125962802711,0.0171493841114184,-0.0280715332303529,0.0391540524864072,0.746617381448657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRAP2,GRB2-related adapter protein 2,36360,-0.0262834415953546,0.0815848049007972,-0.186189659200917,0.133622776010208,0.747340132600116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAL,Galanin peptides,36403,-0.0132162386917426,0.0410850462379281,-0.0937429293180816,0.0673104519345964,0.747704438493714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX3,Probable E3 ubiquitin-protein ligase DTX3,36331,-0.0051370578155033,0.0160170549188165,-0.0365304854563837,0.0262563698253771,0.748428763896636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GART,Trifunctional purine biosynthetic protein adenosine-3,35417,-0.00522067907539167,0.0162892070848721,-0.037147524961741,0.0267061668109577,0.748600640327761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR3,Anterior gradient protein 3,36204,0.0121720178826006,0.0381268817771929,-0.0625566704006975,0.0869007061658987,0.749546240934307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LXN,Latexin,36261,-0.0142575501633806,0.0447244226994586,-0.101917418654319,0.0734023183275582,0.749897701756683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL33,Interleukin-33,36227,-0.00790010045810966,0.0247825561930871,-0.0564739105965604,0.0406737096803411,0.749905345583632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYT1,Synaptotagmin-1,35416,-0.00837850158317213,0.026284651854454,-0.059896419217902,0.0431394160515578,0.749919040246199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GKN1,Gastrokine-1,36053,-0.0055650985171746,0.017475613030685,-0.0398173000573172,0.028687103022968,0.750153765495575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM1,Probable carboxypeptidase X1,36397,-0.0141297961140248,0.0444709667331279,-0.101292890910956,0.0730332986829059,0.750698351305533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPY,Pro-neuropeptide Y,36427,0.0129731323137791,0.0408345713200364,-0.0670626274734923,0.0930088921010504,0.750721886412943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EREG,Proepiregulin,36290,-0.0160807308125251,0.0506232001330786,-0.115302203073359,0.083140741448309,0.750755723462957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ORM1,Alpha-1-acid glycoprotein 1,35431,-0.0040698203496994,0.0128296521122092,-0.0292159384896294,0.0210762977902306,0.751087405237433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLU,Clusterin,35448,-0.00646754700230369,0.0204133766555711,-0.0464777652472231,0.0335426712426157,0.751384033938065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15RA,Interleukin-15 receptor subunit alpha,36227,-0.00717434675146016,0.0226841933675746,-0.0516353657519064,0.0372866722489861,0.751806399774799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT5,"Keratin, type II cytoskeletal 5",36191,0.0099110987559787,0.0313691663249225,-0.0515724672408694,0.0713946647528268,0.752049625682163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRAL,GDNF family receptor alpha-like,35242,0.0123824309629778,0.0392858768298933,-0.0646178876236131,0.0893827495495687,0.752629905820469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN5,CCN family member 5,36382,-0.00758509316593345,0.0240891607763841,-0.0547998482876463,0.0396296619557794,0.752865115186274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANF,Mesencephalic astrocyte-derived neurotrophic factor,36403,0.0238843385270364,0.0758554409120433,-0.124792325660569,0.172561002714641,0.752872117238649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRC1,Protein regulator of cytokinesis 1,35391,0.00843378329206995,0.0268695247444117,-0.044230485206977,0.0610980517911169,0.753623399872107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXTL1,Exostosin-like 1,35214,-0.00952640324867404,0.0304282269910446,-0.0691657281511215,0.0501129216537734,0.754232378370399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC9,Histone deacetylase 9,35212,-0.0130366477232907,0.0416799253300744,-0.0947293013702366,0.0686560059236552,0.754458636857118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXL,Tyrosine-protein kinase receptor UFO,36410,-0.00552410861333393,0.0177587799916025,-0.0403313173968749,0.0292831001702071,0.755761318367487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH7B,Myosin-7B,35206,0.00880877617832554,0.0285191559404068,-0.0470887694648717,0.0647063218215228,0.757429400801316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA12,Serpin A12,36164,-0.0203353898787042,0.065844628545562,-0.149390861828006,0.108720082070597,0.757453223706942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRG2,Developmentally-regulated GTP-binding protein 2,36331,-0.011139517994546,0.0361145714032765,-0.081924077944968,0.059645041955876,0.757749397141273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,36428,-0.01025562385317,0.0332552895733046,-0.0754359914168471,0.0549247437105071,0.757793895692889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPP,"Alkaline phosphatase, placental type",36331,-0.0197707886869629,0.064266557253385,-0.145733240903598,0.106191663529672,0.758367328502634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,36442,-0.0192111566850682,0.0624604903910611,-0.141633717851548,0.103211404481412,0.758416150350761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP2,Cysteine-rich secretory protein 2,36427,-0.0115331147822416,0.0376505589128894,-0.0853282102515049,0.0622619806870216,0.759369918969571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,36421,-0.00676278061351516,0.0221617132372452,-0.0501997385585158,0.0366741773314855,0.76025610067516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES2,Cocaine esterase,36331,0.0108212105405401,0.035533532953237,-0.0588245140478044,0.0804669351288846,0.760729080807315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH5,Cadherin-5,36446,-0.00585645276536181,0.0192940742614294,-0.0436728383177634,0.0319599327870398,0.761489861958197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDN1,Endothelin-1,35281,-0.00584118401396448,0.0192638871333323,-0.0435984027952958,0.0319160347673668,0.761733039093001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACSTD2,Tumor-associated calcium signal transducer 2,35520,-0.0061812836101926,0.0204304002623118,-0.0462248681243236,0.0338623009039384,0.762240308329976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX39A,ATP-dependent RNA helicase DDX39A,35239,0.00428708219500708,0.0141772135330731,-0.0235002563298162,0.0320744207198304,0.762363320774769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN3,Calsyntenin-3,35416,-0.00571626900882504,0.0189071359989401,-0.0427742555667476,0.0313417175490975,0.762407609915301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,36297,-0.0151650283204781,0.0502272092005862,-0.113610358353627,0.0832803017126709,0.76271537243947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH12,Protocadherin-12,35417,-0.00481591037996651,0.0159943793287123,-0.0361648938642426,0.0265330731043096,0.763348168947909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP3,Syntaxin-binding protein 3,36225,-0.00847620059669683,0.0281582676182452,-0.0636664051284575,0.0467140039350638,0.763408175130232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR2,Fibroblast growth factor receptor 2,36397,-0.00431413371726057,0.0143384088568022,-0.0324174150765929,0.0237891476420717,0.763515044395335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP2,Guanylate-binding protein 2,36227,0.0115668460111715,0.0384436724903306,-0.0637827520698766,0.0869164440922195,0.763516605045407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5A,Eukaryotic translation initiation factor 5A-1,36227,-0.00571143809358677,0.0190475054481327,-0.0430445487719269,0.0316216725847533,0.764298690530201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON1,Serum paraoxonase/arylesterase 1,35428,0.00513678400599705,0.0171373503731428,-0.0284524227253629,0.038725990737357,0.764383937889745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2B3,SH2B adapter protein 3,36225,-0.0186506832878554,0.0622672479866744,-0.140694489341737,0.103393122766026,0.764547301856361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM20A,Pseudokinase FAM20A,35420,-0.00541050934666352,0.0181491883099147,-0.0409829184340963,0.0301618997407693,0.765626851886403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD1,Glutamate decarboxylase 1,35206,-0.00501055525672804,0.0168450190910345,-0.0380267926751557,0.0280056821616996,0.766133056563469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL5,C-C motif chemokine 5,36410,-0.0188106142107978,0.0632634984577831,-0.142807071188053,0.105185842766457,0.766217368469671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL3A1,Collagen alpha-1(III) chain,35438,0.00427187190055304,0.0144058368299891,-0.0239635682862256,0.0325073120873316,0.766829439592334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RB,Interleukin-20 receptor subunit beta,35239,-0.00781591340505758,0.0264244443642849,-0.0596078243590559,0.0439759975489407,0.767405619819738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT,Linker for activation of T-cells family member 1,36442,-0.0139666611159016,0.0476472022117236,-0.10735517745088,0.0794218552190766,0.769433797502931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA3,Glutathione S-transferase A3,36225,-0.0144098725792638,0.0493080575003539,-0.111053665279957,0.0822339201214299,0.770110421735331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP7,Dipeptidyl peptidase 2,36295,-0.0110847253286886,0.0383279006740293,-0.0862074106497859,0.0640379599924087,0.772430856013463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD207,C-type lectin domain family 4 member K,36204,0.00737092992787859,0.0255487048334544,-0.042704531545692,0.0574463914014492,0.772968708676964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC13A1,Solute carrier family 13 member 1,35391,-0.011117214166055,0.0385532173423218,-0.0866815201570057,0.0644470918248957,0.773080660218198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POMC,Pro-opiomelanocortin,35281,-0.013000948428999,0.0451431435216628,-0.101481509731458,0.07547961287346,0.773361238962305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPTP,Ceramide-1-phosphate transfer protein,35214,-0.00696232910198192,0.0242612477719346,-0.0545143747349737,0.0405897165310099,0.774142679667945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35321,-0.0201284795794471,0.0702514976511499,-0.157821414975701,0.117564455816807,0.77448934192935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOC1,Apolipoprotein C-I,35438,0.00679734149276396,0.0237913216134622,-0.039833648869622,0.05342833185515,0.775112201397622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS53,Vacuolar protein sorting-associated protein 53 homolog,36331,0.0141125566827646,0.0494547186034727,-0.082818691780042,0.111043805145571,0.775374179940802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRN1,Secernin-1,36352,-0.00999007294391679,0.0350234244822595,-0.0786359849291454,0.0586558390413118,0.775468719076845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPING1,Plasma protease C1 inhibitor,35438,-0.00337058207900752,0.011820451803919,-0.0265386676146887,0.0197975034566736,0.775539962558944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC1,"Myosin-binding protein C, slow-type",35420,-0.0128777961832866,0.0452023957742839,-0.101474491900883,0.0757188995343098,0.775736441416159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,35239,-0.0105540755397493,0.0370875101448092,-0.0832455954235753,0.0621374443440767,0.77598163532956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QL2,Complement C1q-like protein 2,35239,-0.00818673953631349,0.0287799525117922,-0.0645954464594261,0.0482219673867991,0.776067780523662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35417,-0.0190294618205751,0.0669294269058304,-0.150211138556003,0.112152214914853,0.776173622527914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USO1,General vesicular transport factor p115,36331,0.0162283130611333,0.0570804910963877,-0.0956494494877867,0.128106075610053,0.776184311490327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTN3,Myeloblastin,36178,0.00914182565510738,0.0323723810456547,-0.0543080411943758,0.0725916925045905,0.777648374597024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF830,Zinc finger protein 830,35391,0.0134505149635105,0.0477292102741922,-0.0800987371739062,0.106999767100927,0.77809947675363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSND,Barttin,35206,-0.00592107342267552,0.0210469239099379,-0.0471730442861538,0.0353308974408027,0.778469086073975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NADK,NAD kinase,36360,-0.0103259734418463,0.036732249238014,-0.0823211819483536,0.0616692350646611,0.778630580029307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNAR1,Interferon alpha/beta receptor 1,35402,0.0045926793753181,0.0163381080491391,-0.0274300124009946,0.0366153711516308,0.778641322872311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35420,-0.0130806963023113,0.0466419919327539,-0.104499000490509,0.0783376078858863,0.779142426737157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CINP,Cyclin-dependent kinase 2-interacting protein,35321,0.00795850853207141,0.0285011247796293,-0.0479036960360021,0.0638207131001449,0.780073992049646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNH2,Potassium voltage-gated channel subfamily H member 2,35275,-0.0139668287411151,0.0500677802926513,-0.112099678114712,0.0841660206324815,0.780286222732883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRUNE2,Protein prune homolog 2,35321,0.00505528719950285,0.0182516593714075,-0.0307179651684559,0.0408285395674615,0.781807222156092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHBP,Corticotropin-releasing factor-binding protein,36368,-0.00489530559234858,0.0177755366841867,-0.0397353574933544,0.0299447463086573,0.783020212196718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPL,Periplakin,35239,-0.00550985455770313,0.0200269634528767,-0.0447627029253415,0.0337429938099352,0.783232053869345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RAP,Interleukin-1 receptor accessory protein,36382,0.00792686390053699,0.0288779939205246,-0.0486740041836912,0.0645277319847652,0.783712161568748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G7,Platelet-activating factor acetylhydrolase,36382,-0.00574048975182654,0.02092651320911,-0.0467564556416821,0.035275476138029,0.783849218960446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP13,Dual specificity protein phosphatase 13 isoform A,35391,0.00728922115651925,0.0265891347112906,-0.0448254828776104,0.0594039251906489,0.783983982834049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3,Galectin-3,36376,-0.00512328670955832,0.0187062078681147,-0.0417874541310631,0.0315408807119465,0.784183464988986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA1,Annexin A1,35278,0.00772167058718834,0.0282376022386693,-0.0476240298006034,0.0630673709749801,0.784513929965245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD2,Sushi domain-containing protein 2,36382,0.00495817766166238,0.018135056287347,-0.0305865326615378,0.0405028879848625,0.784551349875561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR2,Complement factor H-related protein 2,35404,0.0100286027617637,0.0366985297885193,-0.0619005156237342,0.0819577211472616,0.784654855462419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP10,Stromelysin-2,36350,0.0100954300616909,0.036950517608737,-0.0623275844514336,0.0825184445748154,0.784695951067371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLR1,Oxidized low-density lipoprotein receptor 1,36282,0.0103833598673828,0.0380883643741157,-0.0642698343058839,0.0850365540406495,0.785159131531402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NINJ1,Ninjurin-1,36225,0.0090908100972875,0.0333813535464834,-0.05633664285382,0.0745182630483951,0.785374765716184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YAP1,Transcriptional coactivator YAP1,35416,-0.00491955107150573,0.018104517029117,-0.040404404448575,0.0305653023055635,0.785838194902044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FASLG,Tumor necrosis factor ligand superfamily member 6,36442,0.00634284739279593,0.0234393098157018,-0.0395981998459796,0.0522838946315715,0.78670081705723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,35214,0.0114166614297477,0.0422839427707505,-0.0714598664009232,0.0942931892604187,0.787169565137148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSE,Cathepsin E,35312,-0.00882406579143409,0.0326851312232601,-0.0728869229890239,0.0552387914061557,0.787191005206615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4A,C-type lectin domain family 4 member A,36352,0.0060963154567409,0.0226285576120518,-0.0382556574628807,0.0504482883763625,0.787623461642545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,36225,0.0144822021643538,0.0539735491949349,-0.0913059542577185,0.120270358586426,0.788460607120497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBR1,T-box brain protein 1,35275,0.00831865669558242,0.0311245680994541,-0.0526854967793476,0.0693228101705124,0.789270510689791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CUZD1,CUB and zona pellucida-like domain-containing protein 1,35275,-0.00643299897690646,0.0241308614847807,-0.0537294874870766,0.0408634895332637,0.789795407063753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB1,Lamin-B1,35387,0.0107719041372854,0.0404240424038054,-0.0684592189741732,0.090003027248744,0.789884045399517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREBZF,CREB/ATF bZIP transcription factor,35206,0.00435057533104489,0.0163530481086622,-0.027701398961933,0.0364025496240228,0.790217035638746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAMD9L,Sterile alpha motif domain-containing protein 9-like,36352,-0.0121660369651493,0.0457693785403834,-0.101874018904301,0.0775419449740021,0.790391876385754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP85,Centrosomal protein of 85 kDa,36225,-0.0108726678861038,0.0409225801069651,-0.0910809248957554,0.0693355891235477,0.790486741906138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35417,0.011104630523565,0.0418083213414911,-0.0708396793057574,0.0930489403528875,0.790549813198163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARMCX2,Armadillo repeat-containing X-linked protein 2,35212,0.0103588155687801,0.0391947059367086,-0.0664628080671688,0.087180439204729,0.79156459666033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIFBP,KIF-binding protein,36331,-0.0138786580000179,0.0527176016246272,-0.117205157184287,0.0894478411842515,0.792354539255116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,35212,-0.0104132190531064,0.0395622242204207,-0.087955178525131,0.0671287404189181,0.792396838094347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL6,C-X-C motif chemokine 6,36442,0.0127454264708392,0.0486190908229802,-0.082547991542202,0.10803884448388,0.793214330850761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9,Complement component C9,35428,0.00874430458219409,0.0333950609411126,-0.0567100148623866,0.0741986240267748,0.793450175555984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,36191,-0.0184193527356522,0.0704284713447517,-0.156459156571366,0.119620451100061,0.793689384688342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB5,Serpin B5,36249,-0.00818563131150691,0.0314729488197151,-0.0698726109981484,0.0535013483751346,0.794806057251982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGA,Fibrinogen alpha chain,35299,-0.00505633847207692,0.0194863960111294,-0.0432496746538905,0.0331369977097367,0.795273326641267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRRT3,Proline-rich transmembrane protein 3,35281,0.0064272476893504,0.0247908118689165,-0.042162743573726,0.0550172389524268,0.795443973260978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA2,Glucosamine-6-phosphate isomerase 2,35312,-0.00594570128212219,0.0229983968195341,-0.051022559048409,0.0391311564841646,0.796009086863062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35378,-0.00494738576914383,0.0191832173968312,-0.0425464918669331,0.0326517203286454,0.796491298668023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK1,Kallikrein-1,36286,-0.0214246778129753,0.0831189267166019,-0.184337774177515,0.141488418551564,0.796600142453023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRF1,Killer cell lectin-like receptor subfamily F member 1,35239,-0.00748511595219123,0.0291165715010824,-0.0645535960943127,0.0495833641899303,0.797130332562242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE1,Plasminogen activator inhibitor 1,36446,0.0106482404502286,0.0415562931325251,-0.0708020940895206,0.0920985749899777,0.797775469271221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL4,C-C motif chemokine 4,36385,0.0116278458147962,0.0454066623796117,-0.0773692124492427,0.100624904078835,0.797894558223827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN1,Calsyntenin-1,36191,0.00837428986042478,0.0327109408463503,-0.0557391541984218,0.0724877339192714,0.79795154100557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB116,Beta-defensin 116,35212,-0.0122538624703299,0.0478988221659662,-0.106135553915624,0.0816278289749639,0.79809235403527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO1,Roundabout homolog 1,36381,-0.00400970623096705,0.0157311267772979,-0.0348427147144709,0.0268233022525368,0.798815386139174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX101,Testis-expressed protein 101,35275,-0.00834572679688301,0.0327769705872992,-0.0725885891479894,0.0558971355542234,0.799023934808239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1B,5-hydroxytryptamine receptor 1B,35212,0.00711718018067708,0.0280513906435225,-0.0478635454806269,0.0620979058419811,0.799721062917101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAL,Integrin alpha-L,35239,0.00701506939914101,0.0276662796558597,-0.0472108387263441,0.0612409775246261,0.799843914874764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,36225,0.015681503947602,0.0619424164904181,-0.105725632373617,0.137088640268822,0.800149958372696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT1,NAD-dependent protein deacetylase sirtuin-1,35239,0.0133065270114654,0.0526223776998654,-0.0898333332802707,0.116446387303202,0.800378645921649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,35312,-0.0100041677355501,0.0398066844295544,-0.0880252692174767,0.0680169337463764,0.801576090047769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFLAM,Pikachurin,35402,-0.0050844733825142,0.020259543020994,-0.0447931777036625,0.0346242309386341,0.801848056750579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN8,Tetraspanin-8,35402,0.0163720177456144,0.0652673189170224,-0.111551927331749,0.144295962822978,0.801941810380601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPN3,Calpain-3,35391,0.00585278088241963,0.0233930900643342,-0.0399976756436754,0.0517032374085147,0.802446606749636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D23,TBC1 domain family member 23,36331,0.0143150368585385,0.0572179309300657,-0.0978321077643902,0.126462181481467,0.802451907269819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ID4,DNA-binding protein inhibitor ID-4,35321,-0.00698573556128195,0.0279230711014677,-0.0617149549201586,0.0477434837975947,0.802458155420459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED18,Mediator of RNA polymerase II transcription subunit 18,36225,0.0120549367473598,0.0483543456897478,-0.0827195808045458,0.106829454299265,0.803132840674067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM8,U6 snRNA-associated Sm-like protein LSm8,35321,0.0140964206642227,0.0566071359340957,-0.0968535657666048,0.12504640709505,0.803352131748392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSTN,Growth/differentiation factor 8,36249,-0.00850019670833858,0.0342650831188075,-0.0756597596212012,0.058659366204524,0.804086167336188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),M6PR,Cation-dependent mannose-6-phosphate receptor,35281,-0.00616226237177376,0.024849421583126,-0.0548671286747007,0.0425426039311532,0.804155045006756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,35275,0.00790112405389512,0.0319645104583055,-0.0547493164443836,0.0705515645521738,0.804773966109043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCP11,T-complex protein 11 homolog,35321,0.00879574566960356,0.0356468467505966,-0.0610720739615658,0.0786635653007729,0.805112444865456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF10,Tumor necrosis factor ligand superfamily member 10,36442,-0.00405919045401366,0.0164669242916063,-0.0363343620655621,0.0282159811575348,0.80529778492571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL1,Growth-regulated alpha protein,36365,0.015242188893025,0.0619475236727397,-0.106174957505545,0.136659335291595,0.805650560901613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REEP4,Receptor expression-enhancing protein 4,35417,0.0095548065882871,0.038839223179135,-0.0665700708428176,0.0856796840193918,0.805683216813853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB6,Serpin B6,36395,0.00902707027495598,0.036719244061583,-0.0629426480857467,0.0809967886356587,0.805812859375317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FES,Tyrosine-protein kinase Fes/Fps,36225,-0.00738157252591733,0.03006195305466,-0.066303000513051,0.0515398554612164,0.806041371818801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC34A3,Sodium-dependent phosphate transport protein 2C,35206,0.00751478622452749,0.0306076175147915,-0.0524761441044639,0.0675057165535189,0.806062104252212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1A,Interleukin-1 alpha,36227,0.00921828202221667,0.0375770945764215,-0.0644328233475695,0.0828693873920028,0.806218520073671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABL1,Tyrosine-protein kinase ABL1,36331,-0.0104175778630569,0.0425798511394992,-0.0938740860964754,0.0730389303703616,0.806726890562961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L1CAM,Neural cell adhesion molecule L1,36397,0.00456112331162595,0.0186544541896127,-0.032001606900015,0.0411238535232668,0.806846030644263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPACAM2,HEPACAM family member 2,35416,0.00653475757421915,0.0267386791078123,-0.045873053477093,0.0589425686255313,0.806934186030048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABO,Histo-blood group ABO system transferase,35428,-0.0222765929441388,0.091279803141663,-0.201185007101798,0.156631821213521,0.807202188877361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,36402,-0.0157555439768042,0.0647155683621419,-0.142598057966602,0.111086970012994,0.807657292746245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDAR,Tumor necrosis factor receptor superfamily member EDAR,36352,-0.0138870617655649,0.0572606232463931,-0.126117883328495,0.0983437597973657,0.808381295289231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3A,Uroplakin-3a,35212,-0.00779324115898929,0.0324197754243009,-0.071336000990619,0.0557495186726404,0.810039672136429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEF,Thyrotroph embryonic factor,35214,-0.00640534876759697,0.026653436684275,-0.058646084668776,0.0458353871335821,0.810090523783452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVALB,Parvalbumin alpha,36376,-0.0171856582000543,0.0715782079559489,-0.157478945793714,0.123107629393605,0.810262505585768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35391,-0.00578515817796142,0.0241684527829558,-0.0531553256325547,0.0415850092766319,0.810828029794207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZPR1,Zinc finger protein ZPR1,35212,-0.0148354781053695,0.0622652273269723,-0.136875323666235,0.107204367455496,0.811685499707354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7,Interleukin-7,36352,-0.00974801983544517,0.0411104887793222,-0.0903245778429167,0.0708285381720264,0.81257235579703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA8,Carbonic anhydrase-related protein,35239,0.00381182982893444,0.0160781964949969,-0.0277014353012595,0.0353250949591284,0.81260223053784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164L2,CD164 sialomucin-like 2 protein,35275,0.00544376089453484,0.0230001130923414,-0.0396364607664543,0.050523982555524,0.812909848805419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN7,Septin-7,35321,0.00809946621262623,0.0342417621588359,-0.0590143876186921,0.0752133200439446,0.813023396744221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRKL,Crk-like protein,36383,-0.0157321804625679,0.0666445271802737,-0.146355453735904,0.114891092810769,0.813391982651313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY1,Aminoacylase-1,36360,-0.00909533879409925,0.0386540244649652,-0.0848572267454311,0.0666665491572326,0.813981678287903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD226,CD226 antigen,35239,0.00612862476063235,0.0263633259881295,-0.0455434941761014,0.0578007436973661,0.816182552994911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRME1,Break repair meiotic recombinase recruitment factor 1,35212,-0.00586425526664133,0.0252766747882808,-0.0554065378516717,0.0436780273183891,0.81654385222586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA1A,Heat shock 70 kDa protein 1A,36396,-0.0104299537098678,0.0451559004019977,-0.0989355184977833,0.0780756110780476,0.817339587431836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,35312,0.00438885429196565,0.0191621580723447,-0.0331689755298299,0.0419466841137612,0.818847364217367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG4,Desmoglein-4,36307,0.00742578934412352,0.0324626599554732,-0.056201024168604,0.071052602856851,0.819070863043951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFA,Vascular endothelial growth factor A,36419,-0.00862071896572367,0.0377235353653411,-0.0825588482817922,0.0653174103503449,0.819245661059955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK8,Serine protease inhibitor Kazal-type 8,35214,0.00485745553103992,0.0212645892301082,-0.0368211393599721,0.0465360504220519,0.81932026112864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINC1,Antithrombin-III,35438,0.00217859845330794,0.00954319012298145,-0.0165260541877357,0.0208832510943516,0.819429611152432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAFA5,Chemokine-like protein TAFA-5,36331,-0.00548073822701454,0.0240758442243144,-0.0526693929066708,0.0417079164526417,0.819928990939859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSG,Alpha-2-HS-glycoprotein,35428,-0.00387323601108379,0.0171066275783974,-0.0374022260647427,0.0296557540425751,0.820884316037731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF2,Alpha-2-antiplasmin,35326,0.00197332264658097,0.00872865255065772,-0.0151348363527082,0.0190814816458701,0.821151289505234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK3,Prostate-specific antigen,35438,0.014039982883376,0.0623493568726566,-0.108164756587031,0.136244722353783,0.821844686529963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CABP2,Calcium-binding protein 2,35275,0.00922424658160992,0.041028820331246,-0.0711922412676322,0.089640734430852,0.822124069526993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP1,Secreted frizzled-related protein 1,36271,0.00630548667773439,0.0280583843843259,-0.0486889467155444,0.0612999200710132,0.822197865927036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEXN,Nexilin,35428,-0.00970001847339724,0.0432707090012268,-0.0945106081158018,0.0751105711690073,0.822631947188896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCS1,Neuronal calcium sensor 1,36427,-0.0040466450132914,0.0181334084764304,-0.039588125627095,0.0314948356005122,0.823417559699461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADRA2A,Alpha-2A adrenergic receptor,35214,-0.010005757845433,0.0449163526517618,-0.0980418090428861,0.0780302933520201,0.823726546666942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,36360,-0.00707794248881347,0.0318054466308117,-0.0694166178852044,0.0552607329075774,0.823900898700968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS53,Serine protease 53,35416,-0.00517417314488941,0.0233834073085214,-0.0510056514695914,0.0406573051798126,0.824885253001121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35420,-0.00479750303020357,0.0217104071129892,-0.0473499009716624,0.0377548949112552,0.825117501872445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASHC3,WASH complex subunit 3,35416,0.0103831312618545,0.0470453508556353,-0.0818257564151907,0.1025920189389,0.825329593064153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RUVBL1,RuvB-like 1,36225,0.015050161004083,0.0682010796170754,-0.118623955045385,0.148724277053551,0.825353187593921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP20,Centrosomal protein 20,36225,-0.0106182384601071,0.0481175448113841,-0.10492862629042,0.0836921493702056,0.825353536371284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCAR2,Cell cycle and apoptosis regulator protein 2,35416,-0.00784077230572917,0.035543850198401,-0.0775067186945951,0.0618251740831367,0.825415543438008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,36442,-0.00495097586450508,0.0224482166539472,-0.0489494805062417,0.0390475287772315,0.825448296339547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP152,Centrosomal protein of 152 kDa,35206,0.00590644932113765,0.0268254158261154,-0.0466713656980486,0.0584842643403239,0.825737598457651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO6,Coronin-6,35212,-0.00509276597569922,0.0231509523586059,-0.0504686325985668,0.0402831006471683,0.825893537083935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MITD1,MIT domain-containing protein 1,36297,-0.0135182986508425,0.0615325361696987,-0.134122069543452,0.107085472241767,0.82611617502176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,36191,-0.00880618368409067,0.0401146116561293,-0.087430822530104,0.0698184551619227,0.826247053687187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFP,Properdin,35448,-0.00320145403398084,0.0146269518983369,-0.0318702797547211,0.0254673716867595,0.826755632014648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC26,Anaphase-promoting complex subunit CDC26,35388,-0.0094689406474246,0.0432778643944985,-0.0942935548606416,0.0753556735657925,0.826817664973385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP164,Centrosomal protein of 164 kDa,36227,-0.00966701169128288,0.0441862225192132,-0.0962720078289408,0.0769379844463751,0.826828658100656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,36410,0.0053264449659485,0.0244053588199152,-0.0425080583210853,0.0531609482529823,0.827241286308741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,36225,0.00926262799747588,0.0426415176508304,-0.0743147465981517,0.0928400025931035,0.828042515906819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAP1A,Ras-related protein Rap-1A,35239,0.00980268352719066,0.0453067557170069,-0.078998557678143,0.0986039247325243,0.828712485039856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCAMP3,Secretory carrier-associated membrane protein 3,36331,-0.0116698894499895,0.0539583791817059,-0.117428312646133,0.0940885337461541,0.828778983909374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNMT,Histamine N-methyltransferase,36262,-0.00660645515776531,0.0305921766588885,-0.0665671214091867,0.0533542110936561,0.829031052727596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESYT2,Extended synaptotagmin-2,35416,-0.0110695673214995,0.0512888460142037,-0.111595705509339,0.0894565708663398,0.829128922873001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL24,C-C motif chemokine 24,36390,-0.0115449067983593,0.0535792216760353,-0.116560181283388,0.0934703676866698,0.829404213724053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",36227,0.0080760800016291,0.037596807094251,-0.0656136619031029,0.0817658219063611,0.82992355320549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSA,Arylsulfatase A,36382,-0.00605669461592504,0.0282633157985444,-0.061452793581072,0.0493394043492219,0.830322892537362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP1,Low molecular weight phosphotyrosine protein phosphatase,35239,0.00612574680106677,0.0286071892798672,-0.049944344187473,0.0621958377896065,0.830450468079963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX1,Peroxiredoxin-1,36140,0.0122083458639042,0.0571513360510843,-0.099808272796221,0.124224964524029,0.830854072638506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2B,Sodium channel subunit beta-2,35275,-0.00390189621419037,0.0182722357117054,-0.0397154782091329,0.0319116857807522,0.830911116538153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MET,Hepatocyte growth factor receptor,36358,0.00269919191763429,0.0126752823518753,-0.0221443614920413,0.0275427453273099,0.831372603489672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIC5,Chloride intracellular channel protein 5,35275,-0.00423030041535595,0.0199014859610924,-0.043237212899097,0.0347766120683851,0.831675708637303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK13,Kallikrein-13,36205,0.00619815183789949,0.0291988349678301,-0.0510315646990475,0.0634278683748465,0.831899493312452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSRA,Mitochondrial peptide methionine sulfoxide reductase,36397,0.00974083791578792,0.0460583734738421,-0.0805335740929426,0.100015249924518,0.832511722334712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT2A1,Bile salt sulfotransferase,36352,0.00765118914836298,0.0363456685950297,-0.0635863212978953,0.0788886995946213,0.83327429861088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,35214,0.00508820140587479,0.0241732577660416,-0.0422913838155667,0.0524677866273163,0.83329327117932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),P4HB,Protein disulfide-isomerase,36345,-0.00514759993384423,0.0245109670867921,-0.0531890954239568,0.0428938955562684,0.833664203790229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDRG1,p53 and DNA damage-regulated protein 1,35275,-0.00711900979790108,0.0339043881957201,-0.0735716106615124,0.0593335910657102,0.833695695427094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD63,CD63 antigen,36282,0.00687218784442563,0.0327477940622886,-0.05731348851766,0.0710578642065113,0.833789271053553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF21,Immunoglobulin superfamily member 21,35281,0.00525704978981549,0.0250822462507621,-0.0439041528616783,0.0544182524413092,0.833992776157569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASRGL1,Isoaspartyl peptidase/L-asparaginase,35281,-0.0132927938571652,0.063560988764789,-0.137872331836152,0.111286744121821,0.834350262706621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM1,Myomesin-1,35212,0.0066267410685176,0.0317482954105189,-0.0555999179360995,0.0688534000731347,0.834668066204016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL3,Angiopoietin-related protein 3,36384,0.00470733446846395,0.0228045684001027,-0.0399896195957374,0.0494042885326653,0.836468164743583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAA4,Serum amyloid A-4 protein,35448,-0.00422547708657127,0.0205637919164802,-0.0445305092428725,0.03607955506973,0.837202703717657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICOSLG,ICOS ligand,36331,0.00248102259206709,0.0120743871213749,-0.0211847761658278,0.026146821349962,0.83720443667594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,35275,0.00706827547597151,0.0346169159807639,-0.0607808798463257,0.0749174307982687,0.838215303180416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF20B,Kinesin-like protein KIF20B,35212,-0.00981955130637557,0.0481435053225586,-0.10418082173859,0.0845417191258393,0.838388375668481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35321,0.00848763982510512,0.0417063964381115,-0.0732568971935934,0.0902321768438036,0.838743730483782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPRIP,Myosin phosphatase Rho-interacting protein,35380,0.0056884155016751,0.0281516664590188,-0.0494888507580017,0.0608656817613519,0.839873969622769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR1,Toll-like receptor 1,35239,-0.00349449684950058,0.0173683748326201,-0.0375365115214359,0.0305475178224348,0.840549868672323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOR1AIP1,Torsin-1A-interacting protein 1,35281,-0.00688189554133135,0.0343079265366344,-0.0741254315531348,0.0603616404704721,0.841024316904819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED21,Mediator of RNA polymerase II transcription subunit 21,35214,0.00614127355314282,0.0306295017040509,-0.0538925497867969,0.0661750968930825,0.841094838397388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD33,Myeloid cell surface antigen CD33,36397,0.0103744925917971,0.0517719740543275,-0.0910985765546849,0.111847561738279,0.841182646174439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM2,Neural cell adhesion molecule 2,36382,-0.0034912935994049,0.01742373108723,-0.0376418065303756,0.0306592193315658,0.841192373706079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEPD,Xaa-Pro dipeptidase,35428,0.0032508248505502,0.0163133607382888,-0.0287233621964959,0.0352250118975963,0.842055097315769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IPCEF1,Interactor protein for cytohesin exchange factors 1,36282,-0.0113532007962361,0.0570839212343806,-0.123237686415622,0.10053128482315,0.842357515400769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSC2,Desmocollin-2,36315,-0.00440281880114304,0.0222342514830256,-0.0479819517078732,0.0391763141055871,0.843035338336691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDDM3B,Epididymal secretory protein E3-beta,35391,0.00643730162804879,0.0325183336010826,-0.0572986322300731,0.0701732354861706,0.843083519057378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPGN,Epigen,35391,-0.0054782131257038,0.0277432151143401,-0.0598549147498104,0.0488984884984028,0.843472988594947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCC,Netrin receptor DCC,35275,-0.00270514882754758,0.0137508050715638,-0.0296567267678126,0.0242464291127175,0.84404808445405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD101,Immunoglobulin superfamily member 2,35402,-0.00543397147372522,0.0276809167010357,-0.0596885682077551,0.0488206252603047,0.844375919302923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,36385,-0.0139573901752026,0.0711106008461184,-0.153334167833595,0.125419387483189,0.844398746303342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRF,Receptor-type tyrosine-protein phosphatase F,36446,-0.00360739808519079,0.0184045725506445,-0.039680360284454,0.0324655641140724,0.844611325674398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBL1X,F-box-like/WD repeat-containing protein TBL1X,36225,0.0104441041123714,0.0536364340666826,-0.0946833066583266,0.115571514883069,0.845617521873673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR3,Small proline-rich protein 3,35416,0.00849234952069627,0.0441735388081468,-0.0780877865432716,0.0950724855846641,0.847552892041609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,36088,0.00453343066542891,0.0236429217184342,-0.0418066959027021,0.0508735572335599,0.847946984509605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUCB2,Nucleobindin-2,36412,-0.00447669863407398,0.0233480347698274,-0.0502388467829356,0.0412854495147877,0.847953061910738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCFD2,Multiple coagulation factor deficiency protein 2,36319,0.00534724746530072,0.0279099270273899,-0.0493562095083834,0.0600507044389849,0.84806926939559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",36225,0.00999468783738463,0.0524739050247932,-0.0928541660112101,0.112843541685979,0.848946599968337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAG1,Dystroglycan,36403,-0.00563703040660824,0.0296230241562685,-0.0636981577528945,0.052424096939678,0.849085524301729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGR1,Prostaglandin reductase 1,35420,-0.00991411836267044,0.0521083810391553,-0.112046545199415,0.0922183084740739,0.84911193334551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGMT,Methylated-DNA--protein-cysteine methyltransferase,36352,0.014526282554847,0.07647845171249,-0.135371482801633,0.164424047911327,0.849361887509002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_DRA,,36332,-0.00448181426173856,0.0236340680952679,-0.0508045877284636,0.0418409592049865,0.849601619823083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",35239,-0.00333037036830865,0.0176673701176755,-0.0379584157989526,0.0312976750623353,0.850487888692662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFER,FAD-linked sulfhydryl oxidase ALR,36225,-0.00759091518594622,0.0403335683890974,-0.0866447092285771,0.0714628788566847,0.850722629304068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,35212,0.00743035339886093,0.0395019694199931,-0.0699935066643255,0.0848542134620474,0.850803949213339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,36428,-0.00552184651200212,0.0294649695502862,-0.063273186830563,0.0522294938065588,0.851349319110356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",35281,-0.00428120145640423,0.0228936085495367,-0.0491526742134961,0.0405902713006877,0.851663555007908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HARS1,"Histidine--tRNA ligase, cytoplasmic",36382,-0.00908853142350464,0.0486070806206108,-0.104358409439902,0.0861813465928926,0.851681921976071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHX2,Bifunctional epoxide hydrolase 2,36249,0.00766217718797081,0.0409825705218661,-0.0726636610348867,0.0879880154108283,0.851695921035385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUB1,NEDD8 ultimate buster 1,36352,-0.0100289268143795,0.0536667247298797,-0.115215707284944,0.0951578536561847,0.851764556089245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH1B,All-trans-retinol dehydrogenase,35312,0.00876927370608608,0.04708347576328,-0.0835143387899427,0.101052886202115,0.852255284449569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC9,Sialic acid-binding Ig-like lectin 9,36411,-0.00346477036300047,0.01868995501846,-0.040097082199182,0.0331675414731811,0.852935091600342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX2,Probable E3 ubiquitin-protein ligase DTX2,35275,-0.0070841183773191,0.0382563990797301,-0.08206666057359,0.0678984238189519,0.853098164233977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPB2,Coatomer subunit beta',35214,0.00514996418350598,0.0279190693779041,-0.049571411797186,0.0598713401641979,0.853658462011109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA4H,Leukotriene A-4 hydrolase,36427,-0.00674492987613393,0.0367227364288359,-0.0787214932766524,0.0652316335243845,0.854276107507772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35402,-0.0202048496572913,0.110052979467097,-0.235908689412802,0.195498990098219,0.854339513625144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB44,Ras-related protein Rab-44,35391,-0.00535721937964587,0.0293025446439597,-0.062790206881807,0.0520757681225152,0.854941803881751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT17,"Keratin, type I cytoskeletal 17",35214,0.00448589304824677,0.0246186055407489,-0.0437665738116211,0.0527383599081147,0.855419695895335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,35212,-0.00626600764280587,0.0344089667908981,-0.0737075825529661,0.0611755672673543,0.855507308033647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRL,Prolactin,36428,0.00856866380260885,0.047085431769524,-0.0837187824656582,0.100856110070876,0.855602571582581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAV,Integrin alpha-V,36427,-0.00185862680970842,0.0102608916299007,-0.0219699744043138,0.018252720784897,0.85626514266136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF11,Tumor necrosis factor ligand superfamily member 11,36352,0.0070529238431386,0.0390634080795763,-0.069511355992831,0.0836172036791082,0.856725403559307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VMO1,Vitelline membrane outer layer protein 1 homolog,36331,-0.00813354279774524,0.0450804768114031,-0.0964912773480953,0.0802241917526048,0.856825832004545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD14,Monocyte differentiation antigen CD14,36237,0.00482671601414096,0.0269208274401268,-0.0479381057685077,0.0575915377967896,0.857712797565446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD70,CD70 antigen,36352,0.00496180384425139,0.0278124441533047,-0.0495505866962258,0.0594741943847286,0.858412096365343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF7,Fibroblast growth factor 7,35206,0.00900309902380033,0.0506718428098008,-0.0903137128834091,0.10831991093101,0.858984525738857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPR,Gastric inhibitory polypeptide receptor,35239,0.00541378835716443,0.0304788399807208,-0.0543247380050483,0.0651523147193771,0.859023842802325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCPKMT,Protein-lysine methyltransferase METTL21D,35206,-0.0101184604166257,0.0570091619411979,-0.121856417821374,0.101619496988122,0.859130817649342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX5,Syntaxin-5,35239,0.00456818633210852,0.0257794336554229,-0.0459595036325204,0.0550958762967374,0.859355078729641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN1,Contactin-1,36446,-0.00313058534461804,0.0177198777114815,-0.0378615456591217,0.0316003749698856,0.859771895155457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,36297,0.0121601164906671,0.069088847634633,-0.123254024873214,0.147574257854548,0.860293509609907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PENK,Proenkephalin-A,35312,0.00357274945482044,0.0203067510644192,-0.0362284826314411,0.043373981541082,0.860347689383365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31,Interleukin-31,35239,0.00609641900795435,0.0348309939236108,-0.0621723290823228,0.0743651670982315,0.861063047477905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK8,Kallikrein-8,36125,0.00414824270371045,0.0237144849631881,-0.0423321478241383,0.0506286332315592,0.861144125312222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCXR,L-xylulose reductase,36397,0.0058595646106902,0.0336531719325149,-0.060100652377039,0.0718197815984194,0.861778983746506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17F,Interleukin-17F,36227,0.00827919602916925,0.0476851475483332,-0.0851836931655638,0.101742085223902,0.862167449840598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD2,Bromodomain-containing protein 2,35212,-0.00392770022140173,0.0227457537414244,-0.0485093775545935,0.0406539771117901,0.862910034788004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBK,Lymphokine-activated killer T-cell-originated protein kinase,35206,-0.00332520087120188,0.0193323837429796,-0.041216673007442,0.0345662712650382,0.863442062995187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAVS,Mitochondrial antiviral-signaling protein,36225,-0.00993918642309283,0.0579269821114496,-0.123476071361534,0.103597698515348,0.863771654062437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELL,L-selectin,35448,0.00253177087540817,0.0147927545770453,-0.0264620280956006,0.0315255698464169,0.864111840539113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL,Podocalyxin,36331,0.00166510237336,0.00973788697918731,-0.0174211561058471,0.0207513608525671,0.864234773890745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB2,Pleckstrin homology-like domain family B member 2,35206,-0.0103530085305824,0.0606477046182228,-0.129222509582299,0.108516492521134,0.864459632981167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549L,UPF0606 protein KIAA1549L,35321,-0.00312925646867426,0.0184583338962705,-0.0393075909053644,0.0330490779680159,0.865384729644103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANG,Angiogenin,36366,0.00362000844214372,0.0213897359989421,-0.0383038741157827,0.0455438910000702,0.865612290863156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIABLO,"Diablo homolog, mitochondrial",36342,-0.0118370117359505,0.0699988386356586,-0.149034735461841,0.12536071198994,0.865720431227644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN2,CCN family member 2,36359,0.00598426640344425,0.0354700892933762,-0.063537108611573,0.0755056414184615,0.866027127861044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,36191,0.00508038110462119,0.0302440470572262,-0.0541979511275421,0.0643587133367845,0.866604230102985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLP1R,Glucagon-like peptide 1 receptor,35212,0.0039467297852252,0.0235342290602203,-0.0421803591728065,0.0500738187432569,0.86682360832145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BDNF,Brain-derived neurotrophic factor,35438,0.00870762091093526,0.0521803723345308,-0.093565908864745,0.110981150686616,0.867473487144329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B10,Aldo-keto reductase family 1 member B10,35275,-0.00667960727577938,0.0401856380050125,-0.0854434577656039,0.0720842432140451,0.867990315502766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFC,Vascular endothelial growth factor C,36397,0.00589445296918455,0.0355338761596642,-0.0637519443037573,0.0755408502421264,0.868253969881117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD9,Enhancer of filamentation 1,35239,0.00356118278277771,0.0214766673486574,-0.0385330852205908,0.0456554507861462,0.868307016864361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXADR,Coxsackievirus and adenovirus receptor,36352,0.00554851603592499,0.0335205490148751,-0.0601517600332302,0.0712487921050801,0.868534810887664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MXRA8,Matrix remodeling-associated protein 8,35312,0.00322355276975044,0.019477998301959,-0.0349533239020892,0.0414004294415901,0.868558178667474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS1,Galectin-1,36360,0.00367325727602523,0.0222719229795617,-0.0399797117639158,0.0473262263159662,0.869005532848389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D5,TBC1 domain family member 5,36352,0.00834307541242613,0.050653705867996,-0.0909381880888461,0.107624338913698,0.869178395719509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35321,0.0070564281788504,0.0429359558139349,-0.0770980452164621,0.0912109015741629,0.869462806653118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE3,Eosinophil cationic protein,36329,0.0120484206027477,0.0736093338451286,-0.132225873733704,0.1563227149392,0.869987219278223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHCY,Adenosylhomocysteinase,36360,-0.007068736105208,0.0433703601389068,-0.0920746419774653,0.0779371697670493,0.870534514809048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGN,Secretagogin,36227,-0.00473663871730928,0.029072828379673,-0.0617193823414684,0.0522461049068499,0.870583571687281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,35312,0.00723737790617245,0.0444399413746077,-0.0798649071880586,0.0943396630004034,0.870636010074229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL52,"39S ribosomal protein L52, mitochondrial",35192,-0.00262959056416708,0.0161805642166903,-0.0343434964288802,0.029084315300546,0.870905491227103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECAM1,Platelet endothelial cell adhesion molecule,36382,-0.00310090281571949,0.0191334138254787,-0.0406023939136578,0.0344005882822188,0.871257325522027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IQGAP2,Ras GTPase-activating-like protein IQGAP2,36331,-0.00556918465744657,0.0344890048079982,-0.0731676340811231,0.0620292647662299,0.87172221283987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESPL1,Separin,35206,-0.00596755629299468,0.036956756698178,-0.0784027994214236,0.0664676868354342,0.871725493012493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA2,Protein disulfide-isomerase A2,35206,0.00427681680526872,0.0265145507175198,-0.04769170260107,0.0562453362116075,0.871861955817151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",36225,-0.00520353142586453,0.0323700206686786,-0.0686487719364745,0.0582417090847455,0.872293694140293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERVV_1,,35214,0.00430999064812784,0.0269191666394453,-0.0484515759651849,0.0570715572614406,0.872800881983249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTM4,Glutathione S-transferase Mu 4,35214,0.00737583595358726,0.0462201367008646,-0.0832156319801073,0.0979673038872818,0.873216836010352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L2,Mortality factor 4-like protein 2,35206,0.00380830158468063,0.0239064008795028,-0.0430482441391449,0.0506648473085062,0.873437478876449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL27,C-C motif chemokine 27,36360,-0.00596650589225517,0.0374657713842015,-0.0793994178052901,0.0674664060207797,0.873474680054168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2L,von Willebrand factor C domain-containing protein 2-like,35417,-0.004499138118808,0.0282914818092306,-0.0599504424649,0.050952166227284,0.873651964595248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM2,Junctional adhesion molecule B,36428,-0.00272500972816473,0.0171387159812952,-0.0363168930515033,0.0308668735951738,0.873675432133333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMTN,Smoothelin,35410,-0.00909424702116043,0.0574246963297365,-0.121646651827444,0.103458157785123,0.874171797865676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI2,Protein-arginine deiminase type-2,36227,-0.00560777981801118,0.0354519658101709,-0.0750936328059461,0.0638780731699238,0.87431977403164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDHB,Succinate dehydrogenase,35402,-0.0064754231876972,0.0411543057687504,-0.0871378624944479,0.0741870161190535,0.874978094240972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SGSH,N-sulphoglucosamine sulphohydrolase,35309,0.00572617032509217,0.036397278936577,-0.0656124963905988,0.0770648370407832,0.874994596427563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTCN1,V-set domain-containing T-cell activation inhibitor 1,36225,-0.00320453446233782,0.0203928264240382,-0.0431744742534527,0.0367654053287771,0.875138804798151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOS,Proto-oncogene c-Fos,35193,0.00354593023115598,0.0226166055133544,-0.0407826165750186,0.0478744770373305,0.87542006796799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164,Sialomucin core protein 24,36382,0.00267827976823483,0.0171109442399721,-0.0308591709421105,0.0362157304785801,0.875624107257066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML2,Trem-like transcript 2 protein,36382,-0.00343047177933885,0.0220326417678445,-0.046614449644314,0.0397535060856363,0.87627424650536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF2,Cyclic AMP-dependent transcription factor ATF-2,36191,-0.00674069708905555,0.0434468942895351,-0.0918966098965444,0.0784152157184333,0.876709147164241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDCCAG8,Serologically defined colon cancer antigen 8,35391,-0.0109810991347,0.0709812034346564,-0.150104257866627,0.128142059597227,0.877059458628058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGN,Biglycan,36208,-0.0117497738023795,0.0762448107472805,-0.161189602867049,0.13769005526229,0.877530684235541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,36397,-0.00350696963568727,0.0227697035790323,-0.0481355886505906,0.041121649379216,0.877598977224928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRPV3,Transient receptor potential cation channel subfamily V member 3,35214,0.00468360261248002,0.0304679624007267,-0.0550336036929443,0.0644008089179044,0.877833921903814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR2,TGF-beta receptor type-2,36397,-0.00341384893610339,0.0222140173556424,-0.0469533229531625,0.0401256250809557,0.877866404648032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMNL1,Formin-like protein 1,36191,-0.00646402924288677,0.0422551924353646,-0.0892842064162014,0.0763561479304279,0.878421632905184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSCA,Prostate stem cell antigen,35402,-0.0256278379131614,0.167925231528254,-0.354761291708539,0.303505615882216,0.878707189844848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPKOW,G-patch domain and KOW motifs-containing protein,36191,0.00298420348607883,0.0196558436956807,-0.0355412501574554,0.0415096571296131,0.879331145744567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAX,Protein max,36191,0.0101377806093065,0.0667858773870771,-0.120762539069365,0.141038100287978,0.879352785441871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35321,-0.00996898549158194,0.0657666408713767,-0.13887160159948,0.118933630616316,0.879522262997242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSCAM,Down syndrome cell adhesion molecule,35417,0.00340554599490397,0.0225025153996073,-0.0406993841883263,0.0475104761781343,0.879711885943224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCTN3,Tectonic-3,35420,0.00285775098920171,0.0189187279101366,-0.0342229557146659,0.0399384576930693,0.879937951401328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD69,Early activation antigen CD69,36330,0.00845818625213257,0.0561796795795373,-0.101653985723761,0.118570358228026,0.880330250113347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN10,Ataxin-10,36191,-0.00688915993009965,0.0458262624867499,-0.0967086344041294,0.0829303145439301,0.880506913337869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIK2,"Glutamate receptor ionotropic, kainate 2",35417,0.00426141308056923,0.028404272376142,-0.0514109607766691,0.0599337869378075,0.880748028024885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRP,Agouti-related protein,36442,-0.0048942369471569,0.0327484583293357,-0.0690812152726549,0.0592927413783411,0.881203203957627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPNMB,Transmembrane glycoprotein NMB,36177,0.00275512715142016,0.0184449972879884,-0.0333970675330372,0.0389073218358775,0.881266085741067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC3B,Tetranectin,35297,0.00201715120065712,0.0135239226464036,-0.024489737186294,0.0285240395876082,0.881436808913873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP3,Insulin-like growth factor-binding protein 3,36410,0.00301950086209923,0.0203519384065495,-0.0368702984147379,0.0429093001389363,0.882059427281928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA1,Ephrin type-A receptor 1,36396,-0.00311266923848439,0.0210238920996075,-0.0443194977537151,0.0380941592767463,0.882304374845898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,35214,-0.00450512664626106,0.0304873233273314,-0.0642602803678305,0.0552500270753084,0.882528849577137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO1A,Coronin-1A,36215,-0.00840672972149564,0.0572033540460574,-0.120525303651768,0.103711844208777,0.883166090208469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CADPS,Calcium-dependent secretion activator 1,35275,0.00381852715636956,0.0261302192270668,-0.0473967025286813,0.0550337568414204,0.883820036340651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSV,Cathepsin L2,36400,0.00397887395382061,0.0274413100107313,-0.0498060936672128,0.057763841574854,0.884718264399032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH22,Cadherin-22,35321,-0.00262863187534936,0.0181393202217737,-0.0381816995100258,0.0329244357593271,0.884783955977437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAM,Signal transducing adapter molecule 1,35391,0.00348829870311925,0.024265905129845,-0.0440728753513769,0.0510494727576154,0.88570012551232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XIAP,E3 ubiquitin-protein ligase XIAP,35239,0.00519935909417332,0.0361693143908971,-0.0656924971119849,0.0760912153003316,0.885702238543585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA2A,Chymotrypsin-like elastase family member 2A,35438,0.00564256030510296,0.0393000951948612,-0.0713856262768249,0.0826707468870308,0.885839728970035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKL5,Cyclin-dependent kinase-like 5,35212,-0.00503225091221155,0.0350642743011454,-0.0737582285424565,0.0636937267180334,0.885888234919883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC2,Plexin domain-containing protein 2,35416,-0.00250869128461505,0.0175231904400215,-0.0368541445470572,0.0318367619778271,0.886165240388149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAN,Aggrecan core protein,36288,-0.00249639674003997,0.0176643262674024,-0.0371184762241486,0.0321256827440687,0.887617847164259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJP3,Tight junction protein ZO-3,35212,0.00369200449922546,0.026161227274175,-0.0475840009581575,0.0549680099566085,0.887775878378783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC7,Sialic acid-binding Ig-like lectin 7,36360,-0.00253005584057029,0.0179491005220596,-0.037710292863807,0.0326501811826665,0.887907677004449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRND,Prion-like protein doppel,35416,-0.00460807313138929,0.0327713557604127,-0.0688399304217983,0.0596237841590197,0.888180362469863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMFR,E3 ubiquitin-protein ligase AMFR,36191,0.00556340610330786,0.039597723928121,-0.0720481327958092,0.0831749450024249,0.88827047530521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA4,Ephrin type-A receptor 4,35312,0.00258409283274958,0.0184049248254328,-0.0334895598250986,0.0386577454905978,0.888346803274727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT3,Kunitz-type protease inhibitor 3,35402,0.013069874507126,0.0933812235628537,-0.169957323676067,0.196097072690319,0.888694117497309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHD,SH2 domain-containing adapter protein D,35201,-0.0074742881734716,0.0539506246957773,-0.113217512577195,0.0982689362302518,0.889818762315392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40LG,CD40 ligand,36442,0.00685969289266762,0.0496682205312764,-0.0904900193486342,0.104209405133969,0.890157081277724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",36331,-0.00361589149147153,0.0262357401487669,-0.0550379421830546,0.0478061592001115,0.890384101761468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP8,Ubiquitin carboxyl-terminal hydrolase 8,36249,-0.00826289144158322,0.0599947814527029,-0.125852663088881,0.109326880205714,0.890460239634665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBP1,"Fructose-1,6-bisphosphatase 1",36360,0.00651031989298208,0.0473869363162852,-0.0863680752869369,0.099388715072901,0.890729251696494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA2,Annexin A2,35191,-0.00633080493412217,0.0465651004825712,-0.0975984018799617,0.0849367920117174,0.89186062582594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A3,Protein S100-A3,35391,0.00399878679642816,0.0294489031475027,-0.0537210633726772,0.0617186369655335,0.89199384832495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL14,C-X-C motif chemokine 14,36227,0.0048819135342726,0.0361445223924268,-0.0659613503548839,0.0757251774234291,0.892563174838911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOT,Angiomotin,35312,0.00325895144503293,0.0241357625186583,-0.0440471430915373,0.0505650459816031,0.892595891267882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES1,Retinoic acid receptor responder protein 1,36225,0.0028040260759332,0.0209145458694021,-0.038188483828095,0.0437965359799614,0.893350571089441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MENT,Protein MENT,35312,-0.00197891376913541,0.0148578458799588,-0.0311002916938547,0.0271424641555838,0.894047644634341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2R,Proteinase-activated receptor 1,36390,-0.00472257846678084,0.0355274028265276,-0.074356288006775,0.0649111310732133,0.894254220502356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,35214,0.00175264792111169,0.0133087779809504,-0.0243325569215511,0.0278378527637745,0.895233007809492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC37,Hsp90 co-chaperone Cdc37,36397,-0.00696593268081173,0.0532590974416664,-0.111353763666478,0.0974218983048543,0.895942482208715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCND2,G1/S-specific cyclin-D2,35321,0.00316701060432727,0.024399988614107,-0.0446569670793224,0.050990988287977,0.896732422941444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LG,CMRF35-like molecule 9,36382,-0.00311435829315944,0.0240550248889264,-0.0502622070754551,0.0440334904891363,0.89699088993232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35417,0.00530110917495717,0.0410218348756459,-0.0751016871813087,0.085703905531223,0.897182584449043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK3,Dickkopf-related protein 3,36446,0.00249103098267849,0.0193234187222446,-0.035382869712921,0.040364931678278,0.897430429101463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5,Eukaryotic translation initiation factor 5,35214,-0.00362856103662184,0.0281690087655404,-0.0588398182170811,0.0515826961438374,0.897509177116201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4M,C-type lectin domain family 4 member M,35424,-0.00395221567391126,0.0309078928803057,-0.0645316857193104,0.0566272543714879,0.898255380330237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP3,Latent-transforming growth factor beta-binding protein 3,36225,0.00437755236335998,0.0342964353070208,-0.0628434608384009,0.0715985655651208,0.898438554886468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCOR1,REST corepressor 1,36249,-0.00376053895086566,0.0294955476896827,-0.0615718124226438,0.0540507345209125,0.898552153988598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,35281,0.00496521237914143,0.0389775995321832,-0.0714308827039377,0.0813613074622206,0.898638862847224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOD,Apolipoprotein D,35167,-0.00350722604601548,0.0277260602002603,-0.0578503040385257,0.0508358519464947,0.8993438487565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPR1,Atrial natriuretic peptide receptor 1,35214,-0.00319517953771875,0.025315441917754,-0.0528134456965165,0.046423086621079,0.899566233233224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX18,Sorting nexin-18,35402,-0.00335560680594892,0.0266437596365874,-0.0555773756936603,0.0488661620817624,0.899780772767703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO1,Alpha-enolase,36352,-0.00627375823065319,0.0499899098155934,-0.104253981469216,0.0917064650079099,0.900130860754492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4R,Reticulon-4 receptor,36427,-0.00270631938734589,0.0219305560696358,-0.0456902092838321,0.0402775705091403,0.901790580758265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRD1,Adhesion G-protein coupled receptor D1,35312,-0.00302060154287807,0.0245582635276001,-0.0511547980569743,0.0451135949712182,0.902113229819321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R2,Protein phosphatase inhibitor 2,36360,0.00621389535772534,0.0508341188660586,-0.0934209776197495,0.1058487683352,0.90271342521556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL5,C-X-C motif chemokine 5,36336,0.00896350314207418,0.0737974687633415,-0.135679535634075,0.153606541918224,0.903329440767976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT3,Dynein light chain Tctex-type 3,35391,-0.00338208318188176,0.0280095481735384,-0.0582807976020169,0.0515166312382534,0.903894941801199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFASC,Neurofascin,36442,0.00224394005830394,0.0186552089427171,-0.0343202694694215,0.0388081495860294,0.904260794357164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99,CD99 antigen,36382,-0.00150671764828875,0.0125276131402987,-0.0260608394032742,0.0230474041066967,0.904271262744183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAU,Urokinase-type plasminogen activator,36382,0.00233310213588243,0.0194338817791511,-0.0357573061512536,0.0404235104230185,0.904444260945762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMSB10,Thymosin beta-10,36382,0.00564486541061829,0.0473359746010209,-0.0871336448073827,0.0984233756286193,0.905079783292416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2,Interleukin-2,36227,0.00237083439412206,0.0199889088689599,-0.0368074269890394,0.0415490957772835,0.905589715018498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP2,Lysosome-associated membrane glycoprotein 2,36103,-0.00146890820463519,0.0124383742040219,-0.025848121644518,0.0229103052352476,0.905995919888362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD4B,FERM domain-containing protein 4B,35214,0.00511251041773706,0.0435367787380917,-0.0802195759089226,0.0904445967443968,0.906523475320934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCT,Secretin,35275,-0.00360360557430675,0.0308072555394645,-0.0639858264316572,0.0567786152830437,0.906885608859921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOB,Elongin-B,35214,-0.00281152876012194,0.0240465720060976,-0.0499428098920733,0.0443197523718294,0.9069272320347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXN,Paxillin,36191,-0.00397277233354809,0.0340782467976439,-0.0707661360569302,0.062820591389834,0.907197853382395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK9,Mitogen-activated protein kinase 9,36352,-0.00313092226630736,0.0269382902750498,-0.055929971205405,0.0496681266727903,0.907476911261191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA5A,"Carbonic anhydrase 5A, mitochondrial",36249,0.00681699020899454,0.0590722428925255,-0.108964605860356,0.122598586278345,0.9081306470236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY4,Protein canopy homolog 4,36331,0.00548875029797022,0.0475957487679762,-0.0877989172872632,0.0987764178832036,0.908194588259641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUP50,Nuclear pore complex protein Nup50,35214,-0.00233788571750402,0.0204436516641826,-0.0424074429793019,0.0377316715442939,0.908958184777421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP1,Integrin beta-1-binding protein 1,36225,-0.00293322374673128,0.0257962201499776,-0.0534938152406875,0.0476273677472249,0.909472912097027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN3,Neuronal-specific septin-3,35417,-0.00536825264558493,0.0476106715306853,-0.0986851688457281,0.0879486635545582,0.91022990817326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC21,DnaJ homolog subfamily C member 21,35416,-0.0027489593819823,0.0243975786094867,-0.0505682134565762,0.0450702946926116,0.910293084925987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPE,Coatomer subunit epsilon,36191,-0.00337897688242689,0.0300175139679645,-0.0622133042596372,0.0554553504947835,0.910377199874084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNMBP,Dynamin-binding protein,36297,-0.00432443397171383,0.0385520166173354,-0.0798863865416912,0.0712375185982635,0.910690669102255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDAN1,Codanin-1,35416,0.00157153420744236,0.014136323798241,-0.02613566043711,0.0292787288519947,0.911485177420363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN2,Alpha-actinin-2,35214,0.00408088430575315,0.0368489807526899,-0.0681431179695191,0.0763048865810254,0.911821306912495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR3,Toll-like receptor 3,36442,-0.00426345265115121,0.0387468298202731,-0.0802072390988865,0.0716803337965841,0.912385784774601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1A,T-cell leukemia/lymphoma protein 1A,36288,0.00718098919544959,0.0655644916697525,-0.121325414477265,0.135687392868165,0.912788729191846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDS,Iduronate 2-sulfatase,36442,-0.000616746104670526,0.00564042263470174,-0.0116719744686859,0.0104384822593449,0.912932713522094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,36347,0.00428239383046489,0.0391761429455368,-0.0725028463427872,0.081067634003717,0.912958676482721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FADD,FAS-associated death domain protein,36360,-0.00527658960116062,0.0483426128209786,-0.100028110730279,0.0894749315279574,0.913086681738253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL2,Interleukin-1 receptor-like 2,36227,-0.00266864570241303,0.0245092369105248,-0.0507067500470416,0.0453694586422155,0.913298187703054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3G,Regenerating islet-derived protein 3-gamma,35391,-0.00281020148658987,0.0258519479286,-0.0534800194266459,0.0478596164534662,0.91344105426369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES1,Liver carboxylesterase 1,36384,-0.00561649621034312,0.0516788308832363,-0.106907004741486,0.0956740123208,0.913458710991207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC123,Cell division cycle protein 123 homolog,35206,0.00437750103326151,0.0404060759590831,-0.0748184078465414,0.0835734099130644,0.913731439601644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBR,Delta(14)-sterol reductase LBR,36428,-0.0047617762307717,0.0439976296674722,-0.0909971303790171,0.0814735779174737,0.913817822349228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGER,Advanced glycosylation end product-specific receptor,36361,0.00286032866573317,0.026505978428442,-0.0490913890540132,0.0548120463854795,0.914068054262875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP4,"Fatty acid-binding protein, adipocyte",36446,0.00345073254348524,0.0319930576729282,-0.0592556604954541,0.0661571255824246,0.914110689600865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNNI3,"Troponin I, cardiac muscle",36249,-0.00576541175616888,0.0545720284807819,-0.112726587578501,0.101195764066164,0.915864845093304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLMAP,Sarcolemmal membrane-associated protein,35402,-0.00544348628383999,0.0517579454444808,-0.106889059355022,0.0960020867873424,0.91624273145546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFL4,Insulin growth factor-like family member 4,35239,-0.00483229696531616,0.0463402260629915,-0.0956591400487795,0.0859945461181472,0.916951666948145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFGE8,Lactadherin,36382,0.00280731948173809,0.0272771742320135,-0.0506559420130084,0.0562705809764846,0.91803071126323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SETMAR,Histone-lysine N-methyltransferase SETMAR,36271,-0.00199908283237497,0.0195815288070791,-0.0403788792942501,0.0363807136295001,0.91868794601503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100P,Protein S100-P,36249,-0.00363183296114617,0.0356014396023528,-0.0734106545817576,0.0661469886594653,0.918748736009384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK1,Dickkopf-related protein 1,36428,-0.0038018254720157,0.0373271873068184,-0.0769631125933797,0.0693594616493483,0.918877466607013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF14,Tumor necrosis factor ligand superfamily member 14,36297,-0.00372492850380779,0.0367625544631736,-0.075779535251628,0.0683296782440125,0.919296137071363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCG,Gamma-synuclein,36297,0.00439637681671347,0.0434998422262715,-0.0808633139467787,0.0896560675802057,0.919500523296274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAPL1,Proactivator polypeptide-like 1,35402,0.00322499375115092,0.0321957185944633,-0.0598786146939972,0.066328602196299,0.920213864184005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP1,Inositol polyphosphate 1-phosphatase,36331,-0.00345338136041299,0.0345224030050192,-0.0711172912502506,0.0642105285294246,0.920320894398529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP1,Neuropilin-1,36418,-0.00175809335146083,0.0176335571188001,-0.0363198653043091,0.0328036786013875,0.920584019604354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAG,Myelin-associated glycoprotein,35275,-0.00291792247646169,0.0298059504548292,-0.061337585367927,0.0555017404150036,0.922017059714974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1C4,Aldo-keto reductase family 1 member C4,36249,0.00323170699336663,0.0336343125323807,-0.0626915455700995,0.0691549595568327,0.923456877957131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F7,Coagulation factor VII,36400,-0.00187739704440987,0.0196145436596704,-0.0403219026173639,0.0365671085285442,0.92374995333799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",35281,0.00261764181981249,0.0275259210752478,-0.0513331634876731,0.0565684471272981,0.924240642749492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,35239,0.00333532047201404,0.0351107695622129,-0.0654817878699232,0.0721524288139513,0.924322559631935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDK,Midkine,36372,-0.00309344636388045,0.0326732516545104,-0.0671330196067209,0.06094612687896,0.924573035213917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,35212,-0.00185847746253903,0.0201564663176744,-0.0413651514451808,0.0376481965201027,0.926540186198066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDA1,DET1- and DDB1-associated protein 1,35214,-0.0023428061423614,0.0254620687572736,-0.0522484609066177,0.0475628486218949,0.926691870513751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APP,Amyloid-beta precursor protein,36373,-0.00384190301791085,0.0421653854873956,-0.0864860585732061,0.0788022525373844,0.927403682154635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREH,Trehalase,35438,0.00423298896326238,0.0465352540017397,-0.0869761088801474,0.0954420868066722,0.927524863344561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L2,Seizure 6-like protein 2,36331,0.00139112853712728,0.0152957708715244,-0.0285885823710606,0.0313708394453152,0.92753600655272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OBP2B,Odorant-binding protein 2b,36268,0.00354352073169878,0.0392759649703107,-0.0734373706101102,0.0805244120735077,0.928114072245509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,36428,0.00266083259980681,0.0295179533959692,-0.0551943560562929,0.0605160212559065,0.928176189870157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD46,Membrane cofactor protein,36340,-0.0016439687799905,0.0183011823542358,-0.0375142861942927,0.0342263486343117,0.928425973140802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP7,GTPase IMAP family member 7,35312,0.00187231710216105,0.0208777056751962,-0.0390479860212234,0.0427926202255455,0.928544275480102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",35239,-0.00196577592693261,0.022138173792778,-0.0453565965607775,0.0414250447069122,0.929247170326154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMP,Cartilage oligomeric matrix protein,36311,0.00190515216382692,0.021550317539812,-0.0403334702142046,0.0441437745418585,0.929557409690678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA6,Integrin alpha-6,36352,0.00290889392572068,0.0330313702012651,-0.0618325916687589,0.0676503795202003,0.929827807153719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPVL,Probable serine carboxypeptidase CPVL,36419,-0.00228140403989942,0.0260304715033348,-0.0533011281864357,0.0487383201066368,0.930162382476561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH1,Cadherin-1,36137,0.00214539348860907,0.0249065446747683,-0.0466714340739368,0.0509622210511549,0.931359406115296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS37A,Vacuolar protein sorting-associated protein 37A,36331,0.00436261069420306,0.0508291377334741,-0.0952624992634062,0.103987720651812,0.931604813115449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB9,Serpin B9,36297,0.00180528779667063,0.0211399525674163,-0.0396290192354653,0.0432395948288065,0.931948212488251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TINAGL1,Tubulointerstitial nephritis antigen-like,36331,-0.00119525403386586,0.0141661425499499,-0.0289608934317676,0.0265703853640359,0.932761449376783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMP1,Dentin matrix acidic phosphoprotein 1,35281,-0.00319051078316438,0.0379209614328279,-0.077515595191507,0.0711345736251782,0.932951220570728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN15,Tetraspanin-15,35214,-0.00260747028451547,0.0310164174351728,-0.0633996484574542,0.0581847078884233,0.933005620891854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDK2,Protein sidekick-2,35312,0.00205702726390838,0.0245647735913664,-0.0460899289751698,0.0502039835029865,0.933266763024363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF174,Zinc finger protein 174,35239,-0.00194223890375593,0.0232632784847644,-0.0475382647338942,0.0436537869263823,0.933465110490073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXOSC10,Exosome component 10,35214,-0.00300513998126923,0.0361601910722419,-0.0738791144828634,0.067868834520325,0.933769773147141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP7,Retinoid-binding protein 7,35402,0.00325197001343975,0.0393388155184875,-0.0738521084027958,0.0803560484296753,0.934120038379908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RN,Interleukin-1 receptor antagonist protein,36361,0.00291113779099777,0.0352511634480675,-0.0661811425672146,0.0720034181492101,0.934185629239227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35417,-0.00123062789054077,0.0153387240272986,-0.031294526984046,0.0288332712029644,0.936056803475007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACSL1,Long-chain-fatty-acid--CoA ligase 1,35214,0.00186830581290821,0.0237461430914,-0.0446741346462358,0.0484107462720522,0.937291132977866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35438,0.00704978902916496,0.0901965717052461,-0.169735491513117,0.183835069571447,0.937703064127012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRL,Chymotrypsin-like protease CTRL-1,35416,-0.0033722744117148,0.0434009063394025,-0.0884380508369437,0.0816935020135141,0.938068752856948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDF1,Endothelial differentiation-related factor 1,35417,-0.00342122140341739,0.0441874941844594,-0.0900287100049578,0.083186267198123,0.938287858473136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX8,Syntaxin-8,36352,-0.00237954158282291,0.0309590346498344,-0.0630592494964983,0.0583001663308524,0.938736291384949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,35275,0.00156623817437296,0.020674166204313,-0.0389551275860805,0.0420876039348265,0.939613942770604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP15,Matrix metalloproteinase-15,35420,0.0023249259302782,0.0312728436330124,-0.0589698475904262,0.0636196994509826,0.940739624116136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,35239,-0.00372112486085011,0.0506270525349465,-0.102950147829345,0.095507898107645,0.941410102223485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,35214,0.00255529332662112,0.0348010707164599,-0.0656548052776402,0.0707653919308825,0.941469798600445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOT1,"Aspartate aminotransferase, cytoplasmic",35438,-0.00198001467040875,0.0269889626761682,-0.0548783815156984,0.050918352174881,0.941518919897333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMOD4,Tropomodulin-4,35206,-0.00185880632631552,0.0254118147536355,-0.051665963243441,0.04794835059081,0.941691314268264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR5,Complement factor H-related protein 5,35334,-0.0018919884897345,0.0258697197577157,-0.0525966392148572,0.0488126622353882,0.941700871460991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35448,0.000927407578324536,0.0127043676744066,-0.0239731530635124,0.0258279682201615,0.941809157358997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAP18,Histone deacetylase complex subunit SAP18,35321,-0.00334921112653328,0.0461946489373002,-0.0938907230436416,0.087192300790575,0.942204665171398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBB,Inhibin beta B chain,35312,-0.00250296488317868,0.0349548855799735,-0.0710145406199268,0.0660086108535695,0.94291813919709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX4,Probable ATP-dependent RNA helicase DDX4,35239,0.00240856220734512,0.0337324968672391,-0.0637071316524436,0.0685242560671338,0.943080310498859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",35239,0.00194820723131913,0.027743218875772,-0.052428501765194,0.0563249162278322,0.944018629499252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBIN,Erbin,36331,-0.00455505094971542,0.065111047000412,-0.132172703070523,0.123062601171092,0.944228898175702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID1,Nidogen-1,36384,0.00170858763759056,0.0244496807327963,-0.0462127865986902,0.0496299618738713,0.944289684609988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD4,T-cell surface glycoprotein CD4,36338,0.00133436616656368,0.0192326024210181,-0.0363615345786318,0.0390302669117591,0.944688750250945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN3,Perilipin-3,36360,-0.00187684485258076,0.0271471831366207,-0.0550853238003573,0.0513316340951958,0.94488337683584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNLZ,DNL-type zinc finger protein,35212,-0.00386172320389095,0.0568182420433763,-0.115225477608909,0.107502031201127,0.945814753612369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA4,Annexin A4,36327,0.00309365081759354,0.0458197391816369,-0.0867130379784148,0.0929003396136019,0.946171335176819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF12,Fibroblast growth factor 12,35239,-0.00202603644036688,0.0300839402813275,-0.0609905593917688,0.0569384865110351,0.946308394603244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA11,Annexin A11,36344,0.00285774540159494,0.0426553193087689,-0.0807466804435922,0.086462171246782,0.946586581083747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUK1,Guanylate kinase,35214,-0.00161151329223331,0.0240582273465782,-0.0487656388915265,0.0455426123070599,0.946596764697206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLTA,Clathrin light chain A,36249,-0.00200483012170011,0.0302615102927498,-0.0613173902954896,0.0573077300520894,0.947180533890835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB2,Dynein regulatory complex protein 8,35321,0.00147800398817495,0.0223127097970429,-0.0422549072140291,0.045210915190379,0.947188552431297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB1,Pleckstrin homology-like domain family B member 1,35402,-0.0021934178883845,0.0331794239818611,-0.0672250888928323,0.0628382531160633,0.947294149716155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC2,SPARC-related modular calcium-binding protein 2,36403,-0.00163020309443412,0.0247407232420347,-0.0501220206488222,0.0468616144599539,0.94746604373123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,36360,-0.00350947775796725,0.0532932462974816,-0.107964240501031,0.100945284985097,0.947497330130707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB103A_DEFB103B,Beta-defensin 103,35186,-0.0016432355801987,0.0257299858375033,-0.0520740078217051,0.0487875366613077,0.949080160013441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGN,Mimecan,36382,0.00177065440346164,0.0278067100683862,-0.0527304973305753,0.0562718061374986,0.949229002643381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLIF,Cobalamin binding intrinsic factor,36350,-0.00326551343823504,0.0513649251544429,-0.103940766740943,0.097409739864473,0.949310595279786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TF,Serotransferrin,35448,-0.000865559179836663,0.0137519648289182,-0.0278194102445164,0.0260882918848431,0.949815685211601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP6,Platelet glycoprotein VI,36367,-0.00349393329265475,0.0556748760872252,-0.112616690423616,0.105628823838307,0.949962541235224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGREF1,Cell growth regulator with EF hand domain protein 1,36360,0.00172775835599664,0.0276956426051683,-0.0525557011501333,0.0560112178621266,0.950258966252924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAX,Apoptosis regulator BAX,36182,0.0034925503959948,0.0560010312352828,-0.10626947082516,0.113254571617149,0.950273294976514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,36331,-0.00182579114872508,0.0294678316664588,-0.0595827412149844,0.0559311589175342,0.950597385916754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP6,Guanylate-binding protein 6,35214,-0.00181241133178968,0.0293167673950641,-0.0592732754261153,0.0556484527625359,0.95070690372918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13,Interleukin-13,36227,-0.00193934626185685,0.031493313219663,-0.0636662401723964,0.0597875476486827,0.950899356790465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B3,Testosterone 17-beta-dehydrogenase 3,35214,0.00193486791437259,0.0315259769754238,-0.059856046957458,0.0637257827862032,0.95106358253475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIE1,Tyrosine-protein kinase receptor Tie-1,36446,0.00158986897599431,0.0259359860854962,-0.0492446637515783,0.0524244017035669,0.951122194075973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK7,Proprotein convertase subtilisin/kexin type 7,35391,-0.00171835277040706,0.0281201359086807,-0.0568338191514213,0.0533971136106072,0.951275522419223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35416,-0.00325556314766031,0.0536137189733755,-0.108338452335476,0.101827326040156,0.951582101715756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRN,"Attractin, Isoform 2",35448,0.000646002509517373,0.0107413082474714,-0.0204069616555265,0.0216989666745612,0.952044553733256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB3,Plexin-B3,36338,0.00179020944579205,0.0301338599875008,-0.0572721561297094,0.0608525750212935,0.952628351148232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH15,Cadherin-15,36421,0.00227589804723303,0.0392844947104733,-0.0747217115852946,0.0792735076797606,0.953803002291577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIP2,CAP-Gly domain-containing linker protein 2,36352,0.00415598108780471,0.0718587682827417,-0.136687204746369,0.144999166921978,0.953881349262655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC9,Thioredoxin domain-containing protein 9,35416,0.00190226561270771,0.0333631003485656,-0.0634894110704808,0.0672939422958963,0.954533442895348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB1,Heat shock protein beta-1,36251,0.0025021435831099,0.0439682190312979,-0.0836755657182339,0.0886798528844537,0.954620089518166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAPGEF2,Rap guanine nucleotide exchange factor 2,35321,-0.00186545510379828,0.0329679287454621,-0.066482595444904,0.0627516852373074,0.954878477915851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,35239,0.00121440108860694,0.0216602095112833,-0.0412396095535083,0.0436684117307222,0.955291090309661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARP1,Poly [ADP-ribose] polymerase 1,36352,-0.00210754912312069,0.0383791707678395,-0.0773307238280862,0.0731156255818448,0.956208607617996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",36331,-0.00332393676224566,0.0615912868204196,-0.124042858930268,0.117394985405777,0.956962451932893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1,Methionine aminopeptidase 1,36191,-0.000985435698112245,0.018414682282783,-0.0370782129723669,0.0351073415761424,0.957324233209876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYY,Peptide YY,35214,-0.00343810687957253,0.0650193447061012,-0.130876022503531,0.123999808744386,0.957830696642827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LELP1,Late cornified envelope-like proline-rich protein 1,35212,0.00239155643797643,0.0459395133662369,-0.0876498897598479,0.0924330026358008,0.958483560423479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP4,Secreted frizzled-related protein 4,35312,0.00132956187420083,0.0255466176631064,-0.0487418087454878,0.0514009324938895,0.958494905637215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G10,Group 10 secretory phospholipase A2,36297,-0.00193623742450088,0.037311931072524,-0.0750676223266479,0.0711951474776461,0.958615210758438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G4A,Cytosolic phospholipase A2,36403,-0.00277364584544569,0.0555790862717725,-0.11170865493812,0.106161363247228,0.960199883369316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMA,Repulsive guidance molecule A,36428,0.00100722127847544,0.0202205321001593,-0.0386250216378367,0.0406394641947876,0.960273731511181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,35281,-0.00115001411356559,0.0232470203825003,-0.0467141740632662,0.0444141458361351,0.960546915463914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT4,Vascular endothelial growth factor receptor 3,36397,0.000998775618114441,0.0211548440883599,-0.040464718795071,0.0424622700312999,0.962345078201166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRA,Platelet-derived growth factor receptor alpha,36360,-0.000865742589845485,0.0184642559515053,-0.037055684254796,0.035324199075105,0.962604206362853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPI,Intestinal-type alkaline phosphatase,35239,-0.0036239032779846,0.0777674136998223,-0.156048034129636,0.148800227573667,0.962834167816886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA11,Integrin alpha-11,36352,-0.00099032947192062,0.0218647341976186,-0.0438452084992531,0.0418645495554119,0.963874663416125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS8,Galectin-8,36428,-0.00170633304495076,0.0379379155835137,-0.0760646475886376,0.072651981498736,0.964126895445409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUCL3,Mucin-like protein 3,35206,-0.00120859291301635,0.0270032898346722,-0.0541350409889738,0.0517178551629411,0.964302289315947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPB1,Beta-ureidopropionase,35420,-0.00253686537199799,0.0568519047517261,-0.113966598685381,0.108892867941385,0.964409761783451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM132A,Transmembrane protein 132A,35281,-0.00171553652510698,0.0391167873288279,-0.0783844396896097,0.0749533666393957,0.96502000138096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA1,Apolipoprotein A-I,35448,0.000774870951045612,0.0176836158452918,-0.0338850161057263,0.0354347580078175,0.965050414818113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YY1,Transcriptional repressor protein YY1,35239,-0.0007756256861577,0.0179983140760226,-0.0360523212751619,0.0345010699028465,0.965627744698267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP1,Interstitial collagenase,36121,-0.00252944950862749,0.0594335693350418,-0.119019245405309,0.113960346388054,0.966054088043157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR1,Interferon gamma receptor 1,36403,0.000577905052588678,0.0137868447066156,-0.0264443105723779,0.0276001206775552,0.966565916221508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF1,Wiskott-Aldrich syndrome protein family member 1,36249,-0.00243327271961319,0.0596494078160228,-0.119346112039018,0.114479566599791,0.967462148701177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ING1,Inhibitor of growth protein 1,36184,-0.00124863445921112,0.0307298795843423,-0.061479198444522,0.0589819295260998,0.9675899665907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBC,Inhibin beta C chain,36382,-0.00103970341901163,0.026507890168915,-0.0529951681500851,0.0509157613120618,0.968714153563853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREB3,Cyclic AMP-responsive element-binding protein 3,35206,0.00134167821390972,0.0354441307562062,-0.0681288180682545,0.070812174496074,0.969805884116189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA4,Apolipoprotein A-IV,35448,0.000860248846664593,0.0227304406676966,-0.0436914148620208,0.04541191255535,0.969811935802933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM,Paralemmin-1,35361,-0.000753955987344561,0.0202115468348306,-0.0403685877836126,0.0388606758089234,0.970244437223165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,36161,-0.00201586636446957,0.0549868824143896,-0.109790155896673,0.105758423167734,0.970756467648544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,35239,-0.000721514218187472,0.0198085633859162,-0.0395462984545832,0.0381032700182083,0.9709451943185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID2,Nidogen-2,36382,0.00170754350356462,0.0473143166494163,-0.0910285171292913,0.0944436041364205,0.971212106795151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TUBB3,Tubulin beta-3 chain,35212,0.000605636265773481,0.0172162408490817,-0.0331381957984266,0.0343494683299736,0.971938816596277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCK2,Cytoplasmic protein NCK2,36403,0.00234478478265435,0.0672028883049865,-0.129372876295119,0.134062445860428,0.972167518706011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF2,Growth/differentiation factor 2,36360,0.000789118945310011,0.0227364667525267,-0.0437743558896424,0.0453525937802624,0.972314191669781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RYR1,Ryanodine receptor 1,35214,-0.000692967242059554,0.0213095174287202,-0.0424596214023512,0.0410736869182321,0.974059128348426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3,Receptor-type tyrosine-protein kinase FLT3,36225,-0.000624412478729055,0.0196511620055282,-0.0391406900095643,0.0378918650521061,0.974652515193355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN1,CCN family member 1,36314,-0.00150412658223613,0.0476963778923691,-0.0949890272512796,0.0919807740868074,0.974843407733174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT1A1,Sulfotransferase 1A1,36428,-0.00252579050444945,0.0814440106941158,-0.162156051464916,0.157104470456018,0.975260346912535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SV2A,Synaptic vesicle glycoprotein 2A,35275,0.0012432150459751,0.0403544404454986,-0.0778514882272021,0.0803379183191523,0.975424156660263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDRKH,Tudor and KH domain-containing protein,36191,0.00163617059369834,0.0534858060971021,-0.103196009356622,0.106468350544019,0.975596796513749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",36352,-0.00185789442437724,0.0613231072470544,-0.122051184628604,0.118335395779849,0.975831186666741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL2,Chordin-like protein 2,36360,-0.000918433419226094,0.0305090296097308,-0.0607161314542984,0.0588792646158462,0.975985221037703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB6,Integrin beta-6,36227,0.00059576099425154,0.0200995067671584,-0.0387992722693789,0.039990794257882,0.976354544132535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJAP1,Tight junction-associated protein 1,36397,0.00148813525052071,0.0526126349185766,-0.101632629189889,0.104608899690931,0.977435826675651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,35214,0.000712142747700174,0.0256544414855462,-0.0495705625639703,0.0509948480593707,0.977855252334166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BEX3,Protein BEX3,35206,0.000805484819281486,0.0290207395099771,-0.0560751646202736,0.0576861342588366,0.977858088050972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD10,Frizzled-10,35275,0.00106711764977906,0.0386572002615533,-0.0747009948628655,0.0768352301624236,0.977978395934726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",36314,-0.00135524225165037,0.0494446561785653,-0.0982667683616384,0.0955562838583376,0.978134067630909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP2,Caspase-2,36352,-0.00114331570825733,0.043466580944754,-0.0863378143599751,0.0840511829434605,0.97901613420544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPI,Mannose-6-phosphate isomerase,36331,-0.00140119620616894,0.0539144488314878,-0.107073515915885,0.104271123503547,0.979266637687409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORC3,MORC family CW-type zinc finger protein 3,35416,-0.000452802217479758,0.0177235886623435,-0.0351910359956731,0.0342854315607136,0.979618682951818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXDNL,Peroxidasin-like protein,35391,0.000845752053915112,0.0338742008369423,-0.0655476815864918,0.067239185694322,0.980081739061013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCG22,Protein PBMUCL2,35214,0.000891101232704472,0.0365266763786969,-0.0707011844695415,0.0724833869349504,0.98053762532419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME3,Nucleoside diphosphate kinase 3,36381,-0.000377030513374726,0.0156398719821566,-0.0310311795984016,0.0302771185716522,0.980767922918177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF10,Multiple epidermal growth factor-like domains protein 10,36368,0.000578483698593818,0.0240631058087857,-0.0465852036866261,0.0477421710838137,0.980821151207796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK2,Docking protein 2,36360,-0.0018135467102294,0.0774139834361691,-0.153544954245121,0.149917860824662,0.981310636413679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK4,Serine/threonine-protein kinase 4,36360,-0.0012609718650759,0.0550086851127409,-0.109077994686048,0.106556050955896,0.981712219345019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA1,Interleukin-13 receptor subunit alpha-1,36302,-0.00031216134944691,0.0138533528229653,-0.0274647328824589,0.026840410183565,0.98202320503942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKBKG,NF-kappa-B essential modulator,36352,-0.00129326968324798,0.0576378388403141,-0.114263433810264,0.111676894443768,0.98209930649606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FTCD,Formimidoyltransferase-cyclodeaminase,35402,-0.00118477393842943,0.053424742888257,-0.105897269999413,0.103527722122554,0.982307874076734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA3,Annexin A3,36419,-0.000976034706553679,0.0444565986046427,-0.0881109679716533,0.086158898558546,0.982484635868008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1B,T-cell leukemia/lymphoma protein 1B,36249,-0.00109092714699066,0.0519400018986206,-0.102893330868287,0.100711476574306,0.983243376005203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP23,Synaptosomal-associated protein 23,36360,-0.00115932646094865,0.0553323984587355,-0.10961082744007,0.107292174518173,0.98328449951301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLASP1,CLIP-associating protein 1,35206,0.000935077211225214,0.0468893810525836,-0.0909681096518387,0.0928382640742891,0.984090146338202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOB,Apolipoprotein B-100,35428,0.000280930355321298,0.0142374438531498,-0.0276244595968524,0.028186320307495,0.984257956658766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTR,Methionine synthase,35214,-0.000784396197785409,0.0407517224655931,-0.0806577722303478,0.079088979834777,0.984643766223292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GC,Vitamin D-binding protein,35448,0.000312817183167395,0.0163119771412789,-0.0316586580137393,0.0322842923800741,0.984700400073686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPS,Colipase,36367,-0.000862442817445962,0.0450536505729813,-0.0891675979404894,0.0874427123055975,0.984727901319855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA5,Integrin alpha-5,36382,0.000305187059590723,0.0160281639288244,-0.0311100142409052,0.0317203883600866,0.984809185833192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMARCA2,Probable global transcription activator SNF2L2,36191,-0.000867563473838283,0.0458053578968271,-0.0906460649516193,0.0889109380039428,0.984889335831043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO2,Roundabout homolog 2,36428,0.000275209056695594,0.0148001483551067,-0.0287330817193136,0.0292834998327048,0.985164688326305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL1,Fc receptor-like protein 1,36360,0.00053493156876045,0.0294621490194079,-0.0572108805092789,0.0582807436467998,0.985514454576477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL3,C-X-C motif chemokine 3,36372,-0.00107949010450035,0.0608799260394366,-0.120404145141796,0.118245164932795,0.985853574233216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRF5,Adhesion G protein-coupled receptor F5,35420,0.000307343639083681,0.0179719401025127,-0.0349176589618412,0.0355323462400085,0.986356345351954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MASP1,Mannan-binding lectin serine protease 1,36290,0.00024856964779792,0.0148195056979395,-0.0287976615201635,0.0292948008157594,0.986618069399607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD9,COMM domain-containing protein 9,35391,0.000401653461656895,0.0241371859769194,-0.0469072310531051,0.0477105379764189,0.986723996052475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRELP,Prolargin,36368,-0.000252462388392682,0.0152454914524092,-0.0301336256351147,0.0296287008583293,0.986788250423424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,35281,0.000214824175917137,0.0131691550078995,-0.025596719639566,0.0260263679914003,0.986985478494147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",35212,0.000555282653692605,0.0342344587455971,-0.0665442564876777,0.0676548217950629,0.987059423778511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK1D,Casein kinase I isoform delta,35239,-0.000612199981680995,0.0401824651203693,-0.0793698316176048,0.0781454316542428,0.987844802142899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC5,Glypican-5,36297,-0.000540712857386836,0.0360060496976531,-0.0711125702647869,0.0700311445500132,0.988018817864684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEXIM1,Protein HEXIM1,36352,0.000762784661713998,0.0516421848229107,-0.100455897591191,0.101981466914619,0.988215627998173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB39B,Ras-related protein Rab-39B,35214,-0.000843575803708945,0.057221149379527,-0.112997028587582,0.111309876980164,0.988238198938431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM2,Myomesin-2,35214,-0.000394085485021076,0.0312496092959935,-0.0616433197051683,0.0608551487351261,0.989938647605693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCLS1,Hematopoietic lineage cell-specific protein,36442,0.00042250873519903,0.0349841734454129,-0.0681464712178103,0.0689914886882083,0.990364403669355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHDC3L,KH domain-containing protein 3,35206,-0.000390975849364224,0.0416880836836031,-0.0820996198692264,0.0813176681704979,0.992517380968699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG2,Desmoglein-2,36382,0.000162446362811939,0.0173533856228927,-0.0338501894580577,0.0341750821836816,0.992531310800697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,36331,0.000240050960469774,0.0272969899303504,-0.0532620493030171,0.0537421512239566,0.992983703416467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35321,0.000275953100093393,0.0314689279685147,-0.0614031457181954,0.0619550519183822,0.99300367294435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDC,Nuclear migration protein nudC,36442,-0.000331049064650179,0.0395977766437131,-0.0779426912863279,0.0772805931570276,0.993329758080352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEPR,Leptin receptor,36360,0.000118430707265826,0.0199672777706475,-0.0390174337232033,0.0392542951377349,0.995267748398841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,35214,0.000122424533440051,0.0214816211276329,-0.0419815528767205,0.0422264019436006,0.995453040565751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FN1,Fibronectin,35448,7.58404319555158e-05,0.0171176586483161,-0.033474770518744,0.033626451382655,0.996465095249846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNLY,Granulysin,36382,0.00012984813328048,0.0341926889749057,-0.0668878222575348,0.0671475185240957,0.996970113449425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL9,Interleukin-9,35321,0.00010018862703828,0.0347730959967774,-0.0680550795266454,0.068255456780722,0.997701223198754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAS,Tumor necrosis factor receptor superfamily member 6,36428,-5.55675484163922e-05,0.0219460712151579,-0.0430698671301259,0.0429587320332932,0.997979824773634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,36352,-0.000132169145250314,0.0632889960496946,-0.124178601402652,0.123914263112151,0.99833380259991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS2,"Nitric oxide synthase, inducible",35214,3.38859492415807e-05,0.0249499511405238,-0.0488680182861851,0.0489357901846682,0.998916392882542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB1,Leukocyte elastase inhibitor,36358,3.98346210992344e-05,0.0571512259967197,-0.111976568332471,0.11205623757467,0.999443890889218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPE4,NXPE family member 4,35214,-4.41652236526708e-06,0.0208469922200211,-0.0408645212736066,0.0408556882288761,0.999830971844434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY2,Protein canopy homolog 2,36249,-5.76049241656001e-06,0.0390943635515806,-0.0766307130535146,0.0766191920686815,0.999882437142853
